6-K
MANULIFE FINANCIAL CORP (MFC)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OFFOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August, 2023
Commission File Number: 1-14942
MANULIFE FINANCIAL CORPORATION
(Translation of registrant’s name into English)
200 BloorStreet East
North Tower 10
Toronto, Ontario, Canada M4W 1E5
(416) 926-3000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
The registrant’s Management’s Discussion and Analysis and Unaudited Interim Consolidated Financial Statements for the quarter ended March 31, 2023 included in the registrant’s 2023 First Quarter Report to Shareholders filed with this Form 6-K as Exhibit 99.1, are incorporated by reference in the registration statements filed with the Securities and Exchange Commission by the registrant on Form S-8 (Registration Nos. 333-12610, 333-13072, 333-114951, 333-129430, 333-157326, 333-211366, 333-272672), on Form F-3 (Registration No. 333-159176) and on Form F-10 (Registration No. 333-259543). Except for the foregoing, no other document or portion of a document filed with this Form 6-K is incorporated by reference in the above registration statements.
DOCUMENTS FILED AS PART OF THIS FORM 6-K
The following documents, filed as exhibits to this Form 6-K, are incorporated by reference as part of this Form 6-K:
| Exhibit | Description of Exhibit |
|---|---|
| 99.1 | Second Quarter Report to Shareholders |
| 99.2<br><br> <br>99.3 | Certification Chief Executive Officer<br> <br><br><br><br>Certification Chief Financial Officer |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MANULIFE FINANCIAL CORPORATION | |
|---|---|
| By: | /s/ Kay Song |
| Name: | Kay Song |
| Title: | Assistant Corporate Secretary |
Date: August 9, 2023
EX-99.1
Table of Contents
Manulife Second Quarter Report to Shareholders three and six months ended June 30, 2023 Manulife Financial Corporation
Table of Contents
Manulife reports strong topline results in 2Q23 with APE sales up 12%, NBV up 10%, new business CSM of $592 million up15% and Global Wealth and Asset Management net inflows of $2.2 billion. Net income attributed to shareholders was $1.0 billion in 2Q23 and core earnings were $1.6 billion with strong EPS and core EPS growth
Today, Manulife announced its second quarter of 2023 (“2Q23”) results. Key highlights include:
| • | Net income attributed to shareholders of $1.0 billion in 2Q23, up $0.9 billion compared with transitional net income<br>attributed to shareholders^1^ for the second quarter of 2022 (“2Q22”), and up $3.1 billion compared with 2Q22 net loss attributed to shareholders |
|---|---|
| • | Core earnings^1^ of $1.6 billion in 2Q23, up 4% on a constant exchange<br>rate basis^2^ from 2Q22 |
| --- | --- |
| • | Core EPS^3^ of $0.83 in 2Q23, up 6%^2^ compared with 2Q22, and diluted earnings per common share (“EPS”) of $0.50 in 2Q23, up $0.44 compared with transitional EPS^3^ of $0.06 in<br>2Q22, and up $1.63 compared with EPS of -$1.13 in 2Q22 |
| --- | --- |
| • | Core ROE^3^ of 15.5% and ROE of 9.3% in 2Q23 |
| --- | --- |
| • | APE sales^4^ of $1.6 billion in 2Q23, up 12%^4^ from 2Q22 |
| --- | --- |
| • | NBV^4^ of $585 million in 2Q23, up 10% from 2Q22 |
| --- | --- |
| • | New business contractual service margin (“CSM”)^5^ of $592<br>million in 2Q23, up 15%^2^ from 2Q22 |
| --- | --- |
| • | CSM balance net of NCI of $17.4 billion and post-tax CSM net of NCI^1^<br>of $14.9 billion as at June 30, 2023, an increase of $140 million and $218 million from December 31, 2022, respectively |
| --- | --- |
| • | Global Wealth and Asset Management (“Global WAM”) net<br>inflows^4^ of $2.2 billion in 2Q23, compared with net inflows of $1.7 billion in 2Q22 |
| --- | --- |
| • | LICAT ratio^6^ of 136% |
| --- | --- |
| • | Purchased for cancellation 0.9% of common shares outstanding, or approximately 17.3 million common shares, for $443<br>million in 2Q23 |
| --- | --- |
| • | Adjusted book value per common share^3^ of $29.42 and book value per<br>common share of $21.30 as of June 30, 2023, an increase of $1.36 and $0.68 from June 30, 2022, respectively |
| --- | --- |
“We are pleased to report strong topline performance during the second quarter including double-digit year-over-year growth in new business metrics^7^ from our global insurance business, particularly with new business CSM growing at our medium-term target of 15%,” said Roy Gori, Manulife President & Chief Executive Officer. “Our Asia business generated 26% growth in both APE sales and new business CSM, as we capitalize on the recovery across the region, mainly in Hong Kong. In addition, Global WAM generated net inflows of $2.2 billion while core EBITDA margin improved by 2.2 percentage points quarter-over-quarter to 24.6%^3^. I am encouraged by the momentum we are driving across our global business and the future earnings we expect that these sales will generate.”
“We delivered solid operating results in 2Q23, including core earnings of $1.6 billion, core ROE of 15.5% and core EPS growth of 6%,” Mr. Gori continued. “Our net income of $1.0 billion increased from the prior year despite the impact of downward pressure on real estate valuations.”
| ^1^ | Transitional net income attributed to shareholders, core earnings and post-tax CSM net of NCI (“post-tax CSM”)<br>are non-GAAP financial measures. For more information on non-GAAP and other financial measures, see “Non-GAAP and other financial measures” in our 2Q23 MD&A. |
|---|---|
| ^2^ | Percentage growth / declines in core earnings, diluted core earnings per common share (“core EPS”) and new<br>business CSM stated on a constant exchange rate basis are non-GAAP ratios. |
| --- | --- |
| ^3^ | Core EPS, transitional EPS, core return on common shareholders’ equity (“Core ROE”), adjusted book value<br>per common share, and core EBITDA margin are non-GAAP ratios. |
| --- | --- |
| ^4^ | For more information on annualized premium equivalent (“APE”) sales, new business value (“NBV”), and<br>net flows, see “Non-GAAP and other financial measures” in our 2Q23 MD&A. Percentage growth / declines in NBV and APE sales are stated on a constant exchange rate basis. |
| --- | --- |
| ^5^ | New business CSM is net of non-controlling interests (“NCI”). |
| --- | --- |
| ^6^ | Life Insurance Capital Adequacy Test (“LICAT”) ratio of The Manufacturers Life Insurance Company<br>(“MLI”). LICAT ratio is disclosed under the Office of the Superintendent of Financial Institutions Canada’s (“OSFI’s”) Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.<br> |
| --- | --- |
| ^7^ | Includes APE sales, NBV and new business CSM. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 1 |
| --- | --- |
Table of Contents
Colin Simpson, Chief Financial Officer, said, “Our capital position is strong with a LICAT ratio of 136%. We have repurchased 1.8% of our common shares so far this year^1^ which, along with an increase in core earnings, has resulted in strong second quarter core ROE. We have an enviable portfolio of businesses, which provide us with a strategic advantage and position us well for success, as evidenced by topline growth in 2Q23. We look forward to CSM growth translating into stable and growing insurance earnings.”
BUSINESS HIGHLIGHTS:
To continue helping our customers live longer,healthier, better lives, we:
| • | launched enhanced healthcare coverage in Hong Kong to better address the growing demand for health and protection services.<br>Customers can now use our expanded hospital network covering over 3,000 hospitals across mainland China. We are the first life insurer in the market to cover all Grade III public hospitals; |
|---|---|
| • | continued to expand our behavioural insurance program in Canada by making Manulife Vitality available on new<br>Manulife Par individual insurance policies; and |
| --- | --- |
| • | deepened our collaboration with ŌURA to offer John Hancock Vitality members discounts on ŌURA rings and the<br>ability to earn points for healthy sleep habits and mindfulness. |
| --- | --- |
We remain committed to our Environmental, Social and Governance(“ESG”) strategy:
| • | We strengthened our commitment to reducing emissions by disclosing science-based^2^ targets, including an increased ambition to reduce absolute scope 1 and 2 emissions 40% by 2035, and a combination of sector-specific and asset-class specific interim targets to reduce the General<br>Account’s financed emissions as outlined in our 2022 ESG Report published in May 2023.^3^ Currently, Manulife’s owned timberland and agriculture properties remove more carbon from the<br>atmosphere than emitted in our operations; |
|---|---|
| • | We announced the launch of our industry-first ESG themed funds in Manulife Mandatory Provident Fund (“MPF”) in<br>Hong Kong Retirement. This makes our flagship MPF scheme the first in the MPF market to provide both sustainable equity and fixed income investment options; and |
| --- | --- |
| • | Manulife was named one of Corporate Knights’ Best 50 Corporate Citizens in Canada for the third consecutive year.<br> |
| --- | --- |
We continue to make progress on our digital journey:
| • | In Global WAM, we announced a new partnership with Envestnet in Canada Retail that will provide advisors with a<br>leading-edge portfolio management platform to deliver a better client experience and improve advisor productivity. The Envestnet platform is a market tested portfolio management solution which will give advisors access to advanced trading and<br>modelling capabilities, streamlined workflows and automated tasks, more robust and client-friendly reporting, and the ability to manage accounts in a unified structure. These benefits will enable advisors to increase their efficiency and focus on<br>their client relationships and business growth. This partnership signifies another successful step in our digital transformation journey as a leader of advice in Canada; |
|---|---|
| • | In Asia, we continued to drive utilization of connected agent profiles in Manulife Shop, our proprietary online<br>channel in the Philippines, to enable us to enhance customer experience, fulfill a wider range of customer needs, and improve agent activity and productivity. In 2Q23, this contributed to a 16% increase quarter-over-quarter in organic lead<br>submissions through the channel. We plan to roll out connected agent profiles to additional markets in the second half of 2023; |
| --- | --- |
| • | In Canada, we reduced our call transfer rates by nearly half compared with 2Q22 in our Group Benefits contact centre, by<br>leveraging Amazon AWS Connect, which contributed to a 14% improvement in the contact centre’s transactional NPS. We continue to expand the use of this technology, which enables a more holistic digital customer experience and drives operational<br>efficiency; and |
| --- | --- |
| ^1^ | As of June 30, 2023. |
| --- | --- |
| ^2^ | Targets developed in alignment with the methodology for financial institutions outlined by the Science-based Targets<br>Initiative (SBTi), in combination with Partnership for Carbon Accounting Financials (PCAF) methodologies for emissions accounting. |
| --- | --- |
| ^3^ | See “Caution regarding forward-looking statements” below. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 2 |
| --- | --- |
Table of Contents
| • | In the U.S., we received recognition from LIBRA Insurance Partners, the largest independently owned life insurance<br>marketing organization in the U.S.^1^, as one of the carriers who provide a best-in-class experience on an electronic platform for permanent life insurance products. We also eliminated over<br>3 million pieces of paper by completing our first e-delivery of life insurance policy prospectuses. |
|---|---|
| ^1^ | Based on gross annual production according to Paradigm Partners International, a third-party research firm specializing in<br>the insurance landscape. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 3 |
| --- | --- |
Table of Contents
FINANCIAL HIGHLIGHTS:
| 2Q22 | 2022 | ||||||
| ( millions, unless otherwise stated) | Transitional | Transitional | |||||
| Profitability: | |||||||
| Net income (loss) attributed to<br>shareholders(1) | 1,025 | $ | 168 | 2,431 | $ | 1,493 | |
| Return on common shareholders’ equity<br>(“ROE”)(1) | 9.3% | 1.1% | 11.4% | 7.1% | |||
| Diluted earnings (loss) per common share ()(1) | 0.50 | $ | 0.06 | 1.23 | $ | 0.71 | |
| ( millions, unless otherwise stated) | 2Q22 | 2022 | |||||
| Profitability: | |||||||
| Net income (loss) attributed to shareholders | 1,025 | $ | (2,119) | 2,431 | $ | (3,339) | |
| Core earnings | 1,637 | $ | 1,526 | 3,168 | $ | 2,919 | |
| EPS () | 0.50 | $ | (1.13) | 1.23 | $ | (1.79) | |
| Core EPS () | 0.83 | $ | 0.76 | 1.63 | $ | 1.45 | |
| ROE | 9.3% | (22.4)% | 11.4% | (17.9)% | |||
| Core ROE | 15.5% | 15.1% | 15.2% | 14.5% | |||
| Expense efficiency ratio(2) | 45.1% | 43.1% | 46.1% | 44.7% | |||
| Expenditure efficiency ratio(2) | 51.9% | 50.1% | 52.9% | 51.7% | |||
| General expenses | 1,022 | $ | 884 | 2,108 | $ | 1,815 | |
| Core expenses(3) | 1,598 | $ | 1,381 | 3,203 | $ | 2,797 | |
| Core<br>expenditures(3) | 2,099 | $ | 1,835 | 4,211 | $ | 3,707 | |
| Business performance: | |||||||
| Asia APE sales | 1,181 | $ | 900 | 2,354 | $ | 1,987 | |
| Canada APE sales | 322 | $ | 361 | 615 | $ | 724 | |
| U.S. APE sales | 130 | $ | 147 | 264 | $ | 307 | |
| Total APE sales | 1,633 | $ | 1,408 | 3,233 | $ | 3,018 | |
| Asia new business value | 424 | $ | 393 | 796 | $ | 762 | |
| Canada new business value | 106 | $ | 82 | 198 | $ | 186 | |
| U.S. new business value | 55 | $ | 35 | 100 | $ | 76 | |
| Total new business value | 585 | $ | 510 | 1,094 | $ | 1,024 | |
| Asia new business CSM | 432 | $ | 328 | 733 | $ | 645 | |
| Canada new business CSM | 57 | $ | 47 | 103 | $ | 108 | |
| U.S. new business CSM | 103 | $ | 118 | 198 | $ | 230 | |
| Total new business CSM | 592 | $ | 493 | 1,034 | $ | 983 | |
| Asia CSM net of NCI | 9,630 | $ | 9,025 | 9,630 | $ | 9,025 | |
| Canada CSM | 3,656 | $ | 3,626 | 3,656 | $ | 3,626 | |
| U.S. CSM | 4,106 | $ | 4,026 | 4,106 | $ | 4,026 | |
| Corporate and Other CSM | 31 | $ | 34 | 31 | $ | 34 | |
| Total CSM net of NCI | 17,423 | $ | 16,711 | 17,423 | $ | 16,711 | |
| Post-tax CSM net of NCI | 14,877 | $ | 14,224 | 14,877 | $ | 14,224 | |
| Global WAM net flows ( billions) | 2.2 | $ | 1.7 | 6.6 | $ | 8.5 | |
| Global WAM gross flows ( billions)(4) | 35.2 | $ | 34.1 | 74.0 | $ | 72.5 | |
| Global WAM assets under management and administration ( billions)(3) | 819.6 | $ | 746.8 | 819.6 | $ | 746.8 | |
| Global WAM total invested assets ( billions) | 5.5 | $ | 5.7 | 5.5 | $ | 5.7 | |
| Global WAM segregated funds net assets ( billions) | 238.7 | $ | 213.3 | 238.7 | $ | 213.3 | |
| Financial strength: | |||||||
| MLI’s LICAT ratio | 136% | 137% | 136% | 137% | |||
| Financial leverage ratio(2) | 25.8% | 26.0% | 25.8% | 26.0% | |||
| Book value per common share () | 21.30 | $ | 20.62 | 21.30 | $ | 20.62 | |
| Adjusted book value per common share () | 29.42 | $ | 28.06 | 29.42 | $ | 28.06 |
All values are in US Dollars.
| ^(1)^ | 2022 results for transitional net income attributed to shareholders, transitional EPS and transitional ROE, a non-GAAP<br>ratio, are adjusted to include IFRS 9 hedge accounting and expected credit loss principles (“IFRS 9 transitional impacts”). See 2Q23 MD&A for more information. For 2023, there are no IFRS 9 transitional adjustments as ECL and hedge<br>accounting is effective January 1, 2023 and therefore the impact is included in net income attributed to shareholders. |
|---|---|
| ^(2)^ | This item is a non-GAAP ratio. |
| --- | --- |
| ^(3)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” in our 2Q23 MD&A for<br>additional information. |
| --- | --- |
| ^(4)^ | For more information on gross flows, see “Non-GAAP and other financial measures” in our 2Q23 MD&A.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 4 |
| --- | --- |
Table of Contents
PROFITABILITY:
Reported netincome attributed to shareholders of $1.0 billion in 2Q23, $0.9 billion higher than 2Q22 transitional net income attributed to shareholders, and $3.1 billion higher than 2Q22 net loss attributed to shareholders
The increase in 2Q23 net income attributed to shareholders compared with 2Q22 transitional net income attributed to shareholders was primarily driven by a smaller charge from market experience and growth in core earnings. The net charge from market experience in 2Q23 was driven by lower-than-expected returns (including fair value changes) on alternative long duration assets (“ALDA”) mainly related to real estate and energy as well as changes in foreign currency exchange rates, partially offset by higher-than-expected returns on public equity. Net income attributed to shareholders in 2Q23 increased by $3.1 billion compared with 2Q22, driven by factors mentioned above and $2.3 billion of transitional impacts due to the application of IFRS 9 hedge accounting and ECL principles (transitional impacts are geography-related and do not impact total shareholders’ equity as the corresponding offset is in other comprehensive income).
Delivered core earnings of $1.6 billion in 2Q23, an increase of 4% compared with 2Q22
The increase in core earnings compared with 2Q22 was driven by an increase in expected investment earnings related to higher investment yields and business growth, higher returns on surplus assets net of higher cost of debt financing and a smaller net charge in the provision for expected credit loss. These were partially offset by higher workforce related costs, a charge from net unfavourable insurance experience (compared with a net gain in 2Q22) and a slower CSM amortization on certain variable fee approach (“VFA”) contracts. In addition, lower core earnings in Global WAM were driven by an increase in workforce related costs and lower earnings from seed capital investments due to repatriations, partially offset by higher net fee income from increased fee spread and business mix.
BUSINESSPERFORMANCE:
Annualized premium equivalent (“APE”) sales of $1.6 billion in 2Q23, an increase of 12% compared with 2Q22
In Asia, APE sales increased 26%, driven by growth in Hong Kong and Asia Other^1^, partially offset by lower sales in Japan. In Hong Kong, APE sales doubled, reflecting strong growth in our broker and bancassurance channels, primarily driven by a return of demand from mainland Chinese visitor (“MCV”) customers following the reopening of the border between Hong Kong and mainland China since February 2023. In Japan, APE sales decreased 17%, driven by lower sales in other wealth and corporate-owned life insurance products. Asia Other APE sales increased 12%, as higher sales in mainland China through our bancassurance channel were partially offset by lower sales in Vietnam and international high net worth business^2^. In Canada, APE sales decreased 11%, driven by usual variability in the group insurance market with lower large-case sales partially offset by higher mid-size business sales, as well as lower sales of segregated fund products. In the U.S., APE sales decreased 15% due to the adverse impact of higher short-term interest rates on accumulation insurance products, particularly for our higher net worth customers. APE sales of products with the John Hancock Vitality PLUS feature represented 75% of overall U.S. sales in 2Q23, an increase from 71% in 2Q22.
New business value (“NBV”) of $585 million in 2Q23, an increase of 10% compared with 2Q22
In Asia, NBV increased 3% from 2Q22 driven by higher sales volumes partially offset by business mix. In Canada, NBV increased 29% driven by higher margins in all business lines largely due to product mix, partially offset by lower sales volumes in Annuities and Group Insurance. In the U.S., NBV increased 43% due to pricing actions, higher interest rates and product mix, partially offset by lower sales volumes.
| ^1^ | Asia Other excludes Hong Kong and Japan. |
|---|---|
| ^2^ | Effective January 1, 2023, international high net worth business was reclassified from the U.S. segment to the Asia<br>segment. Prior period comparative information has been restated to reflect the change in segment reporting. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 5 |
| --- | --- |
Table of Contents
New business CSM of $592 million in 2Q23, an increase of 15% compared with 2Q22
In Asia, new business CSM increased 26% from 2Q22 driven by higher sales volumes and model refinements, partially offset by business mix. In Canada, new business CSM increased 21% driven by product mix in Individual Insurance. Under IFRS 17, the majority of Group Insurance and affinity products are classified as premium allocation approach (“PAA”) and do not generate CSM. In the U.S., new business CSM decreased 17% consistent with lower sales volumes.
CSM net of NCI was $17,423 million as at June 30, 2023, an increase of $140 million compared withDecember 31, 2022
The $140 million increase in CSM net of NCI reflects an increase in total CSM movement of $126 million, net of a decrease in NCI of $14 million. Organic CSM movement was an increase of $468 million for the first half of 2023 driven by the impact of new insurance business and expected movements related to finance income or expenses, partially offset by amounts recognized for service provided in year-to-date earnings and a net loss from insurance experience. Inorganic CSM movement was a decrease of $342 million for the first half of 2023 driven by changes in foreign currency exchange rates, partially offset by net positive equity market experience and higher interest rates on VFA contracts. Post-tax CSM net of NCI was $14,877 million as at June 30, 2023.
Reported Global WAMnet inflows of $2.2 billion in 2Q23, compared with 2Q22 net inflows of $1.7 billion
Net inflows in Retirement were $0.7 billion in 2Q23 compared with net inflows of $1.0 billion in 2Q22, driven by higher pension plan redemptions and member withdrawals, partially offset by higher new pension plan sales and growth in member contributions. Net outflows in Retail were $0.1 billion in 2Q23 compared with net outflows of $1.9 billion in 2Q22, reflecting lower mutual fund redemption rates, partially offset by lower sales due to reduced investor demand amid continued equity market and interest rate volatility. Net inflows in Institutional Asset Management were $1.6 billion in 2Q23 compared with net inflows of $2.5 billion in 2Q22, driven by higher redemptions and the non-recurrence of a $1.9 billion equity mandate sale in 2Q22, partially offset by higher sales in mainland China from acquiring full ownership interest of Manulife Fund Management (“MFM”), and higher fixed income and timberland mandate sales.
| Manulife Financial Corporation – Second Quarter 2023 | 6 |
|---|
Table of Contents
MANAGEMENT’S DISCUSSION AND ANALYSIS
This Management’s Discussion and Analysis (“MD&A”) is current as of August 9, 2023, unless otherwise noted. This MD&A should be read in conjunction with our unaudited Interim Consolidated Financial Statements for the three and six months ended June 30, 2023 and the MD&A and audited Consolidated Financial Statements contained in our 2022 Annual Report.
For further information relating to our risk management practices and risk factors affecting the Company, see “Risk Management and Risk Factors” and “Critical Actuarial and Accounting Policies” in the MD&A in our 2022 Annual Report and the “Risk Management” note to the Consolidated Financial Statements in our most recent annual and interim reports.
In this MD&A, the terms “Company”, “Manulife”, “we” and “our” mean Manulife Financial Corporation (“MFC”) and its subsidiaries. All amounts are reported in Canadian dollars, unless otherwise indicated. Any information contained in, or otherwise accessible through, websites mentioned in this MD&A does not form a part of this document.
CONTENTS
| A. | TOTAL COMPANY PERFORMANCE |
|---|---|
| 1. | Implementation of IFRS 17 and IFRS 9 |
| 2. | Profitability |
| 3. | Business performance |
| 4. | Financial strength |
| 5. | Assets under management and administration |
| 6. | Impact of foreign currency exchange rates |
| 7. | Business highlights |
| B. | PERFORMANCE BY SEGMENT |
| 1. | Asia |
| 2. | Canada |
| 3. | U.S. |
| 4. | Global Wealth and Asset Management |
| 5. | Corporate and Other |
| C. | RISK MANAGEMENT AND RISK FACTORS UPDATE |
| --- | --- |
| 1. | Variable annuity and segregated fund guarantees |
| 2. | Caution related to sensitivities |
| 3. | Publicly traded equity performance risk |
| 4. | Interest rate and spread risk sensitivities and exposure measures |
| 5. | Alternative long-duration asset performance risk |
| 6. | Foreign exchange risk sensitivities and exposure measures |
| 7. | Credit risk exposure measures |
| 8. | Risk factors – strategic risk from changes in tax laws |
| D. | CRITICAL ACTUARIAL AND ACCOUNTING POLICIES |
| 1. | Critical actuarial and accounting policies |
| 2. | Sensitivity of earnings to changes in assumptions |
| 3. | Accounting and reporting changes |
| E. | OTHER |
| 1. | Outstanding common shares – selected information |
| 2. | Legal and regulatory proceedings |
| 3. | Non-GAAP and other financial measures |
| 4. | Caution regarding forward-looking statements |
| 5. | Quarterly financial information |
| 6. | Revenue |
| 7. | Other |
| Manulife Financial Corporation – Second Quarter 2023 | 7 |
| --- | --- |
Table of Contents
| A | TOTAL COMPANY PERFORMANCE |
|---|---|
| A1 | Implementation of IFRS 17 and IFRS 9 |
| --- | --- |
Manulife adopted IFRS 17 “Insurance Contracts” and IFRS 9 “Financial Instruments” effective for years beginning on or after January 1, 2023, to be applied retrospectively. See “Future Accounting and Reporting Changes” in the MD&A in our 2022 Annual Report (“2022 MD&A”). Our quarterly and year-to-date 2022 results have been restated in accordance with IFRS 17, including the other comprehensive income option^1^, and IFRS 9. Audited restated consolidated financial statements for the year ended December 31, 2022 will be included in our 2023 Annual Report.
The 2022 comparative results restated in this MD&A may not be fully representative of our market risk profile, as the transition of our general fund portfolio for asset-liability matching purposes under IFRS 17 and IFRS 9 was not completed until early 2023. Consequently, year-over-year variations between our 2023 results compared to the 2022 results should be viewed in this context.
In addition, our 2022 results are also not directly comparable to 2023 results because IFRS 9 hedge accounting and expected credit loss (“ECL”) principles are applied prospectively effective January 1, 2023. Accordingly, we have also presented comparative quarterly and year-to-date 2022 results as if IFRS had allowed such principles to be implemented for 2022 (the “IFRS 9 transitional impacts”). This presentation will only be reported in our MD&A’s for 2023 for certain 2022 comparative results.
These 2022 comparative results are non-GAAP and denoted as being “transitional” and include the financial measures noted below:
| • | Transitional net income (loss) attributed to shareholders; |
|---|---|
| • | Transitional net income (loss) before income taxes; |
| --- | --- |
| • | Transitional net income (loss); |
| --- | --- |
| • | Transitional net income (loss) attributed to shareholders before income taxes; |
| --- | --- |
| • | Common shareholders’ transitional net income (loss); |
| --- | --- |
| • | Transitional return on common shareholders’ equity (“Transitional ROE”); |
| --- | --- |
| • | Transitional basic earnings (loss) per common share; and |
| --- | --- |
| • | Transitional diluted earnings (loss) per common share. |
| --- | --- |
Adoption of IFRS 17 and IFRS 9 has also resulted in additional definitions and revisions to the following financial measures:
| • | New non-GAAP financial measures: post-tax contractual service margin (“post-tax CSM”); post-tax<br>contractual service margin net of non-controlling interests (“NCI”) (“post-tax CSM net of NCI”); Drivers of Earnings (“DOE”) line items for net investment result, other, income tax (expense) recovery and transitional<br>net income attributed to participating policyholders and NCI; and core DOE line items for core net insurance service result, core net investment result, other core earnings, and core income tax (expense) recovery. |
|---|---|
| • | New non-GAAP ratios: expenditure efficiency ratio with its component non-GAAP financial measures: total expenditures<br>and core expenditures (for 2022 and 2023 quarterly results only); and adjusted book value per common share. |
| --- | --- |
| • | Revised definitions of non-GAAP and other financial measures: core earnings; expense efficiency ratio with its new<br>component non-GAAP financial measures: total expenses and core expenses; consolidated capital; and financial leverage ratio. |
| --- | --- |
| ^1^ | More information about the other comprehensive income option can be found in note 2 of the Consolidated Financial<br>Statements contained in our 2022 Annual Report. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 8 |
| --- | --- |
Table of Contents
| A2 | Profitability | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Quarterly Results | YTD Results | ||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ($ millions, unless otherwise stated) | 2Q23 | 1Q23 | 2Q22<br><br><br>Transitional | 2023 | 2022<br><br><br>Transitional | ||||||
| Net income (loss) attributed to<br>shareholders^(1)^ | $ | 1,025 | $ | 1,406 | $ | 168 | $ | 2,431 | $ | 1,493 | |
| Return on common shareholders’ equity<br>(“ROE”)^(1)^ | **** | 9.3% | 13.6% | 1.1% | **** | 11.4% | 7.1% | ||||
| Diluted earnings (loss) per common share<br>($)^(1)^ | $ | 0.50 | $ | 0.73 | $ | 0.06 | $ | 1.23 | $ | 0.71 | |
| Quarterly Results | YTD Results | ||||||||||
| ($ millions, unless otherwise stated) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | ||||||
| Net income (loss) attributed to<br>shareholders^(1)^ | $ | 1,025 | $ | 1,406 | $ | (2,119) | $ | 2,431 | $ | (3,339) | |
| Core earnings^(2)^ | $ | 1,637 | $ | 1,531 | $ | 1,526 | $ | 3,168 | $ | 2,919 | |
| Diluted earnings (loss) per common share ($) | $ | 0.50 | $ | 0.73 | $ | (1.13) | $ | 1.23 | $ | (1.79) | |
| Diluted core earnings per common share (“Core EPS”) ($)^(3)^ | $ | 0.83 | $ | 0.79 | $ | 0.76 | $ | 1.63 | $ | 1.45 | |
| ROE | **** | 9.3% | 13.6% | (22.4)% | **** | 11.4% | (17.9)% | ||||
| Core return on shareholders’ equity (“Core<br>ROE”)^(3)^ | **** | 15.5% | 14.8% | 15.1% | **** | 15.2% | 14.5% | ||||
| Expense efficiency ratio^(3)^ | **** | 45.1% | 47.1% | 43.1% | **** | 46.1% | 44.7% | ||||
| Expenditure efficiency ratio^(3)^ | **** | 51.9% | 54.0% | 50.1% | **** | 52.9% | 51.7% | ||||
| General expenses | $ | 1,022 | $ | 1,086 | $ | 884 | $ | 2,108 | $ | 1,815 | |
| Core expenses^(2)^ | $ | 1,598 | $ | 1,605 | $ | 1,381 | $ | 3,203 | $ | 2,797 | |
| Core expenditures^(2)^ | $ | 2,099 | $ | 2,112 | $ | 1,835 | $ | 4,211 | $ | 3,707 | |
| ^(1)^ | 2022 results for transitional net income attributed to shareholders, transitional diluted earnings per common share and<br>transitional ROE are adjusted to include IFRS 9 hedge accounting and expected credit loss principles (“IFRS 9 transitional impacts”). See section A1 “Implementation of IFRS 17 and IFRS 9” of the MD&A above for more<br>information. For 2023, there are no IFRS 9 transitional adjustments as ECL and hedge accounting is effective January 1, 2023 and therefore the impact is included in net income attributed to shareholders. | ||||||||||
| --- | --- | ||||||||||
| ^(2)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. | ||||||||||
| --- | --- | ||||||||||
| ^(3)^ | This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.<br> | ||||||||||
| --- | --- |
Quarterly profitability
Manulife’s net income attributed to shareholders was $1,025 million in the second quarter of 2023 (“2Q23”) compared with a net loss attributed to shareholders of $2,119 million and transitional net income attributed to shareholders of $168 million in the second quarter of 2022 (“2Q22”). The 2Q22 transitional net income attributed to shareholders includes $2,287 million of IFRS 9 transitional impacts. Net income attributed to shareholders is comprised of core earnings (consisting of items we believe reflect the underlying earnings capacity of the business), which amounted to $1,637 million in 2Q23 compared with $1,526 million in 2Q22, and items excluded from core earnings, which amounted to a net charge of $612 million in 2Q23 compared with a net charge of $3,645 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis amounted to a net charge of $1,358 million. The effective tax rate on net income (loss) attributed to shareholders was 19% in 2Q23 compared with 21% in 2Q22, reflecting differences in the jurisdictional mix of pre-tax profits and losses.
Net income attributed to shareholders in 2Q23 was $857 million higher than 2Q22 transitional net income attributed to shareholders reflecting a smaller charge from market experience and growth in core earnings. The net charge from market experience in 2Q23 was driven by lower-than-expected returns (including fair value changes) on alternative long duration assets (“ALDA”) mainly related to real estate and energy as well as changes in foreign currency exchange rates, partially offset by higher-than-expected returns on public equity. Net income attributed to shareholders in 2Q23 increased by $3,144 million compared with 2Q22, driven by factors mentioned above and the $2,287 million of IFRS 9 transitional impacts (transitional impacts are geography-related and do not impact total shareholders’ equity as the corresponding offset is in other comprehensive income).
Core earnings increased $111 million or 4% on a constant exchange rate basis^1^ compared with 2Q22. The increase in core earnings compared with 2Q22 was driven by an increase in expected investment earnings related to higher investment yields and business growth, higher returns on surplus assets net of higher cost of debt
| ^1^ | Percentage growth / declines in core earnings, pre-tax core earnings, total expenses, core expenses, total expenditures,<br>core expenditures, general expenses, CSM net of NCI, new business CSM, assets under management and administration, assets under management, core EBITDA, and Manulife Bank average net lending assets are stated on a constant exchange rate basis, a<br>non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 9 |
| --- | --- |
Table of Contents
financing and a smaller net charge in the provision for ECL. These were partially offset by higher workforce related costs, a charge from net unfavourable insurance experience (compared with a net gain in 2Q22) and a slower CSM amortization on certain variable fee approach (“VFA”) contracts. In addition, lower core earnings in Global Wealth and Asset Management (“Global WAM”) were driven by an increase in workforce related costs and lower earnings from seed capital investments due to repatriations, partially offset by higher net fee income from increased fee spread and business mix.
Year-to-date profitability
Net income attributed to shareholders for the six months ended June 30, 2023 was $2,431 million compared with a net loss attributed to shareholders of $3,339 million and transitional net income attributed to shareholders of $1,493 million for the six months ended June 30, 2022. The year-to-date 2022 transitional net income attributed to shareholders includes $4,832 million of IFRS 9 transitional impacts. Year-to-date core earnings amounted to $3,168 million in 2023 compared with $2,919 million in the same period of 2022, and items excluded from year-to-date core earnings amounted to a net charge of $737 million in 2023 compared with a net charge of $6,258 million in the same period of 2022. Items excluded from year-to-date core earnings in the same period of 2022 on a transitional basis amounted to a net charge of $1,426 million. The effective tax rate on year-to-date net income (loss) attributed to shareholders was 18% in 2023 compared with 23% for the same period in 2022, reflecting differences in the jurisdictional mix of pre-tax profits and losses.
The increase of $938 million in year-to-date net income attributed to shareholders in 2023 compared with 2022 transitional net income attributed to shareholders reflects an increase in year-to-date core earnings of $249 million and a net charge of $737 million in items excluded from year-to-date core earnings in 2023 compared with a net charge in items excluded from year-to-date core earnings of $1,426 million in 2022 on a transitional basis. Year-to-date net income attributed to shareholders in 2023 increased by $5,770 million compared with the year-to-date net loss attributed to shareholders in 2022, driven by factors mentioned above and the $4,832 million of IFRS 9 transitional impacts (transitional impacts are geography-related and do not impact total shareholders’ equity as the corresponding offset is in other comprehensive income)
Year-to-date core earnings in 2023 increased $249 million or 5% compared with the same period of 2022. The increase in year-to-date core earnings compared with 2022 was driven by an increase in expected investment earnings related to higher investment yields and business growth, less unfavourable insurance experience primarily driven by the non-recurrence of excess mortality claims related to COVID-19 in the U.S. life insurance business in the first quarter of 2022 (“1Q22”), and higher returns on surplus assets net of higher cost of debt financing. These were partially offset by lower CSM amortization reflecting both a slower amortization on certain VFA contracts and the impact of the 2022 U.S. variable annuity reinsurance transactions, a large net charge in 2023 related to the provision for ECL primarily driven by commercial mortgages, and higher workforce related costs. In addition, lower year-to-date core earnings were driven by Global WAM reflecting an increase in workforce related costs, a decrease in net fee income from lower average AUMA^1^ due to equity and fixed income market declines in 2022, and lower earnings from seed capital investments due to repatriation. Actions to improve the capital efficiency of our legacy business resulted in $29 million lower year-to-date core earnings in 2023 compared with the same period of 2022.
On a year-to-date basis, the items excluded from year-to-date core earnings were a net charge of $737 million in 2023 consisting primarily of a net charge from market experience and a net charge related to reinsurance transactions, tax related and other.
| ^1^ | For more information on this metric, see “Non-GAAP and other financial measures” below. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 10 |
| --- | --- |
Table of Contents
Core earnings by segment is presented in the table below.
| Core earnings by segment^(1)^ | Quarterly Results | YTD Results | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unaudited) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | ||||||
| Asia | $ | 473 | $ | 489 | $ | 450 | $ | 962 | $ | 929 | |
| Canada | **** | 374 | 353 | 366 | **** | 727 | 700 | ||||
| U.S. | **** | 458 | 385 | 428 | **** | 843 | 721 | ||||
| Global Wealth and Asset Management | **** | 320 | 287 | 327 | **** | 607 | 671 | ||||
| Corporate and Other | **** | 12 | 17 | (45) | **** | 29 | (102 | ) | |||
| Total core earnings | $ | 1,637 | $ | 1,531 | $ | 1,526 | $ | 3,168 | $ | 2,919 | |
| ^(1)^ | Effective January 1, 2023, we have made a number of changes to the composition of reporting segments to better align<br>our financial reporting with our business strategy and operations. Our international high net worth business was reclassified from the U.S. segment to the Asia segment to reflect the contributions of our Bermuda operations alongside the high net<br>worth business that we report in our Singapore and Hong Kong operations. Our investment in the start-up capital of segregated and mutual funds, and investment-related revenue and expense were reclassified from the Corporate and Other segment to the<br>Global WAM segment to more closely align with Global WAM’s management practices. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to<br>reflect the changes in segment reporting. | ||||||||||
| --- | --- |
The table below presents transitional net income attributed to shareholders and net income attributed to shareholders consisting of core earnings and items excluded from core earnings.
| Quarterly Results | YTD Results | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unaudited) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| Core earnings | $ | 1,637 | $ | 1,531 | $ | 1,526 | $ | 3,168 | $ | 2,919 |
| Items excluded from core earnings: | ||||||||||
| Market experience gains (losses)^(1)^ | **** | (570) | (65) | (1,358) | **** | (635) | (1,355) | |||
| Realized gains (losses) on debt instruments | **** | (24) | (31) | (208) | **** | (55) | (483) | |||
| Derivatives and hedge ineffectiveness | **** | (13) | 93 | (442) | **** | 80 | 95 | |||
| Actual less expected long-term returns on public equity | **** | 86 | 108 | (866) | **** | 194 | (1,190) | |||
| Actual less expected long-term returns on ALDA | **** | (478) | (364) | 497 | **** | (842) | 715 | |||
| Other investment results | **** | (141) | 129 | (339) | **** | (12) | (492) | |||
| Changes in actuarial methods and assumptions that flow directly through income | **** | – | – | – | **** | – | – | |||
| Reinsurance transactions, tax-related items and other^(2)^ | **** | (42) | (60) | – | **** | (102) | (71) | |||
| Total items excluded from core earnings | **** | (612) | (125) | (1,358) | **** | (737) | (1,426) | |||
| Transitional net income attributed to shareholders | **** | n/a | n/a | $ | 168 | **** | n/a | $ | 1,493 | |
| Less: IFRS 9 transitional impacts: | ||||||||||
| Change in expected credit loss | (19) | 1 | ||||||||
| Hedge accounting | 3,099 | 6,457 | ||||||||
| Total IFRS 9 transitional impacts (pre-tax) | 3,080 | 6,458 | ||||||||
| Tax on IFRS 9 transitional impacts | (793) | (1,626) | ||||||||
| Total IFRS 9 transitional impacts (post-tax) | 2,287 | 4,832 | ||||||||
| Net income (loss) attributed to shareholders | $ | 1,025 | $ | 1,406 | $ | (2,119) | $ | 2,431 | $ | (3,339) |
| ^(1)^ | Market experience was a net charge of $570 million in 2Q23 primarily driven by lower-than-expected returns (including fair<br>value changes) on ALDA mainly related to real estate and energy, changes in foreign currency exchange rates, net realized losses from the sale of debt instruments which are classified as fair value through other comprehensive income<br>(“FVOCI”) and a modest net charge from derivatives and hedge ineffectiveness. These were partially offset by higher-than-expected returns on public equity. Market experience was a net charge of $1,358 million in 2Q22 consisting of a net<br>loss from lower-than-expected returns on public equity, a loss from derivatives and hedge ineffectiveness due to unusually large interest rate movements, changes in foreign currency exchange rates, and net realized losses from the sale of debt<br>instruments which are classified as FVOCI. These were partially offset by higher-than-expected returns (including fair value changes) on ALDA related to private equity. | |||||||||
| --- | --- | |||||||||
| ^(2)^ | The 2Q23 net charge of $42 million mainly included a provision for the cancellation of certain policies in our Vietnam<br>operation of $46 million. | |||||||||
| --- | --- | |||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 11 | |||||||||
| --- | --- |
Table of Contents
Transitional net income attributed to shareholders by segment and net income attributed to shareholders by segment are presented in the following tables.
| Transitional net income attributed toshareholders by segment^(1)^ | Quarterly Results | YTD Results | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unaudited) | 2Q23 | 1Q23 | 2Q22 <br>Transitional | 2023 | 2022<br>Transitional | |||||
| Asia | $ | 130 | $ | 519 | $ | (227) | $ | 649 | $ | (22) |
| Canada | **** | 227 | 309 | 271 | **** | 536 | 597 | |||
| U.S. | **** | 183 | 186 | 355 | **** | 369 | 1,240 | |||
| Global Wealth and Asset Management | **** | 317 | 297 | 150 | **** | 614 | 433 | |||
| Corporate and Other | **** | 168 | 95 | (381) | **** | 263 | (755) | |||
| Total transitional net income attributed to shareholders | $ | 1,025 | $ | 1,406 | $ | 168 | $ | 2,431 | $ | 1,493 |
| Net income attributed to shareholders bysegment^(1)^ | Quarterly Results | YTD Results | ||||||||
| ($ millions, unaudited) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| Asia | $ | 130 | $ | 519 | $ | (51) | $ | 649 | $ | 88 |
| Canada | **** | 227 | 309 | (611) | **** | 536 | (1,283) | |||
| U.S. | **** | 183 | 186 | (1,226) | **** | 369 | (1,825) | |||
| Global Wealth and Asset Management | **** | 317 | 297 | 150 | **** | 614 | 433 | |||
| Corporate and Other | **** | 168 | 95 | (381) | **** | 263 | (752) | |||
| Total net income attributed to shareholders | $ | 1,025 | $ | 1,406 | $ | (2,119) | $ | 2,431 | $ | (3,339) |
| ^(1)^ | Effective January 1, 2023, we have made a number of changes to the composition of reporting segments to better align<br>our financial reporting with our business strategy and operations. Our international high net worth business was reclassified from the U.S. segment to the Asia segment to reflect the contributions of our Bermuda operations alongside the high net<br>worth business that we report in our Singapore and Hong Kong operations. Our investment in the start-up capital of segregated and mutual funds, and investment-related revenue and expense were reclassified from the Corporate and Other segment to the<br>Global WAM segment to more closely align with Global WAM’s management practices. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to<br>reflect the changes in segment reporting. | |||||||||
| --- | --- |
Expenditure efficiency ratio and expense efficiency ratio
We introduced our strategic priority of expense efficiency in 2018.
The expense efficiency ratio is a financial measure which we use to measure progress towards our objective of becoming more efficient. The expense efficiency ratio reflects only those expenses that flow directly through core earnings (“core expenses”). Due to changes introduced by IFRS 17, certain costs that are directly attributable to acquire new business are capitalized into the CSM instead of directly flowing through core earnings and are now excluded from the ratio.
To provide a reference point to our expense efficiency ratio prior to the adoption of IFRS 17, we are temporarily introducing an additional efficiency ratio, the expenditure efficiency ratio, for 2022 and 2023 only, which captures all expenses, including costs that are directly attributable to the acquisition of new business (“core expenditures”).
Quarterly expenditure efficiency ratio and expense efficiency ratio
The expenditure efficiency ratio was 51.9% in 2Q23, compared with 50.1% in 2Q22. The 1.8 percentage point increase in the ratio compared with 2Q22 was driven by a 12% increase in core expenditures partially offset by a 3% increase in pre-tax core earnings^1^. 2Q23 core expenditures increased as a result of higher distribution costs reflecting topline growth, higher workforce related costs reflecting inflationary pressures, the tight labour market, and a return to pre-pandemic activities, and additional expenses related to the consolidation of 100% of Manulife TEDA Fund Management Co, LTD. Costs directly attributable to the acquisition of new business represented approximately 24% and 25% of total core expenditures in 2Q23 and 2Q22, respectively.
The expense efficiency ratio was 45.1% in 2Q23, compared with 43.1% in 2Q22. The 2.0 percentage point increase in the ratio compared with 2Q22 was driven by the items noted above related to the increase in the core expenditure efficiency ratio but is net of costs directly attributable to the acquisition of new business.
| ^1^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 12 |
| --- | --- |
Table of Contents
Total 2Q23 general expenses increased 16% on an actual exchange rate basis and 12% on a constant exchange rate basis compared with 2Q22 driven by the items noted above related to the increase in the expenditure efficiency ratio and items outside of core earnings, which were not material in 2Q23. However, general expenses are also net of directly attributable maintenance expenses and directly attributable acquisition expenses for products measured using the premium allocation approach (“PAA”) which are included in insurance service expenses on our financial statements. Directly attributable maintenance expenses and directly attributable acquisition expenses for products measured using the PAA increased 15% in 2Q23 compared with 2Q22.
Year-to-dateexpenditure efficiency ratio and expense efficiency ratio
On a year-to-date basis, the expenditure efficiency ratio was 52.9% in 2023 compared with 51.7% in the same period of 2022. The 1.2 percentage point increase in the year-to-date ratio compared with 2022 was driven by an 11% increase in year-to-date core expenditures partially offset by a 5% increase in year-to-date pre-tax core earnings. 2023 year-to-date core expenditures increased as a result of higher distribution costs reflecting topline growth, higher workforce related costs reflecting inflationary pressures, the tight labour market, higher travel and a return to pre-pandemic activities, and additional expenses related to the consolidation of 100% of Manulife TEDA Fund Management Co, LTD. Year-to-date costs directly attributable to the acquisition of new business represented approximately 24% of total year-to-date core expenditures in both 2023 and 2022. ****
The year-to-date expense efficiency ratio was 46.1% in 2023, compared with 44.7% in the same period of 2022. The 1.4 percentage point increase in the year-to-date ratio compared with 2022 was driven by the items noted above related to the increase in the year-to-date expenditure efficiency ratio but is net of year-to-date costs directly attributable to the acquisition of new business.
Total year-to-date general expenses in 2023 increased 16% on an actual exchange rate basis and 12% on a constant exchange rate basis compared with 2022 driven by the items noted above related to the increase in the expenditure efficiency ratio and items outside of core earnings, which consist primarily of a true-up to an existing legal provision in 2023. However, general expenses are also net of directly attributable maintenance expenses and directly attributable acquisition expenses for products measured using the PAA which are included in insurance service expenses on our financial statements. Directly attributable maintenance expenses and directly attributable acquisition expenses for products measured using the PAA increased 15% in 2023 compared with 2022.
| Manulife Financial Corporation – Second Quarter 2023 | 13 |
|---|
Table of Contents
| A3 | Business performance^1^ | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unless otherwise stated) (unaudited) | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| Asia APE sales | 1,181 | $ | 1,173 | $ | 900 | $ | 2,354 | $ | 1,987 |
| Canada APE sales | 322 | 293 | 361 | **** | 615 | 724 | |||
| U.S. APE sales | 130 | 134 | 147 | **** | 264 | 307 | |||
| Total APE sales(1) | 1,633 | 1,600 | 1,408 | **** | 3,233 | 3,018 | |||
| Asia new business value | 424 | 372 | 393 | **** | 796 | 762 | |||
| Canada new business value | 106 | 92 | 82 | **** | 198 | 186 | |||
| U.S. new business value | 55 | 45 | 35 | **** | 100 | 76 | |||
| Total new business value(1),(2) | 585 | 509 | 510 | **** | 1,094 | 1,024 | |||
| Asia new business CSM(3) | 432 | 301 | 328 | **** | 733 | 645 | |||
| Canada new business CSM | 57 | 46 | 47 | **** | 103 | 108 | |||
| U.S. new business CSM | 103 | 95 | 118 | **** | 198 | 230 | |||
| Total new business CSM(3) | 592 | 442 | 493 | **** | 1,034 | 983 | |||
| Asia CSM net of NCI | 9,630 | 9,678 | 9,025 | **** | 9,630 | 9,025 | |||
| Canada CSM | 3,656 | 3,659 | 3,626 | **** | 3,656 | 3,626 | |||
| U.S. CSM | 4,106 | 4,080 | 4,026 | **** | 4,106 | 4,026 | |||
| Corporate and Other CSM | 31 | 50 | 34 | **** | 31 | 34 | |||
| Total CSM net of NCI | 17,423 | 17,467 | 16,711 | **** | 17,423 | 16,711 | |||
| Post-tax CSM net of NCI(4) | 14,877 | 14,850 | 14,224 | **** | 14,877 | 14,224 | |||
| Global WAM gross flows ( billions)(1) | 35.2 | 38.8 | 34.1 | **** | 74.0 | 72.5 | |||
| Global WAM net flows ( billions)(1) | 2.2 | 4.4 | 1.7 | **** | 6.6 | 8.5 | |||
| Global WAM assets under management and administration ( billions)(4) | 819.6 | 814.5 | 746.8 | **** | 819.6 | 746.8 | |||
| Global WAM total invested assets ( billions) | 5.5 | 5.6 | 5.7 | **** | 5.5 | 5.7 | |||
| Global WAM segregated funds net assets ( billions) | 238.7 | 235.6 | 213.3 | **** | 238.7 | 213.3 | |||
| Total assets under management and administration( billions)(4),(5) | 1,344.8 | 1,349.9 | 1,253.8 | **** | 1,344.8 | 1,253.8 | |||
| Total invested assets ( billions)(5) | 403.4 | 412.5 | 391.1 | **** | 403.4 | 391.1 | |||
| Total segregated funds net assets (<br>billions)(5) | 366.0 | 364.0 | 334.9 | **** | 366.0 | 334.9 |
All values are in US Dollars.
| ^(1)^ | For more information on this metric, see “Non-GAAP and other financial measures” below. |
|---|---|
| ^(2)^ | Quarterly 2022 NBV has not been restated as a result of the adoption of IFRS 17. The impact of not restating 2022 is not<br>material. |
| --- | --- |
| ^(3)^ | New business contractual service margin is net of NCI. |
| --- | --- |
| ^(4)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
| --- | --- |
| ^(5)^ | See section A5 below for more information. |
| --- | --- |
Annualized premium equivalent (“APE”) sales were $1.6 billion in 2Q23, an increase of 12%^2^ compared with 2Q22. In Asia, APE sales increased 26% compared with 2Q22, driven by growth in Hong Kong and Asia Other^3^, partially offset by lower sales in Japan. In Hong Kong, APE sales doubled compared with 2Q22, reflecting strong growth in our broker and bancassurance channels, primarily driven by a return of demand from mainland Chinese visitor (“MCV”) customers following the reopening of the border between Hong Kong and mainland China since February 2023. In Japan, APE sales decreased 17% compared with 2Q22, driven by lower sales in other wealth and corporate-owned life insurance (“COLI”) products. Asia Other APE sales increased 12% compared with 2Q22, as higher sales in mainland China through our bancassurance channel were partially offset by lower sales in Vietnam and international high net worth business. In Canada, APE sales decreased 11% compared with 2Q22, driven by usual variability in the group insurance market with lower large-case sales partially offset by higher mid-size business sales, as well as lower sales of segregated fund products. In the U.S., APE sales decreased 15% compared with 2Q22 due to the adverse impact of higher short-term interest rates on accumulation insurance
| ^1^ | Effective January 1, 2023, our international high net worth business was reclassified from the U.S. segment to the<br>Asia segment to reflect the contributions of our Bermuda operations alongside the high net worth business that we report in our Singapore and Hong Kong operations. Prior period comparative information has been restated to reflect the<br>reclassification. |
|---|---|
| ^2^ | Percentage growth / declines in APE sales is stated on a constant exchange rate basis. |
| --- | --- |
| ^3^ | Asia Other excludes Hong Kong and Japan. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 14 |
| --- | --- |
Table of Contents
products, particularly for our higher net worth customers. APE sales of products with the John Hancock Vitality PLUS feature represented 75% of overall U.S. sales in 2Q23, an increase from 71% in 2Q22.
Year-to-date APE sales of $3.2 billion in 2023 were 4% higher than the same period of 2022, driven by higher year-to-date sales in Asia partially offset by lower year-to-date sales in Canada and the U.S.
New business value(“NBV”) was $585 million in 2Q23, an increase of 10%^1^ compared with 2Q22. In Asia, NBV increased 3% compared with 2Q22 driven by higher sales volumes partially offset by business mix. In Canada, NBV increased 29% compared with 2Q22 driven by higher margins in all business lines largely due to product mix, partially offset by lower sales volumes in Annuities and Group Insurance. In the U.S., NBV increased 43% compared with 2Q22 due to pricing actions, higher interest rates, and product mix, partially offset by lower sales volumes.
Year-to-date NBV was $1,094 million in 2023, an increase of 3% compared with the same period of 2022. In Asia, year-to-date NBV in 2023 was in line with the same period of 2022 as higher sales volumes were offset by business mix. In Canada, year-to-date NBV increased 6% driven by higher margins in all business lines largely due to product mix, partially offset by lower sales volumes in Annuities and Group Insurance. In the U.S., year-to-date NBV increased 23% compared with 2022 due to due to pricing actions, higher interest rates and product mix, partially offset by lower sales volumes.
New business contractual service margin (“New Business CSM”) was $592 million in 2Q23, an increase of 15% compared with 2Q22. In Asia, new business CSM increased 26% compared with 2Q22 driven by higher sales volumes and model refinements, partially offset by business mix. In Canada, new business CSM increased 21% compared with 2Q22 driven by product mix in Individual Insurance. Under IFRS 17, the majority of Group Insurance and affinity products are classified as PAA and do not generate CSM. In the U.S., new business CSM decreased 17% compared with 2Q22 consistent with lower sales volumes.
Year-to-date new business CSM was $1,034 million in 2023, an increase of 1% compared with the same period of 2022. In Asia, year-to-date new business CSM in 2023 increased 9% compared with the same period of 2022, driven by higher sales volumes, partially offset by business mix. In Canada, year-to-date new business CSM decreased 5% compared with 2022 due to lower segregated fund sales volumes, partially offset by product mix in Retail Insurance. As noted above, under IFRS 17, the majority of group insurance and affinity products are classified as PAA and do not generate CSM. In the U.S., year-to-date new business CSM decreased 19% compared with 2022 consistent with lower sales volumes.
The contractual service margin (“CSM”) net of NCI was $17,423 million as at June 30, 2023, an increase of $140 million compared with December 31, 2022. The increase in CSM net of NCI reflects an increase in total CSM movement of $126 million, net of a decrease in NCI of $14 million. Organic CSM movement was an increase of $468 million for the first half of 2023 driven by the impact of new insurance business and expected movements related to finance income or expenses, partially offset by amounts recognized for service provided in year-to-date earnings and a net loss from insurance experience. Inorganic CSM movement was a decrease of $342 million for the first half of 2023 driven by changes in foreign currency exchange rates, partially offset by net positive equity market experience and higher interest rates on VFA contracts. Post-tax CSM net of NCI was $14,877 million as at June 30, 2023.
Global WAM reported net inflows were $2.2 billion in 2Q23 compared with net inflows of $1.7 billion in 2Q22. Net inflows in Retirement were $0.7 billion in 2Q23 compared with net inflows of $1.0 billion in 2Q22, driven by higher pension plan redemptions and member withdrawals, partially offset by higher new pension plan sales and growth in member contributions. Net outflows in Retail were $0.1 billion in 2Q23 compared with net outflows of $1.9 billion in 2Q22, reflecting lower mutual fund redemption rates, partially offset by lower sales due to reduced investor demand amid continued equity market and interest rate volatility. Net inflows in Institutional Asset Management were $1.6 billion in 2Q23 compared with net inflows of $2.5 billion in 2Q22, driven by higher redemptions and the non-recurrence of a $1.9 billion equity mandate sale in 2Q22, partially offset by higher sales
| ^1^ | Percentage growth / declines in NBV is stated on a constant exchange rate basis. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 15 |
| --- | --- |
Table of Contents
in mainland China from acquiring full ownership interest of Manulife Fund Management (“MFM”), and higher fixed income and timberland mandate sales.
Year-to-date net inflows were $6.6 billion in 2023, compared with $8.5 billion in same period of 2022. The decrease was primarily due to lower retail net inflows from lower investor demand, and lower retirement net inflows from higher pension plan redemptions. This was partially offset by higher institutional net inflows in mainland China from acquiring full ownership interest of MFM and new product launches in the first quarter of 2023 (“1Q23”).
| A4 | Financial strength | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Quarterly Results | YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (unaudited) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| MLI’s LICAT ratio^(1)^ | **** | 136% | 138% | 137% | **** | 136% | 137% | |||
| Financial leverage ratio^(2)^ | **** | 25.8% | 26.0% | 26.0% | **** | 25.8% | 26.0% | |||
| Consolidated capital ($ billions)^(3)^ | $ | 69.3 | $ | 71.6 | $ | 69.5 | $ | 69.3 | $ | 69.5 |
| Book value per common share ($) | $ | 21.30 | $ | 22.01 | $ | 20.62 | $ | 21.30 | $ | 20.62 |
| Adjusted book value per common share ($)^(2)^ | $ | 29.42 | $ | 30.04 | $ | 28.06 | $ | 29.42 | $ | 28.06 |
| ^(1)^ | This item is disclosed under OSFI’s Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.<br>Comparative LICAT ratios for 2022 are as reported in 2022 and have not been restated for the implementation of IFRS 17. | |||||||||
| --- | --- | |||||||||
| ^(2)^ | This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.<br> | |||||||||
| --- | --- | |||||||||
| ^(3)^ | This item is a capital management measure. For more information on this metric, see “Non-GAAP and other financial<br>measures” below. | |||||||||
| --- | --- |
The Life Insurance Capital Adequacy Test (“LICAT”) ratio for The Manufacturers Life Insurance Company (“MLI”) as at June 30, 2023 was 136% compared with 138% as at March 31, 2023. The two percentage point decrease was driven by the redemption of subordinated debt and common share buybacks.
MFC’s LICAT ratio was 123% as at June 30, 2023 compared with 125% as at March 31, 2023 with the decrease driven by similar factors that impacted the movement in MLI’s LICAT ratio. The difference between the MLI and MFC ratios as at June 30, 2023 was largely due to the $6.1 billion of MFC senior debt outstanding that does not qualify as available capital at the MFC level but, based on the form it was down-streamed, qualifies as regulatory capital for MLI.
MFC’s financial leverageratio^1^ as at June 30, 2023 was 25.8%, a decrease of 0.2 percentage points from 26.0% as at March 31, 2023. The decrease in the ratio was driven by the redemption of subordinated debt^2^, partially offset by the impact of a stronger Canadian dollar and common share buybacks.
MFC’sconsolidated capital^1^ was $69.3 billion as at June 30, 2023, a decrease of $0.3 billion compared with $69.6 billion as at December 31, 2022. The decrease was primarily driven by the impact of a stronger Canadian dollar and common share buybacks, partially offset by growth in retained earnings, the net issuance of subordinated debt^3^ and higher post-tax CSM.
Cash and cash equivalents and marketable securities^4^ was $242.9 billion as at June 30, 2023 compared with $241.0 billion as at December 31, 2022. The increase was primarily driven by higher market value of public equities due to higher equity markets.
Bookvalue per common share as at June 30, 2023 was $21.30, a 1% decrease compared with $21.56 as at December 31, 2022. The number of common shares outstanding was 1,833 million as at June 30, 2023, a decrease of 32 million shares from 1,865 million as at December 31, 2022, primarily due to common share buybacks.
| ^1^ | Effective January 1, 2022, the calculation of financial leverage ratio and consolidated capital now includes the<br>impact of post-tax CSM. See “Non-GAAP and other financial measures below” for more information. |
|---|---|
| ^2^ | The redemption of subordinated debt in 2Q23 was $0.6 billion. |
| --- | --- |
| ^3^ | The net issuance of subordinated debt consists of the issuance of $1.2 billion in 1Q23 and the redemption of $0.6 billion<br>in 2Q23. |
| --- | --- |
| ^4^ | Includes cash & cash equivalents, comprised of cash on deposit, Canadian and U.S. Treasury Bills and high quality<br>short-term investments, and marketable assets, comprised of investment grade government and agency bonds, investment grade corporate bonds, investment grade securitized instruments, publicly traded common stocks and preferred shares.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 16 |
| --- | --- |
Table of Contents
Adjusted book value per common share as at June 30, 2023 was $29.42, in line with $29.42 as at December 31, 2022 driven by a reduction in adjusted book value^1^ partially offset by a lower number of common shares outstanding. The adjusted book value declined by $1.0 billion driven by the impact of a stronger Canadian dollar and common share buybacks, partially offset by growth in retained earnings and higher post-tax CSM.
| A5 | Assets under management and administration (“AUMA”) |
|---|
AUMA as at June 30, 2023 was $1.3 trillion, an increase of 6% compared with December 31, 2022, primarily due to the favourable impact of markets and net inflows. Total invested assets and segregated funds net assets increased 1% and 5%, respectively, on an actual exchange rate basis primarily due to the favourable impact of markets.
| A6 | Impact of foreign currency exchange rates |
|---|
Changes in foreign currency exchange rates from 2Q22 to 2Q23 increased core earnings by $52 million in 2Q23, primarily due to a weaker Canadian dollar compared with the U.S. dollar. Changes in foreign currency exchange rates increased year-to-date core earnings by $107 million in 2023 compared with the same period of 2022 primarily due to a weaker Canadian dollar compared with the U.S. dollar. The impact of foreign currency exchange rates on items excluded from core earnings does not provide relevant information given the nature of those items.
| A7 | Business highlights |
|---|
To continue helping our customers live longer, healthier, better lives, we:
| • | launched enhanced healthcare coverage in Hong Kong to better address the growing demand for health and protection services.<br>Customers can now use our expanded hospital network covering over 3,000 hospitals across mainland China. We are the first life insurer in the market to cover all Grade III public hospitals; |
|---|---|
| • | continued to expand our behavioural insurance program in Canada by making Manulife Vitality available on new<br>Manulife Par individual insurance policies; and |
| --- | --- |
| • | deepened our collaboration with ŌURA to offer John Hancock Vitality members discounts on ŌURA rings and the<br>ability to earn points for healthy sleep habits and mindfulness. |
| --- | --- |
We remain committed to our Environmental, Social and Governance(“ESG”) strategy:
| • | We strengthened our commitment to reducing emissions by disclosing science-based^2^ targets, including an increased ambition to reduce absolute scope 1 and 2 emissions 40% by 2035, and a combination of sector-specific and asset-class specific interim targets to reduce the General<br>Account’s financed emissions as outlined in our 2022 ESG Report published in May 2023.^3^ Currently, Manulife’s owned timberland and agriculture properties remove more carbon from the<br>atmosphere than emitted in our operations; |
|---|---|
| • | We announced the launch of our industry-first ESG themed funds in Manulife Mandatory Provident Fund (“MPF”) in<br>Hong Kong Retirement. This makes our flagship MPF scheme the first in the MPF market to provide both sustainable equity and fixed income investment options; and |
| --- | --- |
| • | Manulife was named one of Corporate Knights’ Best 50 Corporate Citizens in Canada for the third consecutive year.<br> |
| --- | --- |
We continue to make progress on our digital journey:
| • | In Global WAM, we announced a new partnership with Envestnet in Canada Retail that will provide advisors with a<br>leading-edge portfolio management platform to deliver a better client experience and improve advisor productivity. The Envestnet platform is a market tested portfolio management solution which will give advisors access to advanced trading and<br>modelling capabilities, streamlined workflows and |
|---|---|
| ^1^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
| --- | --- |
| ^2^ | Targets developed in alignment with the methodology for financial institutions outlined by the Science-based Targets<br>Initiative (SBTi), in combination with Partnership for Carbon Accounting Financials (PCAF) methodologies for emissions accounting. |
| --- | --- |
| ^3^ | See “Caution regarding forward-looking statements” below. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 17 |
| --- | --- |
Table of Contents
| <br>automated tasks, more robust and client-friendly reporting, and the ability to manage accounts in a unified structure. These benefits will enable advisors to increase their efficiency and focus<br>on their client relationships and business growth. This partnership signifies another successful step in our digital transformation journey as a leader of advice in Canada; | |
|---|---|
| • | In Asia, we continued to drive utilization of connected agent profiles in Manulife Shop, our proprietary online channel in<br>the Philippines, to enable us to enhance customer experience, fulfill a wider range of customer needs, and improve agent activity and productivity. In 2Q23, this contributed to a 16% increase quarter-over-quarter in organic lead submissions through<br>the channel. We plan to roll out connected agent profiles to additional markets in the second half of 2023; |
| --- | --- |
| • | In Canada, we reduced our call transfer rates by nearly half compared with 2Q22 in our Group Benefits contact centre, by<br>leveraging Amazon AWS Connect, which contributed to a 14% improvement in the contact centre’s transactional NPS. We continue to expand the use of this technology, which enables a more holistic digital customer experience and drives operational<br>efficiency; and |
| --- | --- |
| • | In the U.S., we received recognition from LIBRA Insurance Partners, the largest independently owned life insurance<br>marketing organization in the U.S.^1^, as one of the carriers who provide a best-in-class experience on an electronic platform for permanent life insurance products. We also eliminated over<br>3 million pieces of paper by completing our first e-delivery of life insurance policy prospectuses. |
| --- | --- |
| ^1^ | Based on gross annual production according to Paradigm Partners International, a third-party research firm specializing in<br>the insurance landscape. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 18 |
| --- | --- |
Table of Contents
| B | PERFORMANCE BY SEGMENT | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| B1 | Asia^1^ | ||||||||
| --- | --- | ||||||||
| YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unless otherwise stated) | |||||||||
| Canadian dollars | |||||||||
| Net income attributed to shareholders(1) | 130 | 519 | (227) | 649 | (22) | ||||
| U.S. dollars | |||||||||
| Net income attributed to shareholders(1) | 96 | US | 384 | US | (177) | US | 480 | US | (16) |
| ( millions, unless otherwise stated) | YTD Results | ||||||||
| Canadian dollars | |||||||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 130 | 519 | (51) | 649 | 88 | ||||
| Core earnings(1) | 473 | 489 | 450 | 962 | 929 | ||||
| Business performance: | |||||||||
| Annualized premium equivalent sales | 1,181 | 1,173 | 900 | 2,354 | 1,987 | ||||
| New business value | 424 | 372 | 393 | 796 | 762 | ||||
| New business contractual service margin net of NCI | 432 | 301 | 328 | 733 | 645 | ||||
| Contractual service margin net of NCI | 9,630 | 9,678 | 9,025 | 9,630 | 9,025 | ||||
| Assets under management ( billions)(2) | 159.3 | 162.2 | 145.8 | 159.3 | 145.8 | ||||
| Total invested assets ( billions) | 135.2 | 138.0 | 123.9 | 135.2 | 123.9 | ||||
| Total segregated funds net assets ( billions) | 24.1 | 24.2 | 21.9 | 24.1 | 21.9 | ||||
| U.S. dollars | |||||||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 96 | US | 384 | US | (41) | US | 480 | US | 69 |
| Core earnings(1) | 353 | 361 | 353 | 714 | 731 | ||||
| Business performance: | |||||||||
| Annualized premium equivalent sales | 879 | 868 | 706 | 1,747 | 1563 | ||||
| New business value | 315 | 275 | 307 | 590 | 598 | ||||
| New business contractual service margin net of NCI | 323 | 222 | 258 | 545 | 507 | ||||
| Contractual service margin net of NCI | 7,273 | 7,156 | 7,004 | 7,273 | 7,004 | ||||
| Assets under management ( billions)(2) | 120.3 | 119.9 | 113.0 | 120.3 | 113.0 | ||||
| Total invested assets ( billions) | 102.1 | 102.0 | 96.0 | 102.1 | 96.0 | ||||
| Total segregated funds net assets ( billions) | 18.2 | 17.9 | 17.0 | 18.2 | 17.0 |
All values are in US Dollars.
| ^(1)^ | See “Non-GAAP and other financial measures” below for a reconciliation of quarterly core earnings to net income<br>(loss) attributed to shareholders for 2023 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2022. |
|---|---|
| ^(2)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
| --- | --- |
Asia’s net income attributed to shareholders was $130 million in 2Q23 compared with a net loss attributed to shareholders of $51 million and a transitional net loss attributed to shareholders of $227 million in 2Q22. The 2Q22 transitional net loss includes a $176 million charge from IFRS 9 transitional impacts. Net income attributed to shareholders is comprised of core earnings, which were $473 million in 2Q23 compared with $450 million in 2Q22, and items excluded from core earnings, which amounted to a net charge of $343 million in 2Q23 compared with a net charge of $501 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis amounted to a net charge of $677 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of quarterly core earnings to net income (loss) attributed to shareholders for 2Q23 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2Q22. See section A2 “Profitability” above, for explanations of the items excluded from core earnings. The changes in core earnings expressed in Canadian dollars were due to the factors described below and additionally, reflected a net $16 million favourable impact due to changes in foreign currency exchange rates versus the Canadian dollar.
| ^1^ | Effective January 1, 2023, we have made a change to the composition of reporting segments to better align our<br>financial reporting with our business strategy and operations. Our international high net worth business was reclassified from the U.S. segment to the Asia segment (in Asia Other) to reflect the contributions of our Bermuda operations alongside the<br>high net worth business that we report in our Singapore and Hong Kong operations. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to<br>reflect the changes in segment reporting. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 19 |
| --- | --- |
Table of Contents
Expressed in U.S. dollars, the presentation currency of the segment, net income attributed to shareholders was US$96 million in 2Q23 compared with a net loss attributed to shareholders of US$41 million and a transitional net loss attributed to shareholders of US$177 million in 2Q22. Core earnings were US$353 million in 2Q23 compared with US$353 million in 2Q22 and items excluded from core earnings were a net charge of US$257 million in 2Q23 compared with a net charge of US$394 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis were a net charge of US$530 million.
Core earnings in 2Q23 were in line with 2Q22 driven by higher expected investment income due to higher investment yields and business growth, offset by a slower CSM amortization on certain VFA contracts. Claims experience was relatively neutral across the segment in both periods.
Year-to-date net income attributed to shareholders was US$480 million in 2023 compared with net income attributable to shareholders of US$69 million and a transitional net loss attributed to shareholders of US$16 million in the same period of 2022. The year-to-date transitional net loss includes a charge of US$85 million from IFRS 9 transitional adjustments. Year-to-date core earnings of US$714 million in 2023 were in line with 2022 driven by higher expected investment income due to higher investment yields and business growth and lower maintenance expenses, offset by a slower CSM amortization on certain VFA contracts and less favourable claims experience. Items excluded from year-to-date core earnings were a net charge of US$234 million in 2023 compared with a net charge of US$662 million for the same period of 2022. Items excluded from core earnings in 2022 on a transitional basis amounted to a net charge of US$747 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders for 2023, and year-to-date core earnings and year-to-date transitional net income (loss) to shareholders to year-to-date net income (loss) attributed to shareholders for 2022. Expressed in Canadian dollars, year-to-date core earnings reflected a net $31 million unfavourable impact of changes in foreign currency exchange rates versus the Canadian dollar.
APE sales in 2Q23 were US$879 million, an increase of 26% compared with 2Q22, driven by growth in Hong Kong and Asia Other, partially offset by lower sales in Japan. NBV in 2Q23 was US$315 million, an increase of 3% compared with 2Q22, driven by higher sales volumes, partially offset by business mix. New business value margin (“NBV margin”)^1^ was 40.3% in 2Q23 compared with 46.5% in 2Q22. New business CSM in 2Q23 was US$323 million, an increase of 26% compared with 2Q22, driven by higher sales volumes and model refinements, partially offset by business mix. Year-to-date APE sales were US1,747 million in 2023, an increase of 14%, compared with the same period of 2022, driven by strong growth in our broker and bancassurance channels in Hong Kong and higher bancassurance sales in Asia Other. Year-to-date NBV in 2023 was US$590 million, in line with the same period of 2022. Higher sales volumes were offset by business mix. Year-to-date new business CSM in 2023 was US$545 million, an increase of 9% compared with the same period of 2022, driven by higher sales volumes, partially offset by business mix.
| • | Hong Kong APE sales in 2Q23 were US$268 million, double that of 2Q22. The increase reflected strong growth in our broker<br>and bancassurance channels, primarily driven by a return of demand from MCV customers following the reopening of the border between Hong Kong and mainland China since February 2023. Hong Kong NBV in 2Q23 was US$140 million, an increase of 31%<br>compared with 2Q22 due to higher sales volumes, partially offset by higher proportion of lower margin savings products. Hong Kong NBV margin was 52.3% in 2Q23, a decrease of 28.2 percentage points compared with 2Q22. Hong Kong new business CSM in<br>2Q23 was US$142 million, an increase of 92% compared with 2Q22 due to higher sales volumes and model refinements, partially offset by higher proportion of lower margin savings products. |
|---|---|
| • | Japan APE sales in 2Q23 were US$59 million, a decrease of 17% compared with 2Q22 reflecting lower sales in other wealth and<br>COLI products. Japan NBV was US$26 million in 2Q23, an increase of 20% compared with 2Q22 due to product management actions, partially offset by lower sales volume. Japan NBV margin was 43.3% in 2Q23, an increase of 13.4 percentage points compared<br>with 2Q22. Japan new business CSM was US$14 million in 2Q23, a decrease of 49% compared with 2Q22 due to lower sales volume and model refinements. |
| --- | --- |
| ^1^ | For more information on this metric, see “Non-GAAP and other financial measures” below. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 20 |
| --- | --- |
Table of Contents
| • | Asia Other APE sales in 2Q23 were US$552 million, an increase of 12% compared with 2Q22. Higher sales in mainland China<br>through our bancassurance channel, were partially offset by lower sales in Vietnam and international high net worth business. Asia Other NBV in 2Q23 was US$149 million, a decrease of 16% compared with 2Q22 due to product mix, partially offset by<br>higher sales volumes. Asia Other NBV margin was 32.8% in 2Q23, a decrease of 6.5 percentage points compared with 2Q22. Asia Other new business CSM in 2Q23 was US$167 million in 2Q23, an increase of 7% compared with 2Q22, driven by higher sales<br>volumes and model refinements, partially offset by product mix. |
|---|
CSM net of NCI was US$7,273 million as at June 30, 2023, an increase of US$322 million, net of a US$2 million increase attributed to NCI compared with December 31, 2022. Organic CSM movement was an increase of US$313 million for the first half of 2023 driven by the impact of new insurance business and expected movements related to finance income or expenses partially offset by amounts recognized for service provided in year-to-date earnings and a net loss from insurance experience. Inorganic CSM movement was an increase of US$11 million for the first half of 2023 largely due to the impact of markets from a reduction in interest rates and net positive equity market performance on VFA contracts partially offset by strengthening of the U.S. dollar against Asian currencies.
Assets under management were US$120.3 billion as at June 30, 2023, an increase of US$5.2 billion or 6% compared with December 31, 2022, driven by lower interest rates and positive equity market performance in 2023 on invested assets and segregated funds net assets.
Business highlights – In 2Q23, we:
| • | launched enhanced healthcare coverage in Hong Kong to better address the growing demand for health and protection services.<br>Customers can now use our expanded hospital network covering over 3,000 hospitals across mainland China. We are the first life insurer in the market to cover all Grade III public hospitals; |
|---|---|
| • | continued to drive agency productivity across the region, with the initial roll out of Manulife Pro in Singapore, a<br>comprehensive premier recognition program, providing our 200 top-performing financial consultants and financial advisers, representing approximately 10% of our Singapore agency force, with differentiated resources and tools, including dedicated<br>underwriting support and enhanced customer engagement services with access to customer leads; and |
| --- | --- |
| • | continued to drive utilization of connected agent profiles in Manulife Shop, our proprietary online channel in the<br>Philippines, to enable us to enhance customer experience, fulfill a wider range of customer needs, and improve agent activity and productivity. In 2Q23, this contributed to a 16% increase quarter-over-quarter in organic lead submissions through the<br>channel. We plan to roll out connected agent profiles to additional markets in the second half of 2023. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 21 |
| --- | --- |
Table of Contents
| B2 | Canada^1^ | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unless otherwise stated) | 1Q23 | 2Q22<br>Transitional | 2023 | 2022<br>Transitional | |||||
| Net income attributed to shareholders(1) | 227 | $ | 309 | $ | 271 | $ | 536 | $ | 597 |
| YTD Results | |||||||||
| ( millions, unless otherwise stated) | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 227 | $ | 309 | $ | (611) | $ | 536 | $ | (1,283) |
| Core earnings(1) | 374 | 353 | 366 | **** | 727 | 700 | |||
| Business performance: | |||||||||
| Annualized premium equivalent sales | 322 | 293 | 361 | **** | 615 | 724 | |||
| Contractual service margin | 3,656 | 3,659 | 3,626 | **** | 3,656 | 3,626 | |||
| Manulife Bank average net lending assets (<br>billions)(2) | 24.9 | 24.8 | 24.3 | **** | 24.9 | 24.0 | |||
| Assets under management ( billions)(2) | 144.0 | 143.9 | 139.8 | **** | 144.0 | 139.8 | |||
| Total invested assets ( billions) | 108.0 | 107.5 | 104.2 | **** | 108.0 | 104.2 | |||
| Segregated funds net assets ( billions) | 36.0 | 36.4 | 35.6 | **** | 36.0 | 35.6 |
All values are in US Dollars.
| ^(1)^ | See “Non-GAAP and other financial measures” below for a reconciliation of quarterly core earnings to net income<br>(loss) attributed to shareholders for 2023 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2022. |
|---|---|
| ^(2)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
| --- | --- |
Canada’s net income attributed to shareholders was $227 million in 2Q23 compared with a net loss attributed to shareholders of $611 million and transitional net income attributed to shareholders of $271 million in 2Q22. The 2Q22 transitional net income includes a $882 million gain from IFRS 9 transitional impacts. Net income attributed to shareholders is comprised of core earnings, which were $374 million in 2Q23 compared with $366 million in 2Q22, and items excluded from core earnings, which amounted to a net charge of $147 million in 2Q23 compared with a net charge of $977 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis amounted to a net charge of $95 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of quarterly core earnings to net income (loss) attributed to shareholders for 2Q23 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2Q22. See section A2 “Profitability” above, for explanations of the items excluded from core earnings.
Core earnings in 2Q23 increased $8 million or 2% compared with 2Q22, primarily reflecting higher expected investment earnings due to higher investment yields and business growth, and higher Manulife Bank earnings, largely offset by a slower CSM amortization on certain VFA contracts and less favourable net insurance experience driven by unfavourable experience in Individual Insurance partially offset by higher experience gains in Group Insurance.
Year-to-date net income attributed to shareholders was $536 million in 2023 compared with a year-to-date net loss attributable to shareholders of $1,283 million and year-to-date transitional net income attributed to shareholders of $597 million in the same period of 2022. The year-to-date transitional net income includes a gain of $1,880 million from IFRS 9 transitional adjustments. Year-to-date core earnings were $727 million in 2023 compared with $700 million in the same period of 2022. The increase in year-to-date core earnings of $27 million or 4% reflected higher expected investment earnings due to higher investment yields and business growth, higher Manulife Bank earnings, and favourable insurance experience gains, partially offset by a slower CSM amortization on certain VFA contracts and the impact of an increase in the corporate tax rate enacted in the fourth quarter of 2022 (“4Q22”). Items excluded from year-to-date core earnings were a net charge of $191 million in 2023 compared with a net charge of $1,983 million for the same period of 2022. Items excluded from year-to-date core earnings in 2022 on a transitional basis amounted to a net charge of $103 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders for 2023, and year-to-date core earnings and year-to-date transitional net income (loss) attributed to shareholders to year-to-date net income (loss) attributed to shareholders for 2022.
| ^1^ | Effective January 1, 2023, refinements were made to the allocations of corporate overhead and interest on surplus<br>among segments. Prior period comparative information has been restated to reflect the changes in segment reporting. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 22 |
| --- | --- |
Table of Contents
APE sales of $322 million in 2Q23 decreased by $39 million or 11% compared with 2Q22.
| • | Individual insurance APE sales in 2Q23 of $106 million were in line with 2Q22. |
|---|---|
| • | Group insurance APE sales in 2Q23 of $173 million decreased $20 million or 10% compared with 2Q22, primarily due to usual<br>variability in the group insurance market, as lower large-case sales were partially offset by higher mid-size business sales. |
| --- | --- |
| • | Annuities APE sales in 2Q23 of $43 million decreased $18 million or 30% compared with 2Q22, primarily due to lower sales of<br>segregated fund products. |
| --- | --- |
Year-to-date APE sales in 2023 were $615 million, $109 million or 15% lower than in the same period of 2022, primarily due to lower sales of segregated fund products and usual variability in the large-case group insurance market.
CSM was $3,656 million as at June 30, 2023, a decrease of $19 million compared with December 31, 2022. Organic CSM movement was an increase of $30 million for the first half of 2023 driven by the impact of new insurance business, expected movements related to finance income or expenses and insurance experience gains partially offset by amounts recognized for service provided in year-to-date earnings. Inorganic CSM movement was a decrease of $49 million for the first half of 2023 reflecting unfavourable impact of markets from equity market experience and unfavourable real estate experience on VFA contracts, partially offset by an in-force reinsurance transaction in 1Q23 in Individual Insurance.
Manulife Bank average net lending assets for the quarter were $24.9 billion as at June 30, 2023, up $0.2 billion or 1% compared with December 2022, driven by growth in residential mortgages.
Assets under management were $144.0 billion as at June 30, 2023, an increase of $1.4 billion or 1% compared with December 31, 2022, primarily reflecting the favourable market impacts and business growth.
Business highlights – In 2Q23, we:
| • | continued to expand our behavioural insurance program by making Manulife Vitality available on new Manulife Par<br>individual insurance policies, enabling more customers to get rewarded for making healthier lifestyle choices; |
|---|---|
| • | released our annual Wellness Report, which highlights the need for Canadian employers to offer more internal health and<br>wellness programs and services, as employees across Canada continue to struggle with the after-effects of the pandemic. Following the release of the report, we added new mental health tools and resources to our website for Group Benefits plan<br>sponsors to help them support their employees and develop workplace strategies to enhance company culture; and |
| --- | --- |
| • | reduced our call transfer rates by nearly half compared with 2Q22 in our Group Benefits contact centre, by leveraging<br>Amazon AWS Connect, which contributed to a 14% improvement in the contact centre’s transactional NPS. We continue to expand the use of this technology, which enables a more holistic digital customer experience and drives operational efficiency.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 23 |
| --- | --- |
Table of Contents
| B3 | U.S.^1^ | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unless otherwise stated) | |||||||||
| Canadian dollars | |||||||||
| Net income attributed to shareholders(1) | 183 | 186 | 355 | 369 | 1,240 | ||||
| U.S. dollars | |||||||||
| Net income attributed to shareholders(1) | 136 | US | 138 | US | 278 | US | 274 | US | 977 |
| ( millions, unless otherwise stated) | YTD Results | ||||||||
| Canadian dollars | |||||||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 183 | 186 | (1,226) | 369 | (1,825) | ||||
| Core earnings(1) | 458 | 385 | 428 | 843 | 721 | ||||
| Business performance: | |||||||||
| Annualized premium equivalent sales | 130 | 134 | 147 | 264 | 307 | ||||
| Contractual service margin | 4,106 | 4,080 | 4,026 | 4,106 | 4,026 | ||||
| Assets under management ( billions) | 199.4 | 204.4 | 195.7 | 199.4 | 195.7 | ||||
| Total invested assets ( billions) | 132.1 | 136.5 | 131.5 | 132.1 | 131.5 | ||||
| Total segregated funds invested net assets<br>( billions) | 67.3 | 67.9 | 64.2 | 67.3 | 64.2 | ||||
| U.S. dollars | |||||||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 136 | US | 138 | US | (961) | US | 274 | US | (1,434) |
| Core earnings(1) | 341 | 285 | 334 | 626 | 566 | ||||
| Business performance: | |||||||||
| Annualized premium equivalent sales | 97 | 99 | 114 | 196 | 241 | ||||
| Contractual service margin | 3,104 | 3,016 | 3,121 | 3,104 | 3,121 | ||||
| Assets under management ( billions) | 150.7 | 151.0 | 151.7 | 150.7 | 151.7 | ||||
| Total invested assets ( billions) | 99.8 | 100.8 | 101.9 | 99.8 | 101.9 | ||||
| Total segregated funds invested net assets<br>( billions) | 50.9 | 50.2 | 49.8 | 50.9 | 49.8 |
All values are in US Dollars.
| ^(1)^ | See “Non-GAAP and other financial measures” below for a reconciliation of quarterly core earnings to net income<br>(loss) attributed to shareholders for 2023 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2022. |
|---|
U.S.’s net income attributed to shareholders was $183 million in 2Q23 compared with a net loss attributed to shareholders of $1,226 million and transitional net income attributed to shareholders of $355 million in 2Q22. The 2Q22 transitional net income includes a $1,581 million gain from IFRS 9 transitional impacts. Net income attributed to shareholders is comprised of core earnings, which were $458 million in 2Q23 compared with $428 million in 2Q22, and items excluded from core earnings, which amounted to a net charge of $275 million in 2Q23 compared with a net charge of $1,654 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis amounted to a net charge of $73 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of quarterly core earnings to net income (loss) attributed to shareholders for 2Q23 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2Q22. See section A2 “Profitability” above, for explanations of the items excluded from core earnings. The changes in core earnings expressed in Canadian dollars were due to the factors described below. The change in core earnings reflected a $23 million favourable impact from the strengthening of the U.S. dollar compared with the Canadian dollar.
Expressed in U.S. dollars, the functional currency of the segment, net income attributed to shareholders was US$136 million in 2Q23 compared with a net loss attributed to shareholders of US$961 million and transitional net income attributed to shareholders of US$278 million in 2Q22. Core earnings were US$341 million in 2Q23 compared with US$334 million in 2Q22 and items excluded from core earnings were a net charge of US$205
| ^1^ | Effective January 1, 2023, we have made a number of changes to the composition of reporting segments to better align<br>our financial reporting with our business strategy and operations. Our international high net worth business was reclassified from U.S. Insurance in the U.S. segment to the Asia segment to reflect the contributions of our Bermuda operations<br>alongside the high net worth business that we report in our Singapore and Hong Kong operations. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been<br>restated to reflect the changes in segment reporting. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 24 |
| --- | --- |
Table of Contents
million in 2Q23 compared with a net charge of US$1,295 million in 2Q22. Items excluded from core earnings on a transitional basis in 2Q22 were a net charge of US$56 million.
Core earnings increased US$7 million or 2% compared with 2Q22 reflecting increased expected investment earnings driven by higher investment yields and business growth. This is partially offset by net unfavourable insurance claims experience and a slower CSM amortization on certain VFA contracts. Net unfavourable insurance claims experience was primarily due to less favourable life mortality experience and modestly more unfavourable long-term care claims experience.
Year-to-date net income attributed to shareholders was US$274 million in 2023 compared with a net loss attributable to shareholders of US$1,434 million and transitional net income attributed to shareholders of US$977 million in the same period of 2022. The year-to-date transitional net income includes a gain of US$2,411 million from IFRS 9 transitional adjustments. Year-to-date core earnings were US$626 million in 2023 compared with US$566 million in the same period of 2022. Year-to-date core earnings increased US$60 million mainly due to less unfavourable insurance claims experience, primarily driven by the non-recurrence of excess mortality claims related to COVID-19 in 1Q22, and increased expected investment earnings due to higher investment yields and business growth. These favourable drivers were partially offset by an increase in the ECL provision in 1Q23, driven by commercial mortgages, and lower CSM recognized into earnings in variable annuities due to the reinsurance of a significant portion of the block in the prior year and a slower CSM amortization on certain VFA contracts. Items excluded from year-to-date core earnings were a net charge of US$352 million in 2023 compared with a net charge of US$2,000 million for the same period of 2022. Items excluded from core earnings in 2022 on a transitional basis amounted to a net gain of US$411 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders for 2023 and year-to-date core earnings and year-to-date transitional net income (loss) to shareholders to year-to-date net income (loss) attributed to shareholders for 2022. Expressed in Canadian dollars, year-to-date core earnings reflected a $48 million favourable impact of changes in foreign currency exchange rates versus the Canadian dollar.
APE sales in 2Q23 of US$97 million decreased 15% compared with 2Q22 due to the adverse impact of higher short-term interest rates on accumulation insurance products, particularly for our higher net worth customers. Year-to-date APE sales in 2023 of US$196 million decreased 19% compared with the same period of 2022 due to the reasons outlined above. APE sales of products with the John Hancock Vitality PLUS feature represented 75% and 74% of overall U.S. sales in 2Q23 and year-to-date 2023, respectively, an increase from 71% in the same periods in 2022.
CSM was US$3,104 million as at June 30, 2023, an increase of US$51 million compared with December 31, 2022. Organic CSM movement was an increase of US$28 million for the first half of 2023 driven by the impact of new insurance business and expected movements related to finance income or expenses, partially offset by amounts recognized for service provided in year-to-date earnings and net unfavourable insurance experience. The net unfavourable insurance experience in organic CSM movement was due to unfavourable life insurance lapse and claims experience partially offset by favourable long-term care and annuities claims and lapse experience. Inorganic CSM movement was an increase of US$23 million for the first half of 2023 due to favourable market impacts from an increase in equity markets and higher interest rates on VFA contracts.
Assets under management were US$150.7 billion as at June 30, 2023, an increase of US$3.7 billion or 3% compared with December 31, 2022. The increase in total invested assets and segregated funds net assets was primarily due to the impact from markets, reflecting changes in interest rates and an increase in equity markets.
Business highlights – In 2Q23, we:
| • | furthered our mission of helping customers live longer, healthier, better lives by: |
|---|---|
| • | deepening our collaboration with ŌURA to offer John Hancock Vitality members discounts on ŌURA rings and the<br>ability to earn points for healthy sleep habits and mindfulness; and |
| --- | --- |
| • | offering upgraded underwriting opportunities to eligible life insurance applicants who demonstrate favorable health and<br>lifestyle behaviors. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 25 |
| --- | --- |
Table of Contents
| • | enhanced our digital capabilities which resulted in the following contributions: | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| • | receiving recognition from LIBRA Insurance Partners, the largest independently owned life insurance marketing organization<br>in the U.S.,^1^ as one of the carriers who provide a best-in-class experience on an electronic platform for permanent life insurance products; | ||||||||
| --- | --- | ||||||||
| • | eliminating over 3 million pieces of paper by completing our first e-delivery of life insurance policy prospectuses;<br>and | ||||||||
| --- | --- | ||||||||
| • | achieving a significant year-over-year increase in customer satisfaction specific to our life insurance website reflecting<br>enhanced self-service capabilities. | ||||||||
| --- | --- | ||||||||
| B4 | Global Wealth and Asset Management^2^ | ||||||||
| --- | --- | ||||||||
| YTD Results | |||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ( millions, unless otherwise stated) | |||||||||
| Profitability: | |||||||||
| Net income attributed to shareholders(1) | 317 | 297 | 150 | 614 | 433 | ||||
| Core earnings(1) | 320 | 287 | 327 | 607 | 671 | ||||
| Core EBITDA(2) | 424 | 393 | 448 | 817 | 919 | ||||
| Core EBITDA margin (%)(3) | 24.6% | 22.4% | 28.1% | 23.5% | 28.2% | ||||
| Business performance: | |||||||||
| Sales | |||||||||
| Wealth and asset management gross flows | 35,152 | 38,815 | 34,050 | 73,967 | 72,460 | ||||
| Wealth and asset management net flows | 2,187 | 4,440 | 1,662 | 6,627 | 8,496 | ||||
| Assets under management and administration ( billions) | 819.6 | 814.5 | 746.8 | 819.6 | 746.8 | ||||
| Total invested assets ( billions) | 5.5 | 5.6 | 5.7 | 5.5 | 5.7 | ||||
| Segregated funds net assets ( billions) | 238.7 | 235.6 | 213.3 | 238.7 | 213.3 | ||||
| Average assets under management and administration ( billions)(2) | 814.9 | 804.5 | 778.2 | 809.5 | 801.2 |
All values are in US Dollars.
| ^(1)^ | See “Non-GAAP and other financial measures” below for a reconciliation of quarterly core earnings to net income<br>(loss) attributed to shareholders for 2023 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2022. Transitional impacts in Global WAM are not material.<br> |
|---|---|
| ^(2)^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
| --- | --- |
| ^(3)^ | This item is a non-GAAP ratio. See “Non-GAAP and other financial measures” below for more information.<br> |
| --- | --- |
Global WAM’s net income attributed to shareholders was $317 million in 2Q23 compared with $150 million in 2Q22. Net income attributed to shareholders is comprised of core earnings, which were $320 million in 2Q23 compared with $327 million in 2Q22, and items excluded from core earnings, which amounted to a net charge of $3 million in 2Q23 compared with a net charge of $177 million in 2Q22. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of quarterly core earnings to net income (loss) attributed to shareholders for 2Q23 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2Q22. See section A2 “Profitability” above, for explanations of the items excluded from core earnings.
Core earnings in 2Q23 decreased $7 million or 6% compared with 2Q22, driven by an increase in workforce related costs, and lower earnings from seed capital investments due to repatriations. This was partially offset by an increase in net fee income from higher fee spread and business mix.
Core EBITDA was $424 million in 2Q23, a decrease of 8% compared with 2Q22, and core EBITDA margin was 24.6% in 2Q23, a decrease of 350 basis points compared with 2Q22, both driven by similar factors as noted above for core earnings. See section E3 “Non-GAAP and other financial measures” below, for additional information on core EBITDA and core EBITDA margin.
| ^1^ | Based on gross annual production according to Paradigm Partners International, a third-party research firm specializing in<br>the insurance landscape. |
|---|---|
| ^2^ | Effective January 1, 2023, we have made a number of changes to the composition of reporting segments to better align<br>our financial reporting with our business strategy and operations. Our investment in the start-up capital of segregated and mutual funds, and investment-related revenue and expense were reclassified from the Corporate and Other segment to the Global<br>WAM segment to more closely align with Global WAM’s management practices. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to reflect<br>the changes in segment reporting. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 26 |
| --- | --- |
Table of Contents
Year-to-date net income attributed to shareholders was $614 million in 2023 compared with $433 million in the same period of 2022 and year-to-date core earnings were $607 million in 2023 compared with $671 million in the same period of 2022. The decrease in year-to-date core earnings of $64 million or 13% reflected an increase in workforce related costs, as well as a decrease in net fee income from lower average AUMA due to equity and fixed income market declines in 2022, and lower earnings from seed capital investments due to repatriations. This was partially offset by an increase in net fee income from higher fee spread. Items excluded from year-to-date core earnings were a net gain of $7 million in 2023 compared with a net charge of $238 million in the same period of 2022. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders for 2023 and year-to-date core earnings and year-to-date transitional net income (loss) attributed to shareholders to year-to-date net income (loss) attributed to shareholders for 2022.
Year-to-date core EBITDA was $817 million in 2023 compared with $919 million in the same period of 2022. The decrease in year-to-date core EBITDA of $102 million or 14% was driven by similar factors as noted above for year-to-date core earnings. Year-to-date core EBITDA margin was 23.5% in 2023 compared with 28.2% in the same period of 2022. The decrease of 470 basis points was driven by similar factors as noted above for year-to-date core earnings. See section E3 “Non-GAAP and other financial measures” below, for additional information on year-to-date core EBITDA and year-to-date core EBITDA margin.
Gross flows were $35.2 billion in 2Q23, in line^1^ with 2Q22. By business line, the results were:
| • | Retirement gross flows in 2Q23 were $13.8 billion, an increase of 8% compared with 2Q22, driven by higher new pension plan<br>sales and growth in member contributions. |
|---|---|
| • | Retail gross flows in 2Q23 were $13.6 billion, a decrease of 21% compared with 2Q22, due to lower investor demand amid<br>continued equity market and interest rate volatility. This was partially offset by higher sales in mainland China where 2Q23 gross flows reflected the impact of acquiring full ownership interest of Manulife Fund Management^2^ (“MFM”) in 4Q22. |
| --- | --- |
| • | Institutional Asset Management gross flows in 2Q23 were $7.7 billion, an increase of 47% compared with 2Q22, primarily<br>driven by higher sales in mainland China from acquiring full ownership interest of MFM as mentioned above, and higher fixed income and timberland sales, partially offset by the non-recurrence of a $1.9 billion equity mandate sale in 2Q22.<br> |
| --- | --- |
Year-to-date gross flows were $74.0 billion in 2023, a decrease of 2% compared with the same period of 2022, mainly driven by lower retail sales from lower investor demand. This was partially offset by higher retail and institutional sales in mainland China from acquiring full ownership interest of MFM and new institutional product launches totaling $1.6 billion in 1Q23.
Net inflows were $2.2 billion in 2Q23 compared with net inflows of $1.7 billion in 2Q22. By business line, the results were:
| • | Net inflows in Retirement were $0.7 billion in 2Q23 compared with net inflows of $1.0 billion in 2Q22. The decrease<br>reflected higher pension plan redemptions and member withdrawals, partially offset by higher gross flows as mentioned above. |
|---|---|
| • | Net outflows in Retail were $0.1 billion in 2Q23 compared with net outflows of $1.9 billion in 2Q22, driven by lower mutual<br>fund redemption rates, partially offset by lower gross flows as mentioned above. |
| --- | --- |
| • | Net inflows in Institutional Asset Management were $1.6 billion in 2Q23 compared with inflows of $2.5 billion in 2Q22,<br>mainly driven by higher redemptions and the non-recurrence of a $1.9 billion equity mandate sale in 2Q22. This was partially offset by higher sales in mainland China from acquiring full ownership interest of MFM, and higher fixed income and<br>timberland gross flows. |
| --- | --- |
Year-to-date net inflows were $6.6 billion in 2023, compared with $8.5 billion in same period of 2022. The decrease was primarily due to lower retail net inflows from lower investor demand, and lower retirement net inflows
| ^1^ | Percentage growth / declines in gross flows is stated on a constant exchange rate basis. |
|---|---|
| ^2^ | Manulife Fund Management was formerly known as Manulife TEDA Fund Management Co, LTD (“MTEDA”). In 4Q22, we<br>acquired full ownership in MTEDA by purchasing the remaining 51% of the shares from our joint venture partner. Starting in 1Q23, we report 100% of the gross and net flows from MFM, compared with reporting only 49% of the joint venture’s gross<br>and net flows in 2022. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 27 |
| --- | --- |
Table of Contents
from higher pension plan redemptions. This was partially offset by higher institutional net inflows in mainland China from acquiring full ownership interest of MFM and new product launches in 1Q23.
Assets under management and administration of $819.6 billion as at June 30, 2023 increased 8% compared with December 31, 2022. The increase was driven by the favourable year-to-date impact of markets and net inflows. As at June 30, 2023, Global WAM also managed $203.8 billion in assets for the Company’s non-WAM reporting segments. Including those managed assets, AUMA managed by Global WAM^1^ was $1,023.4 billion compared with $984.3 billion as at December 31, 2022.
Segregated funds net assets were $238.7 billion as at June 30, 2023, 6% higher compared with December 31, 2022 on an actual exchange rate basis, driven by the favourable year-to-date impact of markets. Total invested assets in our general fund form a small portion of Global WAM AUMA.
Business highlights – In 2Q23, we:
| • | announced the launch of our industry-first ESG themed funds in Manulife Mandatory Provident Fund (“MPF”) in Hong<br>Kong Retirement. This makes our flagship MPF scheme the first in the MPF market to provide both sustainable equity and fixed income investment options; and |
|---|---|
| • | announced a new partnership with Envestnet in Canada Retail that will provide advisors with a leading-edge portfolio<br>management platform to deliver a better client experience and improve advisor productivity. The Envestnet platform is a market tested portfolio management solution which will give advisors access to advanced trading and modelling capabilities,<br>streamlined workflows and automated tasks, more robust and client-friendly reporting, and the ability to manage accounts in a unified structure. These benefits will enable advisors to increase their efficiency and focus on their client relationships<br>and business growth. This partnership signifies another successful step in our digital transformation journey as a leader of advice in Canada. |
| --- | --- |
B5 Corporate and Other^2^
| Quarterly Results | YTD Results | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unless otherwise stated) | 2Q23 | |||||||||
| Net income (loss) attributed to shareholders^(1)^ | $ | 168 | 95 | (381) | 263 | (755) | ||||
| Quarterly Results | YTD Results | |||||||||
| ($ millions, unless otherwise stated) | 2Q23 | |||||||||
| Net income (loss) attributed to<br>shareholders^(1)^ | $ | 168 | 95 | (381) | 263 | (752) | ||||
| Core earnings<br>(loss)^(1)^ | **** | 12 | 17 | (45) | 29 | (102) |
All values are in US Dollars.
| ^(1)^ | See “Non-GAAP and other financial measures” below for a reconciliation of quarterly core earnings to net income<br>(loss) attributed to shareholders for 2023 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2022. |
|---|
Corporate and Other is composed of investment performance on assets backing capital, net of amounts allocated to operating segments; financing costs; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); our Property and Casualty (“P&C”) Reinsurance business; as well as our run-off reinsurance operation including variable annuities and accident and health. In addition, for segment reporting purposes, consolidations and eliminations of transactions between operating segments are also included in Corporate and Other earnings.
Corporate and Other reported a net income attributed to shareholders of $168 million in 2Q23 compared with a net loss and transitional net loss attributed to shareholders of $381 million for 2Q22. The 2Q22 transitional net loss includes $nil million from IFRS 9 transitional impacts. Net income attributed to shareholders is comprised of core earnings, which was $12 million in 2Q23 compared with a core loss of $45 million in 2Q22, and the items excluded from core earnings which amounted to a net gain of $156 million in 2Q23 compared with a net charge of
| ^1^ | This item is a non-GAAP financial measure. See “Non-GAAP and other financial measures” below for more<br>information. |
|---|---|
| ^2^ | Effective January 1, 2023, we have made a number of changes to the composition of reporting segments to better align<br>our financial reporting with our business strategy and operations. Our investment in the start-up capital of segregated and mutual funds, and investment-related revenue and expense were reclassified from the Corporate and Other segment to the Global<br>WAM segment to more closely align with Global WAM’s management practices. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to reflect<br>the changes in segment reporting. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 28 |
| --- | --- |
Table of Contents
$336 million in 2Q22. Items excluded from core earnings in 2Q22 on a transitional basis amounted to a charge of $336 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of quarterly core earnings to net income (loss) attributed to shareholders for 2Q23 and quarterly core earnings and transitional net income (loss) attributed to shareholders to net income (loss) attributed to shareholders for 2Q22. See section A2 “Profitability” above, for explanations of the items excluded from core earnings.
The $57 million increase in core earnings was primarily related to higher yields on debt instruments net of higher cost of debt financing, and gains in our P&C Reinsurance business from updates to the provisions for estimated losses recorded in prior years. These items were partially offset by higher core expenses due to higher workforce related costs and investments in technologies, and lower expected investment income from a reduced public equity portfolio.
Year-to-date net income attributed to shareholders was $263 million in 2023 compared with a net loss attributable to shareholders of $752 million and a transitional net loss attributed to shareholders of $755 million in the same period of 2022. The year-to-date transitional net income includes a charge of $3 million from IFRS 9 transitional adjustments. The year-to-date core earnings was $29 million in 2023 compared with a core loss of $102 million in the same period of 2022. The increase in the year-to-date core earnings of $131 million was primarily driven by similar reasons mentioned above. Items excluded from the year-to-date core earnings were a net charge of $234 million in 2023 compared with a net charge of $650 million in the same period of 2022. Items excluded from year-to-date core earnings in 2022 on a transitional basis amounted to a net charge of $653 million. See section E3 “Non-GAAP and other financial measures” below, for a reconciliation of year-to-date core earnings to year-to-date net income (loss) attributed to shareholders for 2023 and year-to-date core earnings and year-to-date transitional net income (loss) attributed to shareholders to year-to-date net income (loss) attributed to shareholders for 2022.
| C | RISK MANAGEMENT AND RISK FACTORS UPDATE |
|---|
This section provides an update to our risk management practices and risk factors outlined in the 2022 MD&A. Text and tables in this section of the MD&A represent our disclosure on insurance, market, and liquidity risk in accordance with IFRS 7 “Financial Instruments – Disclosures” and/or IFRS 17 “Insurance Contracts”. Disclosures in accordance with IFRS 7 and/or IFRS 17 are identified by a vertical line in the left margin of each page. The identified text and tables represent an integral part of our unaudited Interim Consolidated Financial Statements.
| C1 | Variable annuity and segregated fund guarantees |
|---|---|
| As described in the MD&A in our 2022 Annual Report, guarantees on variable annuity products and segregated funds may include one or more of death,<br>maturity, income and withdrawal guarantees. Variable annuity and segregated fund guarantees are contingent and only payable upon the occurrence of the relevant event, if fund values at that time are below guarantee values. Depending on future equity<br>market levels, liabilities on current in-force business would be due primarily in the period from 2023 to 2043. | |
| --- | |
| We seek to mitigate a portion of the risks embedded in our retained (i.e. net of reinsurance) variable annuity and segregated fund guarantee business<br>through the combination of our dynamic and macro hedging strategies (see section C3 “Publicly traded equity performance risk” below). | |
| Manulife Financial Corporation – Second Quarter 2023 | 29 |
| --- | --- |
Table of Contents
| The table below shows selected information regarding the Company’s variable annuity and segregated fund investment-related guarantees gross and net<br>of reinsurance. |
|---|
Variable annuity and segregated fund guarantees, net of reinsurance
| June 30, 2023 | December 31, 2022 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at($ millions) | Guarantee<br><br><br>value^(1)^ | Fund<br>value | Amount at<br>risk^(1),(2),(3)^ | Guarantee<br>value^(1)^ | Fund<br>value | Amount at<br>risk^(1),(2),(3)^ | ||||||
| Guaranteed minimum income benefit | $ | 4,043 | $ | 2,752 | $ | 1,305 | $ | 4,357 | $ | 2,723 | $ | 1,639 |
| Guaranteed minimum withdrawal benefit | **** | 36,120 | **** | 33,644 | **** | 4,568 | 38,319 | 34,203 | 5,734 | |||
| Guaranteed<br>minimum accumulation benefit | **** | 19,530 | **** | 19,516 | **** | 161 | 20,035 | 19,945 | 221 | |||
| Gross living benefits^(4)^ | **** | 59,693 | **** | 55,912 | **** | 6,034 | 62,711 | 56,871 | 7,594 | |||
| Gross death<br>benefits^(5)^ | **** | 9,691 | **** | 16,725 | **** | 1,407 | 10,465 | 15,779 | 2,156 | |||
| Total gross of<br>reinsurance | **** | 69,384 | **** | 72,637 | **** | 7,441 | 73,176 | 72,650 | 9,750 | |||
| Living benefits reinsured | **** | 25,357 | **** | 23,532 | **** | 3,812 | 26,999 | 23,691 | 4,860 | |||
| Death benefits<br>reinsured | **** | 3,618 | **** | 2,635 | **** | 706 | 3,923 | 2,636 | 1,061 | |||
| Total<br>reinsured | **** | 28,975 | **** | 26,167 | **** | 4,518 | 30,922 | 26,327 | 5,921 | |||
| Total, netof reinsurance | $ | 40,409 | $ | 46,470 | $ | 2,923 | $ | 42,254 | $ | 46,323 | $ | 3,829 |
| ^(1)^ | Guarantee Value and Net Amount at Risk in respect of guaranteed minimum withdrawal business in Canada and the U.S. reflect the time value of money of these claims. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Amount at risk (in-the-money amount) is the excess of guarantee values over fund values on all policies where the guarantee value exceeds the fund value. For guaranteed minimum death benefit, the amount at risk is defined as the<br>current guaranteed minimum death benefit in excess of the current account balance and assumes that all claims are immediately payable. In practice, guaranteed death benefits are contingent and only payable upon the eventual death of policyholders if<br>fund values remain below guarantee values. For guaranteed minimum withdrawal benefit, the amount at risk assumes that the benefit is paid as a lifetime annuity commencing at the earliest contractual income start age. These benefits are also<br>contingent and only payable at scheduled maturity/income start dates in the future, if the policyholders are still living and have not terminated their policies and fund values remain below guarantee values. For all guarantees, the amount at risk is<br>floored at zero at the single contract level. | |||||||||||
| ^(3)^ | The amount at risk net of reinsurance at June 30, 2023 was $2,923 million (December 31, 2022 – $3,829 million) of which: US$509 million (December 31, 2022 – US$737 million) was on our U.S. business, $1,810 million<br>(December 31, 2022 – $2,154 million) was on our Canadian business, US$150 million (December 31, 2022 – US$275 million) was on our Japan business and US$181 million (December 31, 2022 – US$224 million) was related to Asia (other than<br>Japan) and our run-off reinsurance business. | |||||||||||
| ^(4)^ | Where a policy includes both living and death benefits, the guarantee in excess of the living benefit is included in the death benefit category as outlined in footnote 5. | |||||||||||
| ^(5)^ | Death benefits include standalone guarantees and guarantees in excess of living benefit guarantees where both death and living benefits are provided on a policy. | |||||||||||
| C2 | Caution related to sensitivities | |||||||||||
| --- | --- | |||||||||||
| In this document, we provide sensitivities and risk exposure measures for certain risks. These include sensitivities due to specific changes in market<br>prices and interest rate levels projected using internal models as at a specific date, and are measured relative to a starting level reflecting the Company’s assets and liabilities at that date. The risk exposures measure the impact of changing<br>one factor at a time and assume that all other factors remain unchanged. Actual results can differ significantly from these estimates for a variety of reasons including the interaction among these factors when more than one changes; changes in<br>liabilities from updates to non-economic assumptions, changes in business mix, effective tax rates and other market factors; and the general limitations of our internal models. For these reasons, the sensitivities should only be viewed as<br>directional estimates of the underlying sensitivities for the respective factors based on the assumptions outlined below. Given the nature of these calculations, we cannot provide assurance that the actual impact on contractual service margin, net<br>income attributed to shareholders, other comprehensive income attributed to shareholders, and total comprehensive income attributed to shareholders or on MLI’s LICAT ratio will be as indicated. | ||||||||||||
| --- |
Market movements affect LICAT capital sensitivities through the available capital, surplus allowance and required capital components of the regulatory capital framework. The LICAT available capital component is primarily affected by total comprehensive income and the CSM.
| C3 | Publicly traded equity performance risk |
|---|
As outlined in our 2022 Annual Report, we have net exposure to equity risk through asset and liability mismatches; our variable annuity guarantee dynamic hedging strategy is not designed to completely offset the sensitivity of insurance contract liabilities to all risks associated with the guarantees embedded in these products. The macro hedging strategy is designed to mitigate public equity risk arising from variable annuity guarantees not dynamically hedged and from other unhedged exposures in our insurance contracts (see pages 60 of our 2022 Annual Report).
| Manulife Financial Corporation – Second Quarter 2023 | 30 |
|---|
Table of Contents
Changes in public equity prices may impact other items including, but not limited to, asset-based fees earned on assets under management and administration or policyholder account value, and estimated profits and amortization of deferred policy acquisition and other costs. These items are not hedged.
| The tables below include the potential impacts from an immediate 10%, 20%<br>and 30% change in market values of publicly traded equities on contractual service margin, net income attributed to shareholders, other comprehensive income attributed to shareholders, and total comprehensive income attributed to shareholders. The<br>potential impact is shown after taking into account the impact of the change in markets on the hedge assets. While we cannot reliably estimate the amount of the change in dynamically hedged variable annuity guarantee liabilities that will not be<br>offset by the change in the dynamic hedge assets, we make certain assumptions for the purposes of estimating the impact on net income attributed to shareholders.<br> <br><br><br><br>This estimate assumes that the performance of the dynamic hedging program would not completely offset the gain/loss from the dynamically hedged variable annuity<br>guarantee liabilities. It assumes that the hedge assets are based on the actual position at the period end, and that equity hedges in the dynamic program offset 95% of the hedged variable annuity liability movement that occur as a result of market<br>changes.<br> <br><br> <br>It is also important to note that these estimates are illustrative, and that the<br>dynamic and macro hedging programs may underperform these estimates, particularly during periods of high realized volatility and/or periods where both interest rates and equity market movements are unfavourable. The adoption of IFRS 17 did not<br>change the method or assumptions used for deriving sensitivity information. |
|---|
Changes in equity markets impact our available and required components of the LICAT ratio. The second set of tables shows the potential impact to MLI’s LICAT ratio resulting from changes in public equity market values.
| Manulife Financial Corporation – Second Quarter 2023 | 31 |
|---|
Table of Contents
Potential immediate impact on net income attributed to shareholders arising from changes to public equity returns^(1)^
| As at June 30, 2023 | Net income attributed to shareholders | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions) | -30% | -20% | -10% | +10% | +20% | +30% | ||||||
| Underlying sensitivity | ||||||||||||
| Variable annuity guarantees^(2)^ | $ | (2,400) | $ | (1,470) | $ | (680) | $ | 570 | $ | 1,040 | $ | 1,430 |
| General fund<br>equity investments^(3)^ | **** | (1,490) | **** | (930) | **** | (460) | **** | 450 | **** | 900 | **** | 1,350 |
| Total underlying sensitivity before<br>hedging | **** | (3,890) | **** | (2,400) | **** | (1,140) | **** | 1,020 | **** | 1,940 | **** | 2,780 |
| Impact of macro<br>and dynamic hedge assets^(4)^ | **** | 840 | **** | 510 | **** | 230 | **** | (180) | **** | (330) | **** | (440) |
| Net potential impact on net income attributed to<br>shareholders after impact of hedging and before impact of reinsurance | **** | (3,050) | **** | (1,890) | **** | (910) | **** | 840 | **** | 1,610 | **** | 2,340 |
| Impact of<br>reinsurance | **** | 1,550 | **** | 960 | **** | 450 | **** | (380) | **** | (710) | **** | (980) |
| Netpotential impact on net income attributed to shareholders after impact of hedging and reinsurance | $ | (1,500) | $ | (930) | $ | (460) | $ | 460 | $ | 900 | $ | 1,360 |
| As at December 31, 2022 | Net income attributed to shareholders | |||||||||||
| ($ millions) | -30% | -20% | -10% | +10% | +20% | +30% | ||||||
| Underlying sensitivity | ||||||||||||
| Variable annuity guarantees^(2)^ | $ | (2,110) | $ | (1,310) | $ | (610) | $ | 530 | $ | 980 | $ | 1,360 |
| General fund<br>equity investments^(3)^ | (1,450) | (920) | (420) | 400 | 780 | 1,170 | ||||||
| Total underlying sensitivity before<br>hedging | (3,560) | (2,230) | (1,030) | 930 | 1,760 | 2,530 | ||||||
| Impact of macro<br>and dynamic hedge assets^(4)^ | 930 | 570 | 260 | (220) | (400) | (540) | ||||||
| Net potential impact on net income attributed to<br>shareholders after impact of hedging and before impact of reinsurance | (2,630) | (1,660) | (770) | 710 | 1,360 | 1,990 | ||||||
| Impact of<br>reinsurance | 1,170 | 740 | 350 | (310) | (580) | (810) | ||||||
| Netpotential impact on net income attributed to shareholders after impact of hedging and reinsurance | $ | (1,460) | $ | (920) | $ | (420) | $ | 400 | $ | 780 | $ | 1,180 |
| ^(1)^ | See “Caution related to sensitivities” above. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | For variable annuity contracts measured under VFA the impact of financial risk and changes in interest rates adjusts CSM, unless the risk mitigation option applies. The Company has elected to apply risk mitigation and therefore a<br>portion of the impact is reported in net income attributed to shareholders instead of adjusting the CSM. If the CSM for a group of variable annuity contracts is exhausted the full impact is reported in net income attributed to<br>shareholders. | |||||||||||
| ^(3)^ | This impact for general fund equity investments includes general fund investments supporting our insurance contract liabilities, investment in seed money investments (in segregated and mutual funds made by Global WAM segment) and<br>the impact on insurance contract liabilities related to the projected future fee income on variable universal life and other unit linked products. The impact does not include any potential impact on public equity weightings. The participating policy<br>funds are largely self-supporting and generate no material impact on net income attributed to shareholders as a result of changes in equity markets. | |||||||||||
| ^(4)^ | Includes the impact of assumed rebalancing of equity hedges in the macro and dynamic hedging program. The impact of dynamic hedge represents the impact of equity hedges offsetting 95% of the dynamically hedged variable annuity<br>liability movement that occurs as a result of market changes, but does not include any impact in respect of other sources of hedge ineffectiveness (e.g. fund tracking, realized volatility and equity, interest rate correlations different from<br>expected among other factors). | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 32 | |||||||||||
| --- | --- |
Table of Contents
Potential immediate impact on contractual service margin, other comprehensive income to shareholders, totalcomprehensive income to shareholders and MLI’s LICAT ratio from changes to public equity market values^(1),(2),(3)^
| As at June 30, 2023 | -30% | -20% | -10% | +10% | +20% | +30% | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable annuity guarantees reported in<br>CSM | $ | (3,790) | $ | (2,360) | $ | (1,100) | $ | 950 | $ | 1,760 | $ | 2,470 |
| Impact of risk mitigation - hedging^(4)^ | **** | 1,090 | **** | 660 | **** | 300 | **** | (240) | **** | (430) | **** | (570) |
| Impact of risk<br>mitigation - reinsurance^(4)^ | **** | 1,960 | **** | 1,220 | **** | 560 | **** | (480) | **** | (900) | **** | (1,250) |
| VA net of risk mitigation | **** | (740) | **** | (480) | **** | (240) | **** | 230 | **** | 430 | **** | 650 |
| General fund<br>equity | **** | (720) | **** | (520) | **** | (260) | **** | 260 | **** | 520 | **** | 780 |
| Contractual service margin ($ millions, pre-tax) | $ | (1,460) | $ | (1,000) | $ | (500) | $ | 490 | $ | 950 | $ | 1,430 |
| Other comprehensive income attributed toshareholders ($ millions, post-tax)^(5)^ | $ | (790) | $ | (530) | $ | (270) | $ | 260 | $ | 510 | $ | 750 |
| Total comprehensive income attributed toshareholders ($ millions, post-tax) | $ | (2,290) | $ | (1,460) | $ | (730) | $ | 720 | $ | 1,410 | $ | 2,110 |
| MLI’s LICAT ratio (change inpercentage points) | **** | (3) | **** | (2) | **** | (1) | **** | 1 | **** | 3 | **** | 4 |
| As at December 31, 2022, except MLI LICAT, which is as at<br>January 1, 2023^(6)^ | -30% | -20% | -10% | +10% | +20% | +30% | ||||||
| Variable annuity guarantees reported in<br>CSM | $ | (3,410) | $ | (2,140) | $ | (1,010) | $ | 890 | $ | 1,670 | $ | 2,360 |
| Impact of risk mitigation - hedging^(4)^ | 1,200 | 740 | 340 | (280) | (510) | (690) | ||||||
| Impact of risk<br>mitigation - reinsurance^(4)^ | 1,480 | 930 | 440 | (390) | (730) | (1,030) | ||||||
| VA net of risk mitigation | (730) | (470) | (230) | 220 | 430 | 640 | ||||||
| General fund<br>equity | (520) | (370) | (210) | 240 | 490 | 730 | ||||||
| Contractualservice margin ($ millions, pre-tax) | $ | (1,250) | $ | (840) | $ | (440) | $ | 460 | $ | 920 | $ | 1,370 |
| Other comprehensive income attributed toshareholders ($ millions, post-tax)^(5)^ | $ | (620) | $ | (410) | $ | (210) | $ | 210 | $ | (400) | $ | 600 |
| Total comprehensive income attributed toshareholders ($ millions, post-tax) | $ | (2,080) | $ | (1,330) | $ | (630) | $ | 610 | $ | (1,180) | $ | 1,780 |
| MLI’s LICAT ratio (change inpercentage points)^(6)^ | (3) | (2) | (1) | 1 | 2 | 3 | ||||||
| ^(1)^ | See “Caution related to sensitivities” above. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | This estimate assumes that the performance of the dynamic hedging program would not completely offset the gain/loss from the dynamically hedged variable annuity guarantee liabilities. It assumes that the hedge assets are based on<br>the actual position at the period end, and that equity hedges in the dynamic program offset 95% of the hedged variable annuity liability movement that occur as a result of market changes. | |||||||||||
| ^(3)^ | The Office of the Superintendent of Financial Institutions (“OSFI”) rules for segregated fund guarantees reflect full capital impacts of shocks over 20 quarters within a prescribed range. As such, the deterioration in<br>equity markets could lead to further increases in capital requirements after the initial shock. | |||||||||||
| ^(4)^ | For variable annuity contracts measured under VFA the impact of financial risk and changes in interest rates adjusts CSM, unless the risk mitigation option applies. The Company has elected to apply risk mitigation and therefore a<br>portion of the impact is reported in net income attributed to shareholders instead of adjusting the CSM. If the CSM for a group of variable annuity contracts is exhausted the full impact is reported in net income attributed to<br>shareholders. | |||||||||||
| ^(5)^ | The impact of financial risk and changes to interest rates for variable annuity contracts is not expected to generate sensitivity in Other Comprehensive Income. | |||||||||||
| ^(6)^ | LICAT capital sensitivity is based on the 2023 LICAT guideline that became effective January 1, 2023. | |||||||||||
| C4 | Interest rate and spread risk sensitivities and exposure measures | |||||||||||
| --- | --- | |||||||||||
| As at June 30, 2023, we estimated the sensitivity of our net income attributed to shareholders to a 50 basis point parallel decline in interest rates<br>to be a benefit of $100 million, and to a 50 basis point parallel increase in interest rates to be a charge of $100 million. | ||||||||||||
| --- | ||||||||||||
| The table below includes the potential impacts from a 50 basis point parallel move in interest rates on contractual service margin, net income attributed<br>to shareholders, other comprehensive income attributed to shareholders, and total comprehensive income attributed to shareholders. This includes a change in current government, swap and corporate rates for all maturities across all markets with no<br>change in credit spreads between government, swap and corporate rates. Also shown separately are the potential impacts from a 50 basis point parallel move in corporate spreads and a 20 basis point parallel move in swap spreads. The impacts reflect<br>the net impact of movements in asset values in liability and surplus segments and movements in the present value of cash flows for insurance contracts including those with cash flows that vary with the returns of underlying items where the present<br>value is measured by stochastic modelling. The adoption of IFRS 17 did not change the method or assumptions used for deriving sensitivity information. | ||||||||||||
| The disclosed interest rate sensitivities reflect the accounting designations of our financial assets and corresponding insurance contract liabilities. In<br>most cases these assets and liabilities are designated as fair value through other comprehensive income (“FVOCI”) and as a result, impacts from changes to interest rates are largely in other comprehensive income. There are also changes in<br>interest rates that impact the CSM for VFA contracts | ||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 33 | |||||||||||
| --- | --- |
Table of Contents
| that relate to amounts that are not passed through to policyholders. In addition, changes in interest rates impacts net income as it relates to<br>derivatives not in hedge accounting relationships and on VFA contracts where the CSM has been exhausted. | |
|---|---|
| The disclosed interest rate sensitivities assume no hedge accounting ineffectiveness, as our hedge accounting programs are optimized for parallel<br>movements in interest rates, leading to immaterial net income impacts under these shocks. However, the actual hedge ineffectiveness is sensitive to non-parallel interest rate movements and will depend on the shape and magnitude of the interest rate<br>movements which could lead to variations in the impact to net income attributed to shareholders. | |
| Our sensitivities vary across all regions in which we operate, and the impacts of yield curve changes will vary depending upon the geography where the<br>change occurs. Furthermore, the impacts from non-parallel movements may be materially different from the estimated impacts of parallel movements. | |
| The interest rate and spread risk sensitivities are determined in isolation of each other and therefore do not reflect the combined impact of changes in<br>government rates and credit spreads between government, swap and corporate rates occurring simultaneously. As a result, the impact of the summation of each individual sensitivity may be materially different from the impact of sensitivities to<br>simultaneous changes in interest rate and spread risk. | |
| The potential impacts also do not take into account other potential effects of changes in interest rate levels, for example, contractual service margin at<br>recognition on the sale of new business or lower interest earned on future fixed income asset purchases. | |
| The impacts do not reflect any potential effect of changing interest rates on the value of our ALDA. Rising interest rates could negatively impact the<br>value of our ALDA (see “Critical Actuarial and Accounting Policies – Fair Value of Invested Assets”, on page 96 of our 2022 Annual Report). More information on ALDA can be found under the section C5 “Alternative long-duration<br>asset performance risk”. | |
| A reduction in interest rates results in a neutral impact to the LICAT ratio while a rise in interest rates results in a small improvement to the LICAT ratio. This reflects the sum of the impacts on total comprehensive income, the<br>LICAT adjustments to earnings for the CSM and the surplus allowance. | |
| --- | |
| Manulife Financial Corporation – Second Quarter 2023 | 34 |
| --- | --- |
Table of Contents
Potential impacts on contractual service margin, net income attributed to shareholders, other comprehensive incomeattributed to shareholders, and total comprehensive income attributed to shareholders of an immediate parallel change in interest rates, corporate spreads or swap spreads relative to currentrates^(1),(2),(3),(4)^
| As at June 30, 2023 | Interest rates^(2),(3)^ | Corporate spreads^(4)^ | Swap spreads^(4)^ | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, post-tax except CSM) | -50bp | +50bp | -50bp | +50bp | -20bp | +20bp | ||||||
| CSM | $ | – | $ | – | $ | (100) | $ | – | $ | – | $ | – |
| Net income attributed to shareholders | **** | 100 | **** | (100) | **** | – | **** | – | **** | 200 | **** | (200) |
| Other comprehensive income attributed to<br>shareholders | **** | (300) | **** | 300 | **** | (300) | **** | 300 | **** | (200) | **** | 200 |
| Total<br>comprehensive income attributed to shareholders | **** | (200) | **** | 200 | **** | (300) | **** | 300 | **** | – | **** | – |
| As at December 31, 2022 | Interest rates^(2),(3)^ | Corporate spreads^(4)^ | Swap spreads^(4)^ | |||||||||
| ($ millions, post-tax except CSM) | -50bp | +50bp | -50bp | +50bp | -20bp | +20bp | ||||||
| CSM | $ | (100) | $ | – | $ | (100) | $ | – | $ | – | $ | – |
| Net income attributed to shareholders | 100 | (100) | – | – | 100 | (100) | ||||||
| Other comprehensive income attributed to<br>shareholders | (300) | 200 | – | – | (100) | 100 | ||||||
| Total<br>comprehensive income attributed to shareholders | (200) | 100 | – | – | – | – | ||||||
| ^(1)^ | See “Caution related to sensitivities” above. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Estimates include changes to the net actuarial gains/losses with respect to the Company’s pension obligations as a result of changes in interest rates. | |||||||||||
| ^(3)^ | Includes guaranteed insurance and annuity products, including variable annuity contracts as well as adjustable benefit products where benefits are generally adjusted as interest rates and investment returns change, a portion of<br>which have minimum credited rate guarantees. For adjustable benefit products subject to minimum rate guarantees, the sensitivities are based on the assumption that credited rates will be floored at the minimum. | |||||||||||
| ^(4)^ | The participating policy funds are largely self-supporting and generate no material impact as a result of changes in corporate and swap spreads. |
Swap spreads remain at low levels, and if they were to rise, this could generate material changes to net income attributed to shareholders.
Potential impact on MLI’s LICAT ratio of an immediate parallel change in interest rates, corporate spreads or swap spreads relative tocurrent rates^(1),(2),(3),(4),(5)^
| As at June 30, 2023 | Interest rates | Corporate spreads | Swap spreads | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (change in percentage points) | -50bp | +50bp | -50bp | +50bp | -20bp | +20bp | ||||||
| MLI’s LICAT ratio | **** | (1) | **** | 1 | **** | (4) | **** | 3 | **** | – | **** | – |
| As at January 1, 2023^(6)^ | Interest rates | Corporate spreads | Swap spreads | |||||||||
| (change in percentage points) | -50bp | +50bp | -50bp | +50bp | -20bp | +20bp | ||||||
| MLI’s LICAT ratio | (1) | 1 | (3) | 3 | – | – |
| ^(1)^ | See “Caution related to sensitivities” above. |
|---|---|
| ^(2)^ | In addition, estimates include changes to the net actuarial gains/losses with respect to the Company’s pension obligations as a result of changes in interest rates. |
| ^(3)^ | Includes guaranteed insurance and annuity products, including variable annuity contracts as well as adjustable benefit products where benefits are generally adjusted as interest rates and investment returns change, a portion of<br>which have minimum credited rate guarantees. For adjustable benefit products subject to minimum rate guarantees, the sensitivities are based on the assumption that credited rates will be floored at the minimum. |
| ^(4)^ | LICAT impacts do not reflect the impact of the scenario switch discussed below. |
| ^(5)^ | Under LICAT, spread movements are determined from a selection of investment grade bond indices with BBB and better bonds for each jurisdiction. For LICAT, we use the following indices: FTSE TMX Canada All Corporate Bond<br>Index, Barclays USD Liquid Investment Grade Corporate Index, and Nomura-BPI (Japan). LICAT impacts presented for corporate spreads do not reflect the impact of the scenario switch discussed below. |
| ^(6)^ | LICAT capital sensitivity is based on the 2023 LICAT guideline that became effective January 1, 2023. |
LICAT Scenario Switch
When interest rates decline past a certain threshold, reflecting the combined movement in risk-free rates and corporate spreads, a different prescribed interest rate stress scenario needs to be taken into account in the LICAT ratio calculation in accordance with OSFI guidelines for LICAT.
The LICAT guideline specifies four stress scenarios for interest rates and prescribes the methodology to determine the most adverse scenario to apply for each LICAT geographic region^1^ based on current market inputs and the Company’s balance sheet.
| ^1^ | LICAT geographic locations include North America, the United Kingdom, Europe, Japan, and Other Region.<br> |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 35 |
| --- | --- |
Table of Contents
With the current level of interest rates in 2Q23, the probability of a scenario switch has decreased significantly. We do not expect IFRS17 to materially affect the previously disclosed estimate of a potential switch in the scenarios of approximately a one-time six percentage point decrease in MLI’s LICAT ratio. Should a scenario switch be triggered in a LICAT geographic region, the full impact would be reflected immediately for non-participating products while the impact for participating products would be reflected over six quarters using a rolling average of interest rate risk capital, in line with the smoothing approach prescribed in the OSFI Advisory effective January 1, 2021 and the LICAT Guideline effective January 1, 2023.
The level of interest rates and corporate spreads that would trigger a switch in the scenarios is dependent on market conditions and movements in the Company’s asset and liability position. The scenario switch, if triggered, could reverse in response to subsequent increases in interest rates and/or corporate spreads.
| C5 | Alternative long-duration asset performance risk |
|---|---|
| The following table shows the potential impact on contractual service margin, net income attributed to shareholders, other comprehensive income attributed<br>to shareholders, and total comprehensive income attributed to shareholders resulting from an immediate 10% change in market values of ALDA. The adoption of IFRS 17 did not change the method or assumptions used for deriving sensitivity<br>information. | |
| --- | |
| ALDA includes commercial real estate, timber and farmland real estate, infrastructure, and private equities, some of which relate to energy^1^. | |
| The impacts do not reflect any future potential changes to non-fixed income return volatility. Refer to “C3 Publicly traded equity performance<br>risk” for more details. |
Potential immediate impacts on contractual service margin, net income attributed to shareholders, other comprehensive incomeattributed to shareholders, and total comprehensive income attributed to shareholders from changes in ALDA market values^(1)^
| As at | June 30, 2023 | December 31, 2022 | ||||||
|---|---|---|---|---|---|---|---|---|
| ($ millions, post-tax except CSM) | -10% | +10% | -10% | +10% | ||||
| CSM excluding NCI | $ | (100) | $ | 100 | $ | (100) | $ | 100 |
| Net income attributed to shareholders^(2)^ | **** | (2,500) | **** | 2,400 | (2,500) | 2,500 | ||
| Other comprehensive income attributed to<br>shareholders | **** | (100) | **** | 100 | (100) | 100 | ||
| Total<br>comprehensive income attributed to shareholders | **** | (2,600) | **** | 2,500 | (2,600) | 2,600 | ||
| ^(1)^ | See “Caution related to sensitivities” above. | |||||||
| --- | --- | |||||||
| ^(2)^ | Net income attributed to shareholders includes core earnings and the amounts excluded from core earnings. |
Potential immediate impact on MLI LICAT ratio arising from changes in ALDA market values^(1)^
| June 30, 2023 | January 1, 2023^(2)^ | |||||||
|---|---|---|---|---|---|---|---|---|
| (change in percentage points) | -10% | +10% | -10% | +10% | ||||
| MLI’s LICAT ratio | **** | (3) | **** | 3 | (3) | 3 | ||
| ^(1)^ | See “Caution Related to Sensitivities” above. | |||||||
| --- | --- | |||||||
| ^(2)^ | LICAT capital sensitivity is based on the 2023 LICAT guideline that became effective January 1, 2023.<br> | |||||||
| --- | --- | |||||||
| C6 | Foreign exchange risk sensitivities and exposure measures | |||||||
| --- | --- | |||||||
| We generally match the currency of our assets with the currency of the insurance and investment contract liabilities they support, with the objective of<br>mitigating risk of loss arising from foreign exchange rate changes. As at December 31, 2022, we did not have a material unmatched currency exposure. | ||||||||
| --- | ||||||||
| ^1^ | Energy includes Oil & Gas equity interests related to upstream and midstream assets, and Energy Transition<br>private equity interests in areas supportive of the transition to lower carbon forms of energy, such as wind, solar, batteries, magnets, etc. | |||||||
| --- | --- | |||||||
| Manulife Financial Corporation – Second Quarter 2023 | 36 | |||||||
| --- | --- |
Table of Contents
The following table shows the potential impact on core earnings of a 10% change in the value of the Canadian dollar relative to our other key operating currencies. Note that the impact of foreign currency exchange rates on items excluded from core earnings does not provide relevant information given the nature of these items.
Potential impact on core earnings of changes in foreign exchange rates^(1),(2)^
| As at December 31, 2022<br><br><br>($ millions) | +10%<br><br><br>strengthening | -10%<br><br><br>weakening | |||
|---|---|---|---|---|---|
| 10% change in the Canadian dollar relative to the U.S. dollar and the Hong Kong dollar | $ | (320 | ) | $ | 320 |
| 10% change in the Canadian dollar relative to the Japanese<br>yen | (40 | ) | 40 | ||
| ^(1)^ | This item is a non-GAAP financial measure. See “Non-GAAP and Other Financial Measures” below for more<br>information. | ||||
| --- | --- | ||||
| ^(2)^ | See “Caution Related to Sensitivities” above. | ||||
| --- | --- |
LICAT regulatory ratios are also sensitive to the fluctuations in the Canadian dollar relative to our other key operating currencies. The direction and materiality of this sensitivity varies across various capital metrics.
| C7 | Credit risk exposure measures |
|---|
We use the ECL impairment allowance model in accordance with IFRS to establish and maintain allowances on our debt instruments measured at FVOCI or amortized cost. ECL allowances are measured on a probability-weighted basis, based on four macroeconomic scenarios, and incorporate past events, current market conditions, and reasonable supportable information about future economic conditions.
We measure ECL allowances using a three-stage approach. We recognize the credit losses expected to result from defaults occurring within 12 months of the reporting date for financial instruments which have not experienced a significant increase in credit risk (Stage 1). Full lifetime ECLs are recognized following a significant increase in credit risk since original recognition or having become 30 days in arrears in principal or interest payments (Stage 2) and when financial instruments are considered credit-impaired (Stage 3). Interest income on Stage 3 financial instruments is determined based on the carrying amount of the asset, net of any credit loss allowance.
For more information on ECL, refer to note 25 of our Consolidated Financial Statements for the year ended December 31, 2022.
| C8 | Risk factors – strategic risk from changes in tax laws^1^ |
|---|
As noted in “Risk Management and Risk Factors – Strategic Risk Factors” in the MD&A in our 2022 Annual Report, we outlined risk factors that could impact our financial plans and ability to implement our business strategy. The macro-economic environment can be significantly impacted by the actions of both the government sector, including central banks, and the private sector. Changes in tax laws, tax regulations, or interpretations of such laws or regulations could make some of our products less attractive to consumers, could increase our corporate taxes or cause us to change the value of our deferred tax assets and liabilities as well as our tax assumptions included in the valuation of our policy liabilities. This could have a material adverse effect on our business, results of operations and financial condition.
| • | In 2021, 136 of the 140 members of the Organization for Economic Co-Operation and Development (“OECD”) / G20<br>Inclusive Framework agreed on a two-pillar solution to address tax challenges from the digital economy, and to close the gaps in international tax systems. These include a new approach to allocating certain profits of multinational entities amongst<br>countries and a global minimum income tax rate of 15%. On July 12, 2023, the Canadian government reaffirmed its commitment to the two-pillar solution and the target date of December 31, 2023 for implementation of the Pillar 2 global<br>minimum tax. This would first apply to the Company’s 2024 fiscal year if enacted on this timeline. The Company is closely monitoring developments and potential impacts and, in particular, for issues unique to the insurance industry. If enacted,<br>we expect an increase in the effective tax rate, pending further details on timing and specific implementation in both Canada and other affected countries. |
|---|---|
| ^1^ | See “Caution regarding forward-looking statements” below. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 37 |
| --- | --- |
Table of Contents
| • | Canada’s 2023 Budget statement proposed to deny financial institutions of the traditional tax deduction of dividends<br>received on shares of Canadian corporations when such shares are held as mark-to-market property. The affected property is a small component of the investment portfolio that supports the Company’s business. Should this rule be enacted as<br>proposed, the Company would expect its tax expense on investment income to increase starting in 2024, though not significantly. The resulting lower net investment income would also reduce the value of certain in-force insurance policies and put<br>pressure on policy pricing going forward. |
|---|---|
| D | CRITICAL ACTUARIAL AND ACCOUNTING POLICIES |
| --- | --- |
Disclosures in accordance with IFRS 7 and/or IFRS 17 are identified by a vertical line in the left margin of each page. The identified text and tables represent an integral part of our unaudited Interim Consolidated Financial Statements.
| D1 | Critical actuarial and accounting policies |
|---|
Our significant accounting policies are described in notes 1 and 25 to our Consolidated Financial Statements for the year ended December 31, 2022. The critical actuarial policies and estimation processes relating to the determination of insurance and investment contract liabilities are described in notes 5 and 6 of our unaudited Interim Consolidated Financial Statements for the three and six months ended June 30, 2023. The critical accounting policies and estimation processes relating to the assessment of control over other entities for consolidation, estimation of fair value of invested assets, evaluation of invested asset impairment under IAS 39, appropriate accounting for derivative financial instruments under IAS 39, determination of pension and other post-employment benefit obligations and expenses, accounting for income taxes and uncertain tax positions and valuation and impairment of goodwill and intangible assets are described starting on page 96 of our 2022 Annual Report. The critical accounting policies and estimation processes relating to the evaluation of invested asset impairment and appropriate accounting for derivative financial instruments under IFRS 9 are described starting on page 222 of our 2022 Annual Report.
| D2 | Sensitivity of earnings to changes in assumptions |
|---|
The following tables present information on how reasonably possible changes in assumptions made by the Company on insurance contracts’ non-economic risk variables and certain economic risk variables impact contractual service margin, net income attributed to shareholders, other comprehensive income attributed to shareholders and total comprehensive income attributed to shareholders. For non-economic risk variables, the impacts are shown separately gross and net of the impacts of reinsurance contracts held. The adoption of IFRS 17 did not change the method or assumptions used for deriving sensitivity information.
The analysis is based on a simultaneous change in assumptions across all business units and holds all other assumptions constant. In practice, experience for each assumption will frequently vary by geographic market and business, and assumption updates are made on a business/geographic specific basis. Actual results can differ materially from these estimates for a variety of reasons including the interaction among these factors when more than one changes, actual experience differing from the assumptions, changes in business mix, effective tax rates, and the general limitations of our internal models.
| Manulife Financial Corporation – Second Quarter 2023 | 38 |
|---|
Table of Contents
Potential impact on contractual service margin, net income attributed to shareholders, other comprehensive incomeattributed to shareholders, and total comprehensive income attributed to shareholders arising from changes to non-economic assumptions^(1)^ ****
| As at December 31, 2022 | CSM net of<br>NCI | Net income<br>attributed to<br>shareholders | Other<br>comprehensive<br>income attributed to<br>shareholders | Total<br>comprehensive<br>income attributed to<br>shareholders | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, post-tax except CSM) | Gross | Net | Gross | Net | Gross | Net | Gross | Net | ||||||||||||||||
| Policy related assumptions | ||||||||||||||||||||||||
| 2% adverse change in future mortalityrates^(2),(3),(5)^ | ||||||||||||||||||||||||
| Portfolios where an increase in rates increases<br>insurance contract liabilities | $ | (1,400 | ) | $ | (600 | ) | $ | 100 | $ | – | $ | 100 | $ | – | $ | 200 | $ | – | ||||||
| Portfolios where a decrease in rates increases<br>insurance contract liabilities | – | (500 | ) | (100 | ) | – | 100 | 100 | – | 100 | ||||||||||||||
| 5% adverse change in future morbidityrates^(4),(5),(6)^ | (1,100 | ) | (1,000 | ) | (3,600 | ) | (3,600 | ) | 600 | 600 | (3,000 | ) | (3,000 | ) | ||||||||||
| (incidence and termination) | ||||||||||||||||||||||||
| 10% change in future policy termination rates^(3),(5)^ | ||||||||||||||||||||||||
| Portfolios where an increase in rates increases<br>insurance contract liabilities | (500 | ) | (400 | ) | (100 | ) | (100 | ) | (100 | ) | (100 | ) | (200 | ) | (200 | ) | ||||||||
| Portfolios where a decrease in rates increases<br>insurance contract liabilities | (1,800 | ) | (1,200 | ) | – | (100 | ) | 400 | 300 | 400 | 200 | |||||||||||||
| 5%increase in future expense levels | (800 | ) | (700 | ) | – | – | – | – | – | – | ||||||||||||||
| ^(1)^ | The participating policy funds are largely self-supporting and experience gains or losses would generally result in changes to future dividends reducing the direct impact to the contractual service margin and shareholder<br>income. | |||||||||||||||||||||||
| --- | --- | |||||||||||||||||||||||
| ^(2)^ | An increase in mortality rates will generally increase insurance contract liabilities for life insurance contracts whereas a decrease in mortality rates will generally increase insurance contract liabilities for policies with<br>longevity risk such as payout annuities. | |||||||||||||||||||||||
| ^(3)^ | The sensitivity is measured for each direct insurance portfolio net of the impacts of any reinsurance held on the policies within that portfolio to determine if the overall insurance contract liabilities increased. | |||||||||||||||||||||||
| ^(4)^ | No amounts related to morbidity risk are included for policies where the insurance contract liability provides only for claims costs expected over a short period, generally less than one year, such as Group Life and<br>Health. | |||||||||||||||||||||||
| ^(5)^ | The impacts of the sensitivities on LTC for morbidity, mortality and lapse do not assume any offsets from the Company’s ability to contractually raise premium rates in such events, subject to state regulatory approval. In<br>practice, we would plan to file for rate increases equal to the amount of deterioration resulting from the sensitivity. | |||||||||||||||||||||||
| ^(6)^ | This includes a 5% deterioration in incidence rates and 5% deterioration in claim termination rates. |
Potential impact on contractual service margin, net income attributed to shareholders, other comprehensive income attributed toshareholders, and total comprehensive income attributed to shareholders arising from changes to non-economic assumptions on Long Term Care^(1)^
| As at December 31, 2022 | CSM net of NCI | Net income<br>attributed to<br>shareholders | Other<br>comprehensive<br>income attributed to<br>shareholders | Total<br>comprehensive<br>income attributed to<br>shareholders | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, post-tax except CSM) | Gross | Net | Gross | Net | Gross | Net | Gross | Net | ||||||||||||||
| Policy related assumptions | ||||||||||||||||||||||
| 2% adverse change in future mortality<br>rates^(2),(3)^ | $ | (400 | ) | $ | (400 | ) | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | ||||
| 5% adverse change in future morbidity incidence<br>rates^(2),(3)^ | (700 | ) | (700 | ) | (1,100 | ) | (1,100 | ) | 200 | 200 | (900 | ) | (900 | ) | ||||||||
| 5% adverse change in future morbidity claims<br>termination rates^(2),(3)^ | (700 | ) | (700 | ) | (1,800 | ) | (1,800 | ) | 300 | 300 | (1,500 | ) | (1,500 | ) | ||||||||
| 10% adverse change in future policy termination<br>rates^(2),(3)^ | (400 | ) | (400 | ) | – | – | 100 | 100 | 100 | 100 | ||||||||||||
| 5% increase<br>in future expense levels^(3)^ | (100 | ) | (100 | ) | – | – | – | – | – | – | ||||||||||||
| ^(1)^ | Translated from US$ at 1.3549 for 2022. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(2)^ | The impacts of the sensitivities on LTC for morbidity, mortality and lapse do not assume any offsets from the Company’s ability to contractually raise premium rates in such events, subject to state regulatory approval. In<br>practice, we would plan to file for rate increases equal to the amount of deterioration resulting from the sensitivities. | |||||||||||||||||||||
| ^(3)^ | The impact of favourable changes to all the sensitivities is relatively symmetrical. | |||||||||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 39 | |||||||||||||||||||||
| --- | --- |
Table of Contents
Potential impact on contractual service margin, net income attributed to shareholders, other comprehensive incomeattributed to shareholders, and total comprehensive income attributed to shareholders arising from changes to certain economic financial assumptions used in the determination of insurance contract liabilities^(1)^
| As at June 30, 2023<br><br><br>($ millions, post-tax except CSM) | CSM net of<br><br><br>NCI | Net income<br><br><br>attributed to<br>shareholders | Other<br>comprehensive<br>income<br><br><br>attributed to<br>shareholders | Total<br>comprehensive<br>income<br><br><br>attributed to<br>shareholders | ||||
|---|---|---|---|---|---|---|---|---|
| Financial assumptions | ||||||||
| 10 basis point reduction in ultimate spot<br>rate | $ | (300) | $ | – | $ | (300) | $ | (300) |
| 50 basis point increase in interest rate<br>volatility^(2)^ | **** | (100) | – | – | – | |||
| 50 basis<br>point increase in non-fixed income return volatility^(2)^ | **** | (100) | – | – | – | |||
| As at December 31, 2022<br><br><br>($ millions, post-tax except CSM) | CSM net of<br>NCI | Net income<br><br><br>attributed to<br>shareholders | Other<br>comprehensive<br>income<br><br><br>attributed to<br>shareholders | Total<br>comprehensive<br>income<br><br><br>attributed to<br>shareholders | ||||
| Financial assumptions | ||||||||
| 10 basis point reduction in ultimate spot<br>rate | $ | (300) | $ | – | $ | (300) | $ | (300) |
| 50 basis point increase in interest rate<br>volatility^(2)^ | (100) | – | – | – | ||||
| 50 basis<br>point increase in non-fixed income return volatility^(2)^ | (100) | – | – | – | ||||
| ^(1)^ | Note that the impact of these assumptions are not linear. | |||||||
| --- | --- | |||||||
| ^(2)^ | Used in the determination of insurance contract liabilities with financial guarantees. This includes universal Life minimum crediting rate guarantees, participating life zero dividend floor implicit guarantees, and variable<br>annuities guarantees, where a stochastic approach is used to capture the asymmetry of the risk. | |||||||
| D3 | Accounting and reporting changes | |||||||
| --- | --- |
Manulife adopted IFRS 17 and IFRS 9 effective for years beginning on January 1, 2023, to be applied retrospectively. See “Future Accounting and Reporting Changes” in the MD&A in our 2022 Annual Report (“2022 MD&A”). Our 2022 results have been restated for the adoption of IFRS 17, including the classification transition option, and IFRS 9. For other accounting and reporting changes during the quarter, refer to note 2 of our unaudited Interim Consolidated Financial Statements for the three and six months ended June 30, 2023.
| E | OTHER |
|---|---|
| E1 | Outstanding common shares – selected information |
| --- | --- |
As at July 31, 2023, MFC had 1,828,737,429 common shares outstanding.
| E2 | Legal and regulatory proceedings |
|---|
We are regularly involved in legal actions, both as a defendant and as a plaintiff. Information on legal and regulatory proceedings can be found in note 13 of our unaudited Interim Consolidated Financial Statements for the three and six months ended June 30, 2023.
| E3 | Non-GAAP and other financial measures |
|---|
The Company prepares its Consolidated Financial Statements in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. We use a number of non-GAAP and other financial measures to evaluate overall performance and to assess each of our businesses. This section includes information required by National Instrument 52-112 –Non-GAAP and Other Financial Measures Disclosure in respect of “specified financial measures” (as defined therein).
Non-GAAP financialmeasures include core earnings (loss); pre-tax core earnings; core earnings available to common shareholders; core earnings before income taxes, depreciation and amortization (“core EBITDA”); total expenses; core expenses; total expenditures; core expenditures; transitional net income (loss) attributed to shareholders; transitional net income (loss) attributed to shareholders before tax; transitional net income (loss) before income taxes; transitional net income (loss); common shareholders’ transitional net income; Drivers of Earnings (“DOE”) line items for net investment result, other, income tax (expense) recovery and transitional net income attributed to participating policyholders and NCI; core DOE line items for core net insurance service result,
| Manulife Financial Corporation – Second Quarter 2023 | 40 |
|---|
Table of Contents
core net investment result, other core earnings, and core income tax (expense) recovery; post-tax contractual service margin (“post-tax CSM”); post-tax contractual service margin net of NCI (“post-tax CSM net of NCI”); Manulife Bank net lending assets; Manulife Bank average net lending assets; assets under management (“AUM”); assets under management and administration (“AUMA”); Global WAM managed AUMA; core revenue; adjusted book value; and net annualized fee income. In addition, non-GAAP financial measures include the following stated on a constant exchange rate (“CER”) basis: any of the foregoing non-GAAP financial measures, net income attributed to shareholders, and common shareholders’ net income.
Non-GAAP ratios include core return on shareholders’ equity (“core ROE”); diluted core earnings per common share (“core EPS”); transitional return on common shareholders’ equity (“transitional ROE”); transitional basic earnings per common share (“transitional basic EPS”); transitional diluted earnings per common share (“transitional diluted EPS”); financial leverage ratio; adjusted book value per common share; common share core dividend payout ratio (“dividend payout ratio”); expense efficiency ratio; expenditure efficiency ratio; core EBITDA margin; effective tax rate on core earnings; effective tax rate on transitional net income attributed to shareholders; and net annualized fee income yield on average AUMA. In addition, non-GAAP ratios include the percentage growth/decline on a CER basis in any of the above non-GAAP financial measures, net income attributed to shareholders, common shareholders’ net income, pre-tax net income attributed to shareholders, general expenses, DOE line item for net insurance service result, CSM, CSM net of NCI, impact of new insurance business, new business CSM net of NCI, basic earnings per common share (“basic EPS”), and diluted earnings per common share (“diluted EPS”).
Other specified financial measures include assets under administration (“AUA”); consolidated capital; embedded value (“EV”); new business value (“NBV”); new business value margin (“NBV margin”); sales; annualized premium equivalent (“APE”) sales; gross flows; net flows; average assets under management and administration (“average AUMA”), Global WAM average managed AUMA; average assets under administration; remittances; any of the foregoing specified financial measures stated on a CER basis; and percentage growth/decline in any of the foregoing specified financial measures on a CER basis. In addition, we provide an explanation below of the components of core DOE line items other than the change in expected credit loss, the items that comprise certain items excluded from core earnings, and the components of CSM movement other than the new business CSM.
Our reporting currency for the Company is Canadian dollars and U.S. dollars is the functional currency for Asia and U.S. segment results. Financial measures presented in U.S. dollars are calculated in the same manner as the Canadian dollar measures. These amounts are translated to U.S. dollars using the period end rate of exchange for financial measures such as AUMA and the CSM balance and the average rates of exchange for the respective quarter for periodic financial measures such as our income statement, core earnings and items excluded from core earnings, transitional net income measures, and line items in our CSM movement schedule and DOE. Year-to-date or full year periodic financial measures presented in U.S. dollars are calculated as the sum of the quarterly results translated to U.S. dollars. See section E5 “Quarterly Financial Information” below for the Canadian to U.S. dollar quarterly rates of exchange.
Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and, therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they should not be considered in isolation or as a substitute for any other financial information prepared in accordance with GAAP.
Core earnings (loss) is a financial measure which we believe aids investors in better understanding the long-term earnings capacity and valuation of the business. Core earnings allows investors to focus on the Company’s operating performance by excluding the impact of market related gains or losses, changes in actuarial methods and assumptions that flow directly through income as well as a number of other items, outlined below, that we believe are material, but do not reflect the underlying earnings capacity of the business. For example, due to the long-term nature of our business, the mark-to-market movements in equity markets, interest rates including impacts on hedge ineffectiveness, foreign currency exchange rates and commodity prices as well as the change in the fair value of ALDA from period-to-period can, and frequently do, have a substantial impact on the reported amounts of our assets, insurance contract liabilities and net income attributed to shareholders. These reported
| Manulife Financial Corporation – Second Quarter 2023 | 41 |
|---|
Table of Contents
amounts may not be realized if markets move in the opposite direction in a subsequent period. This makes it very difficult for investors to evaluate how our businesses are performing from period-to-period and to compare our performance with other issuers.
We believe that core earnings better reflect the underlying earnings capacity and valuation of our business. We use core earnings and core EPS as key metrics in our short-term incentive plans at the total Company and operating segment level. We also base our mid- and long-term strategic priorities on core earnings.
We have updated our definition of core earnings to reflect the change in the recognition, measurement and presentation of insurance contract liabilities and financial assets and liabilities under IFRS 17 and IFRS 9, respectively, and have also replaced the nomenclature of the items included in core earnings and the net income items excluded from core earnings to conform with the nomenclature under IFRS 17 and IFRS 9.
Core earnings includes the expected return on our invested assets and any other gains (charges) from market experience are included in net income but excluded from core earnings. The expected return for fixed income assets is based on the related book yields. For ALDA and public equities, the expected return reflects our long-term view of asset class performance. These returns for ALDA and public equities vary by asset class and range from 3.25% to 11.5%, leading to an average return of between 9.0% to 9.5% on these assets as of June 30, 2023.
While core earnings is relevant to how we manage our business and offers a consistent methodology, it is not insulated from macroeconomic factors which can have a significant impact. See below for a reconciliation of core earnings to net income attributed to shareholders and income before income taxes. Net income attributed to shareholders excludes net income attributed to participating policyholders and non-controlling interests.
Any future changes to the core earnings definition referred to below, will be disclosed.
Items included in core earnings:
| 1. | Expected insurance service result on in-force policies, including expected release of the risk adjustment, CSM recognized<br>for service provided, and expected earnings from short-term products measured under the premium allocation approach (“PAA”). |
|---|---|
| 2. | Impacts from the initial recognition of new contracts (onerous contracts, including the impact of the associated<br>reinsurance contracts). |
| --- | --- |
| 3. | Insurance experience gains or losses that flow directly through net income. |
| --- | --- |
| 4. | Operating and investment expenses compared with expense assumptions used in the measurement of insurance and investment<br>contract liabilities. |
| --- | --- |
| 5. | Expected investment earnings, which is the difference between expected return on our invested assets and the associated<br>finance income or expense from the insurance contract liabilities. |
| --- | --- |
| 6. | Net provision for ECL on FVOCI and amortized cost debt instruments. |
| --- | --- |
| 7. | Expected asset returns on surplus investments. |
| --- | --- |
| 8. | All earnings for the Global WAM segment, except for applicable net income items excluded from core earnings as noted<br>below. |
| --- | --- |
| 9. | All earnings for the Manulife Bank business, except for applicable net income items excluded from core earnings as noted<br>below. |
| --- | --- |
| 10. | Routine or non-material legal settlements. |
| --- | --- |
| 11. | All other items not specifically excluded. |
| --- | --- |
| 12. | Tax on the above items. |
| --- | --- |
| 13. | All tax related items except the impact of enacted or substantively enacted income tax rate changes and taxes on items<br>excluded from core earnings. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 42 |
| --- | --- |
Table of Contents
Net income items excluded from core earnings:
| 1. | Market experience gains (losses) including the items listed below: |
|---|---|
| • | Gains (charges) on general fund public equity and ALDA investments from returns being different than expected.<br> |
| --- | --- |
| • | Gains (charges) on derivatives not in hedging relationships, or gains (charges) resulting from hedge accounting<br>ineffectiveness. |
| --- | --- |
| • | Realized gains (charges) from the sale of FVOCI debt instruments. |
| --- | --- |
| • | Market related gains (charges) on onerous contracts measured using the variable fee approach (e.g. variable annuities, unit<br>linked, participating insurance) net of the performance on any related hedging instruments. |
| --- | --- |
| • | Gains (charges) related to certain changes in foreign exchange rates. |
| --- | --- |
| 2. | Changes in actuarial methods and assumptions used in the measurement of insurance contract liabilities that flow directly<br>through income. |
| --- | --- |
| • | The Company reviews actuarial methods and assumptions annually, and this process is designed to reduce the Company’s<br>exposure to uncertainty by ensuring assumptions remain appropriate. This is accomplished by monitoring experience and selecting assumptions which represent a current view of expected future experience and ensuring that the risk adjustment is<br>appropriate for the risks assumed. |
| --- | --- |
| • | Changes related to the ultimate spot rate within the discount curves are included in the market experience gains (losses).<br> |
| --- | --- |
| 3. | The impact on the measurement of insurance and investment contract liabilities from changes in product features and new<br>or changes to in-force reinsurance contracts, if material. |
| --- | --- |
| 4. | The fair value changes in long-term investment plan (“LTIP”) obligations for Global WAM investment management.<br> |
| --- | --- |
| 5. | Goodwill impairment charges. |
| --- | --- |
| 6. | Gains or losses on acquisition and disposition of a business. |
| --- | --- |
| 7. | Material one-time only adjustments, including highly unusual / extraordinary and material legal settlements and<br>restructuring charges, or other items that are material and exceptional in nature. |
| --- | --- |
| 8. | Tax on the above items. |
| --- | --- |
| 9. | Net income (loss) attributed to participating shareholders and non-controlling interests. |
| --- | --- |
| 10. | Impact of enacted or substantially enacted income tax rate changes. |
| --- | --- |
As noted in section A1 “Implementation of IFRS 17 and IFRS 9”, our 2022 quarterly and year-to-date results are not directly comparable with 2023 results because IFRS 9 hedge accounting and expected credit loss (“ECL”) principles are applied prospectively effective January 1, 2023. Accordingly, we have presented comparative quarterly and year-to-date 2022 core earnings and our transitional net income metrics (see “Transitional net income to shareholders” paragraph below) inclusive of IFRS 9 hedge accounting and expected credit loss principles as if IFRS had allowed such principles to be implemented for 2022 (the “IFRS 9 transitional impacts”).
Transitional net income (loss) attributed to shareholders is a financial measure where our 2022 net income attributed to shareholders includes the effects of the IFRS 9 transitional impacts which we believe will assist investors in evaluating our operational performance because the associated adjustments are reported in our 2023 net income attributed to shareholders. Transitional net income (loss) before income taxes, Transitional net income (loss), Transitional net income (loss) attributed to shareholders before income taxes and Common shareholders’ transitional net income (loss) similarly include the effect of the IFRS 9 transitional impacts on our income (loss) before income taxes, net income (loss), net income (loss) attributed to shareholders before income taxes and common shareholders’ net income (loss), respectively. Transitional financial measures are temporary and will be reported for 2022 comparative periods in our quarterly and annual 2023 MD&A.
| Manulife Financial Corporation – Second Quarter 2023 | 43 |
|---|
Table of Contents
Reconciliation of core earnings to net income attributed to shareholders
| ( millions, post-tax and based on actual foreign exchange rates in<br>effect in the applicable reporting period, unless otherwise stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Income (loss) before income taxes | 345 | $ | 312 | $ | 220 | $ | 362 | $ | 197 | $ | 1,436 |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (73) | **** | (97) | **** | (110) | **** | (45) | **** | 18 | **** | (307) |
| Items excluded from core earnings | (18) | **** | 33 | **** | 73 | **** | 1 | **** | (47) | **** | 42 |
| Income tax (expense) recovery | (91) | **** | (64) | **** | (37) | **** | (44) | **** | (29) | **** | (265) |
| Net income (post-tax) | 254 | **** | 248 | **** | 183 | **** | 318 | **** | 168 | **** | 1,171 |
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests (“NCI”) | 25 | **** | – | **** | – | **** | 1 | **** | – | **** | 26 |
| Participating policyholders | 99 | **** | 21 | **** | – | **** | – | **** | – | **** | 120 |
| Net income (loss) attributed to shareholders (post-tax) | 130 | **** | 227 | **** | 183 | **** | 317 | **** | 168 | **** | 1,025 |
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (297) | **** | (147) | **** | (275) | **** | (7) | **** | 156 | **** | (570) |
| Changes in actuarial methods and assumptions that flow directly through income | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Restructuring charge | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Reinsurance transactions, tax related items and other | (46) | **** | – | **** | – | **** | 4 | **** | – | **** | (42) |
| Core earnings (post-tax) | 473 | $ | 374 | $ | 458 | $ | 320 | $ | 12 | $ | 1,637 |
| Income tax on core earnings (see above) | 73 | **** | 97 | **** | 110 | **** | 45 | **** | (18) | **** | 307 |
| Core earnings (pre-tax) | 546 | $ | 471 | $ | 568 | $ | 365 | $ | (6) | $ | 1,944 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign exchangerates in effect in the<br>applicable reporting period, unless otherwise stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Core earnings (post-tax) | 473 | $ | 374 | $ | 458 | $ | 320 | $ | 12 | $ | 1,637 |
| CER<br>adjustment(1) | – | – | – | – | – | – | |||||
| Core earnings, CER basis (post-tax) | 473 | $ | 374 | $ | 458 | $ | 320 | $ | 12 | $ | 1,637 |
| Income tax on core earnings, CER basis(2) | 73 | **** | 97 | **** | 110 | **** | 45 | **** | (18) | **** | 307 |
| Core earnings, CER basis (pre-tax) | 546 | $ | 471 | $ | 568 | $ | 365 | $ | (6) | $ | 1,944 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 353 | $ | 341 | ||||||||
| CER adjustment US<br>(1) | – | – | |||||||||
| Core earnings, CER basis (post-tax), US | 353 | $ | 341 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q23.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 44 |
| --- | --- |
Table of Contents
Reconciliation of core earnings to net income attributed to shareholders
| ( millions, post-tax and based on actual foreign exchange rates in<br>effect in the applicable reporting period, unless otherwise stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Income (loss) before income taxes | 613 | $ | 423 | $ | 219 | $ | 345 | $ | 119 | $ | 1,719 |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (68) | (85) | (86) | (45) | 14 | (270) | |||||
| Items excluded from core earnings | (37) | (14) | 53 | (3) | (38) | (39) | |||||
| Income tax (expense) recovery | (105) | (99) | (33) | (48) | (24) | (309) | |||||
| Net income (post-tax) | 508 | 324 | 186 | 297 | 95 | 1,410 | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests (“NCI”) | 54 | – | – | – | – | 54 | |||||
| Participating policyholders | (65) | 15 | – | – | – | (50) | |||||
| Net income (loss) attributed to shareholders (post-tax) | 519 | 309 | 186 | 297 | 95 | 1,406 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | 30 | (44) | (166) | 9 | 106 | (65) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | – | – | – | – | – | – | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | – | – | (33) | 1 | (28) | (60) | |||||
| Core earnings (post-tax) | 489 | $ | 353 | $ | 385 | $ | 287 | $ | 17 | $ | 1,531 |
| Income tax on core earnings (see above) | 68 | 85 | 86 | 45 | (14) | 270 | |||||
| Core earnings (pre-tax) | 557 | $ | 438 | $ | 471 | $ | 332 | $ | 3 | $ | 1,801 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreignexchange rates in effect in the<br>applicable reporting period, unless otherwise stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Core earnings (post-tax) | 489 | $ | 353 | $ | 385 | $ | 287 | $ | 17 | $ | 1,531 |
| CER<br>adjustment(1) | (8) | – | (3) | (1) | – | (12) | |||||
| Core earnings, CER basis (post-tax) | 481 | $ | 353 | $ | 382 | $ | 286 | $ | 17 | $ | 1,519 |
| Income tax on core earnings, CER basis(2) | 67 | 85 | 85 | 45 | (14) | 268 | |||||
| Core earnings, CER basis (pre-tax) | 548 | $ | 438 | $ | 467 | $ | 331 | $ | 3 | $ | 1,787 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 361 | $ | 285 | ||||||||
| CER adjustment US<br>(1) | (2) | – | |||||||||
| Core earnings, CER basis (post-tax), US | 359 | $ | 285 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 1Q23.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 45 |
| --- | --- |
Table of Contents
Reconciliation of core earnings and transitional net income attributed to shareholders to net income attributed toshareholders
| ( millions, post-tax and based on actual foreign exchange rates<br>in effect in the applicable reporting period, unless otherwise stated) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Income (loss) before income taxes | 403 | $ | (37) | $ | (68) | $ | 461 | $ | (62) | $ | 697 |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (82) | (81) | (96) | (47) | 71 | (235) | |||||
| Items excluded from core earnings | (21) | 67 | 120 | (13) | 308 | 461 | |||||
| Income tax (expense) recovery | (103) | (14) | 24 | (60) | 379 | 226 | |||||
| Net income (post-tax) | 300 | (51) | (44) | 401 | 317 | 923 | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 32 | – | – | – | 1 | 33 | |||||
| Participating policyholders | (47) | 22 | – | – | – | (25) | |||||
| Net income (loss) attributed to shareholders (post-tax) | 315 | (73) | (44) | 401 | 316 | 915 | |||||
| IFRS 9 transitional impacts (post-tax) | 178 | 193 | (62) | – | 4 | 313 | |||||
| Transitional net income (loss) attributed to shareholders (post-tax) | 493 | 120 | (106) | 401 | 320 | 1,228 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | 12 | (136) | (514) | 45 | (62) | (655) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | – | – | – | – | – | – | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | (15) | (40) | – | 82 | 313 | 340 | |||||
| Core earnings (post-tax) | 496 | $ | 296 | $ | 408 | $ | 274 | $ | 69 | $ | 1,543 |
| Income tax on core earnings (see above) | 82 | 81 | 96 | 47 | (71) | 235 | |||||
| Core earnings (pre-tax) | 578 | $ | 377 | $ | 504 | $ | 321 | $ | (2) | $ | 1,778 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Core earnings (post-tax) | 496 | $ | 296 | $ | 408 | $ | 274 | $ | 69 | $ | 1,543 |
| CER<br>adjustment(1) | 3 | – | (5) | (2) | – | (4) | |||||
| Core earnings, CER basis (post-tax) | 499 | $ | 296 | $ | 403 | $ | 272 | $ | 69 | $ | 1,539 |
| Income tax on core earnings, CER basis(2) | 80 | 82 | 94 | 48 | (71) | 233 | |||||
| Core earnings, CER basis (pre-tax) | 579 | $ | 378 | $ | 497 | $ | 320 | $ | (2) | $ | 1,772 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 365 | $ | 301 | ||||||||
| CER adjustment US<br>(1) | 8 | – | |||||||||
| Core earnings, CER basis (post-tax), US | 373 | $ | 301 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 4Q22.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 46 |
| --- | --- |
Table of Contents
Reconciliation of core earnings and transitional net income attributed to shareholders to net income attributed toshareholders
| ( millions, post-tax and based on actual foreign exchange rates<br>in effect in the applicable reporting period, unless otherwise stated) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Income (loss) before income taxes | 266 | $ | 1,029 | $ | (607) | $ | 324 | $ | (528) | $ | 484 |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (54) | (94) | (83) | (51) | 13 | (269) | |||||
| Items excluded from core earnings | 11 | (92) | 243 | 14 | 33 | 209 | |||||
| Income tax (expense) recovery | (43) | (186) | 160 | (37) | 46 | (60) | |||||
| Net income (post-tax) | 223 | 843 | (447) | 287 | (482) | 424 | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 34 | – | – | – | – | 34 | |||||
| Participating policyholders | (91) | (10) | – | – | – | (101) | |||||
| Net income (loss) attributed to shareholders (post-tax) | 280 | 853 | (447) | 287 | (482) | 491 | |||||
| IFRS 9 transitional impacts (post-tax) | (104) | (372) | 761 | – | 1 | 286 | |||||
| Transitional net income (loss) attributed to shareholders (post-tax) | 176 | 481 | 314 | 287 | (481) | 777 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (202) | 43 | (98) | (67) | (251) | (575) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | (9) | 47 | (12) | – | – | 26 | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | – | – | (13) | – | – | (13) | |||||
| Core earnings (post-tax) | 387 | $ | 391 | $ | 437 | $ | 354 | $ | (230) | $ | 1,339 |
| Income tax on core earnings (see above) | 54 | 94 | 83 | 51 | (13) | 269 | |||||
| Core earnings (pre-tax) | 441 | $ | 485 | $ | 520 | $ | 405 | $ | (243) | $ | 1,608 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Core earnings (post-tax) | 387 | $ | 391 | $ | 437 | $ | 354 | $ | (230) | $ | 1,339 |
| CER<br>adjustment(1) | 13 | – | 12 | 7 | (5) | 27 | |||||
| Core earnings, CER basis (post-tax) | 400 | $ | 391 | $ | 449 | $ | 361 | $ | (235) | $ | 1,366 |
| Income tax on core earnings, CER basis(2) | 56 | 94 | 86 | 51 | (13) | 274 | |||||
| Core earnings, CER basis (pre-tax) | 456 | $ | 485 | $ | 535 | $ | 412 | $ | (248) | $ | 1,640 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 296 | $ | 335 | ||||||||
| CER adjustment US<br>(1) | 2 | – | |||||||||
| Core earnings, CER basis (post-tax), US | 298 | $ | 335 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 3Q22.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 47 |
| --- | --- |
Table of Contents
Reconciliation of core earnings and transitional net income attributed to shareholders to net income attributed toshareholders
| ( millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Income (loss) before income taxes | 49 | $ | (923) | $ | (1,561) | $ | 170 | $ | (391) | $ | (2,656) |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (64) | (88) | (101) | (60) | 12 | (301) | |||||
| Items excluded from core earnings | (35) | 415 | 436 | 40 | (2) | 854 | |||||
| Income tax (expense) recovery | (99) | 327 | 335 | (20) | 10 | 553 | |||||
| Net income (post-tax) | (50) | (596) | (1,226) | 150 | (381) | (2,103) | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 52 | – | – | – | – | 52 | |||||
| Participating policyholders | (51) | 15 | – | – | – | (36) | |||||
| Net income (loss) attributed to shareholders <br>(post-tax) | (51) | (611) | (1,226) | 150 | (381) | (2,119) | |||||
| IFRS 9 transitional impacts (post-tax) | (176) | 882 | 1,581 | – | – | 2,287 | |||||
| Transitional net income (loss) attributed to shareholders (post-tax) | (227) | 271 | 355 | 150 | (381) | 168 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (677) | (95) | (73) | (177) | (336) | (1,358) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | – | – | – | – | – | – | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | – | – | – | – | – | – | |||||
| Core earnings (post-tax) | 450 | $ | 366 | $ | 428 | $ | 327 | $ | (45) | $ | 1,526 |
| Income tax on core earnings (see above) | 64 | 88 | 101 | 60 | (12) | 301 | |||||
| Core earnings (pre-tax) | 514 | $ | 454 | $ | 529 | $ | 387 | $ | (57) | $ | 1,827 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Core earnings (post-tax) | 450 | $ | 366 | $ | 428 | $ | 327 | $ | (45) | $ | 1,526 |
| CER<br>adjustment(1) | 18 | – | 22 | 12 | – | 52 | |||||
| Core earnings, CER basis (post-tax) | 468 | $ | 366 | $ | 450 | $ | 339 | $ | (45) | $ | 1,578 |
| Income tax on core earnings, CER basis(2) | 65 | 88 | 106 | 62 | (12) | 309 | |||||
| Core earnings, CER basis (pre-tax) | 533 | $ | 454 | $ | 556 | $ | 401 | $ | (57) | $ | 1,887 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 353 | $ | 334 | ||||||||
| CER adjustment US<br>(1) | (5) | – | |||||||||
| Core earnings, CER basis (post-tax), US | 348 | $ | 334 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 2Q22.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 48 |
| --- | --- |
Table of Contents
Reconciliation of core earnings to net income attributed to shareholders
| ( millions, post-tax and based on actual foreign exchange rates ineffect in the applicable reporting period, unless otherwise stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Income (loss) before income taxes | 958 | $ | 735 | $ | 439 | $ | 707 | $ | 316 | $ | 3,155 |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (141) | **** | (182) | **** | (196) | **** | (90) | **** | 32 | **** | (577) |
| Items excluded from core earnings | (55) | **** | 19 | **** | 126 | **** | (2) | **** | (85) | **** | 3 |
| Income tax (expense) recovery | (196) | **** | (163) | **** | (70) | **** | (92) | **** | (53) | **** | (574) |
| Net income (post-tax) | 762 | **** | 572 | **** | 369 | **** | 615 | **** | 263 | **** | 2,581 |
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 79 | **** | – | **** | – | **** | 1 | **** | – | **** | 80 |
| Participating policyholders | 34 | **** | 36 | **** | – | **** | – | **** | – | **** | 70 |
| Net income (loss) attributed to shareholders (post-tax) | 649 | **** | 536 | **** | 369 | **** | 614 | **** | 263 | **** | 2,431 |
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (267) | **** | (191) | **** | (441) | **** | 2 | **** | 262 | **** | (635) |
| Changes in actuarial methods and assumptions that flow directly through income | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Restructuring charge | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Reinsurance transactions, tax related items and other | (46) | **** | – | **** | (33) | **** | 5 | **** | (28) | **** | (102) |
| Core earnings (post-tax) | 962 | $ | 727 | $ | 843 | $ | 607 | $ | 29 | $ | 3,168 |
| Income tax on core earnings (see above) | 141 | **** | 182 | **** | 196 | **** | 90 | **** | (32) | **** | 577 |
| Core earnings (pre-tax) | 1,103 | $ | 909 | $ | 1,039 | $ | 697 | $ | (3) | $ | 3,745 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Core earnings (post-tax) | 962 | $ | 727 | $ | 843 | $ | 607 | $ | 29 | $ | 3,168 |
| CER<br>adjustment(1) | (8) | **** | – | **** | (2) | **** | (1) | **** | (1) | **** | (12) |
| Core earnings, CER basis (post-tax) | 954 | $ | 727 | $ | 841 | $ | 606 | $ | 28 | $ | 3,156 |
| Income tax on core earnings, CER basis(2) | 140 | **** | 182 | **** | 195 | **** | 90 | **** | (32) | **** | 575 |
| Core earnings, CER basis (pre-tax) | 1,094 | $ | 909 | $ | 1,036 | $ | 696 | $ | (4) | $ | 3,731 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 714 | $ | 626 | ||||||||
| CER adjustment US<br>(1) | (2) | **** | – | ||||||||
| Core earnings, CER basis (post-tax), US | 712 | $ | 626 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the two<br>respective quarters that make up 2023 year-to-date core earnings. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 49 |
| --- | --- |
Table of Contents
Reconciliation of core earnings and transitional net income attributed to shareholders to net income attributed toshareholders
| ( millions, post-tax and based on actual foreign exchange rates<br>in effect in the applicable reporting period, unless otherwise stated) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Income (loss) before income taxes | 241 | $ | (1,961) | $ | (2,336) | $ | 506 | $ | (769) | $ | (4,319) |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (128) | (160) | (162) | (124) | 32 | (542) | |||||
| Items excluded from core earnings | (44) | 870 | 673 | 51 | (15) | 1,535 | |||||
| Income tax (expense) recovery | (172) | 710 | 511 | (73) | 17 | 993 | |||||
| Net income (post-tax) | 69 | (1,251) | (1,825) | 433 | (752) | (3,326) | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 54 | – | – | – | – | 54 | |||||
| Participating policyholders | (73) | 32 | – | – | – | (41) | |||||
| Net income (loss) attributed to shareholders (post-tax) | 88 | (1,283) | (1,825) | 433 | (752) | (3,339) | |||||
| IFRS 9 transitional impacts (post-tax) | (110) | 1,880 | 3,065 | – | (3) | 4,832 | |||||
| Transitional net income (loss) attributed to shareholders (post-tax) | (22) | 597 | 1,240 | 433 | (755) | 1,493 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (951) | (103) | 519 | (238) | (582) | (1,355) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | – | – | – | – | – | – | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | – | – | – | – | (71) | (71) | |||||
| Core earnings (post-tax) | 929 | $ | 700 | $ | 721 | $ | 671 | $ | (102) | $ | 2,919 |
| Income tax on core earnings (see above) | 127 | 160 | 162 | 124 | (32) | 541 | |||||
| Core earnings (pre-tax) | 1,056 | $ | 860 | $ | 883 | $ | 795 | $ | (134) | $ | 3,460 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Core earnings (post-tax) | 929 | $ | 700 | $ | 721 | $ | 671 | $ | (102) | $ | 2,919 |
| CER<br>adjustment(1) | 27 | – | 40 | 25 | 2 | 94 | |||||
| Core earnings, CER basis (post-tax) | 956 | $ | 700 | $ | 761 | $ | 696 | $ | (100) | $ | 3,013 |
| Income tax on core earnings, CER basis(2) | 130 | 160 | 171 | 127 | (32) | 556 | |||||
| Core earnings, CER basis (pre-tax) | 1,086 | $ | 860 | $ | 932 | $ | 823 | $ | (132) | $ | 3,569 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 731 | $ | 566 | ||||||||
| CER adjustment US<br>(1) | (19) | – | |||||||||
| Core earnings, CER basis (post-tax), US | 712 | $ | 566 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the two<br>respective quarters that make up 2022 year-to-date core earnings. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 50 |
| --- | --- |
Table of Contents
Reconciliation of core earnings and transitional net income attributed to shareholders to net income attributed toshareholders
| ( millions, post-tax and based on actual foreign exchange<br>rates in effect in the applicable reporting period, unless otherwise stated) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Income (loss) before income taxes | 910 | $ | (969) | $ | (3,011) | $ | 1,291 | $ | (1,359) | $ | (3,138) |
| Income tax (expense) recovery | |||||||||||
| Core earnings | (264) | (335) | (341) | (222) | 116 | (1,046) | |||||
| Items excluded from core earnings | (54) | 845 | 1,036 | 52 | 326 | 2,205 | |||||
| Income tax (expense) recovery | (318) | 510 | 695 | (170) | 442 | 1,159 | |||||
| Net income (post-tax) | 592 | (459) | (2,316) | 1,121 | (917) | (1,979) | |||||
| Less: Net income (post-tax) attributed to | |||||||||||
| Non-controlling interests | 120 | – | – | – | 1 | 121 | |||||
| Participating policyholders | (211) | 44 | – | – | – | (167) | |||||
| Net income (loss) attributed to shareholders (post-tax) | 683 | (503) | (2,316) | 1,121 | (918) | (1,933) | |||||
| IFRS 9 transitional impacts (post-tax) | (36) | 1,701 | 3,764 | – | 2 | 5,431 | |||||
| Transitional net income (loss) attributed to shareholders (post-tax) | 647 | 1,198 | 1,448 | 1,121 | (916) | 3,498 | |||||
| Less: Items excluded from core earnings (post-tax) | |||||||||||
| Market experience gains (losses) | (1,141) | (196) | (93) | (260) | (895) | (2,585) | |||||
| Changes in actuarial methods and assumptions that flow directly through income | (9) | 47 | (12) | – | – | 26 | |||||
| Restructuring charge | – | – | – | – | – | – | |||||
| Reinsurance transactions, tax related items and other | (15) | (40) | (13) | 82 | 242 | 256 | |||||
| Core earnings (post-tax) | 1,812 | $ | 1,387 | $ | 1,566 | $ | 1,299 | $ | (263) | $ | 5,801 |
| Income tax on core earnings (see above) | 263 | 335 | 341 | 222 | (116) | 1,045 | |||||
| Core earnings (pre-tax) | 2,075 | $ | 1,722 | $ | 1,907 | $ | 1,521 | $ | (379) | $ | 6,846 |
| Core earnings, CER basis and U.S. dollars | |||||||||||
| (Canadian millions, post-tax and based on actual foreign<br>exchange rates in effect in the applicable reporting period, unless otherwise<br>stated) | |||||||||||
| Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Core earnings (post-tax) | 1,812 | $ | 1,387 | $ | 1,566 | $ | 1,299 | $ | (263) | $ | 5,801 |
| CER<br>adjustment(1) | 43 | – | 48 | 30 | (4) | 117 | |||||
| Core earnings, CER basis (post-tax) | 1,855 | $ | 1,387 | $ | 1,614 | $ | 1,329 | $ | (267) | $ | 5,918 |
| Income tax on core earnings, CER basis(2) | 267 | 335 | 351 | 226 | (116) | 1,063 | |||||
| Core earnings, CER basis (pre-tax) | 2,122 | $ | 1,722 | $ | 1,965 | $ | 1,555 | $ | (383) | $ | 6,981 |
| Core earnings (U.S. dollars) – Asia and U.S. segments | |||||||||||
| Core earnings (post-tax)(3), US | 1,392 | $ | 1,202 | ||||||||
| CER adjustment US<br>(1) | (9) | – | |||||||||
| Core earnings, CER basis (post-tax), US | 1,383 | $ | 1,202 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
| --- | --- |
| ^(3)^ | Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for the 4<br>respective quarters that make up 2022 core earnings. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 51 |
| --- | --- |
Table of Contents
Segment core earnings by business line or geographic source
($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
Asia
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (US $ millions) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Hong Kong | $ | 161 | $ | 159 | $ | 153 | $ | 127 | $ | 184 | $ | 320 | $ | 388 | $ | 668 |
| Japan | **** | 81 | 62 | 76 | 71 | 81 | **** | 143 | 161 | 308 | ||||||
| Asia Other^(1)^ | **** | 119 | 137 | 126 | 102 | 93 | **** | 256 | 191 | 419 | ||||||
| International High Net Worth | 75 | |||||||||||||||
| Mainland China | 29 | |||||||||||||||
| Singapore | 136 | |||||||||||||||
| Vietnam | 109 | |||||||||||||||
| Other EmergingMarkets^(2)^ | 70 | |||||||||||||||
| Regional Office | **** | (8) | 3 | 10 | (4) | (5) | **** | (5) | (9) | (3) | ||||||
| Total Asia core earnings | $ | 353 | $ | 361 | $ | 365 | $ | 296 | $ | 353 | $ | 714 | $ | 731 | $ | 1,392 |
| ^(1)^ | Core earnings for Asia Other is reported by country annually, on a full year basis. | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(2)^ | Other Emerging Markets includes Indonesia, the Philippines, Malaysia, Thailand, Cambodia and Myanmar.<br> | |||||||||||||||
| --- | --- | |||||||||||||||
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| (US $ millions), CER basis^(1)^ | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Hong Kong | $ | 161 | $ | 159 | $ | 152 | $ | 127 | $ | 184 | $ | 320 | $ | 388 | $ | 668 |
| Japan | **** | 81 | 60 | 79 | 72 | 76 | **** | 141 | 144 | 294 | ||||||
| Asia Other^(2)^ | **** | 119 | 137 | 132 | 103 | 93 | **** | 256 | 189 | 424 | ||||||
| International High Net Worth | 75 | |||||||||||||||
| Mainland China | 28 | |||||||||||||||
| Singapore | 141 | |||||||||||||||
| Vietnam | 111 | |||||||||||||||
| Other EmergingMarkets^(3)^ | 69 | |||||||||||||||
| Regional Office | **** | (8) | 3 | 10 | (4) | (5) | **** | (5) | (9) | (3) | ||||||
| Total Asia core earnings, CER basis | $ | 353 | $ | 359 | $ | 373 | $ | 298 | $ | 348 | $ | 712 | $ | 712 | $ | 1,383 |
| ^(1)^ | Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(2)^ | Core earnings for Asia Other is reported by country annually, on a full year basis. | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(3)^ | Other Emerging Markets includes Indonesia, the Philippines, Malaysia, Thailand, Cambodia and Myanmar.<br> | |||||||||||||||
| --- | --- |
Canada
| YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Canadian millions) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| Insurance | 276 | $ | 257 | $ | 206 | $ | 283 | $ | 268 | $ | 533 | $ | 495 | $ | 984 |
| Annuities | 55 | 53 | 45 | 57 | 61 | **** | 108 | 136 | 238 | ||||||
| Manulife Bank | 43 | 43 | 45 | 51 | 37 | **** | 86 | 69 | 165 | ||||||
| Total Canada core earnings | 374 | $ | 353 | $ | 296 | $ | 391 | $ | 366 | $ | 727 | $ | 700 | $ | 1,387 |
All values are in US Dollars.
| Manulife Financial Corporation – Second Quarter 2023 | 52 |
|---|
Table of Contents
U.S.
| YTD Results | Full Year Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (US millions) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| U.S. Insurance | 293 | $ | 257 | $ | 259 | $ | 291 | $ | 297 | $ | 550 | $ | 466 | $ | 1,016 |
| U.S. Annuities | 48 | 28 | 42 | 44 | 37 | **** | 76 | 100 | 186 | ||||||
| Total U.S. core<br>earnings | 341 | $ | 285 | $ | 301 | $ | 335 | $ | 334 | $ | 626 | $ | 566 | $ | 1,202 |
All values are in US Dollars.
Global WAM by business line
| YTD Results | Full Year Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Canadian millions) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| Retirement | 186 | $ | 164 | $ | 156 | $ | 186 | $ | 161 | $ | 350 | $ | 331 | $ | 673 |
| Retail | 119 | 121 | 130 | 149 | 137 | **** | 240 | 292 | 571 | ||||||
| Institutional asset management | 15 | 2 | (12) | 19 | 29 | **** | 17 | 48 | 55 | ||||||
| Total Global WAM core earnings | 320 | $ | 287 | $ | 274 | $ | 354 | $ | 327 | $ | 607 | $ | 671 | $ | 1,299 |
| YTD Results | Full Year Results | ||||||||||||||
| (Canadian millions), CER basis(1) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| Retirement | 186 | $ | 164 | $ | 154 | $ | 191 | $ | 167 | $ | 350 | $ | 345 | $ | 690 |
| Retail | 119 | 120 | 130 | 151 | 141 | **** | 239 | 300 | 581 | ||||||
| Institutional asset management | 15 | 2 | (12) | 19 | 31 | **** | 17 | 51 | 58 | ||||||
| Total Global WAM core earnings, CER basis | 320 | $ | 286 | $ | 272 | $ | 361 | $ | 339 | $ | 606 | $ | 696 | $ | 1,329 |
All values are in US Dollars.
| ^(1)^ | Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
|---|
Global WAM by geographic source
| YTD Results | Full Year Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Canadian millions) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| Asia | 103 | $ | 84 | $ | 79 | $ | 82 | $ | 82 | $ | 187 | $ | 175 | $ | 336 |
| Canada | 96 | 88 | 78 | 113 | 104 | **** | 184 | 210 | 401 | ||||||
| U.S. | 121 | 115 | 117 | 159 | 141 | **** | 236 | 286 | 562 | ||||||
| Total Global WAM core earnings | 320 | $ | 287 | $ | 274 | $ | 354 | $ | 327 | $ | 607 | $ | 671 | $ | 1,299 |
All values are in US Dollars.
| YTD Results | Full Year Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Canadian millions), CER basis(1) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | **** | 2023 | 2022 | 2022 | ||||||
| Asia | 103 | $ | 83 | $ | 79 | $ | 85 | $ | 86 | $ | 186 | $ | 184 | $ | 348 |
| Canada | 96 | 88 | 78 | 112 | 104 | **** | 184 | 210 | 401 | ||||||
| U.S. | 121 | 115 | 115 | 164 | 149 | **** | 236 | 302 | 580 | ||||||
| Total Global WAM core earnings, CER basis | 320 | $ | 286 | $ | 272 | $ | 361 | $ | 339 | $ | 606 | $ | 696 | $ | 1,329 |
All values are in US Dollars.
| ^(1)^ | Core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 53 |
| --- | --- |
Table of Contents
Core earnings available to common shareholders is a financial measure that is used in the calculation of core ROE and core EPS. It is calculated as core earnings (post-tax) less preferred share dividends.
| ($ millions, and based on actual foreign<br><br><br>exchange rates in effect in the<br><br><br>applicable reporting period, unless<br> <br>otherwise stated) | Quarterly Results | YTD Results | Full Year<br><br><br>Results | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| Core earnings | $ | 1,637 | $ | 1,531 | $ | 1,543 | $ | 1,339 | $ | 1,526 | $ | 3,168 | $ | 2,919 | $ | 5,801 |
| Less: Preferred share dividends | **** | (98) | (52) | (97) | (51) | (60) | **** | (150) | (112) | (260) | ||||||
| Core earnings available to common shareholders | **** | 1,539 | 1,479 | 1,446 | 1,288 | 1,466 | **** | 3,018 | 2,807 | 5,541 | ||||||
| CER<br>adjustment^(1)^ | **** | – | (12) | (4) | 27 | 52 | **** | (12) | 94 | 117 | ||||||
| Core earnings available to common shareholders, CERbasis | $ | 1,539 | $ | 1,467 | $ | 1,442 | $ | 1,315 | $ | 1,518 | $ | 3,006 | $ | 2,901 | $ | 5,658 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- |
Core ROE measures profitability using core earnings available to common shareholders as a percentage of the capital deployed to earn the core earnings. The Company calculates core ROE using average common shareholders’ equity quarterly, as the average of common shareholders’ equity at the start and end of the quarter, and annually, as the average of the quarterly average common shareholders’ equity for the year.
| Quarterly Results | YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unless otherwise stated) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Core earnings available to common shareholders | $ | 1,539 | $ | 1,479 | $ | 1,446 | $ | 1,288 | $ | 1,466 | $ | 3,018 | $ | 2,807 | $ | 5,541 |
| Annualized core earnings available to commonshareholders | $ | 6,173 | $ | 5,998 | $ | 5,737 | $ | 5,110 | $ | 5,880 | $ | 6,086 | $ | 5,661 | $ | 5,541 |
| Average common shareholders’ equity (see below) | $ | 39,881 | $ | 40,465 | $ | 40,667 | $ | 40,260 | $ | 39,095 | $ | 40,173 | $ | 38,988 | $ | 39,726 |
| Core ROE (annualized) (%) | **** | 15.5% | 14.8% | 14.1% | 12.7% | 15.1% | **** | 15.2% | 14.5% | 14.0% | ||||||
| Average common shareholders’ equity | ||||||||||||||||
| Total shareholders’ and other equity | $ | 45,707 | $ | 47,375 | $ | 46,876 | $ | 47,778 | $ | 46,061 | $ | 45,707 | $ | 46,061 | $ | 46,876 |
| Less: Preferred shares and other equity | **** | 6,660 | 6,660 | 6,660 | 6,660 | 6,660 | **** | 6,660 | 6,660 | 6,660 | ||||||
| Common shareholders’ equity | $ | 39,047 | $ | 40,715 | $ | 40,216 | $ | 41,118 | $ | 39,401 | $ | 39,047 | $ | 39,401 | $ | 40,216 |
| Average common shareholders’ equity | $ | 39,881 | $ | 40,465 | $ | 40,667 | $ | 40,260 | $ | 39,095 | $ | 40,173 | $ | 38,988 | $ | 39,726 |
Core EPS is equal to core earnings available to common shareholders divided by diluted weighted average common shares outstanding. ****
Core earnings related to strategic priorities
The Company measures its progress on certain strategic priorities using core earnings, including core earnings from highest potential businesses. The core earnings for these businesses is calculated consistent with our definition of core earnings.
| For the six months ended June 30,<br><br><br>($ millions, post-tax and based on actual foreign exchange rates in effect<br> <br>in the<br>applicable reporting period) | 2023 | 2022 | ||
|---|---|---|---|---|
| Core earnings highest potential businesses^(1)^ | $ | 1,875 | $ | 1,790 |
| Core earnings - All other businesses | **** | 1,293 | 1,129 | |
| Core earnings | **** | 3,168 | 2,919 | |
| Items excluded from core earnings | **** | (737) | (1,426) | |
| Net income (loss) attributed to shareholders /Transitional | $ | 2,431 | $ | 1,493 |
| Less: IFRS 9 transitional impacts (post-tax) | **** | – | 4,832 | |
| Net income (loss) attributed to shareholders | $ | 2,431 | $ | (3,339) |
| Highest potential businesses core earningscontribution | **** | 59% | 61% | |
| ^(1)^ | Includes core earnings from Asia and Global WAM segments, Canada Group Benefits, and behavioural insurance products.<br> | |||
| --- | --- | |||
| Manulife Financial Corporation – Second Quarter 2023 | 54 | |||
| --- | --- |
Table of Contents
The effective tax rate on core earnings is equal to income tax on core earnings divided by pre-tax core earnings. The effective tax rate on net income attributed to shareholders is equal to income tax on transitional net income attributed to shareholders divided by pre-tax net income attributed to shareholders.
Common share core dividend payout ratio is a ratio that measures the percentage of core earnings paid to common shareholders as dividends. It is calculated as dividends per common share divided by core EPS.
| Quarterly Results | YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| Per share dividend | $ | 0.37 | $ | 0.37 | $ | 0.33 | $ | 0.33 | $ | 0.33 | $ | 0.73 | $ | 0.66 | $ | 1.32 |
| Core EPS | $ | 0.83 | $ | 0.79 | $ | 0.77 | $ | 0.68 | $ | 0.76 | $ | 1.63 | $ | 1.45 | $ | 2.90 |
| Common share core dividend payout ratio | **** | 44% | 46% | 43% | 49% | 43% | **** | 45% | **** | 45% | 46% |
Drivers of Earnings (“DOE”) is used to identify the primary sources of gains or losses in each reporting period. It is one of the key tools we use to understand and manage our business. The DOE has replaced the Source of Earnings that was disclosed under OSFI’s Source of Earnings Disclosure (Life Insurance Companies) guideline. The DOE line items are comprised of amounts that have been included in our financial statements. The DOE shows the sources of net income (loss) attributed to shareholders and the core DOE shows the sources of core earnings and the items excluded from core earnings, reconciled to net income attributed to shareholders. We have included transitional non-GAAP financial measures for our 2022 comparative quarterly results. The elements of the core earnings view are described below:
Net Insurance Service Result represents the net income attributed to shareholders associated with providing insurance service to policyholders within the period. This includes lines attributed to core earnings including: ****
| • | Expected earnings on insurance contracts which includes the release of risk adjustment for expired non-financial<br>risk, the CSM recognized for service provided and expected earnings on short-term PAA insurance business. |
|---|---|
| • | Impact of new insurance business relates to income at initial recognition from new insurance contracts. Losses would<br>occur if the group of new insurance contracts was onerous at initial recognition. If reinsurance contracts provide coverage for the direct insurance contracts, then the loss is offset by a corresponding gain on reinsurance contracts held.<br> |
| --- | --- |
| • | Insurance experience gains (losses) arise from items such as claims, persistency, and expenses, where the actual<br>experience in the current period differs from the expected results assumed in the insurance and investment contract liabilities. Generally, this line would be driven by claims and expenses, as persistency experience relates to future service and<br>would be offset by changes to the carrying amount of the contractual service margin unless the group is onerous, in which case the impact of persistency experience would be included in core earnings. |
| --- | --- |
| • | Other represents pre-tax transitional net income on residual items in the insurance result section.<br> |
| --- | --- |
Net Investment Result represents the net income attributed to shareholders associated with investment results within the period. Note that results associated with Global WAM and Manulife Bank are shown on separate DOE lines. However within the income statement, the results associated with these businesses would impact the total investment result. This section includes lines attributed to core earnings including:
| • | Expected investment earnings, which is the difference between expected asset returns and the associated finance<br>income or expense from insurance contract liabilities, net of investment expenses. |
|---|---|
| • | Change in expected credit loss, which is the gain or charge to net income attributed to shareholders for credit<br>losses to bring the allowance for credit losses to a level management considers adequate for expected credit-related losses on its portfolio. |
| --- | --- |
| • | Expected earnings on surplus reflects the expected investment return on surplus assets.<br> |
| --- | --- |
| • | Other represents pre-tax net income on residual items in the investment result section.<br> |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 55 |
| --- | --- |
Table of Contents
Global WAM is the pre-tax net income from the Global Wealth and Asset Management segment, adjusted for applicable items excluded from core earnings as noted in the core earnings (loss) section above.
Manulife Bank is the pre-tax net income from Manulife Bank, adjusted for applicable items excluded from core earnings as noted in the core earnings (loss) section above.
Other represents net income associated with items outside of the net insurance service result, net investment result, Global WAM and Manulife Bank. Other includes lines attributed to core earnings such as:
| • | Non-Directly Attributable Expenses are expenses incurred by the Company which are not directly attributable to<br>fulfilling insurance contracts. Non-directly attributable expenses excludes non-directly attributable investment expenses as they are included in the net investment result. |
|---|---|
| • | Other represents pre-tax net income on residual items in the Other section. Most notably this would include the cost<br>of financing debt issued by Manulife. |
| --- | --- |
Net income attributed to shareholders includes the following items excluded from core earnings:
| • | Market experience gains (losses) related to items excluded from core earnings that relate to changes in market<br>variables. |
|---|---|
| • | Changes in actuarial methods and assumptions that flow directly through income related to updates in the methods and<br>assumptions used to value insurance contract liabilities. |
| --- | --- |
| • | Restructuring charges includes a charge taken to reorganize operations. |
| --- | --- |
| • | Reinsurance transactions, tax-related items and other include the impacts of new or changes to in-force reinsurance<br>contracts, the impact of enacted or substantially enacted income tax rate changes and other amounts defined as items excluded from core earnings not specifically captured in the lines above. |
| --- | --- |
All of the above items are discussed in more details in our definition of items excluded from core earnings.
| Manulife Financial Corporation – Second Quarter 2023 | 56 |
|---|
Table of Contents
Drivers of Earnings (“DOE”) – 2Q23
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 2Q23 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 460 | $ | 262 | $ | 131 | $ | – | $ | 34 | $ | 887 |
| Net investment result | **** | (96) | **** | 12 | **** | 105 | **** | – | **** | 351 | **** | 372 |
| Global WAM | **** | – | **** | – | **** | – | **** | 362 | **** | – | **** | 362 |
| Manulife Bank | **** | – | **** | 59 | **** | – | **** | – | **** | – | **** | 59 |
| Other | **** | (19) | **** | (21) | **** | (16) | **** | – | **** | (188) | **** | (244) |
| Net income (loss) before income taxes | **** | 345 | **** | 312 | **** | 220 | **** | 362 | **** | 197 | **** | 1,436 |
| Income tax (expense) recovery | **** | (91) | **** | (64) | **** | (37) | **** | (44) | **** | (29) | **** | (265) |
| Net income (loss) | **** | 254 | **** | 248 | **** | 183 | **** | 318 | **** | 168 | **** | 1,171 |
| Less: Net income (loss) attributed to NCI | **** | (25) | **** | – | **** | – | **** | (1) | **** | – | **** | (26) |
| Less: Net income (loss) attributed to participating<br>policyholders | **** | (99) | **** | (21) | **** | – | **** | – | **** | – | **** | (120) |
| Net income (loss) attributed to shareholders(post-tax) | $ | 130 | $ | 227 | $ | 183 | $ | 317 | $ | 168 | $ | 1,025 |
| Reconciliations of DOE line items to the consolidated financialstatements and DOE presentation | ||||||||||||
| 2Q23 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 460 | $ | 262 | $ | 131 | $ | – | $ | 34 | $ | 887 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (44) | **** | (4) | **** | (26) | **** | – | **** | 1 | **** | (73) |
| NCI | **** | 13 | **** | – | **** | – | **** | – | **** | – | **** | 13 |
| Participating policyholders | **** | 122 | **** | 21 | **** | – | **** | – | **** | – | **** | 143 |
| Core net insurance result | **** | 369 | **** | 245 | **** | 157 | **** | – | **** | 33 | **** | 804 |
| Core net insurance result, CER adjustment^(1)^ | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Core net insurance result, CER basis | $ | 369 | $ | 245 | $ | 157 | $ | – | $ | 33 | $ | 804 |
| Total investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | (96) | $ | 354 | $ | 105 | $ | (244) | $ | 478 | $ | 597 |
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | **** | – | **** | (342) | **** | – | **** | 244 | **** | – | **** | (98) |
| Less: Consolidation adjustments^(2)^ | **** | – | **** | – | **** | – | **** | – | **** | (127) | **** | (127) |
| Less: Other | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Net investment result | **** | (96) | **** | 12 | **** | 105 | **** | – | **** | 351 | **** | 372 |
| Less: Net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (318) | **** | (184) | **** | (319) | **** | – | **** | 183 | **** | (638) |
| NCI | **** | 14 | **** | – | **** | – | **** | – | **** | – | **** | 14 |
| Participating policyholders | **** | (7) | **** | 14 | **** | – | **** | – | **** | – | **** | 7 |
| Core net investment result | **** | 215 | **** | 182 | **** | 424 | **** | – | **** | 168 | **** | 989 |
| Core net investment result, CER adjustment^(1)^ | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Core net investment result, CER basis | $ | 215 | $ | 182 | $ | 424 | $ | – | $ | 168 | $ | 989 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 59 | $ | – | $ | 362 | $ | – | $ | 421 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | **** | – | **** | – | **** | – | **** | (3) | **** | – | **** | (3) |
| Core earnings in Manulife Bank and Global WAM | **** | – | **** | 59 | **** | – | **** | 365 | **** | – | **** | 424 |
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 59 | $ | – | $ | 365 | $ | – | $ | 424 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 57 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 2Q23 (continued)
| 2Q23 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 47 | $ | 72 | $ | 16 | $ | 1,647 | $ | (91) | $ | 1,691 |
| General expenses per financial statements | **** | (61) | **** | (127) | **** | (25) | **** | (709) | **** | (101) | **** | (1,023) |
| Commission related to non-insurance contracts | **** | (2) | **** | (13) | **** | (3) | **** | (329) | **** | 11 | **** | (336) |
| Interest expense per financial statements | **** | (3) | **** | (236) | **** | (4) | **** | (5) | **** | (133) | **** | (381) |
| Total financial statements values included in Other | **** | (19) | **** | (304) | **** | (16) | **** | 604 | **** | (314) | **** | (49) |
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | **** | – | **** | 283 | **** | – | **** | (604) | **** | – | **** | (321) |
| Less: Consolidation adjustments^(1)^ | **** | – | **** | – | **** | – | **** | – | **** | 126 | **** | 126 |
| Other | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Other | **** | (19) | **** | (21) | **** | (16) | **** | – | **** | (188) | **** | (244) |
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | **** | 23 | **** | (1) | **** | (3) | **** | – | **** | 19 | **** | 38 |
| NCI | **** | 4 | **** | – | **** | – | **** | – | **** | – | **** | 4 |
| Participating policyholders | **** | 1 | **** | (3) | **** | – | **** | – | **** | – | **** | (2) |
| Add: Par earnings transfer to shareholders | **** | 9 | **** | 2 | **** | – | **** | – | **** | – | **** | 11 |
| Core Other | **** | (38) | **** | (15) | **** | (13) | **** | – | **** | (207) | **** | (273) |
| Core Other, CER adjustment^(2)^ | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Core Other, CER basis | $ | (38) | $ | (15) | $ | (13) | $ | – | $ | (207) | $ | (273) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (91) | $ | (64) | $ | (37) | $ | (44) | $ | (29) | $ | (265) |
| Less: Income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (4) | **** | 42 | **** | 73 | **** | 1 | **** | (47) | **** | 65 |
| NCI | **** | (6) | **** | – | **** | – | **** | – | **** | – | **** | (6) |
| Participating policyholders | **** | (8) | **** | (9) | **** | – | **** | – | **** | – | **** | (17) |
| Core income tax recovery (expense) | **** | (73) | **** | (97) | **** | (110) | **** | (45) | **** | 18 | **** | (307) |
| Core income tax recovery (expense), CER adjustment^(2)^ | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Core income tax recovery (expense), CER basis | $ | (73) | $ | (97) | $ | (110) | $ | (45) | $ | 18 | $ | (307) |
| Net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 460 | $ | 262 | $ | 131 | $ | – | $ | 34 | $ | 887 |
| Net investment result | **** | (96) | **** | 12 | **** | 105 | **** | – | **** | 351 | **** | 372 |
| Global WAM | **** | – | **** | – | **** | – | **** | 362 | **** | – | **** | 362 |
| Manulife Bank | **** | – | **** | 59 | **** | – | **** | – | **** | – | **** | 59 |
| Other | **** | (19) | **** | (21) | **** | (16) | **** | – | **** | (188) | **** | (244) |
| Net income (loss) before income taxes, CER basis | $ | 345 | $ | 312 | $ | 220 | $ | 362 | $ | 197 | $ | 1,436 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 58 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 1Q23
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 1Q23 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 370 | $ | 259 | $ | 173 | $ | – | $ | 47 | $ | 849 |
| Net investment result | 285 | 117 | 101 | – | 244 | 747 | ||||||
| Global WAM | – | – | – | 345 | – | 345 | ||||||
| Manulife Bank | – | 65 | – | – | – | 65 | ||||||
| Other | (42) | (18) | (55) | – | (172) | (287) | ||||||
| Net income (loss) before income taxes | 613 | 423 | 219 | 345 | 119 | 1,719 | ||||||
| Income tax (expense) recovery | (105) | (99) | (33) | (48) | (24) | (309) | ||||||
| Net income (loss) | 508 | 324 | 186 | 297 | 95 | 1,410 | ||||||
| Less: Net income (loss) attributed to NCI | (54) | – | – | – | – | (54) | ||||||
| Less: Net income (loss) attributed to participating<br>policyholders | 65 | (15) | – | – | – | 50 | ||||||
| Net income (loss) attributed to shareholders(post-tax) | $ | 519 | $ | 309 | $ | 186 | $ | 297 | $ | 95 | $ | 1,406 |
| Reconciliations of DOE line items to the consolidated financialstatements and DOE presentation | ||||||||||||
| 1Q23 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 370 | $ | 259 | $ | 173 | $ | – | $ | 47 | $ | 849 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | 26 | – | 1 | – | (1) | 26 | ||||||
| NCI | 40 | – | – | – | – | 40 | ||||||
| Participating policyholders | (51) | 26 | – | – | – | (25) | ||||||
| Core net insurance result | 355 | 233 | 172 | – | 48 | 808 | ||||||
| Core net insurance result, CER adjustment^(1)^ | (4) | (2) | – | – | (6) | |||||||
| Core net insurance result, CER basis | $ | 351 | $ | 233 | $ | 170 | $ | – | $ | 48 | $ | 802 |
| Total investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | 285 | $ | 463 | $ | 101 | $ | (260) | $ | 381 | $ | 970 |
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (346) | – | 260 | – | (86) | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (137) | (137) | ||||||
| Less: Other | – | – | – | – | – | – | ||||||
| Net investment result | 285 | 117 | 101 | – | 244 | 747 | ||||||
| Less: Net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | 34 | (40) | (200) | – | 81 | (125) | ||||||
| NCI | 24 | – | – | – | – | 24 | ||||||
| Participating policyholders | 3 | – | – | – | – | 3 | ||||||
| Core net investment result | 224 | 157 | 301 | – | 163 | 845 | ||||||
| Core net investment result, CER adjustment^(1)^ | (5) | – | (2) | – | 1 | (6) | ||||||
| Core net investment result, CER basis | $ | 219 | $ | 157 | $ | 299 | $ | – | $ | 164 | $ | 839 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 65 | $ | – | $ | 345 | $ | – | $ | 410 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | 5 | – | 13 | – | 18 | ||||||
| Core earnings in Manulife Bank and Global WAM | – | 60 | – | 332 | – | 392 | ||||||
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | – | – | – | (1) | – | (1) | ||||||
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 60 | $ | – | $ | 331 | $ | – | $ | 391 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 59 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 1Q23 (continued)
| 1Q23 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 10 | $ | 72 | $ | 24 | $ | 1,665 | $ | (80) | $ | 1,691 |
| General expenses per financial statements | (48) | (123) | (74) | (726) | (115) | (1,086) | ||||||
| Commission related to non-insurance contracts | (2) | (16) | (1) | (329) | 10 | (338) | ||||||
| Interest expense per financial statements | (2) | (232) | (4) | (5) | (124) | (367) | ||||||
| Total financial statements values included in Other | (42) | (299) | (55) | 605 | (309) | (100) | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 281 | – | (605) | – | (324) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 137 | 137 | ||||||
| Other | – | – | – | – | – | – | ||||||
| Other | (42) | (18) | (55) | – | (172) | (287) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | (9) | (1) | (53) | – | 36 | (27) | ||||||
| NCI | – | – | – | – | – | – | ||||||
| Participating policyholders | (2) | (3) | – | – | – | (5) | ||||||
| Add: Par earnings transfer to shareholders | 9 | 2 | – | – | – | 11 | ||||||
| Core Other | (22) | (12) | (2) | – | (208) | (244) | ||||||
| Core Other, CER adjustment^(2)^ | – | – | – | – | (1) | (1) | ||||||
| Core Other, CER basis | $ | (22) | $ | (12) | $ | (2) | $ | – | $ | (209) | $ | (245) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (105) | $ | (99) | $ | (33) | $ | (48) | $ | (24) | $ | (309) |
| Less: Income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | (21) | (8) | 53 | (3) | (38) | (17) | ||||||
| NCI | (10) | – | – | – | – | (10) | ||||||
| Participating policyholders | (6) | (6) | – | – | – | (12) | ||||||
| Core income tax recovery (expense) | (68) | (85) | (86) | (45) | 14 | (270) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | 1 | – | 1 | – | – | 2 | ||||||
| Core income tax recovery (expense), CER basis | $ | (67) | $ | (85) | $ | (85) | $ | (45) | $ | 14 | $ | (268) |
| Net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 366 | $ | 259 | $ | 172 | $ | – | $ | 47 | $ | 844 |
| Net investment result | 281 | 117 | 100 | – | 244 | 742 | ||||||
| Global WAM | – | – | – | 343 | – | 343 | ||||||
| Manulife Bank | – | 65 | – | – | – | 65 | ||||||
| Other | (30) | (14) | (2) | – | (209) | (255) | ||||||
| Net income (loss) before income taxes, CER basis | $ | 617 | $ | 427 | $ | 270 | $ | 343 | $ | 82 | $ | 1,739 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 60 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 4Q22
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 4Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 485 | $ | 301 | $ | 126 | $ | – | $ | 49 | $ | 961 |
| Transitional net investment result | 169 | (69) | (259) | – | 62 | (97) | ||||||
| Global WAM | – | – | – | 461 | – | 461 | ||||||
| Manulife Bank | – | 72 | – | – | – | 72 | ||||||
| Other | (39) | (27) | (15) | – | (167) | (248) | ||||||
| Transitional net income (loss) before income taxes | 615 | 277 | (148) | 461 | (56) | 1,149 | ||||||
| Transitional income tax (expense) recovery | (122) | (135) | 42 | (60) | 377 | 102 | ||||||
| Transitional net income (loss) | 493 | 142 | (106) | 401 | 321 | 1,251 | ||||||
| Less: Transitional net income (loss) attributed to NCI | (34) | – | – | – | (1) | (35) | ||||||
| Less: Transitional net income (loss) attributed to participating<br>policyholders | 34 | (22) | – | – | – | 12 | ||||||
| Transitional net income (loss) attributed to shareholders(post-tax) | $ | 493 | $ | 120 | $ | (106) | $ | 401 | $ | 320 | $ | 1,228 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| 4Q22 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 485 | $ | 301 | $ | 126 | $ | – | $ | 49 | $ | 961 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | 69 | 1 | 10 | – | (1) | 79 | ||||||
| NCI | 18 | – | – | – | – | 18 | ||||||
| Participating policyholders | 15 | 84 | – | – | – | 99 | ||||||
| Core net insurance result | 383 | 216 | 116 | – | 50 | 765 | ||||||
| Core net insurance result, CER adjustment^(1)^ | 2 | – | (2) | – | – | – | ||||||
| Core net insurance result, CER basis | $ | 385 | $ | 216 | $ | 114 | $ | – | $ | 50 | $ | 765 |
| Transitional net investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | (45) | $ | (60) | $ | (179) | $ | (149) | $ | 157 | $ | (276) |
| IFRS 9 transitional impacts | 214 | 312 | (80) | – | 7 | 453 | ||||||
| Total including transitional impacts | 169 | 252 | (259) | (149) | 164 | 177 | ||||||
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (324) | – | 149 | – | (175) | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (102) | (102) | ||||||
| Less: Other | – | 3 | – | – | – | 3 | ||||||
| Transitional net investment result | 169 | (69) | (259) | – | 62 | (97) | ||||||
| Less: Transitional net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | (54) | (189) | (662) | – | (75) | (980) | ||||||
| NCI | 31 | – | – | – | – | 31 | ||||||
| Participating policyholders | (15) | (2) | – | – | – | (17) | ||||||
| Core net investment result | 207 | 122 | 403 | – | 137 | 869 | ||||||
| Core net investment result, CER adjustment^(1)^ | 1 | – | (4) | – | – | (3) | ||||||
| Core net investment result, CER basis | $ | 208 | $ | 122 | $ | 399 | $ | – | $ | 137 | $ | 866 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 72 | $ | – | $ | 461 | $ | – | $ | 533 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | 5 | – | 140 | – | 145 | ||||||
| Core earnings in Manulife Bank and Global WAM | – | 67 | – | 321 | – | 388 | ||||||
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | – | – | – | (2) | – | (2) | ||||||
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 67 | $ | – | $ | 319 | $ | – | $ | 386 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 61 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 4Q22 (continued)
| 4Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 15 | $ | 67 | $ | 17 | $ | 1,646 | $ | (74) | $ | 1,671 |
| General expenses per financial statements | (42) | (135) | (29) | (715) | (81) | (1,002) | ||||||
| Commission related to non-insurance contracts | (3) | (14) | 2 | (316) | 11 | (320) | ||||||
| Interest expense per financial statements | (8) | (196) | (4) | (5) | (124) | (337) | ||||||
| Total financial statements values included in Other | (38) | (278) | (14) | 610 | (268) | 12 | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 252 | – | (610) | – | (358) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 101 | 101 | ||||||
| Other | (1) | (1) | (1) | – | – | (3) | ||||||
| Other | (39) | (27) | (15) | – | (167) | (248) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | – | – | – | – | 22 | 22 | ||||||
| NCI | – | – | – | – | – | – | ||||||
| Participating policyholders | (7) | (1) | – | – | – | (8) | ||||||
| Add: Par earnings transfer to shareholders | 20 | (2) | – | – | – | 18 | ||||||
| Core Other | (12) | (28) | (15) | – | (189) | (244) | ||||||
| Core Other, CER adjustment^(2)^ | (2) | – | – | – | 1 | (1) | ||||||
| Core Other, CER basis | $ | (14) | $ | (28) | $ | (15) | $ | – | $ | (188) | $ | (245) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (102) | $ | (14) | $ | 23 | $ | (60) | $ | 379 | $ | 226 |
| IFRS 9 transitional impacts | (20) | (121) | 19 | – | (2) | (124) | ||||||
| Transitional income tax recovery (expense) | (122) | (135) | 42 | (60) | 377 | 102 | ||||||
| Less: Transitional income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | (18) | 6 | 138 | (13) | 306 | 419 | ||||||
| NCI | (13) | – | – | – | – | (13) | ||||||
| Participating policyholders | (9) | (60) | – | – | – | (69) | ||||||
| Core income tax recovery (expense) | (82) | (81) | (96) | (47) | 71 | (235) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | 2 | (1) | 2 | (1) | – | 2 | ||||||
| Core income tax recovery (expense), CER basis | $ | (80) | $ | (82) | $ | (94) | $ | (48) | $ | 71 | $ | (233) |
| Net income (loss) attributed to NCI | $ | 32 | $ | – | $ | – | $ | – | $ | 1 | $ | 33 |
| IFRS 9 transitional impacts | 2 | – | – | – | – | 2 | ||||||
| Transitional net income (loss) to NCI | $ | 34 | $ | – | $ | – | $ | – | $ | 1 | $ | 35 |
| Net income (loss) attributed to participating policyholders | $ | (47) | $ | 22 | $ | – | $ | – | $ | – | $ | (25) |
| IFRS 9 transitional impacts | 13 | – | – | – | – | 13 | ||||||
| Transitional net income (loss) to participating<br>policyholders | $ | (34) | $ | 22 | $ | – | $ | – | $ | – | $ | (12) |
| Transitional net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 488 | $ | 301 | $ | 125 | $ | – | $ | 48 | $ | 962 |
| Net investment result | 168 | (69) | (256) | – | 62 | (95) | ||||||
| Global WAM | – | – | – | 457 | – | 457 | ||||||
| Manulife Bank | – | 73 | – | – | – | 73 | ||||||
| Other | (33) | (28) | (16) | – | (188) | (265) | ||||||
| Transitional net income (loss) before income taxes, CERbasis | $ | 623 | $ | 277 | $ | (147) | $ | 457 | $ | (78) | $ | 1,132 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 62 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 3Q22
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 3Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 296 | $ | 319 | $ | 40 | $ | – | $ | (206) | $ | 449 |
| Transitional net investment result | (99) | 260 | 334 | – | (125) | 370 | ||||||
| Global WAM | – | – | – | 324 | – | 324 | ||||||
| Manulife Bank | – | 66 | – | – | – | 66 | ||||||
| Other | (47) | (23) | (16) | – | (197) | (283) | ||||||
| Transitional net income (loss) before income taxes | 150 | 622 | 358 | 324 | (528) | 926 | ||||||
| Transitional income tax (expense) recovery | (20) | (151) | (44) | (37) | 47 | (205) | ||||||
| Transitional net income (loss) | 130 | 471 | 314 | 287 | (481) | 721 | ||||||
| Less: Transitional net income (loss) attributed to NCI | (33) | – | – | – | – | (33) | ||||||
| Less: Transitional net income (loss) attributed to participating<br>policyholders | 79 | 10 | – | – | – | 89 | ||||||
| Transitional net income (loss) attributed to shareholders(post-tax) | $ | 176 | $ | 481 | $ | 314 | $ | 287 | $ | (481) | $ | 777 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| 3Q22 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result—financial statements | $ | 296 | $ | 319 | $ | 40 | $ | – | $ | (206) | $ | 449 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | (13) | 28 | (12) | – | – | 3 | ||||||
| NCI | 20 | – | – | – | – | 20 | ||||||
| Participating policyholders | (56) | – | – | – | – | (56) | ||||||
| Core net insurance result | 345 | 291 | 52 | – | (206) | 482 | ||||||
| Core net insurance result, CER adjustment^(1)^ | 10 | – | 1 | – | (5) | 6 | ||||||
| Core net insurance result, CER basis | $ | 355 | $ | 291 | $ | 53 | $ | – | $ | (211) | $ | 488 |
| Transitional net investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | 17 | $ | 968 | $ | (631) | $ | (292) | $ | (19) | $ | 43 |
| IFRS 9 transitional impacts | (116) | (406) | 965 | – | (1) | 442 | ||||||
| Total including transitional impacts | (99) | 562 | 334 | (292) | (20) | 485 | ||||||
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (299) | – | 292 | – | (7) | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (105) | (105) | ||||||
| Less: Other | – | (3) | – | – | – | (3) | ||||||
| Transitional net investment result | (99) | 260 | 334 | – | (125) | 370 | ||||||
| Less: Transitional net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | (262) | 131 | (135) | – | (200) | (466) | ||||||
| NCI | 15 | – | – | – | – | 15 | ||||||
| Participating policyholders | (5) | (16) | – | – | – | (21) | ||||||
| Core net investment result | 153 | 145 | 469 | – | 75 | 842 | ||||||
| Core net investment result, CER adjustment^(1)^ | 6 | – | 14 | – | – | 20 | ||||||
| Core net investment result, CER basis | $ | 159 | $ | 145 | $ | 483 | $ | – | $ | 75 | $ | 862 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 66 | $ | – | $ | 324 | $ | – | $ | 390 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | (4) | – | (81) | – | (85) | ||||||
| Core earnings in Manulife Bank and Global WAM | – | 70 | – | 405 | – | 475 | ||||||
| Core earnings in Manulife Bank and Global WAM, CER<br>adjustment^(1)^ | – | – | – | 7 | – | 7 | ||||||
| Core earnings in Manulife Bankand Global WAM, CER basis | $ | – | $ | 70 | $ | – | $ | 412 | $ | – | $ | 482 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 63 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 3Q22 (continued)
| 3Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 47 | $ | 62 | $ | 51 | $ | 1,555 | $ | (168) | $ | 1,547 |
| General expenses per financial statements | (89) | (126) | (65) | (618) | (16) | (914) | ||||||
| Commission related to non-insurance contracts | (4) | (12) | 1 | (319) | 2 | (332) | ||||||
| Interest expense per financial statements | (1) | (182) | (3) | (2) | (121) | (309) | ||||||
| Total financial statements values included in Other | (47) | (258) | (16) | 616 | (303) | (8) | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 233 | – | (616) | – | (383) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 106 | 106 | ||||||
| Other | – | 2 | – | – | – | 2 | ||||||
| Other | (47) | (23) | (16) | – | (197) | (283) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | 16 | – | (15) | – | (85) | (84) | ||||||
| NCI | 1 | – | – | – | – | 1 | ||||||
| Participating policyholders | 2 | – | – | – | – | 2 | ||||||
| Add: Par earnings transfer to shareholders | 9 | 2 | – | – | – | 11 | ||||||
| Core Other | (57) | (21) | (1) | – | (112) | (191) | ||||||
| Core Other, CER adjustment^(2)^ | (1) | – | – | – | – | (1) | ||||||
| Core Other, CER basis | $ | (58) | $ | (21) | $ | (1) | $ | – | $ | (112) | $ | (192) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (43) | $ | (186) | $ | 160 | $ | (37) | $ | 46 | $ | (60) |
| IFRS 9 transitional impacts | 23 | 35 | (204) | – | 1 | (145) | ||||||
| Transitional income tax recovery (expense) | (20) | (151) | (44) | (37) | 47 | (205) | ||||||
| Less: Transitional income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | 47 | (65) | 39 | 14 | 34 | 69 | ||||||
| NCI | (3) | – | – | – | – | (3) | ||||||
| Participating policyholders | (10) | 8 | – | – | – | (2) | ||||||
| Core income tax recovery (expense) | (54) | (94) | (83) | (51) | 13 | (269) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | (2) | – | (3) | – | – | (5) | ||||||
| Core income tax recovery (expense), CER basis | $ | (56) | $ | (94) | $ | (86) | $ | (51) | $ | 13 | $ | (274) |
| Net income (loss) attributed to NCI | $ | 34 | $ | – | $ | – | $ | – | $ | – | $ | 34 |
| IFRS 9 transitional impacts | (1) | – | – | – | – | (1) | ||||||
| Transitional net income (loss) to NCI | $ | 33 | $ | – | $ | – | $ | – | $ | – | $ | 33 |
| Net income (loss) attributed to participating policyholders | $ | (91) | $ | (10) | $ | – | $ | – | $ | – | $ | (101) |
| IFRS 9 transitional impacts | 12 | – | – | – | – | 12 | ||||||
| Transitional net income (loss) to participating<br>policyholders | $ | (79) | $ | (10) | $ | – | $ | – | $ | – | $ | (89) |
| Transitional net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 301 | $ | 319 | $ | 41 | $ | – | $ | (211) | $ | 450 |
| Net investment result | (98) | 260 | 343 | – | (125) | 380 | ||||||
| Global WAM | – | – | – | 332 | – | 332 | ||||||
| Manulife Bank | – | 66 | – | – | – | 66 | ||||||
| Other | (67) | (22) | (1) | – | (112) | (202) | ||||||
| Transitional net income (loss) before income taxes, CERbasis | $ | 136 | $ | 623 | $ | 383 | $ | 332 | $ | (448) | $ | 1,026 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 64 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 2Q22
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 2Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 360 | $ | 293 | $ | 370 | $ | – | $ | 12 | $ | 1,035 |
| Transitional net investment result | (492) | 67 | 83 | – | (159) | (501) | ||||||
| Global WAM | – | – | – | 170 | – | 170 | ||||||
| Manulife Bank | – | 33 | – | – | – | 33 | ||||||
| Other | (61) | (20) | (13) | – | (244) | (338) | ||||||
| Transitional net income (loss) before income taxes | (193) | 373 | 440 | 170 | (391) | 399 | ||||||
| Transitional income tax (expense) recovery | (52) | (87) | (85) | (20) | 10 | (234) | ||||||
| Transitional net income (loss) | (245) | 286 | 355 | 150 | (381) | 165 | ||||||
| Less: Transitional net income (loss) attributed to NCI | (46) | – | – | – | – | (46) | ||||||
| Less: Transitional net income (loss) attributed to participating<br>policyholders | 64 | (15) | – | – | – | 49 | ||||||
| Transitional net income (loss) attributed to shareholders(post-tax) | $ | (227) | $ | 271 | $ | 355 | $ | 150 | $ | (381) | $ | 168 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| 2Q22 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 360 | $ | 293 | $ | 370 | $ | – | $ | 12 | $ | 1,035 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | (61) | (1) | 184 | – | (1) | 121 | ||||||
| NCI | 24 | – | – | – | – | 24 | ||||||
| Participating policyholders | (26) | 21 | – | – | – | (5) | ||||||
| Core net insurance result | 423 | 273 | 186 | – | 13 | 895 | ||||||
| Core net insurance result, CER adjustment^(1)^ | 15 | – | 11 | – | – | 26 | ||||||
| Core net insurance result, CER basis | $ | 438 | $ | 273 | $ | 197 | $ | – | $ | 13 | $ | 921 |
| Transitional net investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | (249) | $ | (1,026) | $ | (1,918) | $ | (439) | $ | (65) | $ | (3,697) |
| IFRS 9 transitional impacts | (243) | 1,296 | 2,001 | – | – | 3,054 | ||||||
| Total including transitional impacts | (492) | 270 | 83 | (439) | (65) | (643) | ||||||
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (197) | – | 439 | – | 242 | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (94) | (94) | ||||||
| Less: Other | – | (6) | – | – | – | (6) | ||||||
| Transitional net investment result | (492) | 67 | 83 | – | (159) | (501) | ||||||
| Less: Transitional net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | (629) | (78) | (271) | – | (213) | (1,191) | ||||||
| NCI | 20 | – | – | – | – | 20 | ||||||
| Participating policyholders | (33) | (2) | – | – | – | (35) | ||||||
| Core net investment result | 150 | 147 | 354 | – | 54 | 705 | ||||||
| Core net investment result, CER adjustment^(1)^ | 5 | – | 18 | – | – | 23 | ||||||
| Core net investment result, CER basis | $ | 155 | $ | 147 | $ | 372 | $ | – | $ | 54 | $ | 728 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 33 | $ | – | $ | 170 | $ | – | $ | 203 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | (18) | – | (217) | – | (235) | ||||||
| Core earnings in Manulife Bank and Global WAM | – | 51 | – | 387 | – | 438 | ||||||
| Core earnings in Manulife Bank and Global WAM, CER<br>adjustment^(1)^ | – | – | – | 14 | – | 14 | ||||||
| Core earnings in Manulife Bankand Global WAM, CER basis | $ | – | $ | 51 | $ | – | $ | 401 | $ | – | $ | 452 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 65 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 2Q22 (continued)
| 2Q22 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 30 | $ | 67 | $ | 16 | $ | 1,552 | $ | (219) | $ | 1,446 |
| General expenses per financial statements | (85) | (131) | (25) | (619) | (24) | (884) | ||||||
| Commission related to non-insurance contracts | (4) | (14) | (1) | (324) | 20 | (323) | ||||||
| Interest expense per financial statements | (2) | (112) | (4) | – | (115) | (233) | ||||||
| Total financial statements values included in Other | (61) | (190) | (14) | 609 | (338) | 6 | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 164 | – | (609) | – | (445) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 94 | 94 | ||||||
| Other | – | 6 | 1 | – | – | 7 | ||||||
| Other | (61) | (20) | (13) | – | (244) | (338) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | (3) | – | (2) | – | (120) | (125) | ||||||
| NCI | 6 | – | – | – | – | 6 | ||||||
| Participating policyholders | 2 | – | – | – | – | 2 | ||||||
| Add: Par earnings transfer to shareholders | 7 | 3 | – | – | – | 10 | ||||||
| Core Other | (59) | (17) | (11) | – | (124) | (211) | ||||||
| Core Other, CER adjustment^(2)^ | (1) | – | (2) | – | – | (3) | ||||||
| Core Other, CER basis | $ | (60) | $ | (17) | $ | (13) | $ | – | $ | (124) | $ | (214) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (100) | $ | 327 | $ | 336 | $ | (20) | $ | 10 | $ | 553 |
| IFRS 9 transitional impacts | 48 | (414) | (421) | – | – | (787) | ||||||
| Transitional income tax recovery (expense) | (52) | (87) | (85) | (20) | 10 | (234) | ||||||
| Less: Transitional income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | 15 | 3 | 16 | 40 | (2) | 72 | ||||||
| NCI | (4) | – | – | – | – | (4) | ||||||
| Participating policyholders | 1 | (2) | – | – | – | (1) | ||||||
| Core income tax recovery (expense) | (64) | (88) | (101) | (60) | 12 | (301) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | (1) | – | (5) | (2) | – | (8) | ||||||
| Core income tax recovery (expense), CER basis | $ | (65) | $ | (88) | $ | (106) | $ | (62) | $ | 12 | $ | (309) |
| Net income (loss) attributed to NCI | $ | 52 | $ | – | $ | – | $ | – | $ | – | $ | 52 |
| IFRS 9 transitional impacts | (6) | – | – | – | – | (6) | ||||||
| Transitional net income (loss) to NCI | $ | 46 | $ | – | $ | – | $ | – | $ | – | $ | 46 |
| Net income (loss) attributed to participating policyholders | $ | (51) | $ | 15 | $ | – | $ | – | $ | – | $ | (36) |
| IFRS 9 transitional impacts | (13) | – | – | – | – | (13) | ||||||
| Transitional net income (loss) to participating<br>policyholders | $ | (64) | $ | 15 | $ | – | $ | – | $ | – | $ | (49) |
| Transitional net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 370 | $ | 292 | $ | 390 | $ | – | $ | 13 | $ | 1,065 |
| Net investment result | (501) | 68 | 87 | – | (159) | (505) | ||||||
| Global WAM | – | – | – | 183 | – | 183 | ||||||
| Manulife Bank | – | 32 | – | – | – | 32 | ||||||
| Other | (68) | (19) | (13) | – | (124) | (224) | ||||||
| Transitional net income (loss) before income taxes, CERbasis | $ | (199) | $ | 373 | $ | 464 | $ | 183 | $ | (270) | $ | 551 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 66 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – YTD 2023
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| YTD 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 830 | $ | 521 | $ | 304 | $ | – | $ | 81 | $ | 1,736 |
| Net investment result | **** | 189 | **** | 129 | **** | 206 | **** | – | **** | 595 | **** | 1,119 |
| Global WAM | **** | – | **** | – | **** | – | **** | 707 | **** | – | **** | 707 |
| Manulife Bank | **** | – | **** | 124 | **** | – | **** | – | **** | – | **** | 124 |
| Other | **** | (61) | **** | (39) | **** | (71) | **** | – | **** | (360) | **** | (531) |
| Net income (loss) before income taxes | **** | 958 | **** | 735 | **** | 439 | **** | 707 | **** | 316 | **** | 3,155 |
| Income tax (expense) recovery | **** | (196) | **** | (163) | **** | (70) | **** | (92) | **** | (53) | **** | (574) |
| Net income (loss) | **** | 762 | **** | 572 | **** | 369 | **** | 615 | **** | 263 | **** | 2,581 |
| Less: Net income (loss) attributed to NCI | **** | (79) | **** | – | **** | – | **** | (1) | **** | – | **** | (80) |
| Less: Net income (loss) attributed to participating<br>policyholders | **** | (34) | **** | (36) | **** | – | **** | – | **** | – | **** | (70) |
| Net income (loss) attributed to shareholders(post-tax) | $ | 649 | $ | 536 | $ | 369 | $ | 614 | $ | 263 | $ | 2,431 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| YTD 2023 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 830 | $ | 521 | $ | 304 | $ | – | $ | 81 | $ | 1,736 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (18) | **** | (4) | **** | (25) | **** | – | **** | – | **** | (47) |
| NCI | **** | 53 | **** | – | **** | – | **** | – | **** | – | **** | 53 |
| Participating policyholders | **** | 71 | **** | 47 | **** | – | **** | – | **** | – | **** | 118 |
| Core net insurance result | **** | 724 | **** | 478 | **** | 329 | **** | – | **** | 81 | **** | 1,612 |
| Core net insurance result, CER adjustment^(1)^ | **** | (5) | **** | – | **** | (1) | **** | – | **** | – | **** | (6) |
| Core net insurance result, CER basis | $ | 719 | $ | 478 | $ | 328 | $ | – | $ | 81 | $ | 1,606 |
| Total investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | 189 | $ | 817 | $ | 206 | $ | (504) | $ | 859 | $ | 1,567 |
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | **** | – | **** | (688) | **** | – | **** | 504 | **** | – | **** | (184) |
| Less: Consolidation adjustments^(2)^ | **** | – | **** | – | **** | – | **** | – | **** | (264) | **** | (264) |
| Less: Other | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Net investment result | **** | 189 | **** | 129 | **** | 206 | **** | – | **** | 595 | **** | 1,119 |
| Less: Net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (284) | **** | (224) | **** | (519) | **** | – | **** | 264 | **** | (763) |
| NCI | **** | 38 | **** | – | **** | – | **** | – | **** | – | **** | 38 |
| Participating policyholders | **** | (4) | **** | 14 | **** | – | **** | – | **** | – | **** | 10 |
| Core net investment result | **** | 439 | **** | 339 | **** | 725 | **** | – | **** | 331 | **** | 1,834 |
| Core net investment result, CER adjustment^(1)^ | **** | (4) | **** | – | **** | (2) | **** | – | **** | – | **** | (6) |
| Core net investment result, CER basis | $ | 435 | $ | 339 | $ | 723 | $ | – | $ | 331 | $ | 1,828 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 124 | $ | – | $ | 707 | $ | – | $ | 831 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | **** | – | **** | 5 | **** | – | **** | 10 | **** | – | **** | 15 |
| Core earnings in Manulife Bank and Global WAM | **** | – | **** | 119 | **** | – | **** | 697 | **** | – | **** | 816 |
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | **** | – | **** | – | **** | – | **** | (1) | **** | – | **** | (1) |
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 119 | $ | – | $ | 696 | $ | – | $ | 815 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 67 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – YTD 2023 (continued)
| YTD 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 57 | $ | 144 | $ | 40 | $ | 3,312 | $ | (171) | $ | 3,382 |
| General expenses per financial statements | **** | (109) | **** | (250) | **** | (99) | **** | (1,435) | **** | (216) | **** | (2,109) |
| Commission related to non-insurance contracts | **** | (4) | **** | (29) | **** | (4) | **** | (658) | **** | 21 | **** | (674) |
| Interest expense per financial statements | **** | (5) | **** | (468) | **** | (8) | **** | (10) | **** | (257) | **** | (748) |
| Total financial statements values included in Other | **** | (61) | **** | (603) | **** | (71) | **** | 1,209 | **** | (623) | **** | (149) |
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | **** | – | **** | 564 | **** | – | **** | (1,209) | **** | – | **** | (645) |
| Less: Consolidation adjustments^(1)^ | **** | – | **** | – | **** | – | **** | – | **** | 263 | **** | 263 |
| Other | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Other | **** | (61) | **** | (39) | **** | (71) | **** | – | **** | (360) | **** | (531) |
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | **** | 14 | **** | (2) | **** | (56) | **** | – | **** | 55 | **** | 11 |
| NCI | **** | 4 | **** | – | **** | – | **** | – | **** | – | **** | 4 |
| Participating policyholders | **** | (1) | **** | (6) | **** | – | **** | – | **** | – | **** | (7) |
| Add: Par earnings transfer to shareholders | **** | 18 | **** | 4 | **** | – | **** | – | **** | – | **** | 22 |
| Core Other | **** | (60) | **** | (27) | **** | (15) | **** | – | **** | (415) | **** | (517) |
| Core Other, CER adjustment^(2)^ | **** | 1 | **** | – | **** | – | **** | – | **** | – | **** | 1 |
| Core Other, CER basis | $ | (59) | $ | (27) | $ | (15) | $ | – | $ | (415) | $ | (516) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (196) | $ | (163) | $ | (70) | $ | (92) | $ | (53) | $ | (574) |
| Less: Income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | **** | (25) | **** | 34 | **** | 126 | **** | (2) | **** | (85) | **** | 48 |
| NCI | **** | (16) | **** | – | **** | – | **** | – | **** | – | **** | (16) |
| Participating policyholders | **** | (14) | **** | (15) | **** | – | **** | – | **** | – | **** | (29) |
| Core income tax recovery (expense) | **** | (141) | **** | (182) | **** | (196) | **** | (90) | **** | 32 | **** | (577) |
| Core income tax recovery (expense), CER adjustment^(2)^ | **** | 1 | **** | – | **** | 1 | **** | – | **** | – | **** | 2 |
| Core income tax recovery (expense), CER basis | $ | (140) | $ | (182) | $ | (195) | $ | (90) | $ | 32 | $ | (575) |
| Net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 826 | $ | 521 | $ | 303 | $ | – | $ | 81 | $ | 1,731 |
| Net investment result | **** | 185 | **** | 129 | **** | 205 | **** | – | **** | 595 | **** | 1,114 |
| Global WAM | **** | – | **** | – | **** | – | **** | 705 | **** | – | **** | 705 |
| Manulife Bank | **** | – | **** | 124 | **** | – | **** | – | **** | – | **** | 124 |
| Other | **** | (48) | **** | (35) | **** | (19) | **** | – | **** | (397) | **** | (499) |
| Net income (loss) before income taxes, CER basis | $ | 963 | $ | 739 | $ | 489 | $ | 705 | $ | 279 | $ | 3,175 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 68 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – YTD 2022
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| YTD 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 773 | $ | 570 | $ | 367 | $ | – | $ | 40 | $ | 1,750 |
| Transitional net investment result | (554) | 189 | 1,197 | – | (329) | 503 | ||||||
| Global WAM | – | – | – | 506 | – | 506 | ||||||
| Manulife Bank | – | 77 | – | – | – | 77 | ||||||
| Other | (189) | (35) | (21) | – | (483) | (728) | ||||||
| Transitional net income (loss) before income taxes | 30 | 801 | 1,543 | 506 | (772) | 2,108 | ||||||
| Transitional income tax (expense) recovery | (95) | (172) | (303) | (73) | 17 | (626) | ||||||
| Transitional net income (loss) | (65) | 629 | 1,240 | 433 | (755) | 1,482 | ||||||
| Less: Transitional net income (loss) attributed to NCI | (47) | – | – | – | – | (47) | ||||||
| Less: Transitional net income (loss) attributed to participating<br>policyholders | 90 | (32) | – | – | – | 58 | ||||||
| Transitional net income (loss) attributed to shareholders(post-tax) | $ | (22) | $ | 597 | $ | 1,240 | $ | 433 | $ | (755) | $ | 1,493 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| YTD 2022 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 773 | $ | 570 | $ | 367 | $ | – | $ | 40 | $ | 1,750 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | (90) | (1) | 181 | – | (1) | 89 | ||||||
| NCI | 32 | – | – | – | – | 32 | ||||||
| Participating policyholders | (32) | 48 | – | – | – | 16 | ||||||
| Core net insurance result | 863 | 523 | 186 | – | 41 | 1,613 | ||||||
| Core net insurance result, CER adjustment^(1)^ | 26 | – | 10 | – | 3 | 39 | ||||||
| Core net insurance result, CER basis | $ | 889 | $ | 523 | $ | 196 | $ | – | $ | 44 | $ | 1,652 |
| Transitional net investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | (342) | $ | (2,208) | $ | (2,683) | $ | (759) | $ | (144) | $ | (6,136) |
| IFRS 9 transitional impacts | (212) | 2,761 | 3,880 | – | (2) | 6,427 | ||||||
| Total including transitional impacts | (554) | 553 | 1,197 | (759) | (146) | 291 | ||||||
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (354) | – | 759 | – | 405 | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (183) | (183) | ||||||
| Less: Other | – | (10) | – | – | – | (10) | ||||||
| Transitional net investment result | (554) | 189 | 1,197 | – | (329) | 503 | ||||||
| Less: Transitional net investment result attributed to: | – | |||||||||||
| Items excluded from core earnings | (842) | (73) | 481 | – | (442) | (876) | ||||||
| NCI | 5 | – | – | – | – | 5 | ||||||
| Participating policyholders | (34) | (13) | – | – | – | (47) | ||||||
| Core net investment result | 317 | 275 | 716 | – | 113 | 1,421 | ||||||
| Core net investment result, CER adjustment^(1)^ | 5 | – | 40 | – | – | 45 | ||||||
| Core net investment result, CER basis | $ | 322 | $ | 275 | $ | 756 | $ | – | $ | 113 | $ | 1,466 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 77 | $ | – | $ | 506 | $ | – | $ | 583 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | (16) | – | (289) | – | (305) | ||||||
| Core earnings in Manulife Bank and Global WAM | – | 93 | – | 795 | – | 888 | ||||||
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | – | – | – | 28 | – | 28 | ||||||
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 93 | $ | – | $ | 823 | $ | – | $ | 916 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 69 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) - YTD 2022 (continued)
| YTD 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br><br><br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | (6) | $ | 133 | $ | 33 | $ | 3,190 | $ | (382) | $ | 2,968 |
| General expenses per financial statements | (172) | (257) | (46) | (1,250) | (90) | (1,815) | ||||||
| Commission related to non-insurance contracts | (8) | (29) | 1 | (675) | 30 | (681) | ||||||
| Interest expense per financial statements | (3) | (170) | (9) | – | (223) | (405) | ||||||
| Total financial statements values included in Other | (189) | (323) | (21) | 1,265 | (665) | 67 | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 277 | – | (1,265) | – | (988) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 182 | 182 | ||||||
| Other | – | 11 | – | – | – | 11 | ||||||
| Other | (189) | (35) | (21) | – | (483) | (728) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | (45) | – | (2) | – | (195) | (242) | ||||||
| NCI | 6 | – | – | – | – | 6 | ||||||
| Participating policyholders | (9) | – | – | – | – | (9) | ||||||
| Add: Par earnings transfer to shareholders | 17 | 4 | – | – | – | 21 | ||||||
| Core Other | (124) | (31) | (19) | – | (288) | (462) | ||||||
| Core Other, CER adjustment^(2)^ | (1) | – | (1) | – | (1) | (3) | ||||||
| Core Other, CER basis | $ | (125) | $ | (31) | $ | (20) | $ | – | $ | (289) | $ | (465) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (173) | $ | 710 | $ | 512 | $ | (73) | $ | 17 | $ | 993 |
| IFRS 9 transitional impacts | 78 | (882) | (815) | – | – | (1,619) | ||||||
| Transitional income tax recovery (expense) | (95) | (172) | (303) | (73) | 17 | (626) | ||||||
| Less: Transitional income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | 25 | (12) | (141) | 51 | (15) | (92) | ||||||
| NCI | 4 | – | – | – | – | 4 | ||||||
| Participating policyholders | 3 | – | – | – | – | 3 | ||||||
| Core income tax recovery (expense) | (127) | (160) | (162) | (124) | 32 | (541) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | (3) | – | (9) | (3) | – | (15) | ||||||
| Core income tax recovery (expense), CER basis | $ | (130) | $ | (160) | $ | (171) | $ | (127) | $ | 32 | $ | (556) |
| Net income (loss) attributed to NCI | $ | 54 | $ | – | $ | – | $ | – | $ | – | $ | 54 |
| IFRS 9 transitional impacts | (7) | – | – | – | – | (7) | ||||||
| Transitional net income (loss) to NCI | $ | 47 | $ | – | $ | – | $ | – | $ | – | $ | 47 |
| Net income (loss) attributed to participating policyholders | $ | (73) | $ | 32 | $ | – | $ | – | $ | – | $ | (41) |
| IFRS 9 transitional impacts | (17) | – | – | – | – | (17) | ||||||
| Transitional net income (loss) to participating<br>policyholders | $ | (90) | $ | 32 | $ | – | $ | – | $ | – | $ | (58) |
| Transitional net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 791 | $ | 569 | $ | 387 | $ | – | $ | 43 | $ | 1,790 |
| Net investment result | (555) | 190 | 1,268 | – | (328) | 575 | ||||||
| Global WAM | – | – | – | 534 | – | 534 | ||||||
| Manulife Bank | – | 76 | – | – | – | 76 | ||||||
| Other | (143) | (34) | (21) | – | (289) | (487) | ||||||
| Transitional net income (loss) before income taxes, CERbasis | $ | 93 | $ | 801 | $ | 1,634 | $ | 534 | $ | (574) | $ | 2,488 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 70 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 2022
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | |||||||
| Net insurance service result | $ | 1,554 | $ | 1,190 | $ | 533 | $ | – | $ | (117) | $ | 3,160 |
| Transitional net investment result | (484) | 380 | 1,272 | – | (392) | 776 | ||||||
| Global WAM | – | – | – | 1,291 | – | 1,291 | ||||||
| Manulife Bank | – | 215 | – | – | – | 215 | ||||||
| Other | (275) | (85) | (52) | – | (847) | (1,259) | ||||||
| Transitional net income (loss) before income taxes | 795 | 1,700 | 1,753 | 1,291 | (1,356) | 4,183 | ||||||
| Transitional income tax (expense) recovery | (237) | (458) | (305) | (170) | 441 | (729) | ||||||
| Transitional net income (loss) | 558 | 1,242 | 1,448 | 1,121 | (915) | 3,454 | ||||||
| Less: Transitional net income (loss) attributed to NCI | (114) | – | – | – | (1) | (115) | ||||||
| Less: Transitional net income (loss) attributed to participating<br>policyholders | 203 | (44) | – | – | – | 159 | ||||||
| Transitional net income (loss) attributed to shareholders(post-tax) | $ | 647 | $ | 1,198 | $ | 1,448 | $ | 1,121 | $ | (916) | $ | 3,498 |
| Reconciliations of DOE line items to the consolidated financial statements and DOEpresentation | ||||||||||||
| 2022 | ||||||||||||
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br><br><br>and Other | Total | |||||||
| Net insurance service result reconciliation | ||||||||||||
| Total insurance service result - financial statements | $ | 1,554 | $ | 1,190 | $ | 533 | $ | – | $ | (117) | $ | 3,160 |
| Less: Insurance service result attributed to: | ||||||||||||
| Items excluded from core earnings | (34) | 28 | 179 | – | (2) | 171 | ||||||
| NCI | 70 | – | – | – | – | 70 | ||||||
| Participating policyholders | (73) | 132 | – | – | – | 59 | ||||||
| Core net insurance result | $ | 1,591 | $ | 1,030 | $ | 354 | $ | – | $ | (115) | $ | 2,860 |
| Core net insurance result, CER adjustment^(1)^ | 38 | – | 10 | – | (4) | 44 | ||||||
| Core net insurance result, CER basis | $ | 1,629 | $ | 1,030 | $ | 364 | $ | – | $ | (119) | $ | 2,904 |
| Transitional net investment result reconciliation | ||||||||||||
| Total investment result per financial statements | $ | (370) | $ | (1,300) | $ | (3,493) | $ | (1,200) | $ | (6) | $ | (6,369) |
| IFRS 9 transitional impacts | (114) | 2,667 | 4,765 | – | 4 | 7,322 | ||||||
| Total including transitional impacts | (484) | 1,367 | 1,272 | (1,200) | (2) | 953 | ||||||
| Less: Reclassify net investment result in each of Manulife Bank in Canada and Global WAM to its own line of<br>the DOE | – | (977) | – | 1,200 | – | 223 | ||||||
| Less: Consolidation adjustments^(2)^ | – | – | – | – | (390) | (390) | ||||||
| Less: Other | – | (10) | – | – | – | (10) | ||||||
| Transitional net investment result | $ | (484) | $ | 380 | $ | 1,272 | $ | – | $ | (392) | $ | 776 |
| Less: Transitional net investment result attributed to: | ||||||||||||
| Items excluded from core earnings | (1,158) | (131) | (316) | – | (717) | (2,322) | ||||||
| NCI | 51 | – | – | – | – | 51 | ||||||
| Participating policyholders | (54) | (31) | – | – | – | (85) | ||||||
| Core net investment result | 677 | 542 | 1,588 | – | 325 | 3,132 | ||||||
| Core net investment result, CER adjustment^(1)^ | 13 | – | 50 | – | (1) | 62 | ||||||
| Core net investment result, CER basis | $ | 690 | $ | 542 | $ | 1,638 | $ | – | $ | 324 | $ | 3,194 |
| Manulife Bank and Global WAM by DOE linereconciliation | ||||||||||||
| Manulife Bank and Global WAM net income attributed to shareholders | $ | – | $ | 215 | $ | – | $ | 1,291 | $ | – | $ | 1,506 |
| Less: Manulife Bank and Global WAM attributed to: | ||||||||||||
| Items excluded from core earnings | – | (15) | – | (230) | – | (245) | ||||||
| Core earnings in Manulife Bank and Global WAM | $ | – | $ | 230 | $ | – | $ | 1,521 | $ | – | $ | 1,751 |
| Core earnings in Manulife Bank and Global WAM, CER adjustment^(1)^ | – | – | – | 34 | – | 34 | ||||||
| Core earnings in Manulife Bank and Global WAM, CERbasis | $ | – | $ | 230 | $ | – | $ | 1,555 | $ | – | $ | 1,785 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 71 | |||||||||||
| --- | --- |
Table of Contents
Drivers of Earnings (“DOE”) – 2022 (continued)
| 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | Canada | U.S. | Global<br>WAM | Corporate<br><br><br>and Other | Total | |||||||
| Other reconciliation | ||||||||||||
| Other revenue per financial statements | $ | 56 | $ | 262 | $ | 101 | $ | 6,391 | $ | (624) | $ | 6,186 |
| General expenses per financial statements | (303) | (518) | (140) | (2,583) | (187) | (3,731) | ||||||
| Commission related to non-insurance contracts | (15) | (55) | 4 | (1,310) | 43 | (1,333) | ||||||
| Interest expense per financial statements | (12) | (548) | (16) | (7) | (468) | (1,051) | ||||||
| Total financial statements values included in Other | (274) | (859) | (51) | 2,491 | (1,236) | 71 | ||||||
| Less: Reclassify Other in each of Manulife Bank in Canada and Global WAM to its own line of the DOE | – | 762 | – | (2,491) | – | (1,729) | ||||||
| Less: Consolidation adjustments^(1)^ | – | – | – | – | 389 | 389 | ||||||
| Other | (1) | 12 | (1) | – | – | 10 | ||||||
| Other | (275) | (85) | (52) | – | (847) | (1,259) | ||||||
| Less: Other attributed to: | ||||||||||||
| Items excluded from core earnings | (29) | – | (17) | – | (258) | (304) | ||||||
| NCI | 7 | – | – | – | – | 7 | ||||||
| Participating policyholders | (14) | (1) | – | – | – | (15) | ||||||
| Add: Par earnings transfer to shareholders | 46 | 4 | – | – | – | 50 | ||||||
| Core Other | (193) | (80) | (35) | – | (589) | (897) | ||||||
| Core Other, CER adjustment^(2)^ | (4) | – | (2) | – | 1 | (5) | ||||||
| Core Other, CER basis | $ | (197) | $ | (80) | $ | (37) | $ | – | $ | (588) | $ | (902) |
| Income tax recovery (expense) reconciliation | ||||||||||||
| Income tax recovery (expense) per financial statements | $ | (318) | $ | 510 | $ | 695 | $ | (170) | $ | 442 | $ | 1,159 |
| IFRS 9 transitional impacts | 81 | (968) | (1,000) | – | (1) | (1,888) | ||||||
| Transitional income tax recovery (expense) | (237) | (458) | (305) | (170) | 441 | (729) | ||||||
| Less: Transitional income tax recovery (expense) attributed to: | ||||||||||||
| Items excluded from core earnings | 54 | (71) | 36 | 52 | 325 | 396 | ||||||
| NCI | (12) | – | – | – | – | (12) | ||||||
| Participating policyholders | (16) | (52) | – | – | – | (68) | ||||||
| Core income tax recovery (expense) | (263) | (335) | (341) | (222) | 116 | (1,045) | ||||||
| Core income tax recovery (expense), CER adjustment^(2)^ | (4) | – | (10) | (4) | – | (18) | ||||||
| Core income tax recovery (expense), CER basis | $ | (267) | $ | (335) | $ | (351) | $ | (226) | $ | 116 | $ | (1,063) |
| Net income (loss) attributed to NCI | $ | 120 | $ | – | $ | – | $ | – | $ | 1 | $ | 121 |
| IFRS 9 transitional impacts | (6) | – | – | – | – | (6) | ||||||
| Transitional net income (loss) to NCI | $ | 114 | $ | – | $ | – | $ | – | $ | 1 | $ | 115 |
| Net income (loss) attributed to participating policyholders | $ | (211) | $ | 44 | $ | – | $ | – | $ | – | $ | (167) |
| IFRS 9 transitional impacts | 8 | – | – | – | – | 8 | ||||||
| Transitional net income (loss) to participating<br>policyholders | $ | (203) | $ | 44 | $ | – | $ | – | $ | – | $ | (159) |
| Transitional net income attributable to shareholders, CER basis^(3)^ | ||||||||||||
| Net insurance service result | $ | 1,580 | $ | 1,189 | $ | 553 | $ | – | $ | (120) | $ | 3,202 |
| Net investment result | (485) | 381 | 1,355 | – | (391) | 860 | ||||||
| Global WAM | – | – | – | 1,323 | – | 1,323 | ||||||
| Manulife Bank | – | 215 | – | – | – | 215 | ||||||
| Other | (243) | (84) | (38) | – | (589) | (954) | ||||||
| Transitional net income (loss) before income taxes, CERbasis | $ | 852 | $ | 1,701 | $ | 1,870 | $ | 1,323 | $ | (1,100) | $ | 4,646 |
| ^(1)^ | Consolidation adjustments in Other DOE line reclassified to net investment result DOE line. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||
| --- | --- | |||||||||||
| ^(3)^ | DOE on a CER basis adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||
| --- | --- | |||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 72 | |||||||||||
| --- | --- |
Table of Contents
The contractual service margin (“CSM”) is a liability that represents future unearned profits on insurance contracts written. It is a component of our insurance and reinsurance contract liabilities on our Statement of Financial Position. Organic and inorganic changes in CSM include amounts attributable to participating shareholders and non-controlling interests. CSM growth is the percentage change in the CSM net of NCI compared with a prior period on a constant exchange rate basis.
Changes in CSM that are classified as organic include the following impacts:
| • | Impact of new business is the impact on CSM from insurance contracts initially recognized in the period and includes<br>acquisition expense related gains (losses) which impact the CSM in the period. It excludes the impact on CSM from entering into new in-force reinsurance contracts which would generally be considered a management action. |
|---|---|
| • | Expected movement related to finance income or expenses includes interest accreted on the CSM during the period and<br>the expected change in the CSM on VFA contracts if returns are as expected. |
| --- | --- |
| • | CSM recognized for service provided is the portion of the CSM that is recognized in net income for service provided<br>in the period. |
| --- | --- |
| • | Insurance experience gains (losses) and other is primarily the change in the CSM balance from experience variances<br>that relate to future periods. This includes persistency experience and changes in future period cash flows caused by other current period experience. |
| --- | --- |
Changes in CSM that are classified as inorganic include:
| • | Changes in actuarial methods and assumptions that adjust the CSM; |
|---|---|
| • | Effect of movement in exchange rates over the reporting period; |
| --- | --- |
| • | Impact of markets; and |
| --- | --- |
| • | Reinsurance transactions, tax-related and other items that reflects the impact related to future cash flows from<br>items such as gains or losses on disposition of a business, the impact of enacted or substantially enacted income tax rate changes, material one-time only adjustments that are exceptional in nature and other amounts not specifically captured in the<br>previous inorganic items. |
| --- | --- |
Post-tax CSM is used in the definition of financial leverage ratio and consolidated capital and is calculated as the CSM adjusted for the marginal income tax rate in the jurisdictions that report a CSM balance. Post-tax CSM net of NCI is used in the adjusted book value per share calculation and is calculated as the CSM excluding non-controlling interests adjusted for the marginal income tax rate in the jurisdictions that report this balance.
New Business CSM is the impact of new business defined above, excluding CSM attributable to non-controlling interests. New business CSM growth is the percentage change in the New Business CSM net of NCI compared with a prior period on a constant exchange rate basis.
| Manulife Financial Corporation – Second Quarter 2023 | 73 |
|---|
Table of Contents
CSM and post-tax CSM information
($ millions and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| As at<br><br><br>($ millions) | Jun 30,2023 | Mar 31,<br>2023 | Dec 31,<br>2022 | Sept 30,<br>2022 | Jun 30,<br>2022 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| CSM | $ | 18,103 | $ | 18,200 | $ | 17,977 | $ | 17,798 | $ | 17,452 |
| Less: CSM for NCI | **** | (680) | (733) | (694) | (712) | (741) | ||||
| CSM, net of NCI | $ | 17,423 | $ | 17,467 | $ | 17,283 | $ | 17,086 | $ | 16,711 |
| CER<br>adjustment^(1)^ | **** | 304 | (189) | (156) | (139) | 507 | ||||
| CSM, net of NCI, CER basis | $ | 17,727 | $ | 17,278 | $ | 17,127 | $ | 16,947 | $ | 17,218 |
| CSM by segment | ||||||||||
| Asia | $ | 9,630 | $ | 9,678 | $ | 9,420 | $ | 9,309 | $ | 9,025 |
| Asia NCI | **** | 680 | 733 | 694 | 712 | 741 | ||||
| Canada | **** | 3,656 | 3,659 | 3,675 | 3,558 | 3,626 | ||||
| U.S. | **** | 4,106 | 4,080 | 4,136 | 4,185 | 4,026 | ||||
| Corporate and Other | **** | 31 | 50 | 52 | 34 | 34 | ||||
| CSM | $ | 18,103 | $ | 18,200 | $ | 17,977 | $ | 17,798 | $ | 17,452 |
| CSM, CER adjustment^(1)^ | ||||||||||
| Asia | $ | 244 | $ | (158) | $ | (119) | $ | (44) | $ | 342 |
| Asia NCI | **** | 32 | (22) | (13) | (8) | (3) | ||||
| Canada | **** | (1) | – | – | – | – | ||||
| U.S. | **** | 61 | (31) | (36) | (94) | 166 | ||||
| Corporate and Other | **** | – | – | – | – | – | ||||
| Total | $ | 336 | $ | (211) | $ | (168) | $ | (146) | $ | 505 |
| CSM, CER basis | ||||||||||
| Asia | $ | 9,874 | $ | 9,520 | $ | 9,301 | $ | 9,265 | $ | 9,367 |
| Asia NCI | **** | 712 | 711 | 681 | 704 | 738 | ||||
| Canada | **** | 3,655 | 3,659 | 3,675 | 3,558 | 3,626 | ||||
| U.S. | **** | 4,167 | 4,049 | 4,100 | 4,091 | 4,192 | ||||
| Corporate and Other | **** | 31 | 50 | 52 | 34 | 34 | ||||
| Total CSM, CER basis | $ | 18,439 | $ | 17,989 | $ | 17,809 | $ | 17,652 | $ | 17,957 |
| Post-tax CSM | ||||||||||
| CSM | $ | 18,103 | $ | 18,200 | $ | 17,977 | $ | 17,798 | $ | 17,452 |
| Marginal tax rate on CSM | **** | (2,645) | (2,724) | (2,726) | (2,632) | (2,595) | ||||
| Post-tax CSM | $ | 15,458 | $ | 15,476 | $ | 15,251 | $ | 15,166 | $ | 14,857 |
| CSM, net of NCI | $ | 17,423 | $ | 17,467 | $ | 17,283 | $ | 17,086 | $ | 16,711 |
| Marginal tax rate on CSM net of NCI | **** | (2,546) | (2,617) | (2,624) | (2,526) | (2,487) | ||||
| Post-tax CSM net of NCI | $ | 14,877 | $ | 14,850 | $ | 14,659 | $ | 14,560 | $ | 14,224 |
| ^(1)^ | The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position<br>in effect for 2Q23. | |||||||||
| --- | --- | |||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 74 | |||||||||
| --- | --- |
Table of Contents
New business CSM detail, CER basis
($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| Quarterly Results | YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| New business CSM, net of NCI | ||||||||||||||||
| Hong Kong | $ | 191 | $ | 119 | $ | 110 | $ | 127 | $ | 94 | $ | 310 | $ | 200 | $ | 437 |
| Japan | **** | 19 | 36 | 28 | 37 | 38 | **** | 55 | 75 | 140 | ||||||
| Asia Other | **** | 222 | 146 | 186 | 176 | 196 | **** | 368 | 370 | 732 | ||||||
| International High Net Worth | 197 | |||||||||||||||
| Mainland China | 12 | |||||||||||||||
| Singapore | 189 | |||||||||||||||
| Vietnam | 305 | |||||||||||||||
| Other Emerging Markets | 29 | |||||||||||||||
| Asia | **** | 432 | 301 | 324 | 340 | 328 | **** | 733 | 645 | 1,309 | ||||||
| Canada | **** | 57 | 46 | 47 | 44 | 47 | **** | 103 | 108 | 199 | ||||||
| U.S. | **** | 103 | 95 | 71 | 86 | 118 | **** | 198 | 230 | 387 | ||||||
| Total new business CSM net of NCI | **** | 592 | 442 | 442 | 470 | 493 | **** | 1,034 | 983 | 1,895 | ||||||
| Asia NCI | **** | 38 | 19 | – | 2 | 1 | **** | 57 | 18 | 20 | ||||||
| Total impact of new insurance business in CSM | $ | 630 | $ | 461 | $ | 442 | $ | 472 | $ | 494 | $ | 1,091 | $ | 1,001 | $ | 1,915 |
| New business CSM, net of NCI, CER adjustment^(1)^ | ||||||||||||||||
| Hong Kong | $ | – | $ | (1) | $ | (1) | $ | 3 | $ | 5 | $ | (1) | $ | 12 | $ | 14 |
| Japan | **** | – | (1) | 1 | 2 | (1) | **** | (1) | (4) | (3) | ||||||
| Asia Other | **** | – | (2) | 2 | 7 | 11 | **** | (2) | 15 | 25 | ||||||
| International High Net Worth | 5 | |||||||||||||||
| Mainland China | – | |||||||||||||||
| Singapore | 12 | |||||||||||||||
| Vietnam | 8 | |||||||||||||||
| Other Emerging Markets | – | |||||||||||||||
| Asia | **** | – | (4) | 2 | 12 | 15 | **** | (4) | 23 | 36 | ||||||
| Canada | **** | – | – | – | – | (1) | **** | – | – | – | ||||||
| U.S. | **** | – | – | (1) | 3 | 6 | **** | – | 13 | 15 | ||||||
| Total new business CSM net of NCI | **** | – | (4) | 1 | 15 | 20 | **** | (4) | 36 | 51 | ||||||
| Asia NCI | **** | – | (1) | (1) | (1) | 1 | **** | (1) | (1) | (1) | ||||||
| Total impact of new insurance business in CSM | $ | – | $ | (5) | $ | – | $ | 14 | $ | 21 | $ | (5) | $ | 35 | $ | 50 |
| New business CSM net of NCI, CER basis | ||||||||||||||||
| Hong Kong | $ | 191 | $ | 118 | $ | 109 | $ | 130 | $ | 99 | $ | 309 | $ | 212 | $ | 451 |
| Japan | **** | 19 | 35 | 29 | 39 | 37 | **** | 54 | 71 | 137 | ||||||
| Asia Other | **** | 222 | 144 | 188 | 183 | 207 | **** | 366 | 385 | 757 | ||||||
| International High Net Worth | 202 | |||||||||||||||
| Mainland China | 12 | |||||||||||||||
| Singapore | 201 | |||||||||||||||
| Vietnam | 313 | |||||||||||||||
| Other Emerging Markets | 29 | |||||||||||||||
| Asia | **** | 432 | 297 | 326 | 352 | 343 | **** | 729 | 668 | 1,345 | ||||||
| Canada | **** | 57 | 46 | 47 | 44 | 46 | **** | 103 | 108 | 199 | ||||||
| U.S. | **** | 103 | 95 | 70 | 89 | 124 | **** | 198 | 243 | 402 | ||||||
| Total new business CSM net of NCI, CER basis | **** | 592 | 438 | 443 | 485 | 513 | **** | 1,030 | 1,019 | 1,946 | ||||||
| Asia NCI, CER basis | **** | 38 | 18 | (1) | 1 | 2 | **** | 56 | 17 | 19 | ||||||
| Total impact of new insurance business in CSM, CERbasis | $ | 630 | $ | 456 | $ | 442 | $ | 486 | $ | 515 | $ | 1,086 | $ | 1,036 | $ | 1,965 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- | |||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 75 | |||||||||||||||
| --- | --- |
Table of Contents
The Company also uses financial performance measures that are prepared on a constant exchange rate basis, which exclude the impact of currency fluctuations (from local currency to Canadian dollars at a total Company level and from local currency to U.S. dollars in Asia). Such financial measures may be stated on a constant exchange rate basis or the percentage growth/decline in the financial measure on a constant exchange rate basis, using the income statement and balance sheet exchange rates effective for the second quarter of 2023.
Information supporting constant exchange rate basis for GAAP and non-GAAP financial measures is presented below and throughout this section.
Basic EPS and diluted EPS, CER basis is equal to common shareholders’ net income on a CER basis divided by the weighted average common shares outstanding and diluted weighted common shares outstanding, respectively.
General expenses, CER basis
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| Quarterly Results | YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| General expenses | $ | 1,022 | $ | 1,086 | $ | 1,002 | $ | 914 | $ | 884 | $ | 2,108 | $ | 1,815 | $ | 3,731 |
| CER<br>adjustment^(1)^ | **** | – | (5) | (4) | 17 | 25 | **** | (5) | 57 | 70 | ||||||
| General expenses, CER basis | $ | 1,022 | $ | 1,081 | $ | 998 | $ | 931 | $ | 909 | $ | 2,103 | $ | 1,872 | $ | 3,801 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- | |||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 76 | |||||||||||||||
| --- | --- |
Table of Contents
Net income financial measures on a CER basis
($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| Net income (loss) attributed to shareholders: | |||||||||||||||
| Asia | 130 | $ | 519 | $ | 315 | $ | 280 | $ | (51) | $ | 649 | $ | 88 | $ | 683 |
| Canada | 227 | 309 | (73) | 853 | (611) | **** | 536 | (1,283) | (503) | ||||||
| U.S. | 183 | 186 | (44) | (447) | (1,226) | **** | 369 | (1,825) | (2,316) | ||||||
| Global WAM | 317 | 297 | 401 | 287 | 150 | **** | 614 | 433 | 1,121 | ||||||
| Corporate and Other | 168 | 95 | 316 | (482) | (381) | **** | 263 | (752) | (918) | ||||||
| Total net income (loss) attributed to shareholders | 1,025 | 1,406 | 915 | 491 | (2,119) | **** | 2,431 | (3,339) | (1,933) | ||||||
| Preferred share dividends and other equity distributions | (98) | (52) | (97) | (51) | (60) | **** | (150) | (112) | (260) | ||||||
| Common shareholders’ net income (loss) | 927 | $ | 1,354 | $ | 818 | $ | 440 | $ | (2,179) | $ | 2,281 | $ | (3,451) | $ | (2,193) |
| CER adjustment(1) | |||||||||||||||
| Asia | – | $ | (4) | $ | 5 | $ | 34 | $ | 40 | $ | (4) | $ | 137 | $ | 175 |
| Canada | – | (1) | (2) | 17 | 20 | **** | (1) | 48 | 64 | ||||||
| U.S. | – | (2) | (1) | (9) | (71) | **** | (2) | (113) | (123) | ||||||
| Global WAM | – | (3) | (3) | 5 | 2 | **** | (3) | 8 | 11 | ||||||
| Corporate and Other | – | (1) | (5) | (14) | (18) | **** | (1) | (42) | (62) | ||||||
| Total net income (loss) attributed to shareholders | – | (11) | (6) | 33 | (27) | **** | (11) | 38 | 65 | ||||||
| Preferred share dividends and other equity distributions | – | – | – | – | – | **** | – | – | – | ||||||
| Common shareholders’ net income (loss) | – | $ | (11) | $ | (6) | $ | 33 | $ | (27) | $ | (11) | $ | 38 | $ | 65 |
| Net income (loss) attributed to shareholders, CER basis | |||||||||||||||
| Asia | 130 | $ | 515 | $ | 320 | $ | 314 | $ | (11) | $ | 645 | $ | 225 | $ | 858 |
| Canada | 227 | 308 | (75) | 870 | (591) | **** | 535 | (1,235) | (439) | ||||||
| U.S. | 183 | 184 | (45) | (456) | (1,297) | **** | 367 | (1,938) | (2,439) | ||||||
| Global WAM | 317 | 294 | 398 | 292 | 152 | **** | 611 | 441 | 1,132 | ||||||
| Corporate and Other | 168 | 94 | 311 | (496) | (399) | **** | 262 | (794) | (980) | ||||||
| Total net income (loss) attributed to shareholders, CER basis | 1,025 | 1,395 | 909 | 524 | (2,146) | **** | 2,420 | (3,301) | (1,868) | ||||||
| Preferred share dividends and other equity distributions, CER<br>basis | (98) | (52) | (97) | (51) | (60) | **** | (150) | (112) | (260) | ||||||
| Common shareholders’ net income (loss), CER<br>basis | 927 | $ | 1,343 | $ | 812 | $ | 473 | $ | (2,206) | $ | 2,270 | $ | (3,413) | $ | (2,128) |
| Asia net income attributed to shareholders, U.S. dollars | |||||||||||||||
| Asia net income (loss) attributed to shareholders, US<br>(2) | 96 | $ | 384 | $ | 231 | $ | 216 | $ | (41) | $ | 480 | $ | 69 | $ | 516 |
| CER adjustment, US<br>(1) | – | – | 9 | 17 | 33 | **** | – | 100 | 126 | ||||||
| Asia net income (loss) attributed to shareholders, U.S. , CER<br>basis(1) | 96 | $ | 384 | $ | 240 | $ | 233 | $ | (8) | $ | 480 | $ | 169 | $ | 642 |
| Net income (loss) attributed to shareholders (pre-tax) | |||||||||||||||
| Net income (loss) attributed to shareholders (post-tax) | 1,025 | $ | 1,406 | $ | 915 | $ | 491 | $ | (2,119) | $ | 2,431 | $ | (3,339) | $ | (1,933) |
| Tax on net income attributed to shareholders | 242 | 287 | (307) | 59 | (564) | **** | 529 | (993) | (1,241) | ||||||
| Net income (loss) attributed to shareholders (pre-tax) | 1,267 | 1,693 | 608 | 550 | (2,683) | **** | 2,960 | (4,332) | (3,174) | ||||||
| CER<br>adjustment(1) | – | (12) | (6) | (1) | (66) | **** | (12) | (77) | (84) | ||||||
| Net income (loss) attributed to shareholders (pre-tax), CER<br>basis | 1,267 | $ | 1,681 | $ | 602 | $ | 549 | $ | (2,749) | $ | 2,948 | $ | (4,409) | $ | (3,258) |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S.<br>dollar Statement of Income rate for the reporting period. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 77 |
| --- | --- |
Table of Contents
Transitional net income financial measures on a CER basis
($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| YTDResults | Full YearResults | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3Q22 | 2Q22 | 1Q22 | 2022 | 2022 | |||||||
| Transitional net income (loss) attributed to shareholders: | |||||||||||
| Asia | 493 | $ | 176 | $ | (227) | $ | 205 | $ | (22) | $ | 647 |
| Canada | 120 | 481 | 271 | 326 | 597 | 1,198 | |||||
| U.S. | (106) | 314 | 355 | 885 | 1,240 | 1,448 | |||||
| Global WAM | 401 | 287 | 150 | 283 | 433 | 1,121 | |||||
| Corporate and Other | 320 | (481) | (381) | (374) | (755) | (916) | |||||
| Total transitional net income (loss) attributed to shareholders | 1,228 | 777 | 168 | 1,325 | 1,493 | 3,498 | |||||
| Preferred share dividends and other equity distributions | (97) | (51) | (60) | (52) | (112) | (260) | |||||
| Common shareholders’ transitional net income<br>(loss) | 1,131 | $ | 726 | $ | 108 | $ | 1,273 | $ | 1,381 | $ | 3,238 |
| CER adjustment(1) | |||||||||||
| Asia | 10 | $ | 16 | $ | 17 | $ | 52 | $ | 69 | $ | 95 |
| Canada | (3) | 12 | 6 | 10 | 16 | 25 | |||||
| U.S. | (1) | 13 | (3) | 48 | 45 | 57 | |||||
| Global WAM | (2) | 5 | 1 | 7 | 8 | 11 | |||||
| Corporate and Other | (4) | (16) | (17) | (25) | (42) | (62) | |||||
| Total CER adjustment - transitional net income attributed to shareholders | – | 30 | 4 | 92 | 96 | 126 | |||||
| Preferred share dividends and other equity distributions | – | – | – | – | – | – | |||||
| Common shareholders’ transitional net income<br>(loss) | – | $ | 30 | $ | 4 | $ | 92 | $ | 96 | $ | 126 |
| Transitional net income (loss) attributed to shareholders, CER basis | |||||||||||
| Asia | 503 | $ | 192 | $ | (210) | $ | 257 | $ | 47 | $ | 742 |
| Canada | 117 | 493 | 277 | 336 | 613 | 1,223 | |||||
| U.S. | (107) | 327 | 352 | 933 | 1,285 | 1,505 | |||||
| Global WAM | 399 | 292 | 151 | 290 | 441 | 1,132 | |||||
| Corporate and Other | 316 | (497) | (398) | (399) | (797) | (978) | |||||
| Total transitional net income (loss) attributed to shareholders, CER basis | 1,228 | 807 | 172 | 1,417 | 1,589 | 3,624 | |||||
| Preferred share dividends and other equity distributions, CER<br>basis | (97) | (51) | (60) | (52) | (112) | (260) | |||||
| Common shareholders’ net income (loss), CER<br>basis | 1,131 | $ | 756 | $ | 112 | $ | 1,365 | $ | 1,477 | $ | 3,364 |
| Asia transitional net income attributed to shareholders, U.S. dollars | |||||||||||
| Asia transitional net income (loss) attributed to shareholders, US (2) | 363 | $ | 134 | $ | (177) | $ | 161 | $ | (16) | $ | 481 |
| CER adjustment, US<br>(1) | 13 | 9 | 21 | 32 | 53 | 75 | |||||
| Asia transitional net income (loss) attributed to<br>shareholders, U.S. , CER basis(1) | 376 | $ | 143 | $ | (156) | $ | 193 | $ | 37 | $ | 556 |
| Transitional net income (loss) attributed to shareholders (pre-tax) | |||||||||||
| Transitional net income (loss) attributed to shareholders (post-tax) | 1,228 | $ | 777 | $ | 168 | $ | 1,325 | $ | 1,493 | $ | 3,498 |
| Tax on transitional net income attributed to shareholders | (184) | 200 | 230 | 403 | 633 | 649 | |||||
| Transitional net income (loss) attributed to shareholders (pre-tax) | 1,044 | 977 | 398 | 1,728 | 2,126 | 4,147 | |||||
| CER<br>adjustment(1) | (3) | 23 | 39 | 99 | 138 | 158 | |||||
| Transitional net income (loss) attributed to shareholders<br>(pre-tax), CER basis | 1,041 | $ | 1,000 | $ | 437 | $ | 1,827 | $ | 2,264 | $ | 4,305 |
All values are in US Dollars.
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
|---|---|
| ^(2)^ | Asia transitional net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using<br>the U.S. dollar Statement of Income rate for the reporting period. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 78 |
| --- | --- |
Table of Contents
Transitional ROE measures profitability in 2022 using common shareholders’ transitional net income (loss) as a percentage of capital deployed to earn that income. The Company calculates transitional ROE using average common shareholders’ equity quarterly, as the average of common shareholders’ equity at the start and end of the quarter, and annually, as the average of the quarterly average common shareholders’ equity for the year. Transitional ROE is a temporary measure and will be reported for 2022 comparative periods in our quarterly and annual 2023 MD&A.
| Quarterly Results | YTDResults | Full Year Results | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unless otherwise stated) | 4Q22 | 3Q22 | 2Q22 | 1Q22 | 2022 | 2022 | ||||||
| Total transitional net income (loss) attributed to shareholders | $ | 1,228 | $ | 777 | $ | 168 | $ | 1,325 | $ | 1,493 | $ | 3,498 |
| Preferred share dividends and other equity distributions | (97) | (51) | (60) | (52) | (112) | (260) | ||||||
| Common shareholders transitional net income (loss) | $ | 1,131 | $ | 726 | $ | 108 | $ | 1,273 | $ | 1,381 | $ | 3,238 |
| Annualized common shareholders transitional net income(loss) | $ | 4,487 | $ | 2,876 | $ | 437 | $ | 5,163 | $ | 2,785 | $ | 3,238 |
| Average common shareholders’ equity (see below) | $ | 40,667 | $ | 40,260 | $ | 39,095 | $ | 38,881 | $ | 38,988 | $ | 39,726 |
| Transitional ROE (annualized) (%) | 11.0% | 7.1% | 1.1% | 13.3% | 7.1% | 8.2% |
Transitional basic EPS and transitional diluted EPS is equal to transitional common shareholders’ net income divided by the weighted average common shares outstanding and diluted weighted common shares outstanding, respectively. Transitional basic EPS and transitional diluted EPS, CER basis is equal to transitional common shareholders’ net income on a CER basis divided by the weighted average common shares outstanding and diluted weighted common shares outstanding, respectively. Each of these EPS measures are temporary and will be reported for 2022 comparative periods in our quarterly and annual 2023 MD&A.
AUMA is a financial measure of the size of the Company. It is comprised of AUM and AUA. AUM includes assets of the General Account, consisting of total invested assets and segregated funds net assets, and external client assets for which we provide investment management services, consisting of mutual fund, institutional asset management and other fund net assets. AUA are assets for which we provide administrative services only. Assets under management and administration is a common industry metric for wealth and asset management businesses.
Our Global WAM business also manages assets on behalf of other segments of the Company. Global WAM-managed AUMA is a financial measure equal to the sum of Global WAM’s AUMA and assets managed by Global WAM on behalf of other segments. It is an important measure of the assets managed by Global WAM. ****
| Manulife Financial Corporation – Second Quarter 2023 | 79 |
|---|
Table of Contents
AUM and AUMA reconciliations
(Canadian $ in millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| US (4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2023 | |||||||||||||
| As at | Canada | U.S. | Global<br><br><br>WAM | Corporate<br><br><br>and Other | Total | Asia | U.S. | ||||||
| Total invested assets | |||||||||||||
| Manulife Bank net lending assets | $ | 25,003 | $ | – | $ | – | $ | – | $ | 25,003 | $ | – | |
| Derivative reclassification(1) | **** | – | **** | – | **** | – | **** | 3,895 | **** | 3,895 | **** | – | |
| Invested assets excluding above items | **** | 83,026 | **** | 132,133 | **** | 5,464 | **** | 18,699 | **** | 374,530 | **** | 99,855 | |
| Total | **** | 108,029 | **** | 132,133 | **** | 5,464 | **** | 22,594 | **** | 403,428 | **** | 99,855 | |
| Segregated funds net assets | |||||||||||||
| Segregated funds net assets - Institutional | **** | – | **** | 3,564 | **** | – | **** | 3,564 | **** | – | |||
| Segregated funds net assets - Other(2) | **** | 35,993 | **** | 67,303 | **** | 235,113 | **** | (44) | **** | 362,417 | **** | 50,862 | |
| Total | **** | 35,993 | **** | 67,303 | **** | 238,677 | **** | (44) | **** | 365,981 | **** | 50,862 | |
| AUM per financial statements | **** | 144,022 | **** | 199,436 | **** | 244,141 | **** | 22,550 | **** | 769,409 | **** | 150,717 | |
| Mutual funds | **** | – | **** | – | **** | 267,835 | **** | – | **** | 267,835 | **** | – | |
| Institutional asset management(3) | **** | – | **** | – | **** | 112,491 | **** | – | **** | 112,491 | **** | – | |
| Other funds | **** | – | **** | – | **** | 14,674 | **** | – | **** | 14,674 | **** | – | |
| Total AUM | **** | 144,022 | **** | 199,436 | **** | 639,141 | **** | 22,550 | **** | 1,164,409 | **** | 150,717 | |
| Assets under administration | **** | – | **** | – | **** | 180,430 | **** | – | **** | 180,430 | **** | – | |
| Total AUMA | $ | 144,022 | $ | 199,436 | $ | 819,571 | $ | 22,550 | $ | 1,344,839 | $ | 150,717 | |
| Total AUMA, US<br>(4) | $ | 1,016,277 | |||||||||||
| Total AUMA | $ | 144,022 | $ | 199,436 | $ | 819,571 | $ | 22,550 | $ | 1,344,839 | |||
| CER<br>adjustment(5) | **** | – | **** | – | **** | – | **** | – | **** | – | |||
| Total AUMA, CER basis | $ | 144,022 | $ | 199,436 | $ | 819,571 | $ | 22,550 | $ | 1,344,839 | |||
| Global WAM Managed AUMA | |||||||||||||
| Global WAM AUMA | $ | 819,571 | |||||||||||
| AUM managed by Global WAM for Manulife’s other<br>segments | **** | 203,825 | |||||||||||
| Total | $ | 1,023,396 |
All values are in US Dollars.
| ^(1)^ | Corporate and Other consolidation adjustment related to net derivative assets reclassified from total invested assets to<br>other lines on the Statement of Financial Position. |
|---|---|
| ^(2)^ | Corporate and Other segregated funds net assets represents elimination of amounts held by the Company.<br> |
| --- | --- |
| ^(3)^ | Institutional asset management excludes Institutional segregated funds net assets. |
| --- | --- |
| ^(4)^ | US $ AUMA is calculated as total AUMA in Canadian $ divided by the US $ exchange rate in effect at the end of the quarter.<br> |
| --- | --- |
| ^(5)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 80 |
| --- | --- |
Table of Contents
| US (4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2023 | |||||||||||||
| As at | Canada | U.S. | Global<br><br><br>WAM | Corporate<br><br><br>and Other | Total | Asia | U.S. | ||||||
| Total invested assets | |||||||||||||
| Manulife Bank net lending assets | $ | 24,747 | $ | – | $ | – | $ | – | $ | 24,747 | $ | – | |
| Derivative reclassification(1) | – | – | – | 3,488 | 3,488 | – | |||||||
| Invested assets excluding above items | 82,733 | 136,454 | 5,565 | 21,460 | 384,241 | 100,827 | |||||||
| Total | 107,480 | 136,454 | 5,565 | 24,948 | 412,476 | 100,827 | |||||||
| Segregated funds net assets | |||||||||||||
| Segregated funds net assets - Institutional | – | – | 3,718 | – | 3,718 | – | |||||||
| Segregated funds net assets - Other(2) | 36,374 | 67,935 | 231,860 | (46) | 360,326 | 50,197 | |||||||
| Total | 36,374 | 67,935 | 235,578 | (46) | 364,044 | 50,197 | |||||||
| AUM per financial statements | 143,854 | 204,389 | 241,143 | 24,902 | 776,520 | 151,024 | |||||||
| Mutual funds | – | – | 267,767 | – | 267,767 | – | |||||||
| Institutional asset management(3) | – | – | 113,781 | – | 113,781 | – | |||||||
| Other funds | – | – | 14,302 | – | 14,302 | – | |||||||
| Total AUM | 143,854 | 204,389 | 636,993 | 24,902 | 1,172,370 | 151,024 | |||||||
| Assets under administration | – | – | 177,510 | – | 177,510 | – | |||||||
| Total AUMA | $ | 143,854 | $ | 204,389 | $ | 814,503 | $ | 24,902 | $ | 1,349,880 | $ | 151,024 | |
| Total AUMA, US<br>(4) | $ | 997,399 | |||||||||||
| Total AUMA | $ | 143,854 | $ | 204,389 | $ | 814,503 | $ | 24,902 | $ | 1,349,880 | |||
| CER<br>adjustment(5) | – | (4,550) | (15,583) | – | (26,830) | ||||||||
| Total AUMA, CER basis | $ | 143,854 | $ | 199,839 | $ | 798,920 | $ | 24,902 | $ | 1,323,050 | |||
| Global WAM Managed AUMA | |||||||||||||
| Global WAM AUMA | $ | 814,503 | |||||||||||
| AUM managed by Global WAM for Manulife’s other<br>segments | 208,013 | ||||||||||||
| Total | $ | 1,022,516 |
All values are in US Dollars.
Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at June 30, 2023 above.
| Manulife Financial Corporation – Second Quarter 2023 | 81 |
|---|
Table of Contents
| US (4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| December 31, 2022 | |||||||||||||
| As at | Canada | U.S. | Global<br><br><br>WAM | Corporate<br><br><br>and Other | Total | Asia | U.S. | ||||||
| Total invested assets | |||||||||||||
| Manulife Bank net lending assets | $ | 24,779 | $ | – | $ | – | $ | – | $ | 24,779 | $ | – | |
| Derivative reclassification(1) | – | – | – | 5,701 | 5,701 | – | |||||||
| Invested assets excluding above items | 82,150 | 133,635 | 5,752 | 15,317 | 369,662 | 98,628 | |||||||
| Total | 106,929 | 133,635 | 5,752 | 21,018 | 400,142 | 98,628 | |||||||
| Segregated funds net assets | |||||||||||||
| Segregated funds net assets - Institutional | – | – | 3,719 | – | 3,719 | – | |||||||
| Segregated funds net assets - Other(2) | 35,695 | 65,490 | 220,472 | (40) | 344,844 | 48,333 | |||||||
| Total | 35,695 | 65,490 | 224,191 | (40) | 348,563 | 48,333 | |||||||
| AUM per financial statements | 142,624 | 199,125 | 229,943 | 20,978 | 748,705 | 146,961 | |||||||
| Mutual funds | – | – | 258,273 | – | 258,273 | – | |||||||
| Institutional asset management(3) | – | – | 109,739 | – | 109,739 | – | |||||||
| Other funds | – | – | 13,617 | – | 13,617 | – | |||||||
| Total AUM | 142,624 | 199,125 | 611,572 | 20,978 | 1,130,334 | 146,961 | |||||||
| Assets under administration | – | – | 170,768 | – | 170,768 | – | |||||||
| Total AUMA | $ | 142,624 | $ | 199,125 | $ | 782,340 | $ | 20,978 | $ | 1,301,102 | $ | 146,961 | |
| Total AUMA, US<br>(4) | $ | 960,259 | |||||||||||
| Total AUMA | $ | 142,624 | $ | 199,125 | $ | 782,340 | $ | 20,978 | $ | 1,301,102 | |||
| CER<br>adjustment(5) | – | (4,675) | (15,342) | – | (26,409) | ||||||||
| Total AUMA, CER basis | $ | 142,624 | $ | 194,450 | $ | 766,998 | $ | 20,978 | $ | 1,274,693 | |||
| Global WAM Managed AUMA | |||||||||||||
| Global WAM AUMA | $ | 782,340 | |||||||||||
| AUM managed by Global WAM for Manulife’s other<br>segments | 201,920 | ||||||||||||
| Total | $ | 984,260 |
All values are in US Dollars.
Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at June 30, 2023 above.
| Manulife Financial Corporation – Second Quarter 2023 | 82 |
|---|
Table of Contents
| US (4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| September 30, 2022 | |||||||||||||
| As at | Canada | U.S. | Global<br><br><br>WAM | Corporate<br><br><br>and Other | Total | Asia | U.S. | ||||||
| Total invested assets | |||||||||||||
| Manulife Bank net lending assets | $ | 24,779 | $ | – | $ | – | $ | – | $ | 24,779 | $ | – | |
| Derivative reclassification(1) | – | – | – | 5,880 | 5,880 | – | |||||||
| Invested assets excluding above items | 81,682 | 133,567 | 5,586 | 17,465 | 365,924 | 97,206 | |||||||
| Total | 106,461 | 133,567 | 5,586 | 23,345 | 396,583 | 97,206 | |||||||
| Segregated funds net assets | |||||||||||||
| Segregated funds net assets - Institutional | 4,118 | 4,118 | – | ||||||||||
| Segregated funds net assets - Other(2) | 34,773 | 63,996 | 210,351 | (26) | 331,127 | 46,575 | |||||||
| Total | 34,773 | 63,996 | 214,469 | (26) | 335,245 | 46,575 | |||||||
| AUM per financial statements | 141,234 | 197,563 | 220,055 | 23,319 | 731,828 | 143,781 | |||||||
| Mutual funds | – | – | 249,591 | – | 249,591 | – | |||||||
| Institutional asset management(3) | – | – | 100,474 | – | 100,474 | – | |||||||
| Other funds | – | – | 12,910 | – | 12,910 | – | |||||||
| Total AUM | 141,234 | 197,563 | 583,030 | 23,319 | 1,094,803 | 143,781 | |||||||
| Assets under administration | – | – | 168,316 | – | 168,316 | – | |||||||
| Total AUMA | $ | 141,234 | $ | 197,563 | $ | 751,346 | $ | 23,319 | $ | 1,263,119 | $ | 143,781 | |
| Total AUMA, US<br>(4) | $ | 932,226 | |||||||||||
| Total AUMA | $ | 141,234 | $ | 197,563 | $ | 751,346 | $ | 23,319 | $ | 1,263,119 | |||
| CER<br>adjustment(5) | – | (7,281) | (19,868) | – | (31,443) | ||||||||
| Total AUMA, CER basis | $ | 141,234 | $ | 190,282 | $ | 731,478 | $ | 23,319 | $ | 1,231,676 | |||
| Global WAM Managed AUMA | |||||||||||||
| Global WAM AUMA | $ | 751,346 | |||||||||||
| AUM managed by Global WAM for Manulife’s other<br>segments | 199,285 | ||||||||||||
| Total | $ | 950,631 |
All values are in US Dollars.
Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at June 30, 2023 above.
| Manulife Financial Corporation – Second Quarter 2023 | 83 |
|---|
Table of Contents
| US (4) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 30, 2022 | |||||||||||||
| As at | Canada | U.S. | Global<br><br><br>WAM | Corporate<br><br><br>and Other | Total | Asia | U.S. | ||||||
| Total invested assets | |||||||||||||
| Manulife Bank net lending assets | $ | 24,779 | $ | – | $ | – | $ | – | $ | 24,779 | $ | – | |
| Derivative reclassification(1) | – | – | – | 5,233 | 5,233 | – | |||||||
| Invested assets excluding above items | 79,402 | 131,463 | 5,698 | 20,598 | 361,086 | 101,913 | |||||||
| Total | 104,181 | 131,463 | 5,698 | 25,831 | 391,098 | 101,913 | |||||||
| Segregated funds net assets | |||||||||||||
| Segregated funds net assets - Institutional | – | – | 4,098 | – | 4,098 | – | |||||||
| Segregated funds net assets - Other(2) | 35,577 | 64,199 | 209,181 | (26) | 330,805 | 49,770 | |||||||
| Total | 35,577 | 64,199 | 213,279 | (26) | 334,903 | 49,770 | |||||||
| AUM per financial statements | 139,758 | 195,662 | 218,977 | 25,805 | 726,001 | 151,683 | |||||||
| Mutual funds | – | – | 250,517 | – | 250,517 | – | |||||||
| Institutional asset management(3) | – | – | 96,997 | – | 96,997 | – | |||||||
| Other funds | – | – | 15,075 | – | 15,075 | – | |||||||
| Total AUM | 139,758 | 195,662 | 581,566 | 25,805 | 1,088,590 | 151,683 | |||||||
| Assets under administration | – | – | 165,197 | – | 165,197 | – | |||||||
| Total AUMA | $ | 139,758 | $ | 195,662 | $ | 746,763 | $ | 25,805 | $ | 1,253,787 | $ | 151,683 | |
| Total AUMA, US<br>(4) | $ | 925,339 | |||||||||||
| Total AUMA | $ | 139,758 | $ | 195,662 | $ | 746,763 | $ | 25,805 | $ | 1,253,787 | |||
| CER<br>adjustment(5) | – | 5,033 | 12,252 | – | 18,947 | ||||||||
| Total AUMA, CER basis | $ | 139,758 | $ | 200,695 | $ | 759,015 | $ | 25,805 | $ | 1,272,734 | |||
| Global WAM Managed AUMA | |||||||||||||
| Global WAM AUMA | $ | 746,763 | |||||||||||
| AUM managed by Global WAM for Manulife’s other<br>segments | 197,001 | ||||||||||||
| Total | $ | 943,764 |
All values are in US Dollars.
Note: For footnotes (1) to (5), refer to the “AUM and AUMA reconciliation” table as at June 30, 2023 above.
| Manulife Financial Corporation – Second Quarter 2023 | 84 |
|---|
Table of Contents
Global WAM AUMA and managed AUMA by business line and geographic source
($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| As at | June 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sept 30, 2022 | June 30, 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Global WAM AUMA by business line | ||||||||||
| Retirement | $ | 419,380 | $ | 413,769 | $ | 395,108 | $ | 380,292 | $ | 378,257 |
| Retail | **** | 281,814 | 281,198 | 271,351 | 264,029 | 262,203 | ||||
| Institutional asset management | **** | 118,377 | 119,536 | 115,881 | 107,025 | 106,303 | ||||
| Total | $ | 819,571 | $ | 814,503 | $ | 782,340 | $ | 751,346 | $ | 746,763 |
| Global WAM AUMA by business line, CERbasis^(1)^ | ||||||||||
| Retirement | $ | 419,380 | $ | 406,582 | $ | 387,908 | $ | 369,281 | $ | 385,904 |
| Retail | **** | 281,814 | 276,162 | 266,352 | 257,551 | 265,711 | ||||
| Institutional asset management | **** | 118,377 | 116,176 | 112,738 | 104,646 | 107,400 | ||||
| Total | $ | 819,571 | $ | 798,920 | $ | 766,998 | $ | 731,478 | $ | 759,015 |
| Global WAM AUMA by geographic source | ||||||||||
| Asia | $ | 112,283 | $ | 115,819 | $ | 110,724 | $ | 97,941 | $ | 97,277 |
| Canada | **** | 226,087 | 223,045 | 213,802 | 205,042 | 207,086 | ||||
| U.S. | **** | 481,201 | 475,639 | 457,814 | 448,363 | 442,400 | ||||
| Total | $ | 819,571 | $ | 814,503 | $ | 782,340 | $ | 751,346 | $ | 746,763 |
| Global WAM AUMA by geographic source, CER basis^(1)^ | ||||||||||
| Asia | $ | 112,283 | $ | 110,814 | $ | 106,086 | $ | 94,638 | $ | 98,102 |
| Canada | **** | 226,087 | 223,045 | 213,802 | 205,042 | 207,086 | ||||
| U.S. | **** | 481,201 | 465,061 | 447,110 | 431,798 | 453,827 | ||||
| Total | $ | 819,571 | $ | 798,920 | $ | 766,998 | $ | 731,478 | $ | 759,015 |
| Global WAM Managed AUMA by business line | ||||||||||
| Retirement | $ | 419,380 | $ | 413,769 | $ | 395,108 | $ | 380,292 | $ | 378,257 |
| Retail | **** | 357,539 | 358,098 | 346,200 | 338,181 | 337,058 | ||||
| Institutional asset management | **** | 246,477 | 250,649 | 242,952 | 232,158 | 228,449 | ||||
| Total | $ | 1,023,396 | $ | 1,022,516 | $ | 984,260 | $ | 950,631 | $ | 943,764 |
| Global WAM Managed AUMA by business line, CERbasis^(1)^ | ||||||||||
| Retirement | $ | 419,380 | $ | 406,582 | $ | 387,908 | $ | 369,281 | $ | 385,904 |
| Retail | **** | 357,539 | 352,015 | 340,118 | 329,999 | 341,759 | ||||
| Institutional asset management | **** | 246,477 | 244,810 | 237,286 | 225,883 | 232,184 | ||||
| Total | $ | 1,023,396 | $ | 1,003,407 | $ | 965,312 | $ | 925,163 | $ | 959,847 |
| Global WAM Managed AUMA by geographic source | ||||||||||
| Asia | $ | 185,198 | $ | 191,720 | $ | 183,893 | $ | 169,985 | $ | 168,893 |
| Canada | **** | 274,957 | 272,101 | 261,756 | 252,669 | 255,501 | ||||
| U.S. | **** | 563,241 | 558,695 | 538,611 | 527,977 | 519,370 | ||||
| Total | $ | 1,023,396 | $ | 1,022,516 | $ | 984,260 | $ | 950,631 | $ | 943,764 |
| Global WAM Managed AUMA by geographic source, CERbasis^(1)^ | ||||||||||
| Asia | $ | 185,198 | $ | 185,035 | $ | 177,539 | $ | 164,025 | $ | 171,562 |
| Canada | **** | 274,957 | 272,101 | 261,756 | 252,669 | 255,501 | ||||
| U.S. | **** | 563,241 | 546,271 | 526,017 | 508,469 | 532,784 | ||||
| Total | $ | 1,023,396 | $ | 1,003,407 | $ | 965,312 | $ | 925,163 | $ | 959,847 |
| ^(1)^ | AUMA adjusted to reflect the foreign exchange rates for the Statement of Financial Position in effect for 2Q23.<br> | |||||||||
| --- | --- |
Average assets under management and administration (“average AUMA”) is the average of Global WAM’s AUMA during the reporting period. It is a measure used in analyzing and explaining fee income and earnings of our Global WAM segment. It is calculated as the average of the opening balance of AUMA and the ending balance of AUMA using daily balances where available and month-end or quarter-end averages when daily averages are unavailable. Similarly, Global WAM average managed AUMA and average AUA are the average of Global WAM’s managed AUMA and AUA, respectively, and are calculated in a manner consistent with average AUMA.
| Manulife Financial Corporation – Second Quarter 2023 | 85 |
|---|
Table of Contents
Manulife Bank net lending assets is a financial measure equal to the sum of Manulife Bank’s loans and mortgages, net of allowances. Manulife Bank average net lending assets is a financial measure which is calculated as the quarter-end average of the opening and the ending balance of net lending assets. Both of these financial measures are a measure of the size of Manulife Bank’s portfolio of loans and mortgages and are used to analyze and explain its earnings.
| As at<br> <br>($millions) | June 30,<br><br><br>2023 | Mar 31,<br><br><br>2023 | Dec 31,<br><br><br>2022 | June 30,<br><br><br>2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Mortgages | $ | 51,459 | $ | 52,128 | $ | 51,765 | 51,445 | $ | 51,276 |
| Less: Mortgages not held by Manulife Bank | **** | 29,088 | 30,087 | 29,767 | 29,607 | 29,558 | |||
| Total mortgages held by Manulife Bank | **** | 22,371 | 22,041 | 21,998 | 21,838 | 21,718 | |||
| Loans to bank clients | **** | 2,632 | 2,706 | 2,781 | 2,799 | 2,782 | |||
| Manulife Bank net lending assets | $ | 25,003 | $ | 24,747 | $ | 24,779 | 24,637 | $ | 24,500 |
| Manulife Bank average net lending assets | |||||||||
| Beginning of period | $ | 24,747 | $ | 24,779 | $ | 24,637 | 24,500 | $ | 24,004 |
| End of period | **** | 25,003 | 24,747 | 24,779 | 24,637 | 24,500 | |||
| Manulife Bank average net lending assets byquarter | $ | 24,875 | $ | 24,763 | $ | 24,708 | 24,569 | $ | 24,252 |
| Manulife Bank average net lending assets –Year-to-date | $ | 24,891 | $ | 23,973 | |||||
| Manulife Bank average net lending assets – fullyear | 24,113 |
All values are in US Dollars.
Financial leverage ratio is a debt-to-equity ratio. With the adoption of IFRS 17 on January 1, 2023, the calculation of financial leverage ratio was updated to include the CSM on a post-tax basis, and prior period comparatives were updated. The ratio is calculated as the sum of long-term debt, capital instruments and preferred shares and other equity instruments divided by the sum of long-term debt, capital instruments, equity and post-tax CSM.
Adjusted book value is the sum of common shareholders’ equity and post-tax CSM net of NCI. It is an important measure for monitoring growth and measuring insurance businesses’ value. Adjusted book value per common share is calculated by dividing adjusted book value by the number of common shares outstanding at the end of the period.
| As at<br> <br>($millions) | June 30,<br><br><br>2023 | Mar 31,<br><br><br>2023 | Dec 31,<br><br><br>2022 | Sept 30,<br><br><br>2022 | June 30,<br><br><br>2022 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Common shareholders’ equity | $ | 39,047 | $ | 40,715 | $ | 40,216 | $ | 41,118 | $ | 39,401 |
| Post tax CSM, net of NCI | **** | 14,877 | 14,850 | 14,659 | 14,560 | 14,224 | ||||
| Adjusted book value | $ | 53,924 | $ | 55,565 | $ | 54,875 | $ | 55,678 | $ | 53,625 |
Consolidated capital serves as a foundation of our capital management activities at the MFC level. Consolidated capital is calculated as the sum of: (i) total equity excluding accumulated other comprehensive income (“AOCI”) on cash flow hedges; (ii) post-tax CSM; and (iii) certain other capital instruments that qualify as regulatory capital. For regulatory reporting purposes under the LICAT framework, the numbers are further adjusted for various additions or deductions to capital as mandated by the guidelines defined by OSFI.
| As at<br> <br>($millions) | June 30,<br><br><br>2023 | Mar 31,<br><br><br>2023 | Dec 31,<br><br><br>2022 | Sept 30,<br><br><br>2022 | June 30,<br><br><br>2022 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total equity | $ | 47,156 | $ | 48,751 | $ | 48,226 | $ | 49,180 | $ | 47,589 |
| Less: AOCI gain/(loss) on cash flow hedges | **** | – | (38) | 8 | (18) | (48) | ||||
| Total equity excluding AOCI on cash flow hedges | **** | 47,156 | 48,789 | 48,218 | 49,198 | 47,637 | ||||
| Post-tax CSM | **** | 15,458 | 15,476 | 15,251 | 15,166 | 14,857 | ||||
| Qualifying capital instruments | **** | 6,662 | 7,317 | 6,122 | 7,118 | 7,001 | ||||
| Consolidated capital | $ | 69,276 | $ | 71,582 | $ | 69,591 | $ | 71,482 | $ | 69,495 |
| Manulife Financial Corporation – Second Quarter 2023 | 86 | |||||||||
| --- | --- |
Table of Contents
Core EBITDA is a financial measure which Manulife uses to better understand the long-term earnings capacity and valuation of our Global WAM business on a basis more comparable to how the profitability of global asset managers is generally measured. Core EBITDA presents core earnings before the impact of interest, taxes, depreciation, and amortization. Core EBITDA excludes certain acquisition expenses related to insurance contracts in our retirement businesses which are deferred and amortized over the expected lifetime of the customer relationship. Core EBITDA was selected as a key performance indicator for our Global WAM business, as EBITDA is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.
Reconciliation of Global WAM core earnings to core EBITDA and Global WAM core EBITDA by business line and geographic source
($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | |||||||||
| Global WAM core earnings (post-tax) | $ | 320 | $ | 287 | $ | 274 | $ | 354 | $ | 327 | $ | 607 | $ | 671 | $ | 1,299 |
| Addback taxes, acquisition costs, other expenses and deferred sales commissions | ||||||||||||||||
| Core income tax (expense) recovery (see above) | **** | 45 | 45 | 47 | 51 | 60 | **** | 90 | 124 | 222 | ||||||
| Amortization of deferred acquisition costs and other depreciation | **** | 40 | 40 | 43 | 36 | 37 | **** | 80 | 75 | 154 | ||||||
| Amortization of deferred sales commissions | **** | 19 | 21 | 25 | 24 | 24 | **** | 40 | 49 | 98 | ||||||
| Core EBITDA | $ | 424 | $ | 393 | $ | 389 | $ | 465 | $ | 448 | $ | 817 | $ | 919 | $ | 1,773 |
| CER<br>adjustment^(1)^ | **** | – | (2) | (3) | 10 | 15 | **** | (2) | 32 | 39 | ||||||
| Core EBITDA, CER basis | $ | 424 | $ | 391 | $ | 386 | $ | 475 | $ | 463 | $ | 815 | $ | 951 | $ | 1,812 |
| Core EBITDA by business line | ||||||||||||||||
| Retirement | $ | 233 | $ | 217 | $ | 211 | $ | 232 | $ | 213 | $ | 450 | $ | 440 | $ | 883 |
| Retail | **** | 168 | 171 | 181 | 207 | 191 | **** | 339 | 408 | 796 | ||||||
| Institutional Asset Management | **** | 23 | 5 | (3) | 26 | 44 | **** | 28 | 71 | 94 | ||||||
| Total | $ | 424 | $ | 393 | $ | 389 | $ | 465 | $ | 448 | $ | 817 | $ | 919 | $ | 1,773 |
| Core EBITDA by geographic source | ||||||||||||||||
| Asia | $ | 125 | $ | 113 | $ | 108 | $ | 117 | $ | 110 | $ | 238 | $ | 230 | $ | 455 |
| Canada | **** | 148 | 136 | 129 | 168 | 158 | **** | 284 | 320 | 617 | ||||||
| U.S. | **** | 151 | 144 | 152 | 180 | 180 | **** | 295 | 369 | 701 | ||||||
| Total | $ | 424 | $ | 393 | $ | 389 | $ | 465 | $ | 448 | $ | 817 | $ | 919 | $ | 1,773 |
| Core EBITDA by business line, CERbasis^(2)^ | ||||||||||||||||
| Retirement | $ | 233 | $ | 216 | $ | 209 | $ | 237 | $ | 221 | $ | 449 | $ | 458 | $ | 904 |
| Retail | **** | 168 | 170 | 181 | 210 | 197 | **** | 338 | 419 | 810 | ||||||
| Institutional Asset Management | **** | 23 | 5 | (4) | 28 | 45 | **** | 28 | 74 | 98 | ||||||
| Total, CER basis | $ | 424 | $ | 391 | $ | 386 | $ | 475 | $ | 463 | $ | 815 | $ | 951 | $ | 1,812 |
| Core EBITDA by geographic source, CERbasis^(2)^ | ||||||||||||||||
| Asia | $ | 125 | $ | 112 | $ | 107 | $ | 123 | $ | 115 | $ | 237 | $ | 241 | $ | 470 |
| Canada | **** | 148 | 136 | 129 | 168 | 158 | **** | 284 | 320 | 617 | ||||||
| U.S. | **** | 151 | 143 | 150 | 184 | 190 | **** | 294 | 390 | 725 | ||||||
| Total, CER basis | $ | 424 | $ | 391 | $ | 386 | $ | 475 | $ | 463 | $ | 815 | $ | 951 | $ | 1,812 |
| ^(1)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(2)^ | Core EBITDA adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 2Q23.<br> | |||||||||||||||
| --- | --- | |||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 87 | |||||||||||||||
| --- | --- |
Table of Contents
Core EBITDA margin is a financial measure which Manulife uses to better understand the long-term profitability of our Global WAM business on a more comparable basis to how profitability of global asset managers are measured. Core EBITDA margin presents core earnings before the impact of interest, taxes, depreciation, and amortization divided by core revenue from these businesses. Core revenue is used to calculate our core EBITDA margin, and is equal to the sum of pre-tax other revenue and investment income in Global WAM included in core EBITDA, and it excludes such items as revenue related to integration and acquisitions and market experience gains (losses). Core EBITDA margin was selected as a key performance indicator for our Global WAM business, as EBITDA margin is widely used among asset management peers, and core earnings is a primary profitability metric for the Company overall.
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unless otherwise stated) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Core EBITDA margin | ||||||||||||||||
| Core EBITDA | $ | 424 | $ | 393 | $ | 389 | $ | 465 | $ | 448 | $ | 817 | $ | 919 | $ | 1,773 |
| Core revenue | $ | 1,722 | $ | 1,756 | $ | 1,646 | $ | 1,610 | $ | 1,596 | $ | 3,478 | $ | 3,260 | $ | 6,516 |
| Core EBITDA margin | **** | 24.6% | 22.4% | 23.6% | 28.9% | 28.1% | **** | 23.5% | 28.2% | 27.2% | ||||||
| Global WAM core revenue | ||||||||||||||||
| Other revenue per financial statements | $ | 1,691 | $ | 1,691 | $ | 1,671 | $ | 1,547 | $ | 1,446 | $ | 3,382 | $ | 2,968 | $ | 6,186 |
| Less: Other revenue in segments other than Global WAM | **** | 44 | 26 | 26 | (9) | (106) | **** | 70 | (222) | (205) | ||||||
| Other revenue in Global WAM (fee income) | $ | 1,647 | $ | 1,665 | $ | 1,645 | $ | 1,556 | $ | 1,552 | $ | 3,312 | $ | 3,190 | $ | 6,391 |
| Investment income per financial statements | $ | 4,135 | $ | 3,520 | $ | 4,271 | $ | 3,832 | $ | 3,531 | $ | 7,655 | $ | 7,101 | $ | 15,204 |
| Realized and unrealized gains (losses) on assets supporting<br>insurance and investment contract liabilities per financial statements | **** | 950 | 1,944 | (2,453) | (1,112) | (5,685) | **** | 2,894 | (10,081) | (13,646) | ||||||
| Total investment income | **** | 5,085 | 5,464 | 1,818 | 2,720 | (2,154) | **** | 10,549 | (2,980) | 1,558 | ||||||
| Less: Investment income in segments other than Global<br>WAM | **** | 5,010 | 5,357 | 1,672 | 2,748 | (1,981) | **** | 10,367 | (2,761) | 1,659 | ||||||
| Investment income in Global WAM | $ | 75 | $ | 107 | $ | 146 | $ | (28) | $ | (173) | $ | 182 | $ | (219) | $ | (101) |
| Total other revenue and investment income in Global WAM | $ | 1,722 | $ | 1,772 | $ | 1,791 | $ | 1,528 | $ | 1,379 | $ | 3,494 | $ | 2,971 | $ | 6,290 |
| Less: Total revenue reported in items excluded from core earnings | ||||||||||||||||
| Market experience gains (losses) | **** | 7 | 12 | 55 | (82) | (217) | **** | 19 | (289) | (316) | ||||||
| Revenue related to integration and acquisitions | **** | (7) | 4 | 90 | – | – | **** | (3) | – | 90 | ||||||
| Global WAM core revenue | $ | 1,722 | $ | 1,756 | $ | 1,646 | $ | 1,610 | $ | 1,596 | $ | 3,478 | $ | 3,260 | $ | 6,516 |
Expense measures
With the adoption of IFRS 17, we have replaced core general expenses with two new measures: core expenses and core expenditures. Under IFRS 17, expenses previously reported in general expenses are now reported as:
| 1. | General expenses that flow directly through income; |
|---|---|
| 2. | Directly attributable maintenance expenses, which are reported in insurance service expenses and flow directly through<br>income; |
| --- | --- |
| 3. | Directly attributable acquisition expenses for contracts measured using the PAA method which are reported in insurance<br>service expenses, and flow directly through income; and |
| --- | --- |
| 4. | Directly attributable acquisition expenses that are capitalized into the CSM. |
| --- | --- |
Total expenses include items 1 to 3 above and total expenditures include items 1 to 4 above.
Core expenses is used to calculate our expense efficiency ratio and is equal to total expenses that are included in core earnings and excludes such items as material legal provisions for settlements, restructuring charges and expenses related to integration and acquisitions.
| Manulife Financial Corporation – Second Quarter 2023 | 88 |
|---|
Table of Contents
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, and based on actual foreign<br>exchange rates in effect in the applicable<br>reporting period, unless otherwise stated) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Core expenses | ||||||||||||||||
| General expenses - Statements of Income | $ | 1,022 | $ | 1,086 | $ | 1,002 | $ | 914 | $ | 884 | $ | 2,108 | $ | 1,815 | $ | 3,731 |
| Directly attributable acquisition expense for contracts measured using the PAA method^(1)^ | **** | 35 | 33 | 15 | 17 | 15 | **** | 68 | 26 | 58 | ||||||
| Directly attributable maintenance expense^(1)^ | **** | 550 | 546 | 577 | 497 | 483 | **** | 1,096 | 965 | 2,039 | ||||||
| Total expenses | **** | 1,607 | 1,665 | 1,594 | 1,428 | 1,382 | **** | 3,272 | 2,806 | 5,828 | ||||||
| Less: General expenses included in items excluded from core earnings | ||||||||||||||||
| Restructuring charge | **** | – | – | – | – | – | **** | – | – | – | ||||||
| Integration and acquisition | **** | – | – | 18 | – | – | **** | – | 8 | 26 | ||||||
| Legal provisions and Other expenses | **** | 9 | 60 | – | 39 | 1 | **** | 69 | 1 | 40 | ||||||
| Total | **** | 9 | 60 | 18 | 39 | 1 | **** | 69 | 9 | 66 | ||||||
| Core expenses | $ | 1,598 | $ | 1,605 | $ | 1,576 | $ | 1,389 | $ | 1,381 | $ | 3,203 | $ | 2,797 | $ | 5,762 |
| CER<br>adjustment^(2)^ | **** | – | (11) | (3) | 25 | 36 | **** | (11) | 72 | 94 | ||||||
| Core expenses, CER basis | $ | 1,598 | $ | 1,594 | $ | 1,573 | $ | 1,414 | $ | 1,417 | $ | 3,192 | $ | 2,869 | $ | 5,856 |
| Total expenses | $ | 1,607 | $ | 1,665 | $ | 1,594 | $ | 1,428 | $ | 1,382 | $ | 3,272 | $ | 2,806 | $ | 5,828 |
| CER<br>adjustment^(2)^ | **** | – | (10) | (3) | 27 | 35 | **** | (10) | 71 | 95 | ||||||
| Total expenses, CER basis | $ | 1,607 | $ | 1,655 | $ | 1,591 | $ | 1,455 | $ | 1,417 | $ | 3,262 | $ | 2,877 | $ | 5,923 |
| ^(1)^ | Expenses are components of insurance service expenses on the Statements of Income that flow directly through income.<br> | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- |
Core expenditures is used to calculate our expenditure efficiency ratio and is equal to total expenditures excluding such items as material legal provisions for settlements, restructuring charges and expenses related to integration and acquisitions. Total expenditures is equal to the sum of total expenses and costs that are directly attributable to the acquisition of new business that are capitalized into the CSM.
| Quarterly Results | YTD Results | Full Year<br><br><br>Results | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, and based on actual foreign<br>exchange rates in effect in the applicable<br>reporting period, unless otherwise stated) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Core expenditures | ||||||||||||||||
| Total expenses | $ | 1,607 | $ | 1,665 | $ | 1,594 | $ | 1,428 | $ | 1,382 | $ | 3,272 | $ | 2,806 | $ | 5,828 |
| Directly attributable acquisition expenses capitalized through the<br>CSM^(1)^ | **** | 501 | 507 | 532 | 467 | 454 | **** | 1,008 | 910 | 1,909 | ||||||
| Total expenditures | **** | 2,108 | 2,172 | 2,126 | 1,895 | 1,836 | **** | 4,280 | 3,716 | 7,737 | ||||||
| Less: General expenses included in items excluded from core<br>earnings (see core expenses reconciliation above) | **** | 9 | 60 | 18 | 39 | 1 | **** | 69 | 9 | 66 | ||||||
| Core expenditures | $ | 2,099 | $ | 2,112 | $ | 2,108 | $ | 1,856 | $ | 1,835 | $ | 4,211 | $ | 3,707 | $ | 7,671 |
| CER<br>adjustment^(2)^ | **** | – | (17) | (3) | 39 | 47 | **** | (17) | 86 | 122 | ||||||
| Core expenditures, CER basis | $ | 2,099 | $ | 2,095 | $ | 2,105 | $ | 1,895 | $ | 1,882 | $ | 4,194 | $ | 3,793 | $ | 7,793 |
| Total expenditures | $ | 2,108 | $ | 2,172 | $ | 2,126 | $ | 1,895 | $ | 1,836 | $ | 4,280 | $ | 3,716 | $ | 7,737 |
| CER<br>adjustment^(2)^ | **** | – | (17) | (3) | 40 | 46 | **** | (17) | 86 | 124 | ||||||
| Total expenditures, CER basis | $ | 2,108 | $ | 2,155 | $ | 2,123 | $ | 1,935 | $ | 1,882 | $ | 4,263 | $ | 3,802 | $ | 7,861 |
| ^(1)^ | Expenses are components of insurance service expenses on the Statements of Income and are then capitalized to CSM.<br> | |||||||||||||||
| --- | --- | |||||||||||||||
| ^(2)^ | The impact of updating foreign exchange rates to that which was used in 2Q23. | |||||||||||||||
| --- | --- | |||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 89 | |||||||||||||||
| --- | --- |
Table of Contents
Expense efficiency ratio is a financial measure which Manulife uses to measure progress towards our target to be more efficient. It is defined as core expenses divided by the sum of core earnings before income taxes (“pre-tax core earnings”) and core expenses.
Expenditure efficiency ratio is a financial measure which Manulife uses to measure progress towards our target to be more efficient. It is defined as core expenditures divided by the sum of core earnings before income taxes (“pre-tax core earnings”) and core expenditures.
Embedded value(“EV”) is a measure of the present value of shareholders’ interests in the expected future distributable earnings on in-force business reflected in the Consolidated Statements of Financial Position of Manulife, excluding any value associated with future new business. EV is calculated as the sum of the adjusted net worth and the value of in-force business calculated as at December 31. The adjusted net worth is the IFRS shareholders’ equity adjusted for goodwill and intangible assets, fair value of surplus assets, the fair value of debt, preferred shares, and other equity, and local statutory balance sheet, regulatory reserve, and capital for our Asian businesses. The value of in-force business in Canada and the U.S. is the present value of expected future IFRS earnings, on an IFRS 4 basis, on in-force business less the present value of the cost of holding capital to support the in-force business under the LICAT framework. The value of in-force business in Asia reflects local statutory earnings and capital requirements. The value of in-force business excludes Global WAM, Bank or P&C Reinsurance businesses.
Net annualized fee income yield on average AUMA (“Net fee income yield”) is a financial measure that represents the net annualized fee income from Global WAM channels over average AUMA. This measure provides information on Global WAM’s adjusted return generated from managing AUMA.
Net annualized feeincome is a financial measure that represents Global WAM income before income taxes, adjusted to exclude items unrelated to net fee income, including general expenses, investment income, non-AUMA related net benefits and claims, and net premium taxes. It also excludes the components of Global WAM net fee income from managing assets on behalf of other segments. This measure is annualized based on the number of days in the year divided by the number of days in the reporting period.
Reconciliation of income before income taxes to net fee income yield
| Quarterly Results | YTD Results | Full YearResults | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ($ millions, unless otherwise stated) | 2Q23 | 1Q23 | 4Q22 | 3Q22 | 2Q22 | 2023 | 2022 | 2022 | ||||||||
| Income before income taxes | $ | 1,436 | $ | 1,719 | $ | 697 | $ | 484 | $ | (2,656) | $ | 3,155 | $ | (4,319) | $ | (3,138) |
| Less: Income before income taxes for segments other than Global<br>WAM | **** | 1,074 | 1,374 | 236 | 160 | (2,826) | **** | 2,448 | (4,825) | (4,429) | ||||||
| Global WAM income before income taxes | **** | 362 | 345 | 461 | 324 | 170 | **** | 707 | 506 | 1,291 | ||||||
| Items unrelated to net fee income | **** | 674 | 676 | 527 | 658 | 793 | **** | 1,350 | 1,468 | 2,653 | ||||||
| Global WAM net fee income | **** | 1,036 | 1,021 | 988 | 982 | 963 | **** | 2,057 | 1,974 | 3,944 | ||||||
| Less: Net fee income from other segments | **** | 142 | 136 | 134 | 136 | 135 | **** | 278 | 277 | 547 | ||||||
| Global WAM net fee income excluding net fee income from other<br>segments | **** | 894 | 885 | 854 | 846 | 828 | **** | 1,779 | 1,697 | 3,397 | ||||||
| Net annualized fee income | $ | 3,584 | $ | 3,589 | $ | 3,388 | $ | 3,356 | $ | 3,321 | $ | 3,586 | $ | 3,422 | $ | 3,397 |
| Average Assets under Management and Administration | $ | 814,945 | $ | 804,455 | $ | 779,642 | $ | 773,575 | $ | 778,180 | $ | 809,457 | $ | 801,233 | $ | 790,268 |
| Net fee income yield (bps) | **** | 44.0 | 44.6 | 43.5 | 43.4 | 42.7 | **** | 44.3 | 42.7 | 43.0 |
New business value (“NBV”) is the change in embedded value as a result of sales in the reporting period. The definition of NBV has changed for periods beginning after 2022 as follows:
| • | adopting IFRS 17 in the calculation of expected future distributable earnings in Canada, and international high net worth<br>business, which was reclassified to the Asia segment in 2023; and |
|---|---|
| • | changing the basis for calculating expected future distributable earnings in the U.S. from IFRS to local capital<br>requirements. |
| --- | --- |
NBV for periods beginning after December 31, 2022 is calculated as the present value of shareholders’ interests in expected future distributable earnings in accordance with IFRS 17, after the cost of capital calculated under the LICAT framework in Canada and the local capital requirements in the U.S. and Asia, on actual new business sold
| Manulife Financial Corporation – Second Quarter 2023 | 90 |
|---|
Table of Contents
in the period using assumptions that are consistent with the assumptions used in the calculation of embedded value.
NBV for periods prior to January 1, 2023 is calculated as the present value of shareholders’ interests in expected future distributable earnings in accordance with IFRS 4 “Insurance Contracts”, after the cost of capital calculated under the LICAT framework in Canada and the U.S. and the local capital requirements in Asia, on actual new business sold in the period using assumptions that are consistent with the assumptions used in the calculation of embedded value.
NBV excludes businesses with immaterial insurance risks, such as the Company’s Global WAM, Manulife Bank and the P&C Reinsurance businesses. NBV is a useful metric to evaluate the value created by the Company’s new business franchise.
New business value margin (“NBV margin”) is calculated as NBV divided by APE sales excluding non-controlling interests. APE sales are calculated as 100% of regular premiums and deposits sales and 10% of single premiums and deposits sales. NBV margin is a useful metric to help understand the profitability of our new business.
Sales are measured according to product type:
For individual insurance, sales include 100% of new annualized premiums and 10% of both excess and single premiums. For individual insurance, new annualized premiums reflect the annualized premium expected in the first year of a policy that requires premium payments for more than one year. Single premium is the lump sum premium from the sale of a single premium product, e.g. travel insurance. Sales are reported gross before the impact of reinsurance.
For group insurance, sales include new annualized premiums and administrative services only premium equivalents on new cases, as well as the addition of new coverages and amendments to contracts, excluding rate increases.
Insurance-based wealth accumulation product sales include all new deposits into variable and fixed annuity contracts. As we discontinued sales of new variable annuity contracts in the U.S. in 1Q13, subsequent deposits into existing U.S. variable annuity contracts are not reported as sales. Asia variable annuity deposits are included in APE sales.
APE sales are comprised of 100% of regular premiums and deposits and 10% of excess and single premiums and deposits for both insurance and insurance-based wealth accumulation products.
Gross flows is a new business measure presented for our Global WAM business and includes all deposits into mutual funds, group pension/retirement savings products, private wealth and institutional asset management products. Gross flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are at attracting assets.
Net flows is presented for our Global WAM business and includes gross flows less redemptions for mutual funds, group pension/retirement savings products, private wealth and institutional asset management products. In addition, net flows include the net flows of exchange traded funds and non-proprietary product sold by Manulife Securities. Net flows is a common industry metric for WAM businesses as it provides a measure of how successful the businesses are at attracting and retaining assets. When net flows are positive, they are referred to as net inflows. Conversely, negative net flows are referred to as net outflows.
Remittances is defined as the cash remitted or available for distribution to the Manulife Group from operating subsidiaries and excess capital generated by standalone Canadian operations. It is one of the key metrics used by management to evaluate our financial flexibility.
| E4 | Caution regarding forward-looking statements |
|---|
From time to time, MFC makes written and/or oral forward-looking statements, including in this document. In addition, our representatives may make forward-looking statements orally to analysts, investors, the media and
| Manulife Financial Corporation – Second Quarter 2023 | 91 |
|---|
Table of Contents
others. All such statements are made pursuant to the “safe harbour” provisions of Canadian provincial securities laws and the U.S. Private Securities Litigation Reform Act of 1995.
The forward-looking statements in this document include, but are not limited to, statements with respect to the impact of changes in tax laws, our journey to net zero, and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “suspect”, “outlook”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “forecast”, “objective”, “seek”, “aim”, “continue”, “goal”, “restore”, “embark” and “endeavour” (or the negative thereof) and words and expressions of similar import, and include statements concerning possible or assumed future results. Although we believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts’ expectations in any way.
Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from expectations include but are not limited to: general business and economic conditions (including but not limited to the performance, volatility and correlation of equity markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market liquidity and creditworthiness of guarantors, reinsurers and counterparties); the ongoing prevalence of COVID-19, including any variants, as well as actions that have been, or may be taken by governmental authorities in response to COVID-19, including the impacts of any variants; changes in laws and regulations; changes in accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements; our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting policies, actuarial methods and embedded value methods; our ability to implement effective hedging strategies and unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated liabilities; level of competition and consolidation; our ability to market and distribute products through current and future distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses; the realization of losses arising from the sale of investments classified as fair value through other comprehensive income; our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations; the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in models used; political, legal, operational and other risks associated with our non-North American operations; geopolitical uncertainty, including international conflicts; acquisitions and our ability to complete acquisitions including the availability of equity and debt financing for this purpose; the disruption of or changes to key elements of the Company’s or public infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property and exposure to claims of infringement; and our inability to withdraw cash from subsidiaries.
Additional information about material risk factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in this document under “Risk Management and Risk Factors Update” and “Critical Actuarial and Accounting Policies”, under “Risk Management and Risk Factors” and “Critical Actuarial and Accounting Policies” in the Management’s Discussion and Analysis in our most recent annual report and, in the “Risk Management” note to the consolidated financial statements in our most recent annual and interim reports and elsewhere in our filings with Canadian and U.S. securities regulators.
| Manulife Financial Corporation – Second Quarter 2023 | 92 |
|---|
Table of Contents
The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are presented for the purpose of assisting investors and others in understanding our financial position and results of operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other purposes. We do not undertake to update any forward-looking statements, except as required by law.
| E5 | Quarterly financial information |
|---|
The following table provides summary information related to our eight most recently completed quarters. With the adoption of IFRS 17 and IFRS 9 on January 1, 2023, we have provided quarterly 2023 and restated quarterly 2022 information based on the new standard. See section A1 “Implementation of IFRS 17 and IFRS 9” for additional information. Information has not been restated prior to January 1, 2022 and as a result, quarterly 2021 information is based on what was reported in those quarters.
| As at and for the three months<br>ended(1) ( millions, except per share amounts orotherwise stated,<br>unaudited) | Mar 31,<br><br><br>2023 | Dec 31,<br><br><br>2022 | Sept 30,<br><br><br>2022 | Jun 30,<br><br><br>2022 | Mar 31,<br><br><br>2022 | Dec 31,<br><br><br>2021 | Sept 30,<br><br><br>2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Insurance revenue | 5,580 | $ | 5,763 | $ | 6,128 | $ | 5,560 | $ | 5,732 | $ | 5,698 | ||||
| Net investment income | 4,819 | 5,153 | 1,440 | 2,439 | (2,454) | (1,088) | |||||||||
| Other revenue | 1,691 | 1,691 | 1,671 | 1,547 | 1,446 | 1,522 | |||||||||
| Total revenue | 12,090 | $ | 12,607 | $ | 9,239 | $ | 9,546 | $ | 4,724 | $ | 6,132 | ||||
| Income (loss) before income taxes | 1,436 | $ | 1,719 | $ | 697 | $ | 484 | $ | (2,656) | $ | (1,663) | ||||
| Income tax (expense) recovery | (265) | (309) | 226 | (60) | 553 | 440 | |||||||||
| Net income (loss) | 1,171 | $ | 1,410 | $ | 923 | $ | 424 | $ | (2,103) | $ | (1,223) | ||||
| Net income (loss) attributed to shareholders | 1,025 | $ | 1,406 | $ | 915 | $ | 491 | $ | (2,119) | $ | (1,220) | ||||
| Basic earnings (loss) per common share | 0.50 | $ | 0.73 | $ | 0.43 | $ | 0.23 | $ | (1.13) | $ | (0.66) | ||||
| Diluted earnings (loss) per common share | 0.50 | $ | 0.73 | $ | 0.43 | $ | 0.23 | $ | (1.13) | $ | (0.66) | ||||
| Segregated funds deposits | 10,147 | $ | 11,479 | $ | 10,165 | $ | 9,841 | $ | 10,094 | $ | 12,328 | ||||
| Total assets (in billions) | 851 | $ | 862 | $ | 834 | $ | 818 | $ | 810 | $ | 865 | ||||
| Revenue | |||||||||||||||
| Life and health insurance net premium income | $ | 9,159 | $ | 9,269 | |||||||||||
| Annuities and pensions net premium income | 901 | 714 | |||||||||||||
| Total net premium income | 10,060 | 9,983 | |||||||||||||
| Investment income | 4,350 | 3,964 | |||||||||||||
| Realized and unrealized gains and losses on assets supporting insurance and investment contract<br>liabilities | 4,460 | (958) | |||||||||||||
| Other revenue | 2,741 | 2,994 | |||||||||||||
| Total revenue | $ | 21,611 | $ | 15,983 | |||||||||||
| Income (loss) before income taxes | $ | 2,481 | $ | 1,480 | |||||||||||
| Income tax (expense) recovery | (430) | (166) | |||||||||||||
| Net income (loss) | $ | 2,051 | $ | 1,314 | |||||||||||
| Net income (loss) attributed to shareholders | $ | 2,084 | $ | 1,592 | |||||||||||
| Basic earnings (loss) per common share | $ | 1.04 | $ | 0.80 | |||||||||||
| Diluted earnings (loss) per common share | $ | 1.03 | $ | 0.80 | |||||||||||
| Segregated funds deposits | $ | 10,920 | $ | 10,929 | |||||||||||
| Total assets (in billions) | $ | 918 | $ | 898 | |||||||||||
| Weighted average common shares (in millions) | 1,842 | 1,858 | 1,878 | 1,902 | 1,921 | 1,938 | 1,943 | 1,942 | |||||||
| Diluted weighted average common shares (in<br>millions) | 1,846 | 1,862 | 1,881 | 1,904 | 1,924 | 1,942 | 1,946 | 1,946 | |||||||
| Dividends per common share | 0.365 | $ | 0.365 | $ | 0.330 | $ | 0.330 | $ | 0.330 | $ | 0.330 | $ | 0.330 | $ | 0.280 |
| CDN to US1 - Statement of Financial Position | 1.3233 | 1.3534 | 1.3549 | 1.3740 | 1.2900 | 1.2496 | 1.2678 | 1.2741 | |||||||
| CDN to US1 - Statement of Income | 1.3430 | 1.3524 | 1.3575 | 1.3057 | 1.2765 | 1.2663 | 1.2601 | 1.2602 |
All values are in US Dollars.
| ^(1)^ | 2021 quarterly results are not restated for IFRS 17 and IFRS 9. |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 93 |
| --- | --- |
Table of Contents
| E6 | Revenue | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Quarterly Results | YTD Results | ||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ($ millions, unaudited) | 2Q23 | 1Q23 | 2Q22 | 2023 | 2022 | |||||
| Insurance revenue | $ | 5,580 | $ | 5,763 | $ | 5,732 | $ | 11,343 | $ | 11,430 |
| Net investment income | **** | 4,819 | 5,153 | (2,454) | **** | 9,972 | (3,542) | |||
| Other revenue | **** | 1,691 | 1,691 | 1,446 | **** | 3,382 | 2,968 | |||
| Total revenue | $ | 12,090 | $ | 12,607 | $ | 4,724 | $ | 24,697 | $ | 10,856 |
| Asia | $ | 3,594 | $ | 3,283 | $ | 1,688 | $ | 6,877 | $ | 3,189 |
| Canada | **** | 3,139 | 3,545 | 336 | **** | 6,684 | 1,052 | |||
| U.S. | **** | 3,422 | 3,856 | 1,726 | **** | 7,278 | 4,380 | |||
| Global Wealth and Asset Management | **** | 1,431 | 1,451 | 1,117 | **** | 2,882 | 2,467 | |||
| Corporate and Other | **** | 504 | 472 | (143) | **** | 976 | (232) | |||
| Total revenue | $ | 12,090 | $ | 12,607 | $ | 4,724 | $ | 24,697 | $ | 10,856 |
Total revenue in 2Q23 was $12.1 billion compared with $4.7 billion in 2Q22. The increase in total revenue of $7.4 billion compared with 2Q22 was due to net realized and unrealized losses on derivatives in 2Q22 as a result of higher interest rates and net realized and unrealized public equity gains in 2Q23 compared with losses in 2Q22 partially offset by lower investment income from ALDA.
| • | Asia total revenue in 2Q23 was $3.6 billion compared with $1.7 billion in 2Q22. The increase in total revenue of $1.9<br>billion was primarily driven by an increase in net investment income due to net realized and unrealized public equity gains in 2Q23 compared with losses in 2Q22. |
|---|---|
| • | Canada total revenue in 2Q23 was $3.1 billion compared with $0.3 billion in 2Q22. The increase in total revenue of $2.8<br>billion was primarily due to net realized and unrealized losses in 2Q22 from derivatives, as a result of higher interest rates, and net unrealized gains from public equities in 2Q23 compared with losses in 2Q22. |
| --- | --- |
| • | U.S. total revenue in 2Q23 was $3.4 billion compared with $1.7 billion in 2Q22. The increase in total revenue of $1.7<br>billion was primarily driven by net realized and unrealized losses on derivatives in 2Q22 as a result of higher interest rates partially offset by lower investment income from ALDA. |
| --- | --- |
| • | Global WAM total revenue in 2Q23 was $1.4 billion compared with $1.1 billion in 2Q22. The increase in total revenue of $0.3<br>billion was mainly due to the favourable impact of markets on seed money investments in 2Q23, compared with losses in 2Q22, the favourable impact of a weaker Canadian dollar compared with the U.S. dollar and higher fee income from higher fee spread<br>and business mix. |
| --- | --- |
| • | Corporate and Other total revenue in 2Q23 was $0.5 billion compared with a loss of $0.1 billion in 2Q22. The increase in<br>total revenue of $0.6 billion was driven by higher net investment income from equity and derivative instruments, higher yields on debt instruments, and lower net realized losses on the sale of FVOCI debt instruments. |
| --- | --- |
On a year-to-date basis total revenue was $24.7 billion in 2023 compared with $10.9 billion for the same period in 2022. The increase in total revenue of $13.8 billion compared with 2022 was due to similar reasons noted above for the quarter.
| • | Asia year-to-date total revenue in 2023 was $6.9 billion compared with $3.2 billion in 2022. The increase in year-to-date<br>total revenue of $3.7 billion was primarily driven by similar reasons noted above for the quarter. |
|---|---|
| • | Canada year-to-date total revenue in 2023 was $6.7 billion compared with $1.1 billion in 2022. The increase in year-to-date<br>total revenue of $5.6 billion was primarily driven by similar reasons noted above for the quarter. |
| --- | --- |
| • | U.S. year-to-date total revenue in 2023 was $7.3 billion compared with $4.4 billion in 2022. The increase in year-to-date<br>total revenue of $2.9 billion was primarily driven by similar reasons noted above for the quarter. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 94 |
| --- | --- |
Table of Contents
| • | Global WAM year-to-date total revenue in 2023 was $2.9 billion compared with $2.5 billion in 2022. The increase in<br>year-to-date total revenue of $0.4 billion was due mainly to the favourable impact of markets on seed money investments in 2023, compared with losses in 2022 and the favourable impact of a weaker Canadian dollar compared with the U.S. dollar.<br> |
|---|---|
| • | Corporate and Other year-to-date total revenue in 2023 was $1.0 billion compared with a loss of $0.2 billion in 2022. The<br>increase in year-to-date total revenue of $1.2 billion was primarily due to similar reasons noted above for the quarter. |
| --- | --- |
| E7 | Other |
| --- | --- |
No changes were made in our internal control over financial reporting during the six months ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except that, in connection with the adoption of IFRS 17 and IFRS 9, the Company made significant updates and modifications to existing internal controls and implemented a number of new internal controls. These changes include controls over new and existing systems, including technological systems, and controls that were implemented or modified in our actuarial and accounting processes to address the risks associated with the newly adopted accounting standards.
As in prior quarters, MFC’s Audit Committee has reviewed this MD&A and the unaudited interim financial report and MFC’s Board of Directors approved this MD&A prior to its release.
| Manulife Financial Corporation – Second Quarter 2023 | 95 |
|---|
Table of Contents
| Consolidated Statements of Financial Position | ||||||
|---|---|---|---|---|---|---|
| As at<br><br><br>(Canadian $ in millions, unaudited) | June 30, 2023 | Restated (note 2)<br><br><br>December 31, 2022 | Restated (note 2)<br><br><br>January 1, 2022 | |||
| --- | --- | --- | --- | --- | --- | --- |
| Assets | ||||||
| Cash and short-term securities | $ | 21,018 | $ | 19,153 | $ | 22,594 |
| Debt securities | **** | 203,324 | 203,842 | 224,139 | ||
| Public equities | **** | 25,075 | 23,519 | 28,067 | ||
| Mortgages | **** | 51,459 | 51,765 | 53,948 | ||
| Private placements | **** | 42,584 | 42,010 | 47,289 | ||
| Loans to Bank clients | **** | 2,632 | 2,781 | 2,506 | ||
| Real estate | **** | 13,426 | 14,269 | 14,269 | ||
| Other invested assets | **** | 43,910 | 42,803 | 35,291 | ||
| Total invested assets (note 3) | **** | 403,428 | 400,142 | 428,103 | ||
| Other assets | ||||||
| Accrued investment income | **** | 2,534 | 2,635 | 2,428 | ||
| Derivatives (note 4) | **** | 8,358 | 8,588 | 17,503 | ||
| Insurance contract assets (note 5) | **** | 404 | 673 | 972 | ||
| Reinsurance contract held assets (note 5) | **** | 43,386 | 45,871 | 52,829 | ||
| Deferred tax assets | **** | 6,863 | 6,708 | 7,767 | ||
| Goodwill and intangible assets | **** | 10,310 | 10,519 | 9,919 | ||
| Miscellaneous | **** | 10,047 | 9,991 | 8,911 | ||
| Total other assets | **** | 81,902 | 84,985 | 100,329 | ||
| Segregated funds net assets (note 15) | **** | 365,981 | 348,562 | 399,788 | ||
| Total assets | $ | 851,311 | $ | 833,689 | $ | 928,220 |
| Liabilities and Equity | ||||||
| Liabilities | ||||||
| Insurance contract liabilities, excluding those for account of segregated fund holders (note 5) | $ | 358,413 | $ | 354,857 | $ | 405,621 |
| Reinsurance contract held liabilities (note 5) | **** | 2,480 | 2,391 | 2,079 | ||
| Investment contract liabilities (note 6) | **** | 10,557 | 10,079 | 10,064 | ||
| Deposits from Bank clients | **** | 21,945 | 22,507 | 20,720 | ||
| Derivatives (note 4) | **** | 12,234 | 14,289 | 10,038 | ||
| Deferred tax liabilities | **** | 1,609 | 1,536 | 1,713 | ||
| Other liabilities | **** | 18,184 | 18,886 | 19,443 | ||
| Long-term debt (note 8) | **** | 6,090 | 6,234 | 4,882 | ||
| Capital instruments (note 9) | **** | 6,662 | 6,122 | 6,980 | ||
| Total liabilities, excluding those for account of segregatedfund holders | **** | 438,174 | 436,901 | 481,540 | ||
| Insurance contract liabilities for account of segregated fund holders (note 5) | **** | 112,529 | 110,216 | 130,836 | ||
| Investment contract liabilities for account of segregated fund<br>holders | **** | 253,452 | 238,346 | 268,952 | ||
| Insurance and investment contract liabilities for account ofsegregated fund holders (note 15) | **** | 365,981 | 348,562 | 399,788 | ||
| Total liabilities | **** | 804,155 | 785,463 | 881,328 | ||
| Equity | ||||||
| Preferred shares and other equity (note 10) | **** | 6,660 | 6,660 | 6,381 | ||
| Common shares (note 10) | **** | 21,816 | 22,178 | 23,093 | ||
| Contributed surplus | **** | 233 | 238 | 262 | ||
| Shareholders’ and other equity holders’ retained earnings | **** | 4,027 | 3,947 | 9,656 | ||
| Shareholders’ accumulated other comprehensive income (loss) (“AOCI”): | ||||||
| Insurance finance income (expenses) | **** | 33,150 | 38,057 | (17,117) | ||
| Reinsurance finance income (expenses) | **** | (4,932) | (5,410) | 984 | ||
| Fair value through other comprehensive income (“OCI”) investments | **** | (20,051) | (24,645) | 17,764 | ||
| Translation of foreign operations | **** | 4,869 | 5,918 | 4,578 | ||
| Pension and other post-employment plans | **** | (103) | (97) | (114) | ||
| Real estate revaluation reserve | **** | 23 | 22 | 23 | ||
| Cost of hedging | **** | 15 | – | – | ||
| Cash flow hedges | **** | – | 8 | (155) | ||
| Total shareholders’ and other equity | **** | 45,707 | 46,876 | 45,355 | ||
| Participating policyholders’ equity | **** | (17) | (77) | 101 | ||
| Non-controlling<br>interests | **** | 1,466 | 1,427 | 1,436 | ||
| Total equity | **** | 47,156 | 48,226 | 46,892 | ||
| Total liabilities and equity | $ | 851,311 | $ | 833,689 | $ | 928,220 |
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
| Roy Gori<br> <br>President and Chief Executive Officer | Don Lindsay<br> <br>Chair of the Board of Directors |
|---|---|
| Manulife Financial Corporation – Second Quarter 2023 | 96 |
| --- | --- |
Table of Contents
| Consolidated Statements of Income | ||||||||
|---|---|---|---|---|---|---|---|---|
| For the<br><br><br>(Canadian $ in millions except per share amounts,<br>unaudited) **** | three months ended June 30, | six months ended June 30, | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2023 | Restated (note 2)<br><br><br>2022 | 2023 | Restated (note 2)<br>2022 | |||||
| Insurance service result | ||||||||
| Insurance revenue (note 5) | $ | 5,580 | $ | 5,732 | $ | 11,343 | $ | 11,430 |
| Insurance service expenses (note 5) | **** | (4,492) | (4,438) | **** | (9,274) | (9,530) | ||
| Net expenses from reinsurance contracts held (note 5) | **** | (201) | (259) | **** | (333) | (150) | ||
| Total insurance service result | **** | 887 | 1,035 | **** | 1,736 | 1,750 | ||
| Investment result | ||||||||
| Investment income (note 3) | ||||||||
| Investment income | **** | 4,135 | 3,531 | **** | 7,655 | 7,101 | ||
| Realized and unrealized gains (losses) on assets supporting insurance and investment contract<br>liabilities | **** | 950 | (5,685) | **** | 2,894 | (10,081) | ||
| Investment expenses | **** | (266) | (300) | **** | (577) | (562) | ||
| Net investment income (loss) | **** | 4,819 | (2,454) | **** | 9,972 | (3,542) | ||
| Insurance finance income (expense) and effect of movement in foreign exchange rates<br>(note 5) | **** | (3,734) | (1,792) | **** | (7,512) | (2,696) | ||
| Reinsurance finance income (expense) and effect of movement in foreign exchange rates<br>(note 5) | **** | (331) | 585 | **** | (653) | 288 | ||
| Decrease (increase) in investment contract liabilities | **** | (157) | (36) | **** | (240) | (186) | ||
| **** | 597 | (3,697) | **** | 1,567 | (6,136) | |||
| Segregated funds investment result (note 15) | ||||||||
| Investment income related to segregated funds net assets | **** | 11,278 | (41,471) | **** | 28,891 | (63,866) | ||
| Financial changes related to insurance and investment contract<br>liabilities for account of segregated fund holders | **** | (11,278) | 41,471 | **** | (28,891) | 63,866 | ||
| Net segregated funds investment result | **** | – | – | **** | – | – | ||
| Total investment result | **** | 597 | (3,697) | **** | 1,567 | (6,136) | ||
| Other revenue (note 11) | **** | 1,691 | 1,446 | **** | 3,382 | 2,968 | ||
| General expenses | **** | (1,022) | (884) | **** | (2,108) | (1,815) | ||
| Commissions related to non-insurance contracts | **** | (336) | (323) | **** | (674) | (681) | ||
| Interest expense | **** | (381) | (233) | **** | (748) | (405) | ||
| Net income (loss) before income taxes | **** | 1,436 | (2,656) | **** | 3,155 | (4,319) | ||
| Income tax recovery (expense) | **** | (265) | 553 | **** | (574) | 993 | ||
| Net income (loss) | $ | 1,171 | $ | (2,103) | $ | 2,581 | $ | (3,326) |
| Net income (loss) attributed to: | ||||||||
| Non-controlling interests | $ | 26 | $ | 52 | $ | 80 | $ | 54 |
| Participating policyholders | **** | 120 | (36) | **** | 70 | (41) | ||
| Shareholders and other equity holders | **** | 1,025 | (2,119) | **** | 2,431 | (3,339) | ||
| $ | 1,171 | $ | (2,103) | $ | 2,581 | $ | (3,326) | |
| Net income (loss) attributed to shareholders | $ | 1,025 | $ | (2,119) | $ | 2,431 | $ | (3,339) |
| Preferred share dividends and other equity distributions | **** | (98) | (60) | **** | (150) | (112) | ||
| Common shareholders’ net income (loss) | $ | 927 | $ | (2,179) | $ | 2,281 | $ | (3,451) |
| Earnings per share | ||||||||
| Basic earnings per common share (note 10) | $ | 0.50 | $ | (1.13) | $ | 1.23 | $ | (1.79) |
| Diluted earnings per common share (note 10) | **** | 0.50 | (1.13) | **** | 1.23 | (1.79) | ||
| Dividends per common share | **** | 0.37 | 0.33 | **** | 0.73 | 0.66 |
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 97 |
|---|
Table of Contents
| Consolidated Statements of Comprehensive Income | ||||||||
|---|---|---|---|---|---|---|---|---|
| For the<br><br><br>(Canadian $ in millions, unaudited) | three months ended June 30, | six months ended June 30, | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2023 | Restated (note 2)<br><br><br>2022 | 2023 | Restated (note 2)<br><br><br>2022 | |||||
| Net income (loss) | $ | 1,171 | $ | (2,103) | $ | 2,581 | $ | (3,326) |
| Other comprehensive income (loss) (“OCI”), net of tax: | ||||||||
| Items that may be subsequently reclassified to net income: | ||||||||
| Foreign exchange gains (losses) on: | ||||||||
| Translation of foreign operations | **** | (1,251) | 678 | **** | (1,223) | (28) | ||
| Net investment hedges | **** | 158 | (154) | **** | 177 | (60) | ||
| Insurance finance income (expense) | **** | 1,380 | 22,889 | **** | (5,716) | 47,508 | ||
| Reinsurance finance income (expense) | **** | (297) | (2,359) | **** | 491 | (4,744) | ||
| Fair value through OCI investments: | ||||||||
| Unrealized gains (losses) arising during the period on assets supporting insurance and investment<br>contract liabilities | **** | (1,683) | (17,579) | **** | 4,799 | (37,494) | ||
| Reclassification of net realized gains (losses) and provision for credit losses recognized in<br>income | **** | 87 | 266 | **** | 133 | 566 | ||
| Cash flow hedges: | ||||||||
| Unrealized gains (losses) arising during the period | **** | 28 | 50 | **** | 13 | 124 | ||
| Reclassification of realized gains (losses) to net income | **** | 10 | (28) | **** | 1 | (16) | ||
| Cost of hedging: | ||||||||
| Unrealized gains (losses) arising during the period | **** | 2 | – | **** | (7) | – | ||
| Share of other comprehensive income (losses) of<br>associates | **** | – | 2 | **** | – | 2 | ||
| Total items that may be subsequently reclassified to netincome | **** | (1,566) | 3,765 | **** | (1,332) | 5,858 | ||
| Items that will not be reclassified to net income: | ||||||||
| Change in actuarial gains (losses) on pension and other post-employment plans | **** | 10 | 53 | **** | (6) | 66 | ||
| Real estate revaluation reserve | **** | (1) | – | **** | 1 | – | ||
| Total items that will not be reclassified to netincome | **** | 9 | 53 | **** | (5) | 66 | ||
| Other comprehensive income (loss), net of tax | **** | (1,557) | 3,818 | **** | (1,337) | 5,924 | ||
| Total comprehensive income (loss), net of tax | $ | (386) | $ | 1,715 | $ | 1,244 | $ | 2,598 |
| Total comprehensive income (loss) attributed to: | ||||||||
| Non-controlling interests | $ | (41) | $ | 29 | $ | 43 | $ | 36 |
| Participating policyholders | **** | 118 | (43) | **** | 60 | (45) | ||
| Shareholders and other equity holders | **** | (463) | 1,729 | **** | 1,141 | 2,607 | ||
| Income Taxes included in Other Comprehensive Income | ||||||||
| --- | ||||||||
| For the<br> <br>(Canadian $ in millions,<br>unaudited) | three months ended June 30, | six months ended June 30, | ||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2023 | Restated (note 2)<br><br><br>2022 | 2023 | Restated (note 2)<br><br><br>2022 | |||||
| Income tax expense (recovery) on: | ||||||||
| Unrealized foreign exchange gains (losses) on net investment hedges | $ | 16 | $ | (16) | $ | 18 | $ | (5) |
| Insurance / reinsurance finance income (expense) | **** | 257 | 4,800 | **** | (1,071) | 9,967 | ||
| Unrealized gains (losses) on fair value through OCI Investments | **** | (383) | (3,603) | **** | 923 | (7,733) | ||
| Reclassification of net realized gains (losses) on fair value through OCI investments | **** | – | 55 | **** | – | 123 | ||
| Unrealized gains (losses) on cash flow hedges | **** | 7 | 16 | **** | (4) | 31 | ||
| Reclassification of realized gains (losses) to net income on cash flow hedges | **** | 3 | (8) | **** | – | (5) | ||
| Unrealized gains (losses) on cost of hedging | **** | 1 | – | **** | 5 | – | ||
| Change in actuarial gains (losses) on pension and other<br>post-employment plans | **** | 2 | 17 | **** | (2) | 25 | ||
| Total income tax expense (recovery) | $ | (97) | $ | 1,261 | $ | (131) | $ | 2,403 |
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 98 |
|---|
Table of Contents
| Consolidated Statements of Changes in Equity | ||||
|---|---|---|---|---|
| For the six months ended June 30,<br><br><br>(Canadian $ in millions, unaudited) | 2023 | Restated (note 2)<br><br><br>2022 | ||
| --- | --- | --- | --- | --- |
| Preferred shares and other equity | ||||
| Balance, beginning of period | $ | 6,660 | $ | 6,381 |
| Issued (note 10) | **** | – | 1,000 | |
| Redeemed (note 10) | **** | – | (711) | |
| Issuance costs, net of tax | **** | – | (10) | |
| Balance, end of period | **** | 6,660 | 6,660 | |
| Common shares | ||||
| Balance, beginning of period | **** | 22,178 | 23,093 | |
| Repurchased (note 10) | **** | (392) | (385) | |
| Issued on exercise of stock options and deferred share<br>units | **** | 30 | 16 | |
| Balance, end of period | **** | 21,816 | 22,724 | |
| Contributed surplus | ||||
| Balance, beginning of period | **** | 238 | 262 | |
| Exercise of stock options and deferred share units | **** | (5) | (3) | |
| Stock option expense | **** | – | 3 | |
| Balance, end of period | **** | 233 | 262 | |
| Shareholders’ and other equity holders’ retained earnings | ||||
| Balance, beginning of period | **** | 3,947 | 23,492 | |
| Opening adjustment of insurance contracts at adoption of IFRS 17 | **** | – | (3,191) | |
| Opening adjustment of financial assets at adoption of IFRS 9 / IFRS<br>17 | **** | (409) | (10,645) | |
| Restated balance, beginning of period | **** | 3,538 | 9,656 | |
| Net income attributed to shareholders and other equity holders | **** | 2,431 | (3,339) | |
| Common shares repurchased | **** | (449) | (420) | |
| Common share dividends | **** | (1,343) | (1,265) | |
| Preferred share dividends and other equity distributions | **** | (150) | (112) | |
| Preferred shares redeemed (note 10) | **** | – | (14) | |
| Balance, end of period | **** | 4,027 | 4,506 | |
| Shareholders’ accumulated other comprehensive income (loss) (“AOCI”) | ||||
| Balance, beginning of period | **** | 13,853 | 5,180 | |
| Opening adjustment of insurance contracts at adoption of IFRS 17 | **** | – | (16,133) | |
| Opening adjustment of financial assets at adoption of IFRS 9 / IFRS<br>17 | **** | 408 | 16,916 | |
| Restated balance, beginning of period | **** | 14,261 | 5,963 | |
| Change in unrealized foreign exchange gains (losses) on net foreign operations | **** | (1,049) | (86) | |
| Change in actuarial gains (losses) on pension and other post-employment plans | **** | (6) | 66 | |
| Changes in insurance / reinsurance finance income (expenses) | **** | (4,380) | 39,725 | |
| Change in unrealized gains (losses) on fair value through OCI investments | **** | 4,137 | (33,869) | |
| Change in unrealized gains (losses) on derivative instruments designated as cash flow hedges | **** | 14 | 108 | |
| Change in cost of hedging | **** | (7) | – | |
| Change in real estate revaluation reserve | **** | 1 | – | |
| Share of other comprehensive income (losses) of<br>associates | **** | – | 2 | |
| Balance, end of period | **** | 12,971 | 11,909 | |
| Total shareholders’ and other equity, end ofperiod | **** | 45,707 | 46,061 | |
| Participating policyholders’ equity | ||||
| Balance, beginning of period | **** | (77) | (1,233) | |
| Opening adjustment of insurance contracts at adoption of IFRS 17 | **** | – | 707 | |
| Opening adjustment of financial assets at adoption of IFRS 9 / IFRS<br>17 | **** | – | 626 | |
| Restated balance, beginning of period | **** | (77) | 100 | |
| Net income (loss) attributed to participating policyholders | **** | 70 | (41) | |
| Other comprehensive income (losses) attributed to participating<br>policyholders | **** | (10) | (4) | |
| Balance, end of period | **** | (17) | 55 | |
| Non-controlling interests | ||||
| Balance, beginning of period | **** | 1,427 | 1,694 | |
| Opening adjustment of insurance contracts at adoption of IFRS 17 | **** | – | (258) | |
| Opening adjustment of financial assets at adoption of IFRS 9 / IFRS<br>17 | **** | – | – | |
| Restated balance, beginning of period | **** | 1,427 | 1,436 | |
| Net income attributed to non-controlling interests | **** | 80 | 54 | |
| Other comprehensive income (losses) attributed to non-controlling<br>interests | **** | (37) | (18) | |
| Contributions (distributions and acquisition), net | **** | (4) | 1 | |
| Balance, end of period | **** | 1,466 | 1,473 | |
| Total equity, end of period | $ | 47,156 | $ | 47,589 |
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 99 |
|---|
Table of Contents
| Consolidated Statements of Cash Flows | ||||
|---|---|---|---|---|
| For the six months ended June 30,<br><br><br>(Canadian $ in millions, unaudited) | 2023 | Restated (note 2)<br><br><br>2022 | ||
| --- | --- | --- | --- | --- |
| Operating activities | ||||
| Net income (loss) | $ | 2,581 | $ | (3,326) |
| Adjustments: | ||||
| Increase (decrease) in net insurance contract liabilities (note 5) | **** | 5,920 | 2,750 | |
| Increase (decrease) in investment contract liabilities | **** | 240 | 186 | |
| (Increase) decrease in reinsurance contract assets excluding reinsurance transaction noted below (note<br>5) | **** | 887 | 767 | |
| Amortization of (premium) discount on invested assets | **** | (22) | (8) | |
| Contractual service margin (“CSM”) amortization | **** | (919) | (1,081) | |
| Other amortization | **** | 279 | 252 | |
| Net realized and unrealized (gains) losses and impairment on assets | **** | (1,869) | 12,332 | |
| Deferred income tax expense (recovery) | **** | 125 | (1,695) | |
| Stock option expense | **** | – | 3 | |
| Gain on U.S. variable annuity reinsurance transaction (pre-tax) (note 5) | **** | – | (1,065) | |
| Cash provided by operating activities before undernoted items | **** | 7,222 | 9,115 | |
| Changes in policy related and operating receivables and payables | **** | 1,527 | (617) | |
| Cash decrease due to U.S. variable annuity reinsurance<br>transaction (note 5) | **** | – | (1,263) | |
| Cash provided by (used in) operating activities | **** | 8,749 | 7,235 | |
| Investing activities | ||||
| Purchases and mortgage advances | **** | (39,601) | (61,677) | |
| Disposals and repayments | **** | 35,362 | 52,865 | |
| Change in investment broker net receivables and payables | **** | 260 | (117) | |
| Net cash increase (decrease) from sale (purchase) of<br>subsidiary | **** | (1) | – | |
| Cash provided by (used in) investing activities | **** | (3,980) | (8,929) | |
| Financing activities | ||||
| Change in repurchase agreements and securities sold but not yet purchased | **** | (430) | 64 | |
| Issue of long-term debt (note 8) | **** | – | 946 | |
| Issue of capital instruments, net (note 9) | **** | 1,194 | – | |
| Redemption of capital instruments (note 9) | **** | (600) | – | |
| Secured borrowing from securitization transactions | **** | 368 | 548 | |
| Change in deposits from Bank clients, net | **** | (555) | 850 | |
| Lease payments | **** | (40) | (62) | |
| Shareholders’ dividends and other equity distributions | **** | (1,493) | (1,391) | |
| Contributions from (distributions to) non-controlling interests,<br>net | **** | (4) | 1 | |
| Common shares repurchased (note 10) | **** | (841) | (805) | |
| Common shares issued, net (note 10) | **** | 30 | 16 | |
| Preferred shares and other equity issued, net (note 10) | **** | – | 990 | |
| Preferred shares redeemed, net (note 10) | **** | – | (711) | |
| Cash provided by (used in) financing activities | **** | (2,371) | 446 | |
| Cash and short-term securities | ||||
| Increase (decrease) during the period | **** | 2,398 | (1,248) | |
| Effect of foreign exchange rate changes on cash and short-term securities | **** | (375) | (39) | |
| Balance, beginning of period | **** | 18,635 | 21,930 | |
| Balance, end of period | **** | 20,658 | 20,643 | |
| Cash and short-term securities | ||||
| Beginning of period | ||||
| Gross cash and short-term securities | **** | 19,153 | 22,594 | |
| Net payments in transit, included in other liabilities | **** | (518) | (664) | |
| Net cash and short-term securities, beginning ofperiod | **** | 18,635 | 21,930 | |
| End of period | ||||
| Gross cash and short-term securities | **** | 21,018 | 21,015 | |
| Net payments in transit, included in other liabilities | **** | (360) | (372) | |
| Net cash and short-term securities, end of period | $ | 20,658 | $ | 20,643 |
| Supplemental disclosures on cash flow information | ||||
| Interest received | $ | 6,194 | $ | 5,550 |
| Interest paid | **** | 793 | 394 | |
| Income taxes paid | **** | 204 | 980 |
The accompanying notes are an integral part of these unaudited Interim Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 100 |
|---|
Table of Contents
CONDENSED NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(Canadian $ in millions except per share amounts or unless otherwise stated, unaudited)
| Note 1 Nature of Operations and Significant Accounting Policies |
|---|
(a) Reporting entity
Manulife Financial Corporation (“MFC”) is a publicly traded company and the holding company of The Manufacturers Life Insurance Company (“MLI”), a Canadian life insurance company. MFC, including its subsidiaries (collectively, “Manulife” or the “Company”) is a leading financial services group with principal operations in Asia, Canada and the United States. Manulife’s international network of employees, agents and distribution partners offers financial protection and wealth management products and services to personal and business clients as well as asset management services to institutional customers. The Company operates as Manulife in Asia and Canada and as Manulife and John Hancock in the United States.
These Interim Consolidated Financial Statements and condensed notes have been prepared in accordance with International Accounting Standard (“IAS”) 34 “Interim Financial Reporting” as issued by the International Accounting Standards Board (“IASB”), using accounting policies which are consistent with those used in the Company’s 2022 Annual Consolidated Financial Statements, and those described in notes 1, 2 and 25 of the Company’s 2022 Annual Consolidated Financial Statements. Notes 2 and 25 notably relate to the adoption of International Financial Reporting Standards (“IFRS”) 17 (“Insurance Contracts”) and IFRS 9 (“Financial Instruments”) and related accounting policies.
These Interim Consolidated Financial Statements should be read in conjunction with the audited Annual Consolidated Financial Statements for the year ended December 31, 2022, included on pages 131 to 229 of the Company’s 2022 Annual Report, as well as the disclosures on risk in denoted components of the “Risk Management and Risk Factors” section of the Second Quarter 2023 Management Discussion and Analysis (“MD&A”). These denoted risk disclosures are an integral part of these Interim Consolidated Financial Statements. Additional disclosures for the year ended December 31, 2022 under IFRS 17 are included directly in these Interim Consolidated Financial Statements.
These Interim Consolidated Financial Statements as at and for the three and six months ended June 30, 2023 were authorized for issue by MFC’s Board of Directors on August 9, 2023.
(b) Basis of preparation
Refer to notes 1, 2 and 25 of the Company’s 2022 Annual Consolidated Financial Statements for a summary of the most significant estimation processes used in the preparation of these Interim Consolidated Financial Statements under IFRS and description of the Company’s measurement techniques in determining carrying values and respective fair values of its assets and liabilities.
| Note 2 Accounting and Reporting Changes |
|---|
(a) Changes in accounting and reporting policy
(I) IFRS 17 “Insurance Contracts”
IFRS 17 “Insurance Contracts” (“IFRS 17”) was issued in May 2017 to be effective for years beginning on January 1, 2021. Amendments to IFRS 17 were issued in June 2020 and included a two-year deferral of the effective date. IFRS 17 as amended, became effective for years beginning on January 1, 2023, to be applied retrospectively. If full retrospective application to a group of contracts is impracticable the modified retrospective or fair value methods may be used. The standard replaced IFRS 4 “Insurance Contracts” (“IFRS 4”) and therefore replaced the Canadian Asset Liability Method (“CALM”) and materially changed the recognition and measurement of insurance contracts and the corresponding presentation and disclosures in the Company’s Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 101 |
|---|
Table of Contents
Narrow-scope amendments to IFRS 17 were issued in December 2021 and were effective on initial application of IFRS 17 and IFRS 9 “Financial Instruments” (“IFRS 9”) which the Company has adopted on January 1, 2023. The amendments reduce accounting mismatches between insurance contract liabilities and financial assets in scope of IFRS 9 within comparative prior periods when initially applying IFRS 17 and IFRS 9. The amendments allow insurers to present comparative information on financial assets as if IFRS 9 were fully applicable during the comparative period. The amendments do not permit application of IFRS 9 hedge accounting principles to the comparative period.
The Company adopted IFRS 17 on January 1, 2023, with an effective date of January 1, 2022. To illustrate the effects of adoption, the Company presented in note 2 (b)(i) of the Company’s 2022 Annual Consolidated Financial Statements a condensed opening Statement of Financial Position prepared under IFRS 17 as at January 1, 2022 and also the Company’s invested assets classified and measured in accordance with IFRS 9 as at January 1, 2022 compared to how they are classified and measured under IAS 39 “Financial Instruments: Recognition and Measurement” (“IAS 39”). The Company’s 2022 Annual Consolidated Financial Statements note 2 b(i) includes explanations of differences in IFRS 17 principles compared to CALM and of the detailed effects of the Company’s adoption.
The 2022 comparative figures as presented in these Interim Consolidated Financial Statements have been restated, where indicated, for the adoption of IFRS 17. For the Company’s accounting policies for applying IFRS 17 to the Company’s insurance and reinsurance contracts, refer to note 25 of the Company’s 2022 Annual Consolidated Financial Statements.
(II) IFRS 9 “Financial Instruments” and IFRS 7 “Financial Instruments: Disclosures”
IFRS 9 was issued in November 2009 and amended in October 2010, November 2013 and July 2014, and is effective for years beginning on or after January 1, 2018, to be applied retrospectively, or on a modified retrospective basis. Additionally, the IASB issued amendments in October 2017 that are effective for annual periods beginning on or after January 1, 2019. In conjunction with the amendments to IFRS 17 issued in June 2020, the IASB amended IFRS 4 to permit eligible insurers to apply IFRS 9 effective January 1, 2023, alongside IFRS 17. The standard replaced IAS 39. IFRS 9 addresses accounting and reporting principles for the classification and measurement of financial assets and financial liabilities, the impairment of financial assets and hedge accounting. IFRS 7 “Financial Instruments: Disclosures” (“IFRS 7”) was amended in conjunction with IFRS 9 and IFRS 17, with expanded qualitative and quantitative disclosures related to financial instruments and became effective along with IFRS 9 and IFRS 17 on January 1, 2023.
The Company adopted IFRS 9 on January 1, 2023, as permitted under the June 2020 amendments to IFRS 4. The Company’s accounting policies for invested assets, and derivative and hedging instruments in accordance with IFRS 9 are presented in note 25 of the Company’s 2022 Annual Consolidated Financial Statements. Note 2 (b)(ii) of the Company’s 2022 Annual Consolidated Financial Statements includes explanations of IFRS 9’s accounting and reporting principles.
IFRS 9 does not require restatement of comparative periods and the Company has not done so. The Company elected the option under IFRS 17 to reclassify financial assets, including those held in respect of activities not connected to contracts within the scope of IFRS 17, on an instrument-by-instrument basis, for 2022 comparatives in order to align with the classifications on initial application of IFRS 9 as at January 1, 2023. These classification changes are illustrated in note 2 (b)(i) of the Company’s 2022 Annual Consolidated Financial Statements. These classification changes led the Company to present certain investment results previously reported in net investment income or OCI under IAS 39, within OCI or net investment income under IFRS 9, respectively. For 2022 comparative information, the Company did not apply IFRS 9’s expected credit loss (“ECL”) impairment model or hedge accounting principles. With respect to these matters, the guidance contained in IAS 39 was maintained. In the case of assets previously classified as fair value through profit or loss (“FVTPL”) under IAS 39 and classified as fair value through other comprehensive income (“FVOCI”) or amortized cost under IFRS 9, no IAS 39 impairment was calculated for these Interim Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 102 |
|---|
Table of Contents
Consistent with IFRS 17 amendments, the adoption of IFRS 9 resulted in certain differences in the classification and measurement of financial assets when compared to their classification and measurement under IAS 39. The most significant classification changes included approximately $184 billion of debt securities previously classified as FVTPL which are classified as FVOCI under IFRS 9.
The Company has elected to apply the hedge accounting requirements under IFRS 9 to all designated hedge accounting relationships prospectively, with the exception to the cost of hedging guidance, that has been applied retrospectively for certain cash flow hedge and net investment hedge relationships. As at January 1, 2023, all existing IAS 39 hedge accounting relationships were assessed and qualified for hedge accounting under IFRS 9. These existing relationships are treated as continuing hedge accounting relationships under IFRS 9 on January 1, 2023 and are disclosed with comparative information for 2022 under IAS 39. Refer to note 4.
The Company has designated new hedge accounting relationships with the objective to reduce potential accounting mismatches between changes in the fair value of derivatives in income, and changes in fair value due to financial risk of insurance liabilities and financial assets in OCI. The incremental notional of derivatives designated in new hedge accounting relationships amounted to $232,637 on transition date. New hedge accounting relationships are effective prospectively on January 1, 2023.
The effects of adoption were as follows:
| • | Effects from applying IFRS 17 asset classification changes among FVTPL, AFS and amortized cost under IAS 39 to FVOCI and<br>FVTPL under IFRS 9 resulted in a reduction in retained earnings of $10,645, net of tax, and an increase in OCI of $16,916, net of tax, as at January 1, 2022 when IFRS 17’s transition option was elected. These were presented under<br>“Opening adjustment of financial assets at adoption of IFRS 9 / IFRS 17” in the Consolidated Statements of Changes in Equity. |
|---|---|
| • | The adoption of IFRS 9 resulted in recognition of ECL of $724. Loss allowances when applied to assets held at amortized<br>cost reduce the carrying value of the assets, and reduce equity. Loss allowances do not affect the fair value of assets held at FVOCI and therefore do not affect their carrying value. Loss allowances for assets held at FVOCI do not change total<br>equity, instead result in movement between OCI and retained earnings. |
| --- | --- |
| • | The impact of adopting IFRS 9’s ECL impairment methodology resulted in a reduction to retained earnings of $409, net<br>of tax, and an increase to accumulated OCI (“AOCI”) of $408 net of tax, on January 1, 2023. This results from the derecognition of loss allowances in accordance with IAS 39, and the recognition of ECL on FVOCI assets with reductions<br>in retained earnings and corresponding increases in AOCI. For financial assets held at amortized cost and investment commitments, ECL was recognized with reductions in retained earnings. |
| --- | --- |
| • | As at January 1, 2023, the retrospective application of IFRS 9 cost of hedging for currency basis spread resulted with<br>a net $22 reclassification from cash flow hedge and foreign currency translation reserve to a new separate component of accumulated OCI, the cost of hedging. Other IFRS 9 hedge accounting principles had $nil impact as at January 1, 2023 for<br>these Interim Consolidated Financial Statements. |
| --- | --- |
| • | The impact of changes made as at January 1, 2023 were presented under line items labeled “Opening adjustment of<br>financial assets at adoption of IFRS 9 / IFRS 17” in the Consolidated Statements of Changes in Equity. |
| --- | --- |
The implementation of IFRS 9 has been incorporated into the Company’s Enterprise Risk Management Framework (“ERM”) and supervised by the Executive Risk Committee (“ERC”). The integration of forward-looking information into the calculation of the ECL and the definition and evaluation of what constitutes a significant increase in credit risk (“SICR”) of an investment are inherently subjective and involve the use of significant expert judgement. Therefore, the Company has developed a front-to-back governance framework over the ECL calculation and has designed controls and procedures to provide reasonable assurance that information is properly recorded. The Company has effective credit risk management processes in place that continue to be applicable and aim to ensure that the effects of economic developments are appropriately considered, mitigation actions are taken where required and risk appetite is reassessed and adjusted as needed.
| Manulife Financial Corporation – Second Quarter 2023 | 103 |
|---|
Table of Contents
The Company adopted IFRS 7 (as amended), which expanded qualitative and quantitative disclosures related to financial instruments on January 1, 2023. Refer to notes 3, 4 and 7.
The following table illustrates the impact on loss allowances for invested assets on transition from the incurred loss impairment under IAS 39 to the expected credit losses impairment allowance under IFRS 9.
| December 31, 2022<br><br><br>IAS 39<br> <br>impairment allowance | January 1, 2023<br><br><br>IFRS 9<br> <br>ECL allowance | |||
|---|---|---|---|---|
| Debt securities at FVOCI under IFRS 9 | $ | – | $ | 348 |
| Private placements at FVOCI under IFRS 9 | **** | – | **** | 255 |
| Private placements at amortized cost under IAS 39 | **** | 25 | **** | – |
| Mortgages at FVOCI under IFRS 9 | **** | – | **** | 83 |
| Mortgages at amortized cost under IAS 39 | **** | 10 | **** | – |
| Other invested assets at FVOCI under IFRS 9 | **** | – | **** | 13 |
| Financial assets at amortized cost under IFRS 9 | **** | – | **** | 14 |
| Mortgages at amortized cost under IAS 39 | **** | 7 | **** | – |
| Loans to Bank clients under IAS 39 | **** | 5 | **** | – |
| Total on-balance sheet exposures | **** | 47 | **** | 713 |
| Allowance for credit losses on<br>off-balance sheet exposures | **** | – | **** | 11 |
| Total | $ | 47 | $ | 724 |
The following table shows financial liabilities under IAS 39 and the impact of classification and measurement changes on adoption of IFRS 9.
| Measurement<br><br><br>category | December 31, 2022<br><br><br>IAS 39<br> <br>Total carrying value | Impact of classification<br>and measurement<br>changes^(1),(2)^ | January 1, 2023<br><br><br>IFRS 9<br> <br>Total carrying value | |||||
|---|---|---|---|---|---|---|---|---|
| Investment contract liabilities | FVTPL | $ | 796 | $ | 2 | $ | 798 | |
| Amortized cost | **** | 2,452 | **** | 6,829 | **** | 9,281 | ||
| Deposits from Bank clients | Amortized cost | **** | 22,507 | **** | – | **** | 22,507 | |
| Derivative liabilities | FVTPL | **** | 14,289 | **** | – | **** | 14,289 | |
| Other liabilities | Amortized cost | **** | 17,421 | **** | 1,465 | **** | 18,886 | |
| Long-term debt | Amortized cost | **** | 6,234 | **** | – | **** | 6,234 | |
| Capital instruments | Amortized cost | **** | 6,122 | **** | – | **** | 6,122 | |
| Totalin-scope financial liabilities | $ | 69,821 | $ | 8,296 | $ | 78,117 | ||
| ^(1)^ | Investment contract liabilities held at amortized cost of $6,829 were reclassified from insurance contract liabilities<br>under IFRS 4. | |||||||
| --- | --- | |||||||
| ^(2)^ | Other liabilities include amounts not in scope of IFRS 9, for example pension obligations. Other liabilities of $1,465<br>held at amortized cost under IFRS 9 were reclassified from insurance contract liabilities under IFRS 4. | |||||||
| --- | --- | |||||||
| (III) | Amendments to IAS 1 “Presentation of Financial Statements” | |||||||
| --- | --- |
Amendments to IAS 1 “Presentation of Financial Statements” and IFRS Practice Statement 2 “Making Materiality Judgements” were issued in February 2021 and are effective prospectively on or after January 1, 2023 with earlier application permitted. The amendments address the process of selecting accounting policy disclosures, which will be based on assessments of the materiality of the accounting policies to the entity’s financial statements. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.
| (IV) | Amendments to IAS 8 “Accounting Policies, Changes to Accounting Estimates and Errors” |
|---|
Amendments to IAS 8 “Accounting Policies, Changes to Accounting Estimates and Errors” were issued in February 2021, and are effective prospectively on or after January 1, 2023, with earlier application permitted. The amendments include new definitions of estimate and change in accounting estimate, intended to help clarify the distinction among changes in accounting estimates, changes in accounting policies, and corrections of errors. Adoption of these amendments did not have a significant impact on the Company’s Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 104 |
|---|
Table of Contents
| (V) | Amendments to IAS 12 “Income Taxes” |
|---|
Amendments to IAS 12 “Income Taxes” were issued in May 2023. The amendments relate to international Pillar Two tax reform, which seeks to establish a global minimum corporate income tax and addresses base erosion and profit shifting. Effective on issuance, the amendments provide a temporary exception to the requirements to recognize and disclose information about deferred taxes related to implementation of Pillar Two tax reforms with disclosure of application of this exception being required. The Company has applied the mandatory temporary exemption from accounting for deferred taxes in respect of the Pillar Two income taxes, which is effective immediately. Effective for annual reporting for the year ending December 31, 2023, disclosure of current tax expense or recovery related to Pillar Two income taxes is required along with, to the extent that Pillar Two legislation is enacted or substantively enacted but not yet in effect, disclosure of known or reasonably estimable information that helps users of financial statements understand the Company’s exposure to Pillar Two income taxes arising from that legislation. The Company is assessing the impact of these amendments on the Company’s Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 105 |
|---|
Table of Contents
| Note 3 Invested Assets and Investment Income |
|---|
(a) Carrying values and fair values of invested assets
| As at June 30, 2023 | FVTPL^(1)^ | FVOCI^(2)^ | Other^(3)^ | Total<br>carrying<br>value | Total fair<br>value^(4)^ | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term securities^(5)^ | $ | 4 | $ | 14,511 | $ | 6,503 | $ | 21,018 | $ | 21,018 |
| Debt securities^(6),(7)^ | ||||||||||
| Canadian government and agency | **** | 1,082 | **** | 19,718 | **** | – | **** | 20,800 | **** | 20,800 |
| U.S. government and agency | **** | 1,433 | **** | 23,521 | **** | 890 | **** | 25,844 | **** | 25,625 |
| Other government and agency | **** | 93 | **** | 28,630 | **** | – | **** | 28,723 | **** | 28,723 |
| Corporate | **** | 2,244 | **** | 123,201 | **** | 488 | **** | 125,933 | **** | 125,781 |
| Mortgage / asset-backed securities | **** | 20 | **** | 2,004 | **** | – | **** | 2,024 | **** | 2,024 |
| Public equities (FVTPL mandatory) | **** | 25,075 | **** | – | **** | – | **** | 25,075 | **** | 25,075 |
| Mortgages | **** | 1,008 | **** | 28,073 | **** | 22,378 | **** | 51,459 | **** | 51,008 |
| Private placements^(7)^ | **** | 635 | **** | 41,949 | **** | – | **** | 42,584 | **** | 42,584 |
| Loans to Bank clients | **** | – | **** | – | **** | 2,632 | **** | 2,632 | **** | 2,617 |
| Real estate | ||||||||||
| Own use property | **** | – | **** | – | **** | 2,711 | **** | 2,711 | **** | 2,843 |
| Investment property | **** | – | **** | – | **** | 10,715 | **** | 10,715 | **** | 10,715 |
| Other invested assets | ||||||||||
| Alternative long-duration assets^(8)^ | **** | 27,981 | **** | 310 | **** | 11,364 | **** | 39,655 | **** | 40,475 |
| Various other | **** | 123 | **** | – | **** | 4,132 | **** | 4,255 | **** | 4,255 |
| Total invested assets | $ | 59,698 | $ | 281,917 | $ | 61,813 | $ | 403,428 | $ | 403,543 |
| As at December 31, 2022 | FVTPL^(1)^ | FVOCI^(2)^ | Other^(3)^ | Total<br>carrying<br>value | Total fair<br>value^(4)^ | |||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash and short-term securities^(5)^ | $ | – | $ | 12,859 | $ | 6,294 | $ | 19,153 | $ | 19,153 |
| Debt securities^(6),(7)^ | ||||||||||
| Canadian government and agency | 987 | 20,279 | – | 21,266 | 21,266 | |||||
| U.S. government and agency | 1,378 | 22,446 | 912 | 24,736 | 24,494 | |||||
| Other government and agency | 159 | 26,314 | – | 26,473 | 26,473 | |||||
| Corporate | 2,209 | 126,371 | 499 | 129,079 | 128,910 | |||||
| Mortgage / asset-backed securities | 22 | 2,266 | – | 2,288 | 2,288 | |||||
| Public equities (FVTPL mandatory) | 23,519 | – | – | 23,519 | 23,519 | |||||
| Mortgages | 1,138 | 28,621 | 22,006 | 51,765 | 51,372 | |||||
| Private placements^(7)^ | 516 | 41,494 | – | 42,010 | 42,010 | |||||
| Loans to Bank clients | – | – | 2,781 | 2,781 | 2,760 | |||||
| Real estate | ||||||||||
| Own use property | – | – | 2,852 | 2,852 | 3,008 | |||||
| Investment property | – | – | 11,417 | 11,417 | 11,417 | |||||
| Other invested assets | ||||||||||
| Alternative long-duration assets^(8)^ | 26,938 | 296 | 11,226 | 38,460 | 39,225 | |||||
| Various other | 130 | – | 4,213 | 4,343 | 4,343 | |||||
| Total invested assets | $ | 56,996 | $ | 280,946 | $ | 62,200 | $ | 400,142 | $ | 400,238 |
| ^(1)^ | FVTPL classification was elected for debt instruments backing certain insurance contract liabilities to substantially<br>reduce any accounting mismatch arising from changes in the fair value of these assets, or changes in the carrying value of the related insurance contract liabilities. | |||||||||
| --- | --- | |||||||||
| ^(2)^ | FVOCI classification for debt instruments backing certain insurance contract liabilities inherently reduces any accounting<br>mismatch arising from changes in the fair value of these assets, or changes in the carrying value of the related insurance contract liabilities. | |||||||||
| --- | --- | |||||||||
| ^(3)^ | Other includes mortgages and loans to Bank clients held at amortized cost, own use properties, investment properties,<br>equity method accounted investments, and leveraged leases. Also includes debt securities, which qualify as having Solely Payment of Principal and Interest (“SPPI”), are held to collect contractual cash flows and are carried at amortized<br>cost. | |||||||||
| --- | --- | |||||||||
| ^(4)^ | Invested assets above include debt securities, mortgages, private placements and approximately $314 (December 31, 2022<br>– $302) of other invested assets, which primarily qualify as SPPI. Invested assets which do not have SPPI qualifying cash flows as at June 30, 2023 include debt securities, private placements and other invested assets with fair values of<br>$nil, $103 and $524 respectively (December 31, 2022 – $nil, $98 and $507). The change in the fair value of these invested assets was $27 increase and $22 increase for the three and six months ended June 30, 2023, respectively ($94 decrease<br>during the year 2022). | |||||||||
| --- | --- | |||||||||
| ^(5)^ | Includes short-term securities with maturities of less than one year at acquisition amounting to $4,286 (December 31, 2022<br>– $4,148), cash equivalents with maturities of less than 90 days at acquisition amounting to $10,339 (December 31, 2022 – $8,711) and cash of $6,393 (December 31, 2022 – $6,294). | |||||||||
| --- | --- | |||||||||
| ^(6)^ | Debt securities include securities which were acquired with maturities of less than one year and less than 90 days of $741<br>and $156, respectively (December 31, 2022 – $1,787 and $870, respectively). | |||||||||
| --- | --- | |||||||||
| ^(7)^ | Floating rate invested assets above which are subject to interest rate benchmark reform, but have not yet transitioned to<br>replacement reference rates, include debt securities benchmarked to CDOR, USD LIBOR and AUD BBSW of $175, $267 and $15 (December 31, 2022 – $173, $892 and $15, respectively), and private placements benchmarked to USD LIBOR, AUD BBSW and NZD<br>BKBM of $1,244, $191 and $24 (December 31, 2022 – $1,613, $199 and $43, respectively). USD LIBOR was decommissioned on June 30, 2023 and exposures indexed to USD LIBOR as at June 30, 2023 represent invested assets with remaining<br>LIBOR-based settlements until the next rate reset date, or fixed to float debt securities currently paying a fixed rate until conversion to a floating rate. Exposures indexed to CDOR represent floating rate invested assets with maturity dates beyond<br>June 28, 2024. The interest rate benchmark reform is expected to have an impact on the valuation of invested assets whose value is tied to the affected interest rate benchmarks. The Company has assessed its exposure at the contract level, by<br>benchmark and instrument type. The Company is monitoring market developments with respect to alternative reference rates and the time horizon during which they will evolve. As at June 30, 2023, the interest rate benchmark reform has not<br>resulted in significant changes in the Company’s risk management strategy. | |||||||||
| --- | --- | |||||||||
| ^(8)^ | Alternative long-duration assets (“ALDA”) include investments in private equity of $14,643, infrastructure of<br>$13,722, timber and agriculture of $5,949, energy of $2,045 and various other ALDA of $3,296 (December 31, 2022 – $14,153, $12,751, $5,979, $2,347 and $3,230, respectively). | |||||||||
| --- | --- | |||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 106 | |||||||||
| --- | --- |
Table of Contents
(b) Investment income
| three months ended<br><br><br>June 30, | six months ended<br><br><br>June 30, | |||||||
|---|---|---|---|---|---|---|---|---|
| For the | 2023 | 2022 | 2023 | 2022 | ||||
| Interest income | $ | 3,226 | $ | 2,762 | $ | 6,149 | $ | 5,613 |
| Dividend, rental income and other income | **** | 704 | 1,022 | **** | 1,386 | 1,962 | ||
| Impairments, provisions and recoveries,<br>net^(1)^ | **** | 21 | (5) | **** | (170) | (20) | ||
| Other | **** | 184 | (248) | **** | 290 | (454) | ||
| **** | 4,135 | 3,531 | **** | 7,655 | 7,101 | |||
| Realized and unrealized gains (losses) on assets supporting insurance and investment contract<br>liabilities | ||||||||
| Debt securities | **** | 666 | 827 | **** | 966 | 895 | ||
| Public equities | **** | 568 | (2,710) | **** | 1,678 | (3,659) | ||
| Mortgages | **** | 46 | (6) | **** | 73 | (8) | ||
| Private placements | **** | 357 | 194 | **** | 440 | 367 | ||
| Real estate | **** | (404) | 59 | **** | (636) | 383 | ||
| Other invested assets | **** | 216 | 1,090 | **** | 432 | 1,483 | ||
| Derivatives | **** | (499) | (5,139) | **** | (59) | (9,542) | ||
| **** | 950 | (5,685) | **** | 2,894 | (10,081) | |||
| Investment expenses | **** | (266) | (300) | **** | (577) | (562) | ||
| Total investment income (loss) | $ | 4,819 | $ | (2,454) | $ | 9,972 | $ | (3,542) |
| ^(1)^ | The Company adopted IFRS 9’s ECL impairment requirements as at January 1, 2023 without restating the comparative<br>period. Impairments for 2023 are based on IFRS 9’s ECL requirements and impairments for 2022 are based on IAS 39’s incurred loss impairment requirements. | |||||||
| --- | --- | |||||||
| Manulife Financial Corporation – Second Quarter 2023 | 107 | |||||||
| --- | --- |
Table of Contents
(c) Fair value measurement
The following table presents fair values and the fair value hierarchy of invested assets and segregated funds net assets measured at fair value in the Consolidated Statements of Financial Position.
| Total fair | ||||||||
|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | value | Level 1 | Level 2 | Level 3 | ||||
| Cash and short-term securities | ||||||||
| FVOCI | $ | 14,511 | $ | – | $ | 14,511 | $ | – |
| FVTPL | **** | 4 | **** | – | **** | 4 | **** | – |
| Other | **** | 6,392 | **** | 6,392 | **** | – | **** | – |
| Debt securities | ||||||||
| FVOCI | ||||||||
| Canadian government and agency | **** | 19,718 | **** | – | **** | 19,718 | **** | – |
| U.S. government and agency | **** | 23,521 | **** | – | **** | 23,521 | **** | – |
| Other government and agency | **** | 28,630 | **** | – | **** | 28,620 | **** | 10 |
| Corporate | **** | 123,201 | **** | – | **** | 123,099 | **** | 102 |
| Residential mortgage-backed securities | **** | 6 | **** | – | **** | 6 | **** | – |
| Commercial mortgage-backed securities | **** | 464 | **** | – | **** | 464 | **** | – |
| Other asset-backed securities | **** | 1,534 | **** | – | **** | 1,511 | **** | 23 |
| FVTPL | ||||||||
| Canadian government and agency | **** | 1,082 | **** | – | **** | 1,082 | **** | – |
| U.S. government and agency | **** | 1,433 | **** | – | **** | 1,433 | **** | – |
| Other government and agency | **** | 93 | **** | – | **** | 93 | **** | – |
| Corporate | **** | 2,244 | **** | – | **** | 2,244 | **** | – |
| Commercial mortgage-backed securities | **** | 5 | **** | – | **** | 5 | **** | – |
| Other asset-backed securities | **** | 15 | **** | – | **** | 15 | **** | – |
| Private placements | ||||||||
| FVOCI | **** | 41,949 | **** | – | **** | 33,031 | **** | 8,918 |
| FVTPL | **** | 635 | **** | – | **** | 571 | **** | 64 |
| Mortgages | ||||||||
| FVOCI | **** | 28,073 | **** | – | **** | – | **** | 28,073 |
| FVTPL | **** | 1,008 | **** | – | **** | – | **** | 1,008 |
| Public equities | ||||||||
| FVTPL | **** | 25,075 | **** | 25,004 | **** | 67 | **** | 4 |
| Real estate^(1)^ | ||||||||
| Investment property | **** | 10,715 | **** | – | **** | – | **** | 10,715 |
| Own use property | **** | 2,548 | **** | – | **** | – | **** | 2,548 |
| Other invested assets^(2)^ | **** | 32,093 | **** | – | **** | – | **** | 32,093 |
| Segregated funds net assets^(3)^ | **** | 365,981 | **** | 331,376 | **** | 30,866 | **** | 3,739 |
| Total | $ | 730,930 | $ | 362,772 | $ | 280,861 | $ | 87,297 |
| ^(1)^ | For real estate properties, the significant unobservable inputs are capitalization rates (ranging from 2.72% to 10.00%<br>during the six months ended June 30, 2023 and ranging from 2.25% to 9.00% during the year ended December 31, 2022), terminal capitalization rates (ranging from 3.00% to 10.00% during the six months ended June 30, 2023 and ranging from<br>3.25% to 9.50% during the year ended December 31, 2022) and discount rates (ranging from 3.20% to 14.00% during the six months ended June 30, 2023 and ranging from 3.30% to 11.00% during the year ended December 31, 2022). Holding other factors<br>constant, a lower capitalization or terminal capitalization rate will tend to increase the fair value of an investment property. Changes in fair value based on variations in unobservable inputs generally cannot be extrapolated because the<br>relationship between the directional changes of each input is not usually linear. | |||||||
| --- | --- | |||||||
| ^(2)^ | Other invested assets measured at fair value are held primarily in infrastructure and timber sectors. The significant<br>inputs used in the valuation of the Company’s infrastructure investments are primarily future distributable cash flows, terminal values and discount rates. Holding other factors constant, an increase to future distributable cash flows or<br>terminal values would tend to increase the fair value of an infrastructure investment, while an increase in the discount rate would have the opposite effect. Discount rates during the period ranged from 7.35% to 15.60% during the six months ended<br>June 30, 2023 (during the year ended December 31, 2022 – ranged from 7.15% to 15.60%). Disclosure of distributable cash flow and terminal value ranges are not meaningful given the disparity in estimates by project. The significant<br>inputs used in the valuation of the Company’s investments in timberland properties are timber prices and discount rates. Holding other factors constant, an increase to timber prices would tend to increase the fair value of a timberland<br>investment, while an increase in the discount rates would have the opposite effect. Discount rates during the period ranged from 4.00% to 7.00% during the six months ended June 30, 2023 (during the year ended December 31, 2022 –<br>ranged from 4.25% to 7.00%). A range of prices for timber is not meaningful as the market price depends on factors such as property location and proximity to markets and export yards. | |||||||
| --- | --- | |||||||
| ^(3)^ | Segregated funds net assets are measured at fair value. The Company’s Level 3 segregated funds assets are<br>predominantly investment properties and timberland properties valued as described above. | |||||||
| --- | --- | |||||||
| Manulife Financial Corporation – Second Quarter 2023 | 108 | |||||||
| --- | --- |
Table of Contents
| Total fair | ||||||||
|---|---|---|---|---|---|---|---|---|
| As at December 31, 2022 | value | Level 1 | Level 2 | Level 3 | ||||
| Cash and short-term securities | ||||||||
| FVOCI | $ | 12,859 | $ | – | $ | 12,859 | $ | – |
| Other | 6,294 | 6,294 | – | – | ||||
| Debt securities | ||||||||
| FVOCI | ||||||||
| Canadian government and agency | 20,279 | – | 20,279 | – | ||||
| U.S. government and agency | 22,446 | – | 22,446 | – | ||||
| Other government and agency | 26,314 | – | 26,305 | 9 | ||||
| Corporate | 126,371 | – | 126,339 | 32 | ||||
| Residential mortgage-backed securities | 7 | – | 7 | – | ||||
| Commercial mortgage-backed securities | 589 | – | 589 | – | ||||
| Other asset-backed securities | 1,670 | – | 1,644 | 26 | ||||
| FVTPL | ||||||||
| Canadian government and agency | 987 | – | 987 | – | ||||
| U.S. government and agency | 1,378 | – | 1,378 | – | ||||
| Other government and agency | 159 | – | 159 | – | ||||
| Corporate | 2,209 | – | 2,209 | – | ||||
| Commercial mortgage-backed securities | 6 | – | 6 | – | ||||
| Other asset-backed securities | 16 | – | 16 | – | ||||
| Private placements | ||||||||
| FVOCI | 41,494 | – | 33,666 | 7,828 | ||||
| FVTPL | 516 | – | 485 | 31 | ||||
| Mortgages | ||||||||
| FVOCI | 28,621 | – | – | 28,621 | ||||
| FVTPL | 1,138 | – | – | 1,138 | ||||
| Public equities | ||||||||
| FVTPL | 23,519 | 23,448 | – | 71 | ||||
| Real estate^(1)^ | ||||||||
| Investment property | 11,417 | – | – | 11,417 | ||||
| Own use property | 2,682 | – | – | 2,682 | ||||
| Other invested assets^(2)^ | 31,095 | 26 | – | 31,069 | ||||
| Segregated funds net assets^(3)^ | 348,562 | 314,436 | 30,141 | 3,985 | ||||
| Total | $ | 710,628 | $ | 344,204 | $ | 279,515 | $ | 86,909 |
| ^(1)^ | For footnotes (1) to (3), refer to the “Fair value measurement” table as at June 30, 2023 above.<br> | |||||||
| --- | --- |
The following table presents fair value of invested assets not measured at fair value by the fair value hierarchy.
| Carrying | Total fair | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | value | value | Level 1 | Level 2 | Level 3 | |||||
| Short-term securities | $ | 111 | $ | 111 | $ | – | $ | 111 | $ | – |
| Mortgages | **** | 22,378 | **** | 21,927 | **** | – | **** | – | **** | 21,927 |
| Loans to Bank clients | **** | 2,632 | **** | 2,617 | **** | – | **** | 2,617 | **** | – |
| Real estate - own use property | **** | 163 | **** | 295 | **** | – | **** | – | **** | 295 |
| Public bonds held at amortized cost | **** | 1,378 | **** | 1,007 | **** | – | **** | 1,007 | **** | – |
| Other invested assets^(1)^ | **** | 11,817 | **** | 12,637 | **** | 280 | **** | – | **** | 12,357 |
| Total invested assets disclosed at fair value | $ | 38,479 | $ | 38,594 | $ | 280 | $ | 3,735 | $ | 34,579 |
| Carrying | Total fair | |||||||||
| As at December 31, 2022 | value | value | Level 1 | Level 2 | Level 3 | |||||
| Mortgages | $ | 22,006 | $ | 21,613 | $ | – | $ | – | $ | 21,613 |
| Loans to Bank clients | 2,781 | 2,760 | – | 2,760 | – | |||||
| Real estate - own use property | 170 | 326 | – | – | 326 | |||||
| Public bonds held at amortized cost | 1,411 | 1,000 | – | 1,000 | – | |||||
| Other invested<br>assets^(1)^ | 11,708 | 12,473 | 72 | – | 12,401 | |||||
| Total invested assets disclosed at fair value | $ | 38,076 | $ | 38,172 | $ | 72 | $ | 3,760 | $ | 34,340 |
| ^(1)^ | Other invested assets disclosed at fair value include $3,770 (December 31, 2022 – $3,840) of leveraged leases which<br>are disclosed at their carrying values as fair value is not routinely calculated on these investments. | |||||||||
| --- | --- | |||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 109 | |||||||||
| --- | --- |
Table of Contents
Transfers between Level 1 and Level 2
The Company records transfers of assets and liabilities between Level 1 and Level 2 at their fair values as at the end of each reporting period, consistent with the date of the determination of fair value. Assets are transferred out of Level 1 when they are no longer transacted with sufficient frequency and volume in an active market. Conversely, assets are transferred from Level 2 to Level 1 when transaction volume and frequency are indicative of an active market. During the three and six months ended June 30, 2023 and 2022, the Company had $nil transfers between Level 1 and Level 2.
For segregated funds net assets, during the three and six months ended June 30, 2023, the Company had $nil and $nil transfers from Level 1 to Level 2 (June 30, 2022 – $nil and $nil). During the three and six months ended June 30, 2023, the Company had $1 and $nil transfers from Level 2 to Level 1 (June 30, 2022 – $nil and $nil).
Invested assets and segregated funds net assets measured at fair value using significant unobservable inputs (Level 3)
The Company classifies fair values of invested assets and segregated funds net assets as Level 3 if there are no observable markets for these assets or, in the absence of active markets, most of the inputs used to determine fair value are based on the Company’s own assumptions about market participant assumptions. The Company prioritizes the use of market-based inputs over entity-based assumptions in determining Level 3 fair values. The gains and losses in the table below include the changes in fair value due to both observable and unobservable factors.
| Manulife Financial Corporation – Second Quarter 2023 | 110 |
|---|
Table of Contents
The following table presents the movement in invested assets, net derivatives and segregated funds net assets measured at fair value using significant unobservable inputs (Level 3) for the three months ended June 30, 2023 and 2022.
| For the three<br><br><br>months ended<br> <br>June 30, 2023 | Balance,<br>April 1,<br>2023 | Total<br>gains<br>(losses)<br>included<br>in net<br>income^(1)^ | Total<br>gains<br>(losses)<br>included<br>in AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br><br>in^(3)^ | Transfer<br><br><br>out^(3),(4)^ | Currency<br>movement | Balance,June 30,2023 | Change in<br>unrealized<br>gains<br>(losses)<br>on assets<br>still held | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt instruments | ||||||||||||||||||||||
| FVOCI | ||||||||||||||||||||||
| Other government & agency | $ | 10 | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 10 | $ | – |
| Corporate | **** | 39 | **** | – | **** | 1 | **** | 66 | **** | – | **** | (3) | **** | – | **** | – | **** | (1) | **** | 102 | **** | – |
| Other securitized assets | **** | 23 | **** | – | **** | 1 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (1) | **** | 23 | **** | – |
| Public equities | ||||||||||||||||||||||
| FVTPL | **** | 4 | **** | 1 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (1) | **** | 4 | **** | 1 |
| Private placements | ||||||||||||||||||||||
| FVOCI | **** | 10,468 | **** | 4 | **** | 13 | **** | 476 | **** | (51) | **** | (233) | **** | 91 | **** | (1,499) | **** | (351) | **** | 8,918 | **** | – |
| FVTPL | **** | 44 | **** | 2 | **** | – | **** | 5 | **** | – | **** | (1) | **** | 13 | **** | – | **** | 1 | **** | 64 | **** | 3 |
| Mortgages | ||||||||||||||||||||||
| FVOCI | **** | 28,981 | **** | 55 | **** | (413) | **** | 510 | **** | (410) | **** | (183) | **** | – | **** | – | **** | (467) | **** | 28,073 | **** | – |
| FVTPL | **** | 1,098 | **** | (13) | **** | – | **** | 18 | **** | (86) | **** | (9) | **** | – | **** | – | **** | – | **** | 1,008 | **** | – |
| Investment property | **** | 11,202 | **** | (315) | **** | – | **** | 84 | **** | (67) | **** | – | **** | – | **** | – | **** | (189) | **** | 10,715 | **** | (319) |
| Own use property | **** | 2,669 | **** | (62) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (59) | **** | 2,548 | **** | (62) |
| Other invested assets | **** | 32,010 | **** | 176 | **** | 5 | **** | 1,106 | **** | (294) | **** | (192) | **** | – | **** | – | **** | (718) | **** | 32,093 | **** | 80 |
| Total invested assets | **** | 86,548 | **** | (152) | **** | (393) | **** | 2,265 | **** | (908) | **** | (621) | **** | 104 | **** | (1,499) | **** | (1,786) | **** | 83,558 | **** | (297) |
| Derivatives, net | **** | (2,295) | **** | (216) | **** | – | **** | – | **** | – | **** | (65) | **** | – | **** | 118 | **** | 67 | **** | (2,391) | **** | (226) |
| Segregated funds net assets | **** | 3,962 | **** | 42 | **** | – | **** | 42 | **** | (266) | **** | – | **** | – | **** | 1 | **** | (42) | **** | 3,739 | **** | 7 |
| Total | $ | 88,215 | $ | (326) | $ | (393) | $ | 2,307 | $ | (1,174) | $ | (686) | $ | 104 | $ | (1,380) | $ | (1,761) | $ | 84,906 | $ | (516) |
| For the three<br> <br>months<br>ended<br> <br>June 30, 2022 | Balance,<br>April 1,<br>2022 | Total<br>gains<br>(losses)<br>included<br>in net<br>income^(1)^ | Total<br>gains<br>(losses)<br>included<br>in AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br><br>in^(3)^ | Transfer<br><br><br>out^(3)^ | Currency<br>movement | Balance,June 30,2022 | Change in<br>unrealized<br>gains<br>(losses)<br>on assets<br>still held | |||||||||||
| Debt instruments | ||||||||||||||||||||||
| FVOCI | ||||||||||||||||||||||
| Other government & agency | $ | 10 | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | (1) | $ | 9 | $ | – |
| Corporate | 13 | – | – | – | – | – | – | – | (1) | 12 | – | |||||||||||
| Other securitized assets | 26 | – | 2 | – | – | – | – | – | (2) | 26 | – | |||||||||||
| Public equities | ||||||||||||||||||||||
| FVTPL | 1 | – | – | – | – | – | – | – | – | 1 | – | |||||||||||
| Private placements | ||||||||||||||||||||||
| FVOCI | 4,632 | – | (655) | 129 | (12) | (4) | 642 | (182) | 67 | 4,617 | – | |||||||||||
| FVTPL | 28 | (5) | – | 1 | – | – | – | – | – | 24 | (5) | |||||||||||
| Mortgages | ||||||||||||||||||||||
| FVOCI | 29,483 | 9 | (1,768) | 1,116 | (801) | (182) | – | – | 545 | 28,402 | – | |||||||||||
| FVTPL | 1,126 | (44) | – | 74 | – | (10) | – | – | 2 | 1,148 | – | |||||||||||
| Investment property | 11,573 | 99 | – | 47 | (47) | – | – | – | 119 | 11,791 | 91 | |||||||||||
| Own use property | 2,658 | 12 | – | 7 | – | – | – | – | 38 | 2,715 | 12 | |||||||||||
| Other invested assets | 25,435 | 965 | (32) | 1,440 | (268) | (412) | – | – | 425 | 27,553 | 944 | |||||||||||
| Total invested assets | 74,985 | 1,036 | (2,453) | 2,814 | (1,128) | (608) | 642 | (182) | 1,192 | 76,298 | 1,042 | |||||||||||
| Derivatives, net | (27) | (1,958) | (47) | 1 | – | 58 | – | (77) | (11) | (2,061) | (1,920) | |||||||||||
| Segregated funds net assets | 4,379 | 68 | – | 79 | (204) | (18) | – | (1) | 71 | 4,374 | 59 | |||||||||||
| Total | $ | 79,337 | $ | (854) | $ | (2,500) | $ | 2,894 | $ | (1,332) | $ | (568) | $ | 642 | $ | (260) | $ | 1,252 | $ | 78,611 | $ | (819) |
| ^(1)^ | These amounts are included in net investment income on the Consolidated Statements of Income except for the amount<br>related to segregated funds net assets, where the amount is recorded in investment income related to segregated funds net assets. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(2)^ | These amounts are included in AOCI on the Consolidated Statements of Financial Position. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(3)^ | The Company uses fair values of the assets at the beginning of the period for assets transferred into and out of<br>Level 3 except for derivatives, where the Company uses fair value at the end of the period and at the beginning of the period, respectively. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(4)^ | Private placement bonds of $1,499 with maturity dates beyond 30 years were reclassed from Level 3 to Level 2<br>in the current period to align with the fair value leveling treatment of public bonds. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 111 | |||||||||||||||||||||
| --- | --- |
Table of Contents
The following table presents the movement in invested assets, net derivatives and segregated funds net assets measured at fair value using significant unobservable inputs (Level 3) for the six months ended June 30, 2023 and 2022.
| For the six<br><br><br>months ended<br> <br>June 30, 2023 | Balance,<br>January 1,<br>2023 | Total<br>gains<br>(losses)<br>included<br>in net<br>income^(1)^ | Total<br>gains<br>(losses)<br>included<br>in AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br><br>in^(3)^ | Transfer<br><br><br>out^(3),(4)^ | Currency<br>movement | Balance,June 30,2023 | Change in<br>unrealized<br>gains<br>(losses)<br>on assets<br>still held | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt instruments | ||||||||||||||||||||||
| FVOCI | ||||||||||||||||||||||
| Other government & agency | $ | 9 | $ | – | $ | – | $ | 2 | $ | – | $ | – | $ | – | $ | – | $ | (1) | $ | 10 | $ | – |
| Corporate | **** | 32 | **** | – | **** | – | **** | 66 | **** | – | **** | (3) | **** | 8 | **** | – | **** | (1) | **** | 102 | **** | – |
| Other securitized assets | **** | 26 | **** | – | **** | 1 | **** | – | **** | – | **** | (3) | **** | – | **** | – | **** | (1) | **** | 23 | **** | – |
| Public equities | ||||||||||||||||||||||
| FVTPL | **** | 71 | **** | 1 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (67) | **** | (1) | **** | 4 | **** | 1 |
| Private placements | ||||||||||||||||||||||
| FVOCI | **** | 7,828 | **** | (5) | **** | 195 | **** | 1,325 | **** | (309) | **** | (348) | **** | 2,328 | **** | (1,771) | **** | (325) | **** | 8,918 | **** | – |
| FVTPL | **** | 31 | **** | 3 | **** | – | **** | 17 | **** | – | **** | (1) | **** | 13 | **** | – | **** | 1 | **** | 64 | **** | 4 |
| Mortgages | ||||||||||||||||||||||
| FVOCI | **** | 28,621 | **** | 74 | **** | 84 | **** | 834 | **** | (668) | **** | (378) | **** | – | **** | – | **** | (494) | **** | 28,073 | **** | – |
| FVTPL | **** | 1,138 | **** | 2 | **** | – | **** | 18 | **** | (130) | **** | (20) | **** | – | **** | – | **** | – | **** | 1,008 | **** | – |
| Investment property | **** | 11,418 | **** | (532) | **** | – | **** | 131 | **** | (102) | **** | – | **** | – | **** | – | **** | (200) | **** | 10,715 | **** | (534) |
| Own use property | **** | 2,682 | **** | (80) | **** | – | **** | 2 | **** | – | **** | – | **** | – | **** | – | **** | (56) | **** | 2,548 | **** | (80) |
| Other invested assets | **** | 31,038 | **** | 481 | **** | 4 | **** | 2,304 | **** | (456) | **** | (502) | **** | – | **** | – | **** | (776) | **** | 32,093 | **** | 390 |
| Total invested assets | **** | 82,894 | **** | (56) | **** | 284 | **** | 4,699 | **** | (1,665) | **** | (1,255) | **** | 2,349 | **** | (1,838) | **** | (1,854) | **** | 83,558 | **** | (219) |
| Derivatives, net | **** | (3,188) | **** | 285 | **** | – | **** | – | **** | – | **** | 250 | **** | – | **** | 188 | **** | 74 | **** | (2,391) | **** | 269 |
| Segregated funds net assets | **** | 3,985 | **** | 33 | **** | – | **** | 72 | **** | (304) | **** | (4) | **** | – | **** | 1 | **** | (44) | **** | 3,739 | **** | 11 |
| Total | $ | 83,691 | $ | 262 | $ | 284 | $ | 4,771 | $ | (1,969) | $ | (1,009) | $ | 2,349 | $ | (1,649) | $ | (1,824) | $ | 84,906 | $ | 61 |
| For the six<br> <br>months<br>ended<br> <br>June 30, 2022 | Balance,<br>January 1,<br>2022 | Total<br>gains<br>(losses)<br>included<br>in net<br>income^(1)^ | Total<br>gains<br>(losses)<br>included<br>in AOCI^(2)^ | Purchases | Sales | Settlements | Transfer<br><br><br>in^(3)^ | Transfer<br><br><br>out^(3)^ | Currency<br>movement | Balance,June 30,2022 | Change in<br>unrealized<br>gains<br>(losses)<br>on assets<br>still held | |||||||||||
| Debt instruments | ||||||||||||||||||||||
| FVOCI | ||||||||||||||||||||||
| Other government & agency | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 9 | $ | – | $ | – | $ | 9 | $ | – |
| Corporate | 41 | – | – | – | – | – | – | (29) | – | 12 | – | |||||||||||
| Other securitized assets | 28 | – | 3 | – | – | (2) | – | – | (3) | 26 | – | |||||||||||
| Public equities | ||||||||||||||||||||||
| FVTPL | – | – | – | – | – | – | – | – | 1 | 1 | – | |||||||||||
| Private placements | ||||||||||||||||||||||
| FVOCI | 5,136 | – | (1,221) | 228 | (12) | (9) | 820 | (342) | 17 | 4,617 | – | |||||||||||
| FVTPL | 30 | (7) | – | 1 | – | – | – | – | – | 24 | (7) | |||||||||||
| Mortgages | ||||||||||||||||||||||
| FVOCI | 31,798 | 44 | (3,969) | 2,016 | (1,353) | (386) | – | – | 252 | 28,402 | – | |||||||||||
| FVTPL | 1,203 | (111) | – | 74 | – | (19) | – | – | 1 | 1,148 | – | |||||||||||
| Investment property | 11,443 | 380 | – | 96 | (149) | – | – | – | 21 | 11,791 | 375 | |||||||||||
| Own use property | 2,661 | 39 | – | 10 | – | – | – | – | 5 | 2,715 | 39 | |||||||||||
| Other invested assets | 24,884 | 1,261 | (47) | 2,455 | (300) | (773) | 4 | – | 69 | 27,553 | 1,394 | |||||||||||
| Total invested assets | 77,224 | 1,606 | (5,234) | 4,880 | (1,814) | (1,189) | 833 | (371) | 363 | 76,298 | 1,801 | |||||||||||
| Derivatives, net | 2,101 | (3,792) | (26) | 1 | – | 170 | – | (513) | (2) | (2,061) | (3,255) | |||||||||||
| Segregated funds net assets | 4,281 | 194 | – | 147 | (255) | (30) | – | (1) | 38 | 4,374 | 93 | |||||||||||
| Total | $ | 83,606 | $ | (1,992) | $ | (5,260) | $ | 5,028 | $ | (2,069) | $ | (1,049) | $ | 833 | $ | (885) | $ | 399 | $ | 78,611 | $ | (1,361) |
| ^(1)^ | These amounts are included in net investment income on the Consolidated Statements of Income except for the amount<br>related to segregated funds net assets, where the amount is recorded in investment income related to segregated funds net assets. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(2)^ | These amounts are included in AOCI on the Consolidated Statements of Financial Position. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(3)^ | The Company uses fair values of the assets at the beginning of the year for assets transferred into and out of<br>Level 3 except for derivatives, where the Company uses fair value at the end of the period and at the beginning of the year, respectively. | |||||||||||||||||||||
| --- | --- | |||||||||||||||||||||
| ^(4)^ | Private placement bonds of $1,771 with maturity dates beyond 30 years were reclassed from Level 3 to Level 2<br>in the current period to align with the fair value leveling treatment of public bonds. | |||||||||||||||||||||
| --- | --- |
Transfers into Level 3 primarily result from securities that were impaired during the periods or securities where a lack of observable market data (versus the previous period) resulted in reclassifying assets into Level 3. Transfers from Level 3 primarily result from observable market data becoming available for the entire term structure of the debt security.
| Manulife Financial Corporation – Second Quarter 2023 | 112 |
|---|
Table of Contents
(d) Remaining term to maturity
The following table presents remaining term to maturity for invested assets.
| Remaining terms to maturities^(1)^ | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | Less<br>than 1<br>year | 1 to 3<br>years | 3 to 5<br>years | 5 to 10<br>years | Over 10<br>years | With no<br>specific<br>maturity | Total | |||||||
| Cash and short-term securities | $ | 21,018 | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 21,018 |
| Debt securities | ||||||||||||||
| Canadian government and agency | **** | 430 | **** | 1,342 | **** | 1,908 | **** | 3,912 | **** | 13,208 | **** | – | **** | 20,800 |
| U.S. government and agency | **** | 279 | **** | 824 | **** | 538 | **** | 3,717 | **** | 20,486 | **** | – | **** | 25,844 |
| Other government and agency | **** | 418 | **** | 661 | **** | 1,779 | **** | 3,685 | **** | 22,180 | **** | – | **** | 28,723 |
| Corporate | **** | 6,244 | **** | 14,995 | **** | 17,402 | **** | 34,198 | **** | 53,042 | **** | 52 | **** | 125,933 |
| Mortgage / asset-backed securities | **** | 23 | **** | 89 | **** | 289 | **** | 613 | **** | 1,010 | **** | – | **** | 2,024 |
| Public equities | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 25,075 | **** | 25,075 |
| Mortgages | **** | 3,295 | **** | 9,928 | **** | 10,336 | **** | 7,907 | **** | 10,181 | **** | 9,812 | **** | 51,459 |
| Private placements | **** | 1,383 | **** | 3,076 | **** | 4,576 | **** | 8,669 | **** | 24,806 | **** | 74 | **** | 42,584 |
| Loans to Bank clients | **** | 38 | **** | 19 | **** | 6 | **** | – | **** | 2 | **** | 2,567 | **** | 2,632 |
| Real estate | ||||||||||||||
| Own use property | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 2,711 | **** | 2,711 |
| Investment property | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 10,715 | **** | 10,715 |
| Other invested assets | ||||||||||||||
| Alternative long-duration assets | **** | 1 | **** | 122 | **** | 22 | **** | 52 | **** | 680 | **** | 38,778 | **** | 39,655 |
| Various<br>other^(2)^ | **** | 45 | **** | – | **** | 19 | **** | 1,500 | **** | 2,206 | **** | 485 | **** | 4,255 |
| Total invested assets | $ | 33,174 | $ | 31,056 | $ | 36,875 | $ | 64,253 | $ | 147,801 | $ | 90,269 | $ | 403,428 |
| Remaining terms to maturities^(1)^ | ||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| As at December 31, 2022 | Less<br><br><br>than 1<br> <br>year | 1 to 3<br><br><br>years | 3 to 5<br>years | 5 to 10<br>years | Over 10<br>years | With no<br>specific<br>maturity | Total | |||||||
| Cash and short-term securities | $ | 19,153 | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 19,153 |
| Debt securities | ||||||||||||||
| Canadian government and agency | 738 | 1,242 | 2,536 | 3,811 | 12,939 | – | 21,266 | |||||||
| U.S. government and agency | 380 | 775 | 505 | 3,560 | 19,516 | – | 24,736 | |||||||
| Other government and agency | 457 | 753 | 1,490 | 3,801 | 19,972 | – | 26,473 | |||||||
| Corporate | 8,599 | 14,542 | 16,767 | 36,778 | 52,392 | 1 | 129,079 | |||||||
| Mortgage / asset-backed securities | 6 | 89 | 265 | 574 | 1,354 | – | 2,288 | |||||||
| Public equities | – | – | – | – | – | 23,519 | 23,519 | |||||||
| Mortgages | 3,288 | 7,838 | 10,911 | 7,906 | 11,629 | 10,193 | 51,765 | |||||||
| Private placements | 1,485 | 2,962 | 4,090 | 7,958 | 25,440 | 75 | 42,010 | |||||||
| Loans to Bank clients | 40 | 18 | 5 | – | 2 | 2,716 | 2,781 | |||||||
| Real estate | ||||||||||||||
| Own use property | – | – | – | – | – | 2,852 | 2,852 | |||||||
| Investment property | – | – | – | – | – | 11,417 | 11,417 | |||||||
| Other invested assets | ||||||||||||||
| Alternative long-duration assets | 1 | 46 | 22 | 35 | 674 | 37,682 | 38,460 | |||||||
| Various<br>other^(2)^ | 105 | – | 19 | 509 | 3,206 | 504 | 4,343 | |||||||
| Total invested assets | $ | 34,252 | $ | 28,265 | $ | 36,610 | $ | 64,932 | $ | 147,124 | $ | 88,959 | $ | 400,142 |
| ^(1)^ | Represents contractual maturities. Actual maturities may differ due to prepayment privileges in the applicable contract.<br> | |||||||||||||
| --- | --- | |||||||||||||
| ^(2)^ | Primarily includes equity method accounted investments and leveraged leases. | |||||||||||||
| --- | --- | |||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 113 | |||||||||||||
| --- | --- |
Table of Contents
| Note 4 Derivative and Hedging Instruments |
|---|
Derivatives are financial contracts, the value of which is derived from a variety of factors described in note 4 (a). The Company uses derivatives including swaps, forward and futures agreements, and options to manage current and anticipated exposures to changes in interest rates, foreign exchange rates, commodity prices and equity market prices, and to replicate exposure to different types of investments.
Swaps are contractual agreements between the Company and a third party to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency. Cross currency swaps involve the exchange of principal amounts between parties as well as the exchange of interest payments in one currency for the receipt of interest payments in another currency. Total return swaps are contracts that involve the exchange of payments based on changes in the values of a reference asset, including any returns such as interest earned on these assets, in return for amounts based on reference rates specified in the contract.
Forward and futures agreements are contractual obligations to buy or sell a financial instrument, foreign currency or other underlying commodity on a predetermined future date at a specified price. Forward contracts are OTC contracts negotiated between counterparties, whereas futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.
Options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) a security, exchange rate, interest rate, or other financial instrument at a predetermined price/rate within a specified time.
See variable annuity dynamic hedging strategy in the “Risk Management and Risk Factors” section of the MD&A in the Company’s 2022 Annual Report for an explanation of the Company’s dynamic hedging strategy for its variable annuity product guarantees.
(a) Fair value of derivatives
The pricing models used to value derivatives are based on market standard valuation methodologies and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, foreign exchange rates, financial indices, commodity prices or indices, credit spreads, default risk (including the counterparties to the contract), and market volatility. The significant inputs to the pricing models for most derivatives are inputs that are observable or can be corroborated by observable market data and are classified as Level 2. Inputs that are observable generally include interest rates, foreign exchange rates and interest rate curves. However, certain derivatives may rely on inputs that are significant to the fair value that are not observable in the market or cannot be derived principally from, or corroborated by, observable market data and these derivatives are classified as Level 3. Inputs that are unobservable generally include broker quoted prices, volatilities and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation. Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all derivatives after considering the effects of netting agreements and collateral arrangements.
| Manulife Financial Corporation – Second Quarter 2023 | 114 |
|---|
Table of Contents
The following table presents gross notional amount and fair value of derivative instruments by the underlying risk exposure.
| June 30, 2023 | December 31, 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | Notional | Fair value | Notional | Fair value | |||||||||
| Type of hedge | Instrument type | amount^(1)^ | Assets | Liabilities | amount | Assets | Liabilities | ||||||
| Qualifying hedge accounting relationships | |||||||||||||
| Fair value hedges | Interest rate swaps | $ | 265,944 | $ | 2,907 | $ | 3,447 | $ | – | $ | – | $ | – |
| Foreign currency swaps | **** | 9,435 | **** | 152 | **** | 1,427 | 48 | 5 | – | ||||
| Forward contracts | **** | 20,612 | **** | 52 | **** | 2,497 | – | – | – | ||||
| Cash flow hedges | Interest rate swaps | **** | 6,288 | **** | 19 | **** | – | – | – | – | |||
| Foreign currency swaps | **** | 1,139 | **** | 25 | **** | 180 | 1,155 | 40 | 203 | ||||
| Forward contracts | **** | 40 | **** | – | **** | 1 | – | – | – | ||||
| Equity contracts | **** | 283 | **** | – | **** | 1 | 173 | 3 | – | ||||
| Net investment hedges | Forward contracts | **** | 390 | **** | 9 | **** | – | 626 | – | 28 | |||
| Total derivatives in qualifying hedge accounting<br>relationships | **** | 304,131 | **** | 3,164 | **** | 7,553 | 2,002 | 48 | 231 | ||||
| Derivatives not designated in qualifying hedge accounting relationships | |||||||||||||
| Interest rate swaps | **** | 91,960 | **** | 2,601 | **** | 3,759 | 268,081 | 5,751 | 7,557 | ||||
| Interest rate futures | **** | 10,104 | **** | – | **** | – | 11,772 | – | – | ||||
| Interest rate options | **** | 6,201 | **** | 46 | **** | – | 6,090 | 98 | – | ||||
| Foreign currency swaps | **** | 30,796 | **** | 1,595 | **** | 378 | 39,667 | 2,029 | 1,579 | ||||
| Currency rate futures | **** | 2,321 | **** | – | **** | – | 2,319 | – | – | ||||
| Forward contracts | **** | 29,103 | **** | 414 | **** | 503 | 45,124 | 295 | 4,697 | ||||
| Equity contracts | **** | 18,147 | **** | 534 | **** | 41 | 16,930 | 363 | 225 | ||||
| Credit default swaps | **** | 128 | **** | 4 | **** | – | 159 | 4 | – | ||||
| Equity futures | **** | 4,099 | **** | – | **** | – | 3,813 | – | – | ||||
| Total derivatives not designated in qualifying hedge<br>accounting relationships | **** | 192,859 | **** | 5,194 | **** | 4,681 | 393,955 | 8,540 | 14,058 | ||||
| Total derivatives | $ | 496,990 | $ | 8,358 | $ | 12,234 | $ | 395,957 | $ | 8,588 | $ | 14,289 | |
| ^(1)^ | The notional amount as at June 30, 2023 includes an additional $83 billion due to the recent LIBOR transition.<br>This additional notional amount represents the derivative instruments cleared on the Chicago Mercantile Exchange (“CME”) and London Clearing House (“LCH”) related to the remaining LIBOR-based settlements, and new SOFR-based<br>contracts that are in place as at June 30, 2023 to replace the remaining maturity of the original LIBOR-based contracts. At conversion date, there was no material difference between the valuation on the original LIBOR-based contracts and the<br>net valuation on the new SOFR-based replacement contracts and additional short dated LIBOR-based overlay contracts. | ||||||||||||
| --- | --- |
The total notional amount above includes $190 billion (December 31, 2022 – $211 billion) of derivative instruments which reference rates that are impacted under the interest rate benchmark reform, with a significant majority to USD LIBOR and CDOR. USD LIBOR was decommissioned on June 30, 2023 and exposures indexed to USD LIBOR as at June 30, 2023 include derivative instruments cleared on the CME and LCH as well as OTC bilateral derivative instruments, related to the remaining LIBOR-based settlements. Exposures indexed to CDOR represent derivatives with a maturity date beyond June 28, 2024. Upon adoption of IFRS 9, the Company designated additional existing derivatives in hedge accounting relationships. The exposure in the Company’s hedge accounting programs is primarily to USD LIBOR and CDOR benchmarks. Compared to the overall risk exposure, the effect of interest rate benchmark reform on existing accounting hedges is not significant. The Company continues to apply high probability and high effectiveness expectation assumptions for cash flows and there would be no automatic de-designation of qualifying hedge relationships due to the impact from interest rate benchmark reform.
The following table presents the fair values of the derivative instruments by the remaining term to maturity. Fair values disclosed below do not incorporate the impact of master netting agreements (refer to note 7).
| Remaining term to maturity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | Less than<br><br><br>1 year | 1 to 3<br><br><br>years | 3 to 5<br><br><br>years | Over 5<br><br><br>years | Total | |||||
| Derivative assets | $ | 892 | $ | 570 | $ | 491 | $ | 6,405 | $ | 8,358 |
| Derivative liabilities | **** | 1,337 | **** | 1,995 | **** | 815 | **** | 8,087 | **** | 12,234 |
| Remaining term to maturity | ||||||||||
| As at December 31, 2022 | Less than<br><br><br>1 year | 1 to 3<br><br><br>years | 3 to 5<br><br><br>years | Over 5<br><br><br>years | Total | |||||
| Derivative assets | $ | 580 | $ | 556 | $ | 556 | $ | 6,896 | $ | 8,588 |
| Derivative liabilities | 2,656 | 1,956 | 1,146 | 8,531 | 14,289 | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 115 | |||||||||
| --- | --- |
Table of Contents
The following table presents gross notional amount by the remaining term to maturity, total fair value (including accrued interest), credit equivalent amount and capital requirement by contract type.
| Remaining term to maturity (notional amounts) | Fair value | Credit<br>equivalent<br>amount^(1)^ | Capital<br>requirement^(2)^ | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | Under 1<br>year | 1 to 5<br>years | Over 5<br>years | Total | Positive | Negative | Net | |||||||||||
| Interest rate contracts | ||||||||||||||||||
| OTC swap contracts | $ | 6,873 | $ | 19,095 | $ | 99,988 | $ | 125,956 | $ | 5,774 | $ | (7,774) | $ | (2,000) | $ | 380 | $ | 9 |
| Cleared swap contracts | **** | 88,550 | **** | 21,218 | **** | 128,468 | **** | 238,236 | **** | 314 | **** | (279) | **** | 35 | **** | – | **** | – |
| Forward contracts | **** | 13,006 | **** | 15,728 | **** | 434 | **** | 29,168 | **** | 156 | **** | (2,801) | **** | (2,645) | **** | 9 | **** | – |
| Futures | **** | 10,104 | **** | – | **** | – | **** | 10,104 | **** | – | **** | – | **** | – | **** | – | **** | – |
| Options purchased | **** | 569 | **** | 1,899 | **** | 3,733 | **** | 6,201 | **** | 46 | **** | – | **** | 46 | **** | 10 | **** | – |
| Subtotal | **** | 119,102 | **** | 57,940 | **** | 232,623 | **** | 409,665 | **** | 6,290 | **** | (10,854) | **** | (4,564) | **** | 399 | **** | 9 |
| Foreign exchange | ||||||||||||||||||
| Swap contracts | **** | 2,011 | **** | 10,907 | **** | 28,452 | **** | 41,370 | **** | 1,777 | **** | (2,063) | **** | (286) | **** | 982 | **** | 18 |
| Forward contracts | **** | 20,977 | **** | – | **** | – | **** | 20,977 | **** | 320 | **** | (199) | **** | 121 | **** | 70 | **** | 1 |
| Futures | **** | 2,321 | **** | – | **** | – | **** | 2,321 | **** | – | **** | – | **** | – | **** | – | **** | – |
| Subtotal | **** | 25,309 | **** | 10,907 | **** | 28,452 | **** | 64,668 | **** | 2,097 | **** | (2,262) | **** | (165) | **** | 1,052 | **** | 19 |
| Credit derivatives | **** | 9 | **** | 119 | **** | – | **** | 128 | **** | 4 | **** | – | **** | 4 | **** | – | **** | – |
| Equity contracts | ||||||||||||||||||
| Swap contracts | **** | 1,078 | **** | 628 | **** | – | **** | 1,706 | **** | 9 | **** | (18) | **** | (9) | **** | 31 | **** | – |
| Futures | **** | 4,099 | **** | – | **** | – | **** | 4,099 | **** | – | **** | – | **** | – | **** | – | **** | – |
| Options purchased | **** | 13,247 | **** | 3,477 | **** | – | **** | 16,724 | **** | 530 | **** | (24) | **** | 506 | **** | 229 | **** | 2 |
| Subtotal | **** | 18,433 | **** | 4,224 | **** | – | **** | 22,657 | **** | 543 | **** | (42) | **** | 501 | **** | 260 | **** | 2 |
| Subtotal including accrued interest | **** | 162,844 | **** | 73,071 | **** | 261,075 | **** | 496,990 | **** | 8,930 | **** | (13,158) | **** | (4,228) | **** | 1,711 | **** | 30 |
| Less accrued interest | **** | – | **** | – | **** | – | **** | – | **** | 572 | **** | (924) | **** | (352) | **** | – | **** | – |
| Total | $ | 162,844 | $ | 73,071 | $ | 261,075 | $ | 496,990 | $ | 8,358 | $ | (12,234) | $ | (3,876) | $ | 1,711 | $ | 30 |
| Remaining term to maturity (notional amounts) | Fair value | Credit<br>equivalent<br>amount^(1)^ | Capital<br>requirement^(2)^ | |||||||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| As at December 31, 2022 | Under 1<br>year | 1 to 5<br>years | Over 5<br>years | Total | Positive | Negative | Net | |||||||||||
| Interest rate contracts | ||||||||||||||||||
| OTC swap contracts | $ | 8,817 | $ | 19,253 | $ | 98,380 | $ | 126,450 | $ | 5,992 | $ | (8,135) | $ | (2,143) | $ | 419 | $ | 9 |
| Cleared swap contracts | 2,494 | 16,823 | 122,314 | 141,631 | 254 | (219) | 35 | – | – | |||||||||
| Forward contracts | 14,290 | 13,926 | 198 | 28,414 | 70 | (4,468) | (4,398) | 8 | – | |||||||||
| Futures | 11,772 | – | – | 11,772 | – | – | – | – | – | |||||||||
| Options purchased | 1,199 | 1,069 | 3,822 | 6,090 | 98 | – | 98 | 64 | 4 | |||||||||
| Subtotal | 38,572 | 51,071 | 224,714 | 314,357 | 6,414 | (12,822) | (6,408) | 491 | 13 | |||||||||
| Foreign exchange | ||||||||||||||||||
| Swap contracts | 2,026 | 10,475 | 28,369 | 40,870 | 2,067 | (1,846) | 221 | 1,166 | 23 | |||||||||
| Forward contracts | 17,336 | – | – | 17,336 | 226 | (258) | (32) | 89 | – | |||||||||
| Futures | 2,319 | – | – | 2,319 | – | – | – | – | – | |||||||||
| Subtotal | 21,681 | 10,475 | 28,369 | 60,525 | 2,293 | (2,104) | 189 | 1,255 | 23 | |||||||||
| Credit derivatives | 15 | 144 | – | 159 | 4 | – | 4 | – | – | |||||||||
| Equity contracts | ||||||||||||||||||
| Swap contracts | 547 | 396 | – | 943 | 26 | (7) | 19 | 24 | – | |||||||||
| Futures | 3,813 | – | – | 3,813 | – | – | – | – | – | |||||||||
| Options purchased | 12,634 | 3,526 | – | 16,160 | 335 | (218) | 117 | 232 | 2 | |||||||||
| Subtotal | 17,009 | 4,066 | – | 21,075 | 365 | (225) | 140 | 256 | 2 | |||||||||
| Subtotal including accrued interest | 77,262 | 65,612 | 253,083 | 395,957 | 9,072 | (15,151) | (6,079) | 2,002 | 38 | |||||||||
| Less accrued interest | – | – | – | – | 484 | (862) | (378) | – | – | |||||||||
| Total | $ | 77,262 | $ | 65,612 | $ | 253,083 | $ | 395,957 | $ | 8,588 | $ | (14,289) | $ | (5,701) | $ | 2,002 | $ | 38 |
| ^(1)^ | Credit equivalent amount is the sum of replacement cost and the potential future credit exposure less any collateral held.<br>Replacement cost represents the current cost of replacing all contracts with a positive fair value. The amounts take into consideration legal contracts that permit offsetting of positions. The potential future credit exposure is calculated based on<br>a formula prescribed by OSFI. | |||||||||||||||||
| --- | --- | |||||||||||||||||
| ^(2)^ | Capital requirement represents the credit equivalent amount, weighted according to the creditworthiness of the<br>counterparty, as prescribed by OSFI. | |||||||||||||||||
| --- | --- |
The total notional amount of $497 billion (December 31, 2022 – $396 billion) includes $80 billion (December 31, 2022 – $77 billion) related to derivatives utilized in the Company’s variable annuity guarantee dynamic hedging. Due to the Company’s variable annuity hedging practices, many trades are in offsetting positions, resulting in materially lower net fair value exposure for the Company than what the gross notional amount would suggest.
| Manulife Financial Corporation – Second Quarter 2023 | 116 |
|---|
Table of Contents
The average rate of the hedging instruments in hedge relationships that do not frequently reset is presented as below:
| As at June 30, 2023 | Fair value | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hedged item | Hedging<br><br><br>instrument | Average rate | 1 to 5<br><br><br>years | Over 5<br><br><br>years | Total | Positive | Negative | Net | |||||||
| Inflation risk | |||||||||||||||
| Inflation linked insurance liabilities | Interest rate swaps | CPI rate:289.00 | 87 | $ | 441 | $ | 5,760 | $ | 6,288 | $ | 19 | $ | – | $ | 19 |
| Foreign exchange risk | |||||||||||||||
| Fixed rate liabilities | Foreign currency<br>swaps | SGD/CAD:0.93503 | – | **** | 489 | **** | – | **** | 489 | **** | 25 | **** | – | **** | 25 |
| Foreign exchange and interest rate risk | |||||||||||||||
| Floating rate foreign currency liabilities | Foreign currency<br>swaps | CAD/:0.86655 | – | **** | – | **** | 650 | **** | 650 | **** | – | **** | (180) | **** | (180) |
| Debt securities at fair value through OCI | Foreign currency<br>swaps | CAD/:1.22914 | – | **** | 47 | **** | – | **** | 47 | **** | 5 | **** | – | **** | 5 |
| Equity risk | |||||||||||||||
| Stock-based compensation | Equity contracts | MFC price:26.22 | 35 | **** | 248 | **** | – | **** | 283 | **** | – | **** | (1) | **** | (1) |
| Total | 122 | $ | 1,225 | $ | 6,410 | $ | 7,757 | $ | 49 | $ | (181) | $ | (132) | ||
| As at December 31, 2022 | Fair value | ||||||||||||||
| Hedged item | Hedging<br>instrument | Average rate | 1 to 5<br>years | Over 5<br><br><br>years | Total | Positive | Negative | Net | |||||||
| Foreign exchange risk | |||||||||||||||
| Fixed rate liabilities | Foreign currency<br>swaps | SGD/CAD:0.93503 | – | $ | 505 | $ | – | $ | 505 | $ | 40 | $ | – | $ | 40 |
| Foreign exchange and interest rate risk | |||||||||||||||
| Floating rate foreign currency liabilities | Foreign currency<br>swaps | CAD/:0.86655 | – | – | 650 | 650 | – | (203) | (203) | ||||||
| Debt securities at fair value through OCI | Foreign currency<br>swaps | CAD/:1.22914 | – | 48 | – | 48 | 5 | – | 5 | ||||||
| Equity risk | |||||||||||||||
| Stock-based compensation | Equity contracts | MFC price:25.39 | 9 | 164 | – | 173 | 3 | – | 3 | ||||||
| Total | 9 | $ | 717 | $ | 650 | $ | 1,376 | $ | 48 | $ | (203) | $ | (155) |
All values are in US Dollars.
| Fair value and the fair value hierarchy of derivative instruments | ||||||||
|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | Fair value | Level 1 | Level 2 | Level 3 | ||||
| Derivative assets | ||||||||
| Interest rate contracts | $ | 5,728 | $ | – | $ | 5,589 | $ | 139 |
| Foreign exchange contracts | **** | 2,092 | **** | – | **** | 2,092 | **** | – |
| Equity contracts | **** | 534 | **** | – | **** | 527 | **** | 7 |
| Credit default swaps | **** | 4 | **** | – | **** | 4 | **** | – |
| Total derivative assets | $ | 8,358 | $ | – | $ | 8,212 | $ | 146 |
| Derivative liabilities | ||||||||
| Interest rate contracts | $ | 10,008 | $ | – | $ | 7,473 | $ | 2,535 |
| Foreign exchange contracts | **** | 2,184 | **** | – | **** | 2,182 | **** | 2 |
| Equity contracts | **** | 42 | **** | – | **** | 42 | **** | – |
| Total derivative liabilities | $ | 12,234 | $ | – | $ | 9,697 | $ | 2,537 |
| As at December 31, 2022 | Fair value | Level 1 | Level 2 | Level 3 | ||||
| Derivative assets | ||||||||
| Interest rate contracts | $ | 5,919 | $ | – | $ | 5,766 | $ | 153 |
| Foreign exchange contracts | 2,299 | – | 2,298 | 1 | ||||
| Equity contracts | 366 | – | 361 | 5 | ||||
| Credit default swaps | 4 | – | 4 | – | ||||
| Total derivative assets | $ | 8,588 | $ | – | $ | 8,429 | $ | 159 |
| Derivative liabilities | ||||||||
| Interest rate contracts | $ | 12,025 | $ | – | $ | 8,689 | $ | 3,336 |
| Foreign exchange contracts | 2,039 | – | 2,037 | 2 | ||||
| Equity contracts | 225 | – | 216 | 9 | ||||
| Total derivative liabilities | $ | 14,289 | $ | – | $ | 10,942 | $ | 3,347 |
Movement in net derivatives measured at fair value using significant unobservable inputs (Level 3) is presented in note 3 (c).
| Manulife Financial Corporation – Second Quarter 2023 | 117 |
|---|
Table of Contents
(b) Hedge accounting relationships
The Company uses derivatives for economic hedging purposes. In certain circumstances, these hedges also meet the requirements of hedge accounting and designation of a derivative in a qualifying hedge accounting relationship achieves the desired IFRS presentation. Risk management strategies eligible for hedge accounting are designated as fair value hedges, cash flow hedges or net investment hedges.
At the inception of a hedge accounting relationship, the Company documents the relationship between hedging instrument and hedged item, its risk management objective, and its strategy for undertaking the hedge. At hedge inception and on an ongoing basis, an assessment is performed and documented to demonstrate that the hedging relationship qualifies for hedge accounting. In order to qualify for hedge accounting, there has to be an economic relationship between the hedging instrument and the hedged item, an assessment that the effect of credit risk does not dominate the economic relationship, and the hedge ratio between the hedging instrument and the hedged item will be based on the approach actually used by risk management, unless the hedge ratio used by risk management results in an imbalance that would create hedge ineffectiveness that is inconsistent with the purpose of hedge accounting.
| • | The Company designates a specific risk component or a combination of risk components as the hedged risk, including<br>benchmark interest rate, foreign exchange rate, equity price and consumer price index components. All these risk components are observable in the relevant market environment and the changes in fair value or variability in cash flows attributable to<br>these risk components can be reliably measured for hedged items. The hedged risk is generally the most significant risk component of the overall changes in fair value or in cash flows. The Company acquires derivatives with underlying variables that<br>offset the hedged risk based on the risk management strategy, and an economic relationship is established. |
|---|---|
| • | The Company executes hedging derivatives with counterparties with high credit quality and monitors the creditworthiness of<br>the counterparties to ensure they are expected to meet cash flow obligations on the hedging instruments as they come due, and that the probability of counterparty default is remote. Further, changes in the Company’s own credit risk are<br>immaterial and had insignificant impact to the hedging relationship. |
| --- | --- |
| • | A hedge ratio is calculated as the ratio between the quantity of the hedged item that the Company actually hedges and the<br>quantity of the hedging instrument the Company actually uses to hedge that quantity of hedged item. |
| --- | --- |
| • | For group fair value hedges of interest rate risk of insurance liabilities and group fair value hedges of foreign exchange<br>and interest rate risk of foreign currency denominated debt instruments, the Company constructs the hedge relationships by comparing interest rate sensitivities of the group of hedging derivatives and the group of hedged items in the same currency.<br>Interest rate sensitivities are compared by estimating the change in the present value of the cash flows of the hedged items and hedging derivatives from an instantaneous shock to interest rates, assuming no rebalancing actions are undertaken.<br> |
| --- | --- |
| • | For the rest of the Company’s hedge accounting relationships, the Company generally constructs the hedge relationships<br>by comparing the notional amounts of the hedging derivatives and of hedged items. |
| --- | --- |
Hedge ineffectiveness in various hedging relationships may still exist and potential sources of hedge ineffectiveness by risk category are summarized as below:
| Interest<br><br><br>rate risk | Foreign<br> <br>currency<br><br><br>risk | Equity<br>risk | Consumer<br>price index<br>risk | |
|---|---|---|---|---|
| Mismatches in some critical terms of hedging instrument and hedged item | ✓ | ✓ | ✓ | ✓ |
| Differences in valuation methodologies including discounting factor | ✓ | ✓ | ✓ | |
| Changes in timing and amount of forecasted hedged items | ✓ | ✓ | ||
| Differences due to the use of non-zero fair value hedging instruments | ✓ | ✓ | ||
| Manulife Financial Corporation – Second Quarter 2023 | 118 | |||
| --- | --- |
Table of Contents
Hedging relationships that frequently reset
The Company uses a portfolio of derivatives to fair value hedge the foreign exchange rate and interest rate fluctuations of fixed rate debt instruments denominated in non-functional currencies, as well as the interest rate fluctuations of guaranteed insurance liabilities. The risk management objective is to hedge these foreign exchange and interest rate fluctuations with a hedge horizon of three months. At the end of each hedge horizon, the hedging relationships will mature naturally; and new fair value hedging relationships will be designated with a new pool of hedging instruments and hedged items.
Fair value hedges
The Company uses interest rate swaps to manage its exposure to changes in the fair value of fixed rate financial instruments and guaranteed insurance liabilities due to changes in interest rates. The Company also uses cross currency swaps to manage its exposure to foreign exchange rate fluctuations, interest rate fluctuations, or both.
The Company recognizes gains and losses on derivatives and the related hedged items in fair value hedges in Total investment result. These investment gains (losses) are shown in the following table.
| Change in | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change in | value of the | Ineffectiveness | Accumulated | |||||||||
| value of the | hedging | recognized in | Carrying | Accumulated | fair value | |||||||
| hedged item for | instrument for | Total | amount for | fair value | adjustments on | |||||||
| For the six months ended June 30,2023 | ineffectiveness<br><br><br>measurement | ineffectiveness<br><br><br>measurement | investment<br><br><br>result | hedged<br><br><br>items^(1)^ | adjustments on<br><br><br>hedged items | de-designated<br><br><br>hedged items | ||||||
| Assets | ||||||||||||
| Interest rate risk | ||||||||||||
| Debt securities at FVOCI | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 252 |
| Foreign currency and interest rate risk | ||||||||||||
| Debt securities at FVOCI | **** | 612 | **** | (659) | **** | (47) | **** | 9,495 | **** | (249) | **** | 184 |
| Total assets | $ | 612 | $ | (659) | $ | (47) | $ | 9,495 | $ | (249) | $ | 436 |
| Liabilities | ||||||||||||
| Interest rate risk | ||||||||||||
| Insurance contract liabilities | $ | (781) | $ | 935 | $ | 154 | $ | 29,647 | $ | 468 | $ | (1,202) |
| Total liabilities | $ | (781) | $ | 935 | $ | 154 | $ | 29,647 | $ | 468 | $ | (1,202) |
| For the year ended December 31,<br>2022 | Change in<br><br><br>value of the<br> <br>hedged item for<br><br><br>ineffectiveness<br> <br>measurement | Change in<br><br><br>value of the<br> <br>hedging<br><br><br>instrument for<br> <br>ineffectiveness<br><br><br>measurement | Ineffectiveness<br><br><br>recognized in<br> <br>Total<br><br><br>investment<br> <br>result | Carrying<br><br><br>amount for<br> <br>hedged<br><br><br>items | Accumulated<br><br><br>fair value<br> <br>adjustments on<br><br><br>hedged items | Accumulated<br><br><br>fair value<br> <br>adjustments on<br><br><br>de-designated<br><br><br>hedged items | ||||||
| Assets^(2)^ | ||||||||||||
| Interest rate risk | ||||||||||||
| Debt securities at FVOCI | $ | – | $ | – | $ | – | $ | – | $ | – | $ | 265 |
| Foreign currency and interest rate risk | ||||||||||||
| Debt securities at FVOCI | 7 | (5) | 2 | 31 | 7 | – | ||||||
| Total assets | $ | 7 | $ | (5) | $ | 2 | $ | 31 | $ | 7 | $ | 265 |
| Total liabilities | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – |
| ^(1)^ | The carrying amounts for hedged items presented are related to hedged items in active hedging relationships as at the<br>reporting date. Out of the $9,495 related to assets, $9,465 relates to new hedge relationships designated under IFRS 9 and does not have amounts presented for the comparative period. Further, $29,647 related to liabilities are new hedge<br>relationships designated under IFRS 9 and do not have amounts presented for the comparative period. | |||||||||||
| --- | --- | |||||||||||
| ^(2)^ | Represents existing hedges designated under IAS 39. | |||||||||||
| --- | --- |
Cash flow hedges
The Company uses interest rate swaps to hedge the variability in cash flows from variable rate financial instruments and forecasted transactions. The Company also uses cross currency swaps and foreign currency forward contracts to hedge the variability from foreign currency financial instruments and foreign currency expenses. Total return swaps are used to hedge the variability in cash flows associated with certain stock-based compensation awards. Inflation swaps are used to reduce inflation risk generated from inflation-indexed liabilities.
| Manulife Financial Corporation – Second Quarter 2023 | 119 |
|---|
Table of Contents
The effects of derivatives in cash flow hedging relationships on the Consolidated Statements of Income and the Consolidated Statements of Comprehensive Income are shown in the following table. The effective portion of the change in fair value of hedging instruments associated with the CPI cash flow hedge accounting program is presented in AOCI, in the same line as the hedged item – Insurance finance income (expense). The AOCI balances of $74 as at June 30, 2023 (December 31, 2022 – $86) are all related to continuing cash flow hedges, of which $23 (December 31, 2022 – $nil) related to CPI cash flow hedges were reported in AOCI – Insurance finance income (expense). There is $nil balance in AOCI related to de-designated hedges as at June 30, 2023 and December 31, 2022, respectively.
| Change in fair | Change in fair | Ineffectiveness | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hedged items in | value of hedged | value of hedging | Gains (losses) | recognized in | |||||||
| qualifying cash flow | items for | instruments for | Gains (losses) | reclassified from | Total | ||||||
| For the six months | hedging | ineffectiveness | ineffectiveness | deferred in AOCI | AOCI into Total | investment | |||||
| ended June 30, 2023 | relationships | measurement | measurement | on derivatives | investment result | result | |||||
| Interest rate risk | |||||||||||
| Treasury lock | Forecasted liability issuance | $ | (3) | $ | 3 | $ | 3 | $ | – | $ | – |
| Foreign exchange risk | |||||||||||
| Foreign currency swaps | Fixed rate liabilities | **** | 15 | **** | (15) | **** | (15) | **** | (17) | **** | – |
| Interest and foreign exchange risk | |||||||||||
| Foreign currency swaps | Floating rate liabilities | **** | (21) | **** | 21 | **** | 21 | **** | 14 | **** | – |
| Equity price risk | |||||||||||
| Equity contracts | Stock-based compensation | **** | – | **** | – | **** | – | **** | 2 | **** | – |
| CPI risk | |||||||||||
| Interest rate<br>swaps^(1)^ | Inflation linked insurance liabilities | **** | (92) | **** | 92 | **** | 92 | **** | 69 | **** | – |
| Total | $ | (101) | $ | 101 | $ | 101 | $ | 68 | $ | – | |
| Change in fair | Change in fair | Ineffectiveness | |||||||||
| Hedged items in | value of hedged | value of hedging | Gains (losses) | recognized in | |||||||
| qualifying cash flow | items for | instruments for | Gains (losses) | reclassified from | Total | ||||||
| For the year ended | hedging | ineffectiveness | ineffectiveness | deferred in AOCI | AOCI into Total | investment | |||||
| December 31, 2022 | relationships | measurement | measurement | on derivatives | investment result | result | |||||
| Foreign exchange risk | |||||||||||
| Foreign currency swaps | Fixed rate assets | $ | 1 | $ | (1) | $ | (1) | $ | (1) | $ | – |
| Fixed rate liabilities | (34) | 34 | 34 | 35 | – | ||||||
| Interest and foreign exchange risk | |||||||||||
| Foreign currency swaps | Floating rate liabilities | (175) | 175 | 175 | (49) | – | |||||
| Equity price risk | |||||||||||
| Equity contracts | Stock-based compensation | (2) | 2 | 2 | 6 | – | |||||
| Total | $ | (210) | $ | 210 | $ | 210 | $ | (9) | $ | – | |
| ^(1)^ | Gains (losses) deferred in AOCI on derivatives are presented in AOCI under Insurance finance income (expense).<br> | ||||||||||
| --- | --- |
The Company anticipates that net losses of approximately $11 will be reclassified from AOCI to net income within the next 12 months. The maximum time frame for which variable cash flows are hedged is 14 years with exception to CPI hedge relationships where the maximum time frame for which variable cash flows are hedged is 26 years.
Hedges of net investments in foreign operations
The Company may use non-functional currency denominated long-term debt, forward currency contracts, and cross currency swaps to mitigate the foreign exchange translation risk of net investments in foreign operations. Refer to note 8.
| Manulife Financial Corporation – Second Quarter 2023 | 120 |
|---|
Table of Contents
The effects of net investment hedging relationships on the Consolidated Statements of Income and the Consolidated Statements of Other Comprehensive Income are shown in the following table.
| Change in fair | Gains (losses) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Change in fair | value of | reclassified | Ineffectiveness | |||||||
| value of hedged | hedging | from AOCI | recognized in | |||||||
| items for | instruments for | Gains (losses) | into Total | Total | ||||||
| ineffectiveness | ineffectiveness | deferred in | investment | investment | ||||||
| For the six months ended June 30, 2023 | measurement | measurement | AOCI | result | result | |||||
| Non-functional currency denominated debt | $ | (170) | $ | 170 | $ | 170 | $ | – | $ | – |
| Forward currency contracts | **** | (24) | **** | 24 | **** | 24 | **** | – | **** | – |
| Total | $ | (194) | $ | 194 | $ | 194 | $ | – | $ | – |
| Change in fair | Gains (losses) | |||||||||
| Change in fair | value of | reclassified | Ineffectiveness | |||||||
| value of hedged | hedging | from AOCI | recognized in | |||||||
| items for | instruments for | Gains (losses) | into Total | Total | ||||||
| ineffectiveness | ineffectiveness | deferred in | investment | investment | ||||||
| For the year ended December 31, 2022 | measurement | measurement | AOCI | result | result | |||||
| Non-functional currency denominated debt | $ | 458 | $ | (458) | $ | (458) | $ | – | $ | – |
| Forward currency contracts | (14) | 14 | 14 | – | – | |||||
| Total | $ | 444 | $ | (444) | $ | (444) | $ | – | $ | – |
The table below details the movement in the Company’s net investment hedge reserve.
| As at | June 30, 2023 | December 31, 2022 | ||
|---|---|---|---|---|
| Balances in the foreign currency translation reserve for continuing hedges | $ | 57 | $ | (137) |
| Balances remaining in the cash flow hedge reserve on de-designated hedges | **** | – | – | |
| Total | $ | 57 | $ | (137) |
Reconciliation of accumulated other comprehensive income (loss) related to cash flow hedges
| Reclassification | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| adjustment | ||||||||||||
| Reclassification | related to items | |||||||||||
| Accumulated | adjustment | for which the | ||||||||||
| Accumulated other | Hedging gains | other | related to de- | hedged future | ||||||||
| comprehensive | or losses | comprehensive | designated | cash flows are | ||||||||
| income (loss), | recognized in | Reclassification | income (loss), | hedges as | no longer | |||||||
| For the six months | beginning of the | AOCI during | from AOCI to | end of the | hedged item | expected to | ||||||
| ended June 30, 2023 | period | the period | income | period | affects income | occur | ||||||
| Interest rate risk | $ | – | $ | 3 | $ | – | $ | 3 | $ | – | $ | – |
| Interest rate and foreign exchange risk | **** | (114) | **** | 21 | **** | 14 | **** | (107) | **** | – | **** | – |
| Foreign exchange translation risk | **** | 5 | **** | (15) | **** | (17) | **** | 7 | **** | – | **** | – |
| CPI risk | **** | – | **** | 92 | **** | 69 | **** | 23 | **** | – | **** | – |
| Equity price risk | **** | 2 | **** | – | **** | 2 | **** | – | **** | – | **** | – |
| Total | $ | (107) | $ | 101 | $ | 68 | $ | (74) | $ | – | $ | – |
| Reclassification | ||||||||||||
| adjustment | ||||||||||||
| Reclassification | related to items | |||||||||||
| Accumulated | adjustment | for which the | ||||||||||
| Accumulated other | Hedging gains | other | related to de- | hedged future | ||||||||
| comprehensive | or losses | comprehensive | designated | cash flows are | ||||||||
| income (loss), | recognized in | Reclassification | income (loss), | hedges as | no longer | |||||||
| For the year ended | beginning of the | AOCI during | from AOCI to | end of the | hedged item | expected to | ||||||
| December 31, 2022 | period | the period | income | period | affects income | occur | ||||||
| Interest rate risk | $ | – | $ | – | $ | – | $ | – | $ | – | $ | – |
| Interest rate and foreign exchange risk | (313) | 175 | (49) | (89) | – | – | ||||||
| Foreign exchange translation risk | 3 | 33 | 34 | 2 | – | – | ||||||
| CPI risk | – | – | – | – | – | – | ||||||
| Equity price risk | 6 | 2 | 6 | 2 | – | – | ||||||
| Total | $ | (304) | $ | 210 | $ | (9) | $ | (85) | $ | – | $ | – |
| Manulife Financial Corporation – Second Quarter 2023 | 121 | |||||||||||
| --- | --- |
Table of Contents
Reconciliation of accumulated other comprehensive income (loss) related to net investment hedges
| Reclassification | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| adjustment | ||||||||||||
| Reclassification | related to items | |||||||||||
| Accumulated | adjustment | for which the | ||||||||||
| Accumulated other | Hedging gains | other | related to de- | hedged future | ||||||||
| comprehensive | or losses | comprehensive | designated | cash flows are | ||||||||
| income (loss), | recognized in | Reclassification | income (loss), | hedges as | no longer | |||||||
| For the six months ended | beginning of the | AOCI during | from AOCI to | end of the | hedged item | expected to | ||||||
| June 30, 2023 | period | the period | Income | period | affects income | occur | ||||||
| Foreign exchange translation risk | $ | (137) | $ | 194 | $ | – | $ | 57 | $ | – | $ | – |
| Reclassification<br><br><br>adjustment | ||||||||||||
| Reclassification | related to items | |||||||||||
| Accumulated | adjustment | for which the | ||||||||||
| Accumulated other | Hedging gains | other | related to de- | hedged future | ||||||||
| comprehensive | or losses | comprehensive | designated | cash flows are | ||||||||
| income (loss), | recognized in | Reclassification | income (loss), | hedges as | no longer | |||||||
| For the year ended December 31,<br>2022 | beginning of the<br><br><br>period | AOCI during<br><br><br>the period | from AOCI to<br><br><br>income | end of the<br><br><br>period | hedged item<br><br><br>affects income | expected to<br><br><br>occur | ||||||
| Foreign exchange translation risk | $ | 307 | $ | (444) | $ | – | $ | (137) | $ | – | $ | – |
Cost of hedging
The Company has elected to apply cost of hedging guidance retrospectively for certain hedging relationships existing on January 1, 2023. The excluded components from hedging relationships related to forward elements and foreign currency basis spreads are presented in AOCI as cost of hedging and the following table provides details of the movement in the cost of hedging by hedged risk category.
| For the six months | ||
|---|---|---|
| ended June 30, 2023 | ||
| Foreign exchange risk | ||
| Balance, beginning of year | $ | (3) |
| Changes in fair value | **** | – |
| Balance, end of period | $ | (3) |
| Foreign exchange and interest rate risk | ||
| Balance, beginning of year | $ | 25 |
| Changes in fair value | **** | (2) |
| Balance, end of period | $ | 23 |
| (c) | Derivatives not designated in qualifying hedge accounting relationships | |
| --- | --- |
The Company uses derivatives to economically hedge various financial risks, however, not all derivatives qualify for hedge accounting requirements and in some cases, the Company has not elected to apply hedge accounting. As noted above, upon adoption of IFRS 9, the Company has designated additional existing derivatives in hedge accounting relationships. Below are the investment income impacts of derivatives not designated in qualifying hedge accounting relationships.
Investment income on derivatives not designated in qualifying hedge accounting relationships
| For the six months | For the year ended | |||
|---|---|---|---|---|
| ended June 30, 2023 | December 31, 2022 | |||
| Interest rate swaps | $ | 201 | $ | (3,428) |
| Interest rate futures | **** | 70 | (431) | |
| Interest rate options | **** | – | (258) | |
| Foreign currency swaps | **** | (254) | 1,171 | |
| Currency rate futures | **** | (12) | (103) | |
| Forward contracts | **** | 259 | (7,561) | |
| Equity futures | **** | (335) | 794 | |
| Equity contracts | **** | 224 | (818) | |
| Total | $ | 153 | $ | (10,634) |
| Manulife Financial Corporation – Second Quarter 2023 | 122 | |||
| --- | --- |
Table of Contents
(d) Embedded derivatives
Certain insurance contracts contain features that are classified as embedded derivatives and are measured separately at FVTPL, including reinsurance contracts related to guaranteed minimum income benefits and contracts containing certain credit and interest rate features.
Certain reinsurance contracts related to guaranteed minimum income benefits contain embedded derivatives requiring separate measurement at FVTPL as the financial component contained in the reinsurance contracts does not contain significant insurance risk. Claims recovered under reinsurance ceded contracts offset claims expenses and claims paid on the reinsurance assumed. As at June 30, 2023, reinsurance ceded guaranteed minimum income benefits had a fair value of $450 (December 31, 2022 – $535) and reinsurance assumed guaranteed minimum income benefits had a fair value of $52 (December 31, 2022 – $58).
The Company’s credit and interest rate embedded derivatives promise to pay the returns on a portfolio of assets to the contract holder. These embedded derivatives contain credit and interest rate risks that are financial risks embedded in the underlying insurance contract. As at June 30, 2023, these embedded derivative liabilities had a fair value of $342 (December 31, 2022 – $395).
Other insurance contract features which are classified as embedded derivatives but are exempt from separate measurement at fair value include variable universal life and variable life products’ minimum guaranteed credited rates, no lapse guarantees, guaranteed annuitization options, CPI indexing of benefits, and segregated fund minimum guarantees other than reinsurance ceded/assumed guaranteed minimum income benefits. These embedded derivatives are measured and reported within insurance contract liabilities and are exempt from separate fair value measurement as they contain insurance risk and/or are closely related to the insurance host contract.
| Note 5 Insurance and Reinsurance Contract Assets and Liabilities |
|---|
(a) Movements in carryingamounts of insurance and reinsurance contracts
The following tables present the movement in the net carrying amounts of insurance contracts issued and reinsurance contracts held during the period for each reporting segment. The changes are due to cash flows and amounts recognized in income and OCI.
There are two types of tables presented:
| • | Tables which analyze movements in the liabilities for remaining coverage and liabilities for incurred claims separately and<br>reconciles them to the relevant Consolidated Statements of Income and Consolidated Statements of Comprehensive Income line items. |
|---|---|
| • | Tables which analyze movements of contracts by measurement components including estimates of the present value of future<br>cash flows, risk adjustment and CSM for portfolios. |
| --- | --- |
| Manulife Financial Corporation – Second Quarter 2023 | 123 |
| --- | --- |
Table of Contents
Insurance contracts
The following table presents the movement in the net assets or liabilities for insurance contracts issued, showing the liabilities for remaining coverage and the liabilities for incurred claims.
| Liabilities for remaining coverage | Liabilities for incurred claims | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excluding loss<br>component | Loss<br>component | Products not<br>under PAA | PAA<br>Estimates of<br>PV of future<br>cash flows | PAA Risk<br>adjustment<br>for non-<br>financial risk | Assets for<br>insurance<br>acquisition<br>cash flows | Total | ||||||||
| Opening insurance contract assets | $ | (659) | $ | – | $ | 7 | $ | (12) | $ | – | $ | (9) | $ | (673) |
| Opening insurance contract liabilities | **** | 335,711 | **** | 1,328 | **** | 7,135 | **** | 10,877 | **** | 602 | **** | (796) | **** | 354,857 |
| Opening insurance contract liabilities for account of segregated fund<br>holders | **** | 110,216 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 110,216 |
| Net opening balance, January 1, 2023 | **** | 445,268 | **** | 1,328 | **** | 7,142 | **** | 10,865 | **** | 602 | **** | (805) | **** | 464,400 |
| Insurance revenue | ||||||||||||||
| Expected incurred claims and other insurance service result | **** | (6,235) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (6,235) |
| Change in risk adjustment for non-financial risk expired | **** | (717) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (717) |
| CSM recognized for services provided | **** | (1,032) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (1,032) |
| Recovery of insurance acquisition cash flows | **** | (381) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (381) |
| Contracts under Premium Allocation Approach<br>(“PAA”) | **** | (2,978) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (2,978) |
| **** | (11,343) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (11,343) | |
| Insurance service expense | ||||||||||||||
| Incurred claims and other insurance service expenses | **** | – | **** | (272) | **** | 6,481 | **** | 2,715 | **** | 151 | **** | – | **** | 9,075 |
| Losses and reversal of losses on onerous contracts (future service) | **** | – | **** | 122 | **** | – | **** | – | **** | – | **** | – | **** | 122 |
| Changes to liabilities for incurred claims (past service) | **** | – | **** | – | **** | (30) | **** | (548) | **** | (136) | **** | – | **** | (714) |
| Amortization of insurance acquisition cash flows | **** | 791 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 791 |
| Net impairment of assets for insurance acquisition cash<br>flows | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| **** | 791 | **** | (150) | **** | 6,451 | **** | 2,167 | **** | 15 | **** | – | **** | 9,274 | |
| Investment components and premium refunds | **** | (9,350) | **** | – | **** | 8,606 | **** | 744 | **** | – | **** | – | **** | – |
| Insurance service result | **** | (19,902) | **** | (150) | **** | 15,057 | **** | 2,911 | **** | 15 | **** | – | **** | (2,069) |
| Insurance finance (income) expense | **** | 13,882 | **** | 13 | **** | (91) | **** | 348 | **** | (5) | **** | – | **** | 14,147 |
| Effects of movements in foreign exchange rates | **** | (9,637) | **** | (43) | **** | (116) | **** | (8) | **** | – | **** | 6 | **** | (9,798) |
| Total changes in income and OCI | **** | (15,657) | **** | (180) | **** | 14,850 | **** | 3,251 | **** | 10 | **** | 6 | **** | 2,280 |
| Cash flows | ||||||||||||||
| Premiums and premium tax received | **** | 24,484 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 24,484 |
| Claims and other insurance service expenses paid, including investment components | **** | – | **** | – | **** | (15,438) | **** | (3,961) | **** | – | **** | – | **** | (19,399) |
| Insurance acquisition cash flows | **** | (3,456) | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (3,456) |
| Total cash flows | **** | 21,028 | **** | – | **** | (15,438) | **** | (3,961) | **** | – | **** | – | **** | 1,629 |
| Allocation from assets for insurance acquisition cash flows to groups of insurance contracts | **** | (142) | **** | – | **** | – | **** | – | **** | – | **** | 142 | **** | – |
| Acquisition cash flows incurred in the period | **** | – | **** | – | **** | – | **** | – | **** | – | **** | (84) | **** | (84) |
| Movements related to insurance contract liabilities for account of<br>segregated fund holders | **** | 2,313 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 2,313 |
| Net closing balance | **** | 452,810 | **** | 1,148 | **** | 6,554 | **** | 10,155 | **** | 612 | **** | (741) | **** | 470,538 |
| Closing insurance contract assets | **** | (327) | **** | 3 | **** | (55) | **** | (18) | **** | – | **** | (7) | **** | (404) |
| Closing insurance contract liabilities | **** | 340,608 | **** | 1,145 | **** | 6,609 | **** | 10,173 | **** | 612 | **** | (734) | **** | 358,413 |
| Closing insurance contract liabilities for account of segregated fund<br>holders | **** | 112,529 | **** | – | **** | – | **** | – | **** | – | **** | – | **** | 112,529 |
| Net closing balance, June 30, 2023 | $ | 452,810 | $ | 1,148 | $ | 6,554 | $ | 10,155 | $ | 612 | $ | (741) | $ | 470,538 |
| Insurance finance (income) expense (“IFIE”) | ||||||||||||||
| Insurance finance (income) expense, per disclosure above | $ | 14,147 | ||||||||||||
| Reclassification of derivative OCI to IFIE – cash flow hedges | **** | (92) | ||||||||||||
| Reclassification of derivative (income) loss changes to<br>IFIE – fair value hedge | **** | (935) | ||||||||||||
| Insurance finance (income) expense, per disclosurein note 5 (f) | $ | 13,120 | ||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 124 | |||||||||||||
| --- | --- |
Table of Contents
| Liabilities for remaining coverage | Liabilities for incurred claims | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excluding loss<br>component | Loss<br>component | Products<br>not under<br>PAA | PAA<br>Estimates of<br>PV of future<br>cash flows | PAA Risk<br>adjustment<br>for non-<br>financial risk | Assets for<br>insurance<br>acquisition<br>cash flows | Total | ||||||||
| Opening insurance contract assets | $ | (842) | $ | – | $ | 60 | $ | 27 | $ | – | $ | (217) | $ | (972) |
| Opening insurance contract liabilities | 388,585 | 303 | 4,342 | 12,230 | 689 | (528) | 405,621 | |||||||
| Opening insurance contract liabilities for account of segregated fund<br>holders | 130,836 | – | – | – | – | – | 130,836 | |||||||
| Net opening balance, January 1, 2022 | 518,579 | 303 | 4,402 | 12,257 | 689 | (745) | 535,485 | |||||||
| Insurance revenue | ||||||||||||||
| Expected incurred claims and other insurance service result | (13,019) | – | – | – | – | – | (13,019) | |||||||
| Change in risk adjustment for non-financial risk expired | (1,665) | – | – | – | – | – | (1,665) | |||||||
| CSM recognized for service provided | (2,298) | – | – | – | – | – | (2,298) | |||||||
| Recovery of insurance acquisition cash flows | (534) | – | – | – | – | – | (534) | |||||||
| Contracts under PAA | (5,602) | – | – | – | – | – | (5,602) | |||||||
| (23,118) | – | – | – | – | – | (23,118) | ||||||||
| Insurance service expense | ||||||||||||||
| Incurred claims and other insurance service expenses | – | 233 | 12,775 | 5,982 | 266 | – | 19,256 | |||||||
| Losses and reversal of losses on onerous contracts (future service) | – | 742 | – | – | – | – | 742 | |||||||
| Changes to liabilities for incurred claims (past service) | – | – | (41) | (1,554) | (353) | – | (1,948) | |||||||
| Amortization of insurance acquisition cash flows | 1,285 | – | – | – | – | – | 1,285 | |||||||
| Net impairment of assets for insurance acquisition cash<br>flows | – | – | – | – | – | – | – | |||||||
| 1,285 | 975 | 12,734 | 4,428 | (87) | – | 19,335 | ||||||||
| Investment components and premium refunds | (18,222) | – | 16,514 | 1,708 | – | – | – | |||||||
| Insurance service result | (40,055) | 975 | 29,248 | 6,136 | (87) | – | (3,783) | |||||||
| Insurance finance (income) expense | (68,375) | 9 | 762 | (1,229) | – | – | (68,833) | |||||||
| Effects of movements in foreign exchange rates | 15,811 | 41 | 211 | 12 | – | (14) | 16,061 | |||||||
| Total changes in income and OCI | (92,619) | 1,025 | 30,221 | 4,919 | (87) | (14) | (56,555) | |||||||
| Cash flows | ||||||||||||||
| Premiums and premium tax received | 46,340 | – | – | – | – | – | 46,340 | |||||||
| Claims and other insurance service expenses paid, including investment components | – | – | (27,481) | (6,311) | – | – | (33,792) | |||||||
| Insurance acquisition cash flows | (6,266) | – | – | – | – | – | (6,266) | |||||||
| Total cash flows | 40,074 | – | (27,481) | (6,311) | – | – | 6,282 | |||||||
| Allocation from assets for insurance acquisition cash flows to groups of insurance contracts | (146) | – | – | – | – | 146 | – | |||||||
| Acquisition cash flows incurred in the period | – | – | – | – | – | (192) | (192) | |||||||
| Movements related to insurance contract liabilities for account of<br>segregated fund holders | (20,620) | – | – | – | – | – | (20,620) | |||||||
| Net closing balance | 445,268 | 1,328 | 7,142 | 10,865 | 602 | (805) | 464,400 | |||||||
| Closing insurance contract assets | (659) | – | 7 | (12) | – | (9) | (673) | |||||||
| Closing insurance contract liabilities | 335,711 | 1,328 | 7,135 | 10,877 | 602 | (796) | 354,857 | |||||||
| Closing insurance contract liabilities for account of segregated fund<br>holders | 110,216 | – | – | – | – | – | 110,216 | |||||||
| Net closing balance, December 31, 2022 | $ | 445,268 | $ | 1,328 | $ | 7,142 | $ | 10,865 | $ | 602 | $ | (805) | $ | 464,400 |
| Manulife Financial Corporation – Second Quarter 2023 | 125 | |||||||||||||
| --- | --- |
Table of Contents
Insurance contracts
The following table presents the movement in the net assets or liabilities for insurance contracts issued, showing estimates of the present value of future cash flows, risk adjustment and CSM.
| CSM | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimates of<br>PV of future<br>cash flows | Risk<br>adjustment<br>for non-<br>financial risk | Fair value | Other | Assets for<br>insurance<br>acquisition<br>cash flows | Total | |||||||
| Opening General Measurement Method (“GMM”) and Variable Fee Approach (“VFA”) insurance<br>contract assets | $ | (1,827) | $ | 512 | $ | 100 | $ | 557 | $ | – | $ | (658) |
| Opening GMM and VFA insurance contract liabilities | **** | 297,975 | **** | 25,750 | **** | 17,105 | **** | 2,087 | **** | (56) | **** | 342,861 |
| Opening PAA insurance contract net liabilities | **** | 12,125 | **** | 605 | **** | – | **** | – | **** | (749) | **** | 11,981 |
| Opening insurance contract liabilities for account of segregated fund<br>holders | **** | 110,216 | **** | – | **** | – | **** | – | **** | – | **** | 110,216 |
| Net opening balance, January 1, 2023 | **** | 418,489 | **** | 26,867 | **** | 17,205 | **** | 2,644 | **** | (805) | **** | 464,400 |
| CSM recognized for services provided | **** | – | **** | – | **** | (875) | **** | (157) | **** | – | **** | (1,032) |
| Change in risk adjustment for non-financial risk for risk<br>expired | **** | – | **** | (826) | **** | – | **** | – | **** | – | **** | (826) |
| Experience adjustments | **** | 135 | **** | – | **** | – | **** | – | **** | – | **** | 135 |
| Changes that relate to current services | **** | 135 | **** | (826) | **** | (875) | **** | (157) | **** | – | **** | (1,723) |
| Contracts initially recognized during the period | **** | (1,609) | **** | 707 | **** | – | **** | 1,089 | **** | – | **** | 187 |
| Changes in estimates that relate to change in non-financial<br>assumptions and experience | **** | 786 | **** | (75) | **** | (473) | **** | (238) | **** | – | **** | – |
| Changes in estimates that relate to time value of money and changes<br>in financial assumptions for direct participation contracts | **** | (972) | **** | 199 | **** | 714 | **** | 59 | **** | – | **** | – |
| Total changes in estimates that adjust the CSM | **** | (186) | **** | 124 | **** | 241 | **** | (179) | **** | – | **** | – |
| Changes in estimates that relate to losses and reversal of losses on<br>onerous contracts | **** | (69) | **** | 5 | **** | – | **** | – | **** | – | **** | (64) |
| Changes that relate to future services | **** | (1,864) | **** | 836 | **** | 241 | **** | 910 | **** | – | **** | 123 |
| Adjustments to liabilities for incurred claims | **** | (27) | **** | (3) | **** | – | **** | – | **** | – | **** | (30) |
| Changes that relate to past services | **** | (27) | **** | (3) | **** | – | **** | – | **** | – | **** | (30) |
| Insurance service result | **** | (1,756) | **** | 7 | **** | (634) | **** | 753 | **** | – | **** | (1,630) |
| Insurance finance (income) expense | **** | 12,625 | **** | 969 | **** | 139 | **** | 32 | **** | – | **** | 13,765 |
| Effects of movements in foreign exchange rates | **** | (8,447) | **** | (829) | **** | (388) | **** | (74) | **** | – | **** | (9,738) |
| Total changes in income and OCI | **** | 2,422 | **** | 147 | **** | (883) | **** | 711 | **** | – | **** | 2,397 |
| Total cash flows | **** | 1,385 | **** | – | **** | – | **** | – | **** | – | **** | 1,385 |
| Allocation from assets for insurance acquisition cash flows to groups of insurance contracts | **** | (3) | **** | – | **** | – | **** | – | **** | 3 | **** | – |
| Acquisition cash flows incurred in the period | **** | – | **** | – | **** | – | **** | – | **** | (4) | **** | (4) |
| Change in PAA balance | **** | (29) | **** | 11 | **** | – | **** | – | **** | 65 | **** | 47 |
| Movements related to insurance contract liabilities for account of<br>segregated fund holders | **** | 2,313 | **** | – | **** | – | **** | – | **** | – | **** | 2,313 |
| Net closing balance | **** | 424,577 | **** | 27,025 | **** | 16,322 | **** | 3,355 | **** | (741) | **** | 470,538 |
| Closing GMM and VFA insurance contract assets | **** | (858) | **** | 243 | **** | 65 | **** | 167 | **** | – | **** | (383) |
| Closing GMM and VFA insurance contract liabilities | **** | 300,810 | **** | 26,166 | **** | 16,257 | **** | 3,188 | **** | (57) | **** | 346,364 |
| Closing PAA insurance contract net liabilities | **** | 12,096 | **** | 616 | **** | – | **** | – | **** | (684) | **** | 12,028 |
| Closing insurance contract liabilities for account of segregated fund<br>insurance holders | **** | 112,529 | **** | – | **** | – | **** | – | **** | – | **** | 112,529 |
| Net closing balance, June 30, 2023 | $ | 424,577 | $ | 27,025 | $ | 16,322 | $ | 3,355 | $ | (741) | $ | 470,538 |
| Insurance finance (income) expense | ||||||||||||
| Insurance finance (income) expense, per disclosure above | $ | 13,765 | ||||||||||
| Reclassification of derivative OCI to IFIE - cash flow hedges | **** | (92) | ||||||||||
| Reclassification of derivative (income) loss changes to IFIE – fair value hedge | **** | (909) | ||||||||||
| PAA items: | ||||||||||||
| PAA IFIE per disclosure | **** | 382 | ||||||||||
| PAA Reclassification of derivative OCI to IFIE – cash flow hedges | **** | – | ||||||||||
| PAA Reclassification of derivative (income) loss changes<br>to IFIE – fair value hedge | **** | (26) | ||||||||||
| Insurance finance (income) expense, per disclosurein note 5 (f) | $ | 13,120 | ||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 126 | |||||||||||
| --- | --- |
Table of Contents
| CSM | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Estimates of<br>PV of future<br>cash flows | Risk<br>adjustment<br>for non-<br><br><br>financial risk | Fair value | Other | Assets for<br>insurance<br>acquisition<br>cash flows | Total | |||||||
| Opening GMM and VFA insurance contract assets | $ | (1,955) | $ | 365 | $ | 179 | $ | 453 | $ | – | $ | (958) |
| Opening GMM and VFA insurance contract liabilities | 341,125 | 30,780 | 19,842 | 992 | (54) | 392,685 | ||||||
| Opening PAA insurance contract net liabilities | 12,919 | 694 | – | – | (691) | 12,922 | ||||||
| Opening insurance contract liabilities for account of segregated fund<br>holders | 130,836 | – | – | – | – | 130,836 | ||||||
| Net opening balance, January 1, 2022 | 482,925 | 31,839 | 20,021 | 1,445 | (745) | 535,485 | ||||||
| CSM recognized for services provided | – | – | (2,064) | (234) | – | (2,298) | ||||||
| Change in risk adjustment for non-financial risk for risk<br>expired | – | (1,582) | – | – | – | (1,582) | ||||||
| Experience adjustments | 6 | – | – | – | – | 6 | ||||||
| Changes that relate to current services | 6 | (1,582) | (2,064) | (234) | – | (3,874) | ||||||
| Contracts initially recognized during the period | (2,880) | 1,396 | 35 | 1,963 | – | 514 | ||||||
| Changes in estimates that relate to change in non-financial<br>assumptions and experience | 3,988 | (459) | (3,030) | (499) | – | – | ||||||
| Changes in estimates that relate to time value of money and changes<br>in financial assumptions for direct participation contracts | (611) | (535) | 1,293 | (147) | – | – | ||||||
| Total changes in estimates that adjust the CSM | 3,377 | (994) | (1,737) | (646) | – | – | ||||||
| Changes in estimates that relate to losses and reversal of losses on<br>onerous contracts | 229 | (2) | – | – | – | 227 | ||||||
| Changes that relate to future services | 726 | 400 | (1,702) | 1,317 | – | 741 | ||||||
| Adjustments to liabilities for incurred claims | (33) | (7) | – | – | – | (40) | ||||||
| Changes that relate to past services | (33) | (7) | – | – | – | (40) | ||||||
| Insurance service result | 699 | (1,189) | (3,766) | 1,083 | – | (3,173) | ||||||
| Insurance finance (income) expense | (62,812) | (5,105) | 311 | 31 | – | (67,575) | ||||||
| Effects of movements in foreign exchange rates | 13,898 | 1,411 | 639 | 85 | – | 16,033 | ||||||
| Total changes in income and OCI | (48,215) | (4,883) | (2,816) | 1,199 | – | (54,715) | ||||||
| Total cash flows | 5,198 | – | – | – | – | 5,198 | ||||||
| Allocation from assets for insurance acquisition cash flows to groups of insurance contracts | (5) | – | – | – | 5 | – | ||||||
| Acquisition cash flows incurred in the period | – | – | – | – | (7) | (7) | ||||||
| Change in PAA balance | (794) | (89) | – | – | (58) | (941) | ||||||
| Movements related to insurance contract liabilities for account of<br>segregated fund holders | (20,620) | – | – | – | – | (20,620) | ||||||
| Net closing balance | 418,489 | 26,867 | 17,205 | 2,644 | (805) | 464,400 | ||||||
| Closing GMM and VFA insurance contract assets | (1,827) | 512 | 100 | 557 | – | (658) | ||||||
| Closing GMM and VFA insurance contract liabilities | 297,975 | 25,750 | 17,105 | 2,087 | (56) | 342,861 | ||||||
| Closing PAA insurance contract net liabilities | 12,125 | 605 | – | – | (749) | 11,981 | ||||||
| Closing insurance contract liabilities for account of segregated fund<br>insurance holders | 110,216 | – | – | – | – | 110,216 | ||||||
| Net closing balance, December 31, 2022 | $ | 418,489 | $ | 26,867 | $ | 17,205 | $ | 2,644 | $ | (805) | $ | 464,400 |
| Manulife Financial Corporation – Second Quarter 2023 | 127 | |||||||||||
| --- | --- |
Table of Contents
Reinsurance contracts held
The following table presents the movement in the net assets or liabilities for reinsurance contracts held, showing assets for remaining coverage and amounts recoverable on incurred claims arising from business ceded to reinsurers.
| Assets for remaining coverage | Assets for incurred claims | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Excluding<br>loss recovery<br>component | Loss recovery<br>component | Products not<br>under PAA | PAA Estimates<br>of PV of future<br>cash flows | PAA<br>Risk<br>adjustment<br>for non-<br> <br>financial risk | Total | |||||||
| Opening reinsurance contract held assets | $ | 37,853 | $ | 209 | $ | 7,521 | $ | 280 | $ | 8 | $ | 45,871 |
| Opening reinsurance contract held liabilities | **** | (2,196) | **** | 4 | **** | (137) | **** | (62) | **** | – | **** | (2,391) |
| Net opening balance, January 1, 2023 | **** | 35,657 | **** | 213 | **** | 7,384 | **** | 218 | **** | 8 | **** | 43,480 |
| Changes in income and OCI | ||||||||||||
| Allocation of reinsurance premium paid | **** | (3,227) | **** | – | **** | – | **** | – | **** | – | **** | (3,227) |
| Amounts recoverable from reinsurers | ||||||||||||
| Recoveries of incurred claims and other insurance service expenses | **** | – | **** | (20) | **** | 2,593 | **** | 289 | **** | – | **** | 2,862 |
| Recoveries and reversals of recoveries of losses on onerous underlying contracts | **** | – | **** | 35 | **** | – | **** | – | **** | – | **** | 35 |
| Adjustments to assets for incurred claims | **** | – | **** | – | **** | 3 | **** | (12) | **** | 6 | **** | (3) |
| Insurance service result | **** | (3,227) | **** | 15 | **** | 2,596 | **** | 277 | **** | 6 | **** | (333) |
| Investment components and premium refunds | **** | (786) | **** | – | **** | 786 | **** | – | **** | – | **** | – |
| Net expenses from reinsurance contracts | **** | (4,013) | **** | 15 | **** | 3,382 | **** | 277 | **** | 6 | **** | (333) |
| Net finance (income) expense from reinsurance contracts | **** | 222 | **** | 4 | **** | (46) | **** | 6 | **** | 2 | **** | 188 |
| Effect of changes in non-performance risk of reinsurers | **** | (11) | **** | – | **** | – | **** | – | **** | – | **** | (11) |
| Effects of movements in foreign exchange rates | **** | (822) | **** | (5) | **** | (153) | **** | – | **** | – | **** | (980) |
| Contracts measured under PAA | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Total changes in income and OCI | **** | (4,624) | **** | 14 | **** | 3,183 | **** | 283 | **** | 8 | **** | (1,136) |
| Cash flows | ||||||||||||
| Premiums paid | **** | 2,358 | **** | – | **** | – | **** | – | **** | – | **** | 2,358 |
| Amounts received | **** | – | **** | – | **** | (3,509) | **** | (287) | **** | – | **** | (3,796) |
| Total cash flows | **** | 2,358 | **** | – | **** | (3,509) | **** | (287) | **** | – | **** | (1,438) |
| Net closing balance | **** | 33,391 | **** | 227 | **** | 7,058 | **** | 214 | **** | 16 | **** | 40,906 |
| Closing reinsurance contract held assets | **** | 35,739 | **** | 226 | **** | 7,121 | **** | 284 | **** | 16 | **** | 43,386 |
| Closing reinsurance contract held liabilities | **** | (2,348) | **** | 1 | **** | (63) | **** | (70) | **** | – | **** | (2,480) |
| Net closing balance, June 30, 2023 | $ | 33,391 | $ | 227 | $ | 7,058 | $ | 214 | $ | 16 | $ | 40,906 |
| Assets for remaining coverage | Assets for incurred claims | |||||||||||
| Excluding<br>loss recovery<br>component | Loss recovery<br>component | Products not<br>under PAA | PAA Estimates<br>of PV of future<br>cash flows | PAA<br>Risk<br>adjustment<br>for non-<br> <br>financial risk | Total | |||||||
| Opening reinsurance contract held assets | $ | 45,699 | $ | 79 | $ | 6,740 | $ | 303 | $ | 8 | $ | 52,829 |
| Opening reinsurance contract held liabilities | (2,030) | 19 | (27) | (41) | – | (2,079) | ||||||
| Net opening balance, January 1, 2022 | 43,669 | 98 | 6,713 | 262 | 8 | 50,750 | ||||||
| Changes in income and OCI | ||||||||||||
| Allocation of reinsurance premium paid | (6,024) | – | – | – | – | (6,024) | ||||||
| Amounts recoverable from reinsurers | ||||||||||||
| Recoveries of incurred claims and other insurance service expenses | – | (30) | 4,925 | 417 | (4) | 5,308 | ||||||
| Recoveries and reversals of recoveries of losses on onerous underlying contracts | – | 132 | – | – | – | 132 | ||||||
| Adjustments to assets for incurred claims | – | – | 3 | (33) | (9) | (39) | ||||||
| Insurance service result | (6,024) | 102 | 4,928 | 384 | (13) | (623) | ||||||
| Investment components and premium refunds | (1,341) | – | 1,341 | – | – | – | ||||||
| Net expenses from reinsurance contracts | (7,365) | 102 | 6,269 | 384 | (13) | (623) | ||||||
| Net finance (income) expense from reinsurance contracts | (9,586) | 5 | 446 | (14) | 13 | (9,136) | ||||||
| Effect of changes in non-performance risk of reinsurers | 97 | – | – | – | – | 97 | ||||||
| Effects of movements in foreign exchange rates | 2,683 | 8 | 455 | – | – | 3,146 | ||||||
| Contracts measured under PAA | – | – | – | – | – | – | ||||||
| Total changes in income and OCI | (14,171) | 115 | 7,170 | 370 | – | (6,516) | ||||||
| Cash flows | ||||||||||||
| Premiums paid | 6,159 | – | – | – | – | 6,159 | ||||||
| Amounts received | – | – | (6,499) | (414) | – | (6,913) | ||||||
| Total cash flows | 6,159 | – | (6,499) | (414) | – | (754) | ||||||
| Net closing balance | 35,657 | 213 | 7,384 | 218 | 8 | 43,480 | ||||||
| Closing reinsurance contract held assets | 37,853 | 209 | 7,521 | 280 | 8 | 45,871 | ||||||
| Closing reinsurance contract held liabilities | (2,196) | 4 | (137) | (62) | – | (2,391) | ||||||
| Net closing balance, December 31, 2022 | $ | 35,657 | $ | 213 | $ | 7,384 | $ | 218 | $ | 8 | $ | 43,480 |
| Manulife Financial Corporation – Second Quarter 2023 | 128 | |||||||||||
| --- | --- |
Table of Contents
Reinsurance contracts held
The following table presents the movement in the net assets or liabilities for reinsurance contracts held, showing estimates of the present value of future cash flows, risk adjustment and CSM.
| CSM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Estimates of<br>PV of future<br>cash flows | Risk<br>adjustment<br>for non-<br><br><br>financial risk | Fair value | Other | Total | ||||||
| Opening reinsurance contract held assets | $ | 39,656 | $ | 4,049 | $ | 1,774 | $ | 99 | $ | 45,578 |
| Opening reinsurance contract held liabilities | **** | (3,919) | **** | 1,574 | **** | (39) | **** | 38 | **** | (2,346) |
| Opening PAA reinsurance contract net assets | **** | 240 | **** | 8 | **** | – | **** | – | **** | 248 |
| Net opening balance, January 1, 2023 | **** | 35,977 | **** | 5,631 | **** | 1,735 | **** | 137 | **** | 43,480 |
| CSM recognized for services received | **** | – | **** | – | **** | (142) | **** | 29 | **** | (113) |
| Change in risk adjustment for non-financial risk for risk<br>expired | **** | – | **** | (237) | **** | – | **** | – | **** | (237) |
| Experience adjustments | **** | (7) | **** | – | **** | – | **** | – | **** | (7) |
| Changes that relate to current services | **** | (7) | **** | (237) | **** | (142) | **** | 29 | **** | (357) |
| Contracts initially recognized during the year | **** | (28) | **** | 221 | **** | – | **** | (149) | **** | 44 |
| Changes in recoveries of losses on onerous underlying contracts that adjust the CSM | **** | – | **** | – | **** | 3 | **** | (12) | **** | (9) |
| Changes in estimates that adjust the CSM | **** | (9) | **** | 15 | **** | (10) | **** | 4 | **** | – |
| Changes in estimates that relate to losses and reversal of losses on<br>onerous contracts | **** | 23 | **** | (22) | **** | – | **** | – | **** | 1 |
| Changes that relate to future services | **** | (14) | **** | 214 | **** | (7) | **** | (157) | **** | 36 |
| Adjustments to liabilities for incurred claims | **** | 4 | **** | – | **** | – | **** | – | **** | 4 |
| Changes that relate to past services | **** | 4 | **** | – | **** | – | **** | – | **** | 4 |
| Insurance service result | **** | (17) | **** | (23) | **** | (149) | **** | (128) | **** | (317) |
| Insurance finance (income) expense from reinsurance contracts | **** | (84) | **** | 250 | **** | 31 | **** | (18) | **** | 179 |
| Effects of changes in non-performance risk of reinsurers | **** | (11) | **** | – | **** | – | **** | – | **** | (11) |
| Effects of movements in foreign exchange rates | **** | (764) | **** | (181) | **** | (32) | **** | (2) | **** | (979) |
| Total changes in income and OCI | **** | (876) | **** | 46 | **** | (150) | **** | (148) | **** | (1,128) |
| Total cash flows | **** | (1,454) | **** | – | **** | – | **** | – | **** | (1,454) |
| Change in PAA balance | **** | – | **** | 8 | **** | – | **** | – | **** | 8 |
| Net closing balance | **** | 33,647 | **** | 5,685 | **** | 1,585 | **** | (11) | **** | 40,906 |
| Closing reinsurance contract held assets | **** | 37,548 | **** | 4,113 | **** | 1,483 | **** | (62) | **** | 43,082 |
| Closing reinsurance contract held liabilities | **** | (4,141) | **** | 1,556 | **** | 102 | **** | 51 | **** | (2,432) |
| Closing PAA reinsurance contract net assets | **** | 240 | **** | 16 | **** | – | **** | – | **** | 256 |
| Net closing balance, June 30, 2023 | $ | 33,647 | $ | 5,685 | $ | 1,585 | $ | (11) | $ | 40,906 |
| CSM | ||||||||||
| Estimates of<br>PV of future<br>cash flows | Risk<br>adjustment<br>for non-<br><br><br>financial risk | Fair value | Other | Total | ||||||
| Opening reinsurance contract held assets | $ | 46,025 | $ | 4,977 | $ | 2,012 | $ | (501) | $ | 52,513 |
| Opening reinsurance contract held liabilities | (5,138) | 1,719 | 1,262 | 105 | (2,052) | |||||
| Opening PAA reinsurance contract net assets | 281 | 8 | – | – | 289 | |||||
| Net opening balance, January 1, 2022 | 41,168 | 6,704 | 3,274 | (396) | 50,750 | |||||
| CSM recognized for services received | – | – | (231) | (74) | (305) | |||||
| Change in risk adjustment for non-financial risk for risk<br>expired | – | (424) | – | – | (424) | |||||
| Experience adjustments | 9 | – | – | – | 9 | |||||
| Changes that relate to current services | 9 | (424) | (231) | (74) | (720) | |||||
| Contracts initially recognized during the year | (1,276) | 717 | (7) | 717 | 151 | |||||
| Changes in recoveries of losses on onerous underlying contracts that adjust the CSM | – | – | (15) | (50) | (65) | |||||
| Changes in estimates that adjust the CSM | 1,337 | 173 | (1,440) | (70) | – | |||||
| Changes in estimates that relate to losses and reversal of losses on<br>onerous contracts | 106 | (60) | – | – | 46 | |||||
| Changes that relate to future services | 167 | 830 | (1,462) | 597 | 132 | |||||
| Adjustments to liabilities for incurred claims | 3 | – | – | – | 3 | |||||
| Changes that relate to past services | 3 | – | – | – | 3 | |||||
| Insurance service result | 179 | 406 | (1,693) | 523 | (585) | |||||
| Insurance finance (income) expense from reinsurance contracts | (7,463) | (1,715) | 56 | (14) | (9,136) | |||||
| Effects of changes in non-performance risk of reinsurers | 97 | – | – | – | 97 | |||||
| Effects of movements in foreign exchange rates | 2,787 | 236 | 98 | 24 | 3,145 | |||||
| Total changes in income and OCI | (4,400) | (1,073) | (1,539) | 533 | (6,479) | |||||
| Total cash flows | (750) | – | – | – | (750) | |||||
| Change in PAA balance | (41) | – | – | – | (41) | |||||
| Net closing balance | 35,977 | 5,631 | 1,735 | 137 | 43,480 | |||||
| Closing reinsurance contract held assets | 39,656 | 4,049 | 1,774 | 99 | 45,578 | |||||
| Closing reinsurance contract held liabilities | (3,919) | 1,574 | (39) | 38 | (2,346) | |||||
| Closing PAA reinsurance contract net assets | 240 | 8 | – | – | 248 | |||||
| Net closing balance, December 31, 2022 | $ | 35,977 | $ | 5,631 | $ | 1,735 | $ | 137 | $ | 43,480 |
| Manulife Financial Corporation – Second Quarter 2023 | 129 | |||||||||
| --- | --- |
Table of Contents
| (b) | Insurance revenue by transition method |
|---|
The following table provides information as a supplement to the insurance revenue disclosures in note 5 (a).
| For the six months ended June 30, 2023 | Asia | Canada | U.S. | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Contracts under the fair value method | $ | 1,231 | $ | 1,643 | $ | 4,780 | $ | (9) | $ | 7,645 |
| Contracts under the full retrospective method | **** | 303 | **** | 17 | **** | 87 | **** | – | **** | 407 |
| Other contracts | **** | 958 | **** | 2,456 | **** | (161) | **** | 38 | **** | 3,291 |
| Total | $ | 2,492 | $ | 4,116 | $ | 4,706 | $ | 29 | $ | 11,343 |
| For the year ended December 31, 2022 | Asia | Canada | U.S. | Other | Total | |||||
| Contracts under the fair value method | $ | 2,656 | $ | 3,370 | $ | 9,901 | $ | (96) | $ | 15,831 |
| Contracts under the full retrospective method | 666 | 122 | 76 | – | 864 | |||||
| Other contracts | 1,412 | 4,625 | 268 | 118 | 6,423 | |||||
| Total | $ | 4,734 | $ | 8,117 | $ | 10,245 | $ | 22 | $ | 23,118 |
| (c) | Effect of new business recognized in the period | |||||||||
| --- | --- |
The following table presents components of new business for insurance contracts issued for the periods presented.
| For the six<br><br><br>months ended<br> <br>June 30, 2023 | For the year ended<br><br><br>December 31, 2022 | |||||||
|---|---|---|---|---|---|---|---|---|
| Non-onerous | Onerous | Non-onerous | Onerous | |||||
| New business insurance contracts | ||||||||
| Estimates of present value of cash outflows | $ | 7,952 | $ | 2,089 | $ | 13,316 | $ | 5,572 |
| Insurance acquisition cash flows | **** | 1,346 | **** | 350 | 2,809 | 838 | ||
| Claims and other insurance service expenses payable | **** | 6,606 | **** | 1,739 | 10,507 | 4,734 | ||
| Estimates of present value of cash inflows | **** | (9,608) | **** | (2,042) | (16,346) | (5,422) | ||
| Risk adjustment for non-financial risk | **** | 567 | **** | 140 | 1,032 | 364 | ||
| Contractual service margin | **** | 1,089 | **** | – | 1,998 | – | ||
| Amount included in insurance contract liabilities for theperiod | $ | – | $ | 187 | $ | – | $ | 514 |
The following table presents components of new business for reinsurance contracts held portfolios for the periods presented:
| For the six<br><br><br>months ended<br> <br>June 30,2023 | For the year ended<br><br><br>December 31, 2022 | |||
|---|---|---|---|---|
| New business reinsurance contracts | ||||
| Estimates of present value of cash outflows | $ | (479) | $ | (7,894) |
| Estimates of present value of cash inflows | **** | 451 | 6,618 | |
| Risk adjustment for non-financial risk | **** | 221 | 717 | |
| Contractual service margin | **** | (149) | 710 | |
| Amount included in reinsurance assets for theperiod | $ | 44 | $ | 151 |
| (d) | Expected recognition of contractual service margin | |||
| --- | --- |
The following table presents expectations for the timing of recognition of CSM in income in future years.
| As at December 31, 2022 | Less than<br>1 year | 1 to 5<br>years | 5 to 10<br>years | 10 to 20<br>years | More than 20<br><br><br>years | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | ||||||||||||
| Insurance contracts issued | $ | 333 | $ | 1,088 | $ | 936 | $ | 1,015 | $ | 620 | $ | 3,992 |
| Reinsurance contracts held | (36) | (100) | (69) | (62) | (48) | (315) | ||||||
| 297 | 988 | 867 | 953 | 572 | 3,677 | |||||||
| US | ||||||||||||
| Insurance contracts issued | 541 | 1,770 | 1,468 | 1,375 | 547 | 5,701 | ||||||
| Reinsurance contracts held | (189) | (586) | (433) | (296) | (62) | (1,566) | ||||||
| 352 | 1,184 | 1,035 | 1,079 | 485 | 4,135 | |||||||
| Asia | ||||||||||||
| Insurance contracts issued | 922 | 2,933 | 2,442 | 2,435 | 1,516 | 10,248 | ||||||
| Reinsurance contracts held | (17) | (79) | (55) | 5 | 11 | (135) | ||||||
| 905 | 2,854 | 2,387 | 2,440 | 1,527 | 10,113 | |||||||
| Corporate | ||||||||||||
| Insurance contracts issued | (8) | (27) | (23) | (24) | (10) | (92) | ||||||
| Reinsurance contracts held | 12 | 40 | 35 | 38 | 19 | 144 | ||||||
| 4 | 13 | 12 | 14 | 9 | 52 | |||||||
| Total | $ | 1,558 | $ | 5,039 | $ | 4,301 | $ | 4,486 | $ | 2,593 | $ | 17,977 |
| Manulife Financial Corporation – Second Quarter 2023 | 130 | |||||||||||
| --- | --- |
Table of Contents
| (e) | Amortization of contractual service margin |
|---|
The CSM represents the unearned profit for a group of insurance contracts where the Company will recognize in insurance revenue as it provides insurance services in the period. The amortization of the CSM as insurance revenue is determined by (1) identifying the coverage units in the group, (2) allocating the CSM at the end of the period (before amortizing any amounts in insurance revenue in the current period) equally to each coverage unit provided in the period and expected to be provided in future periods, and (3) recognizing in insurance revenue the amount allocated to coverage units provided in the current period.
The number of coverage units is the quantity of services provided by the contracts in the group, determined by considering for each contract the quantity of benefits provided and its expected coverage period. The coverage units are reviewed and updated at each reporting date.
| (f) | Investment income and insurance finance income and expense | |||||
|---|---|---|---|---|---|---|
| For the three months ended June 30, 2023 | Insurancecontracts | Non-<br><br><br>insurance^(1)^ | Total | |||
| --- | --- | --- | --- | --- | --- | --- |
| Investment return | ||||||
| Investment related income | $ | 3,150 | $ | 782 | $ | 3,932 |
| Net gains (losses) on financial assets at FVTPL | **** | (167) | **** | 238 | **** | 71 |
| Unrealized gains (losses) on FVOCI assets | **** | (414) | **** | (459) | **** | (873) |
| Impairment loss on financial assets | **** | 19 | **** | 2 | **** | 21 |
| Investment expenses | **** | (98) | **** | (168) | **** | (266) |
| Interest on required surplus | **** | 129 | **** | (129) | **** | – |
| Total investment return | **** | 2,619 | **** | 266 | **** | 2,885 |
| Portion recognized in income (expense) | **** | 4,195 | **** | 624 | **** | 4,819 |
| Portion recognized in OCI | **** | (1,576) | **** | (358) | **** | (1,934) |
| Insurance finance income (expense) from insurance contracts issued and effect of movement in exchangerates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | **** | (1,812) | **** | 6 | **** | (1,806) |
| Due to changes in interest rates and other financial assumptions | **** | 1,211 | **** | (62) | **** | 1,149 |
| Changes in fair value of underlying items of direct participation contracts | **** | (714) | **** | – | **** | (714) |
| Effects of risk mitigation option | **** | 1,048 | **** | – | **** | 1,048 |
| Net foreign exchange income (expense) | **** | (24) | **** | – | **** | (24) |
| Hedge accounting offset from insurance contracts issued | **** | (33) | **** | – | **** | (33) |
| Reclassification of derivative OCI to IFIE – cash flow hedges | **** | 29 | **** | – | **** | 29 |
| Reclassification of derivative income (loss) changes to IFIE – fair value hedge | **** | (344) | **** | – | **** | (344) |
| Other | **** | 119 | **** | – | **** | 119 |
| Total insurance finance income (expense) from insurance contracts issued | **** | (520) | **** | (56) | **** | (576) |
| Effect of movements in foreign exchange rates | **** | (1,457) | **** | – | **** | (1,457) |
| Total insurance finance income (expense) from insurance contractsissued and effect of movement in foreign exchange rates | **** | (1,977) | **** | (56) | **** | (2,033) |
| Portion recognized in income (expense), including effects of exchange rates | **** | (3,756) | **** | 22 | **** | (3,734) |
| Portion recognized in OCI, including effects of exchange<br>rates | **** | 1,779 | **** | (78) | **** | 1,701 |
| Reinsurance finance income (expense) from reinsurance contracts held and effect of movement in foreignexchange rates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | **** | 325 | **** | (3) | **** | 322 |
| Due to changes in interest rates and other financial assumptions | **** | (1,130) | **** | 1 | **** | (1,129) |
| Changes in risk of non-performance of reinsurer | **** | 2 | **** | – | **** | 2 |
| Other | **** | (10) | **** | – | **** | (10) |
| Total reinsurance finance income (expense) from reinsurance contracts held | **** | (813) | **** | (2) | **** | (815) |
| Effect of movements in foreign exchange rates | **** | 123 | **** | – | **** | 123 |
| Total reinsurance finance income (expense) from reinsurancecontracts held and effect of movement in foreign exchange rates | **** | (690) | **** | (2) | **** | (692) |
| Portion recognized in income (expense), including effects of foreign exchange rates | **** | (326) | **** | (5) | **** | (331) |
| Portion recognized in OCI, including effects of exchange<br>rates | **** | (364) | **** | 3 | **** | (361) |
| Increase (decrease) in investment contract liabilities | **** | (12) | **** | (145) | **** | (157) |
| Total net investment income (loss), insurance finance income(expense) and reinsurance finance income (expense) | **** | (60) | **** | 63 | **** | 3 |
| Amounts recognized in income (expense) | **** | 101 | **** | 496 | **** | 597 |
| Amounts recognized in OCI | **** | (161) | **** | (433) | **** | (594) |
| ^(1)^ | Non-insurance includes consolidations and eliminations of transactions between<br>operating segments. | |||||
| --- | --- | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 131 | |||||
| --- | --- |
Table of Contents
| For the three months ended June 30, 2022 | Insurance<br>contracts | Non-<br><br><br>insurance^(1)^ | Total | |||
|---|---|---|---|---|---|---|
| Investment return | ||||||
| Investment related income | $ | 3,459 | $ | 325 | $ | 3,784 |
| Net gains (losses) on financial assets at FVTPL | (7,001) | (279) | (7,280) | |||
| Unrealized gains (losses) on FVOCI assets | (16,631) | (2,854) | (19,485) | |||
| Impairment loss on financial assets | – | (5) | (5) | |||
| Investment expenses | (91) | (209) | (300) | |||
| Interest on required surplus | 127 | (127) | – | |||
| Total investment return | (20,137) | (3,149) | (23,286) | |||
| Portion recognized in income (expense) | (2,172) | (282) | (2,454) | |||
| Portion recognized in OCI | (17,965) | (2,867) | (20,832) | |||
| Insurance finance income (expense) from insurance contracts issued and effect of movement in exchangerates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | (1,199) | 3 | (1,196) | |||
| Due to changes in interest rates and other financial assumptions | 25,150 | (123) | 25,027 | |||
| Changes in fair value of underlying items of direct participation contracts | 4,458 | – | 4,458 | |||
| Effects of risk mitigation option | 196 | – | 196 | |||
| Net foreign exchange income (expense) | (55) | – | (55) | |||
| Hedge accounting offset from insurance contracts issued | – | – | – | |||
| Reclassification of derivative OCI to IFIE – cash flow hedges | – | – | – | |||
| Reclassification of derivative income (loss) changes to IFIE – fair value hedge | – | – | – | |||
| Other | 69 | (2) | 67 | |||
| Total insurance finance income (expense) from insurance contracts issued | 28,619 | (122) | 28,497 | |||
| Effect of movements in foreign exchange rates | (1,554) | – | (1,554) | |||
| Total insurance finance income (expense) from insurance contractsissued and effect of movement in foreign exchange rates | 27,065 | (122) | 26,943 | |||
| Portion recognized in income (expense), including effects of exchange rates | (1,793) | 1 | (1,792) | |||
| Portion recognized in OCI, including effects of exchange<br>rates | 28,858 | (123) | 28,735 | |||
| Reinsurance finance income (expense) from reinsurance contracts held and effect of movement in foreignexchange rates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | 146 | (1) | 145 | |||
| Due to changes in interest rates and other financial assumptions | (3,309) | 28 | (3,281) | |||
| Changes in risk of non-performance of reinsurer | 44 | – | 44 | |||
| Other | 92 | – | 92 | |||
| Total reinsurance finance income (expense) from reinsurance contracts held | (3,027) | 27 | (3,000) | |||
| Effect of movements in foreign exchange rates | 179 | – | 179 | |||
| Total reinsurance finance income (expense) from reinsurancecontracts held and effect of movement in foreign exchange rates | (2,848) | 27 | (2,821) | |||
| Portion recognized in income (expense), including effects of foreign exchange rates | 588 | (3) | 585 | |||
| Portion recognized in OCI, including effects of exchange<br>rates | (3,436) | 30 | (3,406) | |||
| Increase (decrease) in investment contract liabilities | (25) | (11) | (36) | |||
| Total net investment income (loss), insurance finance income(expense) and reinsurance finance income (expense) | 4,055 | (3,255) | 800 | |||
| Amounts recognized in income (expense) | (3,402) | (295) | (3,697) | |||
| Amounts recognized in OCI | 7,457 | (2,960) | 4,497 | |||
| ^(1)^ | Non-insurance includes consolidations and eliminations of transactions between<br>operating segments. | |||||
| --- | --- | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 132 | |||||
| --- | --- |
Table of Contents
| For the six months ended June 30, 2023 | Insurancecontracts | Non-<br><br><br>insurance^(1)^ | Total | |||
|---|---|---|---|---|---|---|
| Investment return | ||||||
| Investment related income | $ | 5,998 | $ | 1,637 | $ | 7,635 |
| Net gains (losses) on financial assets at FVTPL | **** | 1,582 | **** | 229 | **** | 1,811 |
| Unrealized gains (losses) on FVOCI assets | **** | 6,103 | **** | 1,033 | **** | 7,136 |
| Impairment loss on financial assets | **** | (162) | **** | (8) | **** | (170) |
| Investment expenses | **** | (199) | **** | (378) | **** | (577) |
| Interest on required surplus | **** | 261 | **** | (261) | **** | – |
| Total investment return | **** | 13,583 | **** | 2,252 | **** | 15,835 |
| Portion recognized in income (expense) | **** | 8,788 | **** | 1,184 | **** | 9,972 |
| Portion recognized in OCI | **** | 4,795 | **** | 1,068 | **** | 5,863 |
| Insurance finance income (expense) from insurance contracts issued and effect of movement in exchangerates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | **** | (3,631) | **** | 12 | **** | (3,619) |
| Due to changes in interest rates and other financial assumptions | **** | (7,737) | **** | (52) | **** | (7,789) |
| Changes in fair value of underlying items of direct participation contracts | **** | (3,722) | **** | – | **** | (3,722) |
| Effects of risk mitigation option | **** | 863 | **** | – | **** | 863 |
| Net foreign exchange income (expense) | **** | (46) | **** | – | **** | (46) |
| Hedge accounting offset from insurance contracts issued | **** | (34) | **** | – | **** | (34) |
| Reclassification of derivative OCI to IFIE – cash flow hedges | **** | 92 | **** | – | **** | 92 |
| Reclassification of derivative income (loss) changes to IFIE – fair value hedge | **** | 935 | **** | – | **** | 935 |
| Other | **** | 200 | **** | – | **** | 200 |
| Total insurance finance income (expense) from insurance contracts issued | **** | (13,080) | **** | (40) | **** | (13,120) |
| Effect of movements in foreign exchange rates | **** | (1,582) | **** | – | **** | (1,582) |
| Total insurance finance income (expense) from insurance contractsissued and effect of movement in foreign exchange rates | **** | (14,662) | **** | (40) | **** | (14,702) |
| Portion recognized in income (expense), including effects of exchange rates | **** | (7,540) | **** | 28 | **** | (7,512) |
| Portion recognized in OCI, including effects of exchange<br>rates | **** | (7,122) | **** | (68) | **** | (7,190) |
| Reinsurance finance income (expense) from reinsurance contracts held and effect of movement in foreignexchange rates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | **** | (288) | **** | (6) | **** | (294) |
| Due to changes in interest rates and other financial assumptions | **** | 570 | **** | (13) | **** | 557 |
| Changes in risk of non-performance of reinsurer | **** | (11) | **** | – | **** | (11) |
| Other | **** | (75) | **** | – | **** | (75) |
| Total reinsurance finance income (expense) from reinsurance contracts held | **** | 196 | **** | (19) | **** | 177 |
| Effect of movements in foreign exchange rates | **** | 64 | **** | – | **** | 64 |
| Total reinsurance finance income (expense) from reinsurancecontracts held and effect of movement in foreign exchange rates | **** | 260 | **** | (19) | **** | 241 |
| Portion recognized in income (expense), including effects of foreign exchange rates | **** | (645) | **** | (8) | **** | (653) |
| Portion recognized in OCI, including effects of exchange<br>rates | **** | 905 | **** | (11) | **** | 894 |
| Increase (decrease) in investment contract liabilities | **** | (15) | **** | (225) | **** | (240) |
| Total net investment income (loss), insurance finance income(expense) and reinsurance finance income (expense) | **** | (834) | **** | 1,968 | **** | 1,134 |
| Amounts recognized in income (expense) | **** | 588 | **** | 979 | **** | 1,567 |
| Amounts recognized in OCI | **** | (1,422) | **** | 989 | **** | (433) |
| ^(1)^ | Non-insurance includes consolidations and eliminations of transactions between<br>operating segments. | |||||
| --- | --- | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 133 | |||||
| --- | --- |
Table of Contents
| For the six months ended June 30, 2022 | Insurance<br>contracts | Non-<br><br><br>insurance^(1)^ | Total | |||
|---|---|---|---|---|---|---|
| Investment return | ||||||
| Investment related income | $ | 6,819 | $ | 756 | $ | 7,575 |
| Net gains (losses) on financial assets at FVTPL | (12,075) | (431) | (12,506) | |||
| Unrealized gains (losses) on FVOCI assets | (36,735) | (5,699) | (42,434) | |||
| Impairment loss on financial assets | – | (20) | (20) | |||
| Investment expenses | (178) | (384) | (562) | |||
| Interest on required surplus | 254 | (254) | – | |||
| Total investment return | (41,915) | (6,032) | (47,947) | |||
| Portion recognized in income (expense) | (3,065) | (477) | (3,542) | |||
| Portion recognized in OCI | (38,850) | (5,555) | (44,405) | |||
| Insurance finance income (expense) from insurance contracts issued and effect of movement in exchangerates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | (2,725) | 5 | (2,720) | |||
| Due to changes in interest rates and other financial assumptions | 52,067 | (283) | 51,784 | |||
| Changes in fair value of underlying items of direct participation contracts | 8,817 | – | 8,817 | |||
| Effects of risk mitigation option | 1,593 | – | 1,593 | |||
| Net foreign exchange income (expense) | (120) | – | (120) | |||
| Hedge accounting offset from insurance contracts issued | – | – | – | |||
| Reclassification of derivative OCI to IFIE – cash flow hedges | – | – | – | |||
| Reclassification of derivative income (loss) changes to IFIE – fair value hedge | – | – | – | |||
| Other | 289 | (2) | 287 | |||
| Total insurance finance income (expense) from insurance contracts issued | 59,921 | (280) | 59,641 | |||
| Effect of movements in foreign exchange rates | (2,657) | (1) | (2,658) | |||
| Total insurance finance income (expense) from insurance contractsissued and effect of movement in foreign exchange rates | 57,264 | (281) | 56,983 | |||
| Portion recognized in income (expense), including effects of exchange rates | (2,698) | 2 | (2,696) | |||
| Portion recognized in OCI, including effects of exchange<br>rates | 59,962 | (283) | 59,679 | |||
| Reinsurance finance income (expense) from reinsurance contracts held and effect of movement in foreignexchange rates | ||||||
| Interest accreted to insurance contracts using locked-in<br>rate | 335 | (3) | 332 | |||
| Due to changes in interest rates and other financial assumptions | (7,567) | 67 | (7,500) | |||
| Changes in risk of non-performance of reinsurer | 85 | – | 85 | |||
| Other | 161 | – | 161 | |||
| Total reinsurance finance income (expense) from reinsurance contracts held | (6,986) | 64 | (6,922) | |||
| Effect of movements in foreign exchange rates | 261 | – | 261 | |||
| Total reinsurance finance income (expense) from reinsurancecontracts held and effect of movement in foreign exchange rates | (6,725) | 64 | (6,661) | |||
| Portion recognized in income (expense), including effects of foreign exchange rates | 293 | (5) | 288 | |||
| Portion recognized in OCI, including effects of exchange<br>rates | (7,018) | 69 | (6,949) | |||
| Increase (decrease) in investment contract liabilities | (63) | (123) | (186) | |||
| Total net investment income (loss), insurance finance income(expense) and reinsurance finance income (expense) | 8,561 | (6,372) | 2,189 | |||
| Amounts recognized in income (expense) | (5,533) | (603) | (6,136) | |||
| Amounts recognized in OCI | 14,094 | (5,769) | 8,325 | |||
| ^(1)^ | Non-insurance includes consolidations and eliminations of transactions between<br>operating segments. | |||||
| --- | --- | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 134 | |||||
| --- | --- |
Table of Contents
| (g) | Significant judgements and estimates |
|---|---|
| (I) | Fulfilment cash flows |
| --- | --- |
Fulfilment cash flows have three major components:
| • | Estimate of future cash flows |
|---|---|
| • | An adjustment to reflect the time value of money and the financial risk related the future cash flows if not included in<br>the estimate of future cash flows |
| --- | --- |
| • | A risk adjustment for non-financial risk |
| --- | --- |
The determination of insurance fulfilment cash flows involves the use of estimates and assumptions. A comprehensive review of valuation assumptions and methods is performed annually. The review reduces the Company’s exposure to uncertainty by ensuring assumptions for liability risks remain appropriate. This is accomplished by monitoring experience and updating assumptions which represent a best estimate of expected future experience, and margins that are appropriate for the risks assumed. While the assumptions selected represent the Company’s current best estimates and assessment of risk, the ongoing monitoring of experience and the changes in economic environment are likely to result in future changes to the actuarial assumptions, which could materially impact the insurance contract liabilities.
Method used to measure insurance & reinsurance contract fulfilment cash flows
The Company primarily uses deterministic projection using best estimate assumption to determine the present value of future cash flows. For product features such as Universal Life minimum crediting rates guarantees, Participating life zero dividend floor implicit guarantees and variable annuities guarantees, the Company developed a stochastic approach to capture the asymmetry of the risk.
Determination of assumptions use for deterministic projections
For the deterministic projections, assumptions are made with respect to mortality, morbidity, rates of policy termination, operating expenses and certain taxes. Actual experience is monitored to ensure that assumptions remain appropriate and assumptions are changed as warranted. Assumptions are discussed in more detail in the following table.
| Nature of factors and assumption methodology | Risk management | |
|---|---|---|
| Mortality | Mortality relates to the occurrence of death. Mortality is a key assumption for life insurance and certain forms of annuities.<br>Mortality assumptions are based on the Company’s internal experience as well as past and emerging industry experience. Assumptions are differentiated by sex, underwriting class, policy type and geographic market. Assumptions are made for future<br>mortality improvements. | The Company maintains underwriting standards to determine the insurability of applicants. Claim trends are<br>monitored on an ongoing basis. Exposure to large claims is managed by establishing policy retention limits, which vary by market and geographic location. Policies in excess of the limits are reinsured with other companies. Mortality is monitored<br>monthly. |
| Morbidity | Morbidity relates to the occurrence of accidents and sickness for insured risks. Morbidity is a key assumption for long-term care insurance, disability<br>insurance, critical illness and other forms of individual and group health benefits. Morbidity assumptions are based on the Company’s internal experience as well as past and emerging industry experience and are established for each type of<br>morbidity risk and geographic market. Assumptions are made for future morbidity improvements. | The Company maintains underwriting standards to determine the insurability of applicants. Claim trends are monitored on an ongoing basis.<br>Exposure to large claims is managed by establishing policy retention limits, which vary by market and geographic location. Policies in excess of the limits are reinsured with other companies. Morbidity is also monitored monthly. |
| Manulife Financial Corporation – Second Quarter 2023 | 135 | |
| --- | --- |
Table of Contents
| Policy termination | Policies are terminated through lapses and surrenders, where lapses represent the termination of policies due to non-payment of premiums and surrenders<br>represent the voluntary termination of policies by policyholders. Premium persistency represents the level of ongoing deposits on contracts where there is policyholder discretion as to the amount and timing of deposits. Policy termination and<br>premium persistency assumptions are primarily based on the Company’s recent experience adjusted for expected future conditions. Assumptions reflect differences by type of contract within each geographic market. | The Company seeks to design products that minimize financial exposure to lapse, surrender and premium persistency risk. The Company monitors lapse, surrender and persistency<br>experience. |
|---|---|---|
| Directly attributable expenses | Directly attributable operating expense assumptions reflect the projected costs of maintaining and servicing in-force policies, including associated directly attributable overhead expenses. The directly attributable expenses are derived from internal cost studies projected into the future with an allowance for inflation.<br>For some developing businesses, there is an expectation that unit costs will decline as these businesses grow.<br> <br><br><br><br>Directly attributable acquisitions expenses are derived from internal cost studies. | The Company prices its products to cover the expected costs of servicing and maintaining them. In addition, the Company monitors expenses monthly, including comparisons of<br>actual expenses to expense levels allowed for in pricing and valuation. |
| Tax | Taxes reflect assumptions for future premium taxes and other non-income related taxes. | The Company prices its products to cover the expected cost of taxes. |
| Policyholder dividends, experience rating refunds, and other adjustable policy elements | The best estimate projections for policyholder dividends and experience rating refunds, and other adjustable elements of policy benefits are determined to be<br>consistent with management’s expectation of how these elements will be managed should experience emerge consistently with the best estimate assumptions. | The Company monitors policy experience and adjusts policy benefits and other adjustable elements to reflect this experience. Policyholder<br>dividends are reviewed annually for all businesses under a framework of Board-approved policyholder dividend policies. |
The Company reviews actuarial methods and assumptions on an annual basis. If changes are made to non-economic assumptions, the impact based on locked-in economic assumption would adjust the contractual service margin for general model and VFA contracts if there is any remaining contractual service margin for the group of policies where the change was made. This amount would then be recognized in income over the period of service provided. Changes could also impact net income and other comprehensive income to the extent that the contractual service margin has been deleted, or discount rates are different than the locked-in rates used to quantify changes to the contractual service margin.
| (II) | Determination of discretionary changes |
|---|
The terms of some contracts measured under the GMM give the Company discretion over the cash flows to be paid to the policyholders, either in their timing or in their amount. Changes in discretionary cash flows are regarded as relating to future service and accordingly adjusts the CSM. The Company determines how to identify a change in discretionary cash flows by specifying the basis on which it expects to determine its commitment under the contract; for example, based on a fixed interest rate, or on returns that vary based on specified asset returns. This determination is specified at the inception of the contract.
| Manulife Financial Corporation – Second Quarter 2023 | 136 |
|---|
Table of Contents
| (III) | Discount rates |
|---|
Insurance contract cash flows for non-participating business are discounted using risk free yield curves adjusted by an illiquidity premium to reflect the liquidity characteristics of the liabilities. Cash flows that vary based on the returns of underlying items are adjusted to reflect their variability under these adjusted yield curves. Each yield curve is interpolated between the spot rate at the last observable market data point and an ultimate spot rate which reflects the long-term real interest rate plus inflation expectations.
For participating business, insurance contract cash flows that vary based on the returns of underlying items are discounted at rates reflecting that variability.
For insurance contracts with cash flows that vary with the returns of underlying items and where the present value is measured by stochastic modelling, the cash flows are both projected and discounted at scenario specific rates calibrated on average to be the risk free yield curves adjusted for liquidity.
The spot rates used for discounting the liability cash flows are as follows and include an illiquidity premium determined with reference to net asset spreads indicative of the liquidity characteristics of the liabilities by geography.
| June 30, 2023 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | Liquiditycategory | Observableyears | Ultimateyear | 1 year | 5 years | 10 years | 20 years | 30 years | Ultimate | |||||||
| Canada | CAD | Illiquid | 30 | 70 | **** | 5.77% | **** | 4.95% | **** | 5.15% | **** | 5.00% | **** | 4.76% | **** | 4.40% |
| More liquid | 30 | 70 | **** | 5.72% | **** | 4.80% | **** | 4.84% | **** | 4.77% | **** | 4.67% | **** | 4.40% | ||
| U.S. | USD | Illiquid | 30 | 70 | **** | 5.97% | **** | 4.99% | **** | 5.54% | **** | 5.68% | **** | 5.18% | **** | 5.00% |
| More liquid | 30 | 70 | **** | 5.89% | **** | 4.99% | **** | 5.42% | **** | 5.58% | **** | 5.07% | **** | 4.88% | ||
| Japan | JPY | Mixed | 30 | 70 | **** | 0.51% | **** | 0.63% | **** | 0.86% | **** | 1.36% | **** | 1.83% | **** | 1.60% |
| Hong Kong | HKD | Illiquid | 15 | 55 | **** | 4.47% | **** | 4.69% | **** | 5.54% | **** | 5.01% | **** | 4.38% | **** | 3.80% |
| December 31, 2022 | ||||||||||||||||
| Currency | Liquidity<br><br><br>category | Observable<br><br><br>years | Ultimate<br><br><br>year | 1 year | 5 years | 10 years | 20 years | 30 years | Ultimate | |||||||
| Canada | CAD | Illiquid | 30 | 70 | 5.29% | 4.81% | 5.35% | 5.35% | 5.03% | 4.40% | ||||||
| More liquid | 30 | 70 | 5.21% | 4.63% | 4.97% | 5.02% | 4.91% | 4.40% | ||||||||
| U.S. | USD | Illiquid | 30 | 70 | 5.28% | 4.87% | 5.74% | 5.86% | 5.34% | 5.00% | ||||||
| More liquid | 30 | 70 | 5.23% | 4.88% | 5.61% | 5.76% | 5.23% | 4.88% | ||||||||
| Japan | JPY | Mixed | 30 | 70 | 0.72% | 0.98% | 0.91% | 1.70% | 2.22% | 1.60% | ||||||
| Hong Kong | HKD | Illiquid | 15 | 55 | 4.69% | 4.95% | 5.60% | 4.99% | 4.36% | 3.80% |
Amounts presented in income for policies where changes in assumptions that relate to financial risk do not have a substantial impact on amounts paid to policyholders reflect discount rates locked in beginning with the adoption of IFRS 17 or locked in at issue for later insurance contracts. These policies include term insurance, guaranteed whole life insurance, and health products including critical illness and long-term care. For policies where changes in assumptions to financial risk have a substantial impact on amounts paid to policyholders, discount rates are updated as future cash flows change due to changes in financial risk, so that the amount presented in income from future changes in financial variables is $nil. These policies include adjustable universal life contracts. Impacts from differences between current period rates and discount rates used to determine income are presented in other comprehensive income.
| (IV) | Risk adjustment and confidence level used to determine risk adjustment |
|---|
Risk adjustments for non-financial risk represent the compensation an entity requires for bearing the uncertainty about the amount and timing of the cash flows that arises from non-financial risk as the entity fulfils insurance contracts. The risk adjustment considers insurance, lapse and expense risks, includes both favourable and unfavourable outcomes, and reflects diversification benefits from the insurance contracts issued.
The Company has estimated the risk adjustment using a margin approach. This approach applies a margin for adverse deviation, typically in terms of a percentage of best estimate assumptions, where future cash flows are uncertain. The resulting cash flows are discounted at rates consistent with the best estimate cash flows to arrive at the total risk adjustment. The ranges of these margins are set by the Company and reviewed periodically.
The risk adjustment for non-financial risk for insurance contracts correspond to a 90% – 95% confidence level for all segments.
| Manulife Financial Corporation – Second Quarter 2023 | 137 |
|---|
Table of Contents
| (V) | Investment component, investment-return service and investment-related service |
|---|
The Company identifies the investment component, investment return-service (contract without direct participation features) and investment-related service (contract with direct participation features) of a contract as part of the product governance process.
Investment components are amounts that are to be paid to the policyholder under all circumstances. Investment components are excluded from insurance revenue and insurance service expenses.
Investment-return service and investment-related service are investment service rendered as part of an insurance contract and are part of the insurance contract service provided to the policyholder.
| (VI) | Relative weighting of the benefit provided by insurance coverage, investment-return service and investment- relatedservice |
|---|
The contractual service margin is released into income, when insurance contract services are provided, by using coverage units. Coverage units represents the quantity of service (insurance coverage, investment-return and investment-related services) provided and are determined by considering the benefit provided under the contract and its expected coverage duration. When the relative size of the investment-related service coverage or the investment-return service coverage unit is disproportionate compared to the insurance service coverage unit, or vice-versa, the Company must determine a relative weighting of the services to reflect the delivery of each of those services. The Company identifies the coverage units as part of the product governance process and did not identify contracts where such weighting was required.
| (h) | Composition of underlying items |
|---|
The following table sets out the composition and fair value of the underlying items supporting the Company’s liabilities for direct participation contracts at the reporting date.
| December 31, 2022 | ||||||
|---|---|---|---|---|---|---|
| As at | Participating | Variable<br>annuity | Unit linked | |||
| Underlying assets | ||||||
| Debt securities | $ | 39,894 | $ | – | $ | – |
| Public equities | 12,119 | – | – | |||
| Mortgages | 3,813 | – | – | |||
| Private placements | 5,666 | – | – | |||
| Real estate | 3,190 | – | – | |||
| Other | 26,009 | 69,033 | 13,476 | |||
| Total | $ | 90,691 | $ | 69,033 | $ | 13,476 |
| (i) | Insurance and reinsurance contracts contractual obligations – maturity analysis and amounts payable on demand | |||||
| --- | --- |
The table below represents the maturity of the insurance and reinsurance contract liabilities.
As at December 31, 2022
| Payments due by period | Less than<br><br><br>1 year | 1 to 2 years | 2 to 3 years | 3 to 4 years | 4 to 5 years | Over<br>5 years | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance contract liabilities^(1)^ | $ | 3,091 | $ | 4,976 | $ | 7,224 | $ | 9,212 | $ | 11,223 | $ | 996,460 | $ | 1,032,186 |
| Reinsurance contract liabilities^(1)^ | 235 | 237 | 250 | 243 | 337 | 5,320 | 6,622 | |||||||
| ^(1)^ | Insurance contract liabilities cash flows include estimates related to the timing and payment of death and disability<br>claims, policy surrenders, policy maturities, annuity payments, minimum guarantees on segregated fund products, policyholder dividends, commissions and premium taxes offset by contractual future premiums on<br>in-force contracts and exclude amount from insurance contract liabilities for account of segregated fund holders. These estimated cash flows are based on the best estimate assumptions used in the determination<br>of insurance contract liabilities. These amounts are undiscounted. Reinsurance contract liabilities cash flows include estimates related to the timing and payment of future reinsurance premiums offset by recoveries on<br>in-force reinsurance agreements. Due to the use of assumptions, actual cash flows may differ from these estimates. Cash flows include embedded derivatives measured separately at fair value.<br> | |||||||||||||
| --- | --- | |||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 138 | |||||||||||||
| --- | --- |
Table of Contents
The amounts from insurance contract liabilities that are payable on demand are set out below.
| December 31, 2022 | ||||
|---|---|---|---|---|
| As at | Amounts<br>payable on<br>demand | Carrying<br><br><br>amount | ||
| Asia | $ | 85,144 | $ | 108,196 |
| Canada | 25,745 | 52,300 | ||
| U.S. | 56,027 | 72,915 | ||
| Total | $ | 166,916 | $ | 233,411 |
The amounts payable on demand represent the policyholders’ cash and/or account values less applicable surrender fees as at the time of the reporting date. Segregated fund insurance net liabilities are excluded from the amounts payable on demand and the carrying amount.
| (j) | Reinsurance transaction |
|---|
On November 15, 2021 and October 3, 2022, the Company, through its subsidiary John Hancock Life Insurance Company (U.S.A.) (“JHUSA”), entered into reinsurance agreements with Venerable Holdings, Inc. to reinsure a block of legacy U.S. variable annuity (“VA”) policies. Under the terms of the transaction, the Company will retain responsibility for the maintenance of the policies with no intended impact to VA policyholders. The transaction was structured as coinsurance for the general fund liabilities and modified coinsurance for the segregated fund liabilities.
The transaction closed on February 1, 2022 and October 3, 2022, respectively, resulting in a cumulative pre-tax decrease to the contractual service margin of $905, recognized in 2022.
| Note 6 Investment Contract Liabilities |
|---|
Investment contract liabilities are contractual financial obligations of the Company that do not contain significant insurance risk. Those contracts are subsequently measured either at FVTPL or at amortized cost.
As at June 30, 2023, the fair value of investment contract liabilities measured at fair value was $746 (December 31, 2022 – $798). The carrying value and fair value of investment contract liabilities measured at amortized cost were $9,811 and $9,499, respectively (December 31, 2022 – $9,281 and $9,034, respectively). The carrying value and fair value of investment contract liabilities net of reinsurance assets were $9,779 and $9,467, respectively (December 31, 2022 – $9,243 and $8,996, respectively).
| Note 7 Risk Management |
|---|
The Company’s policies and procedures for managing risk related to financial instruments and insurance contracts can be found in note 9 of the Company’s 2022 Annual Consolidated Financial Statements as well as the denoted text and tables in the “Risk Management and Risk Factors” section of the Company’s MD&A in the Company’s 2022 Annual Report.
| (a) | Risk disclosures included in the Second Quarter 2023 MD&A |
|---|
Market risk sensitivities related to variable annuity and segregated fund guarantees, publicly traded equity performance risk, interest rate and spread risk and alternative long-duration asset performance risk are disclosed in denoted text and tables in the “Risk Management and Risk Factors” section of the Second Quarter 2023 MD&A. These disclosures are in accordance with IFRS 7 “Financial Instruments: Disclosures” and IAS 34 “Interim Financial Reporting” and are an integral part of these Interim Consolidated Financial Statements. The risks to which the Company is exposed at the end of the reporting period are representative of risks it is typically exposed to throughout the reporting period.
| Manulife Financial Corporation – Second Quarter 2023 | 139 |
|---|
Table of Contents
| (b) | Credit risk |
|---|
Credit risk is the risk of loss due to inability or unwillingness of a borrower, or counterparty, to fulfill its payment obligations. Worsening regional and global economic conditions, segment or industry sector challenges, or company specific factors could result in defaults or downgrades and could lead to increased provisions or impairments related to the Company’s general fund invested assets.
The Company’s exposure to credit risk is managed through risk management policies and procedures which include a defined credit evaluation and adjudication process, delegated credit approval authorities and established exposure limits by borrower, corporate connection, credit rating, industry and geographic region. The Company measures derivative counterparty exposure as net potential credit exposure, which takes into consideration mark-to-market values of all transactions with each counterparty, net of any collateral held, and an allowance to reflect future potential exposure. Reinsurance counterparty exposure is measured reflecting the level of ceded liabilities.
The Company also ensures where warranted, that mortgages, private placements and loans to Bank clients are secured by collateral, the nature of which depends on the credit risk of the counterparty.
Credit risk associated with derivative counterparties is discussed in note 7(e).
| Manulife Financial Corporation – Second Quarter 2023 | 140 |
|---|
Table of Contents
| (I) | Credit quality |
|---|
The following tables present the gross carrying amount of financial instruments subject to credit exposure, without considering any collateral held or other credit enhancements, and other significant credit risk exposures from loan commitments by credit quality ratings, presenting separately Stage 1, Stage 2, and Stage 3 allowances.
| As at June 30, 2023 | Stage 1 | Stage 2 | Stage 3 | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Debt securities | ||||||||
| Investment grade | $ | 190,724 | $ | 1,409 | $ | – | $ | 192,133 |
| Non-investment grade | **** | 4,493 | **** | 675 | **** | 13 | **** | 5,181 |
| Default | **** | – | **** | – | **** | – | **** | – |
| Total | **** | 195,217 | **** | 2,084 | **** | 13 | **** | 197,314 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | 1 | **** | – | **** | – | **** | 1 |
| Net of allowance | **** | 195,216 | **** | 2,084 | **** | 13 | **** | 197,313 |
| Allowance for credit losses on assets measured at FVOCI | **** | 268 | **** | 69 | **** | 13 | **** | 350 |
| Private placements | ||||||||
| Investment grade | **** | 38,928 | **** | 817 | **** | – | **** | 39,745 |
| Non-investment<br>grade | **** | 4,331 | **** | 565 | **** | 95 | **** | 4,991 |
| Total | **** | 43,259 | **** | 1,382 | **** | 95 | **** | 44,736 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | 1 | **** | – | **** | – | **** | 1 |
| Net of allowance | **** | 43,258 | **** | 1,382 | **** | 95 | **** | 44,735 |
| Allowance for credit losses on assets measured at FVOCI | **** | 136 | **** | 52 | **** | 65 | **** | 253 |
| Commercial mortgages | ||||||||
| AAA | **** | 664 | **** | – | **** | – | **** | 664 |
| AA | **** | 6,223 | **** | – | **** | – | **** | 6,223 |
| A | **** | 15,321 | **** | 40 | **** | – | **** | 15,361 |
| BBB | **** | 4,723 | **** | 727 | **** | – | **** | 5,450 |
| BB | **** | 72 | **** | 369 | **** | – | **** | 441 |
| B and lower | **** | 131 | **** | 66 | **** | 110 | **** | 307 |
| Total | **** | 27,134 | **** | 1,202 | **** | 110 | **** | 28,446 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | 1 | **** | 2 | **** | – | **** | 3 |
| Net of allowance | **** | 27,133 | **** | 1,200 | **** | 110 | **** | 28,443 |
| Allowance for credit losses on assets measured at FVOCI | **** | 41 | **** | 28 | **** | 129 | **** | 198 |
| Residential mortgages | ||||||||
| Performing | **** | 19,314 | **** | 2,653 | **** | – | **** | 21,967 |
| Non-performing | **** | – | **** | – | **** | 38 | **** | 38 |
| Total | **** | 19,314 | **** | 2,653 | **** | 38 | **** | 22,005 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | 2 | **** | 3 | **** | 2 | **** | 7 |
| Net of allowance | **** | 19,312 | **** | 2,650 | **** | 36 | **** | 21,998 |
| Allowance for credit losses on assets measured at FVOCI | **** | – | **** | – | **** | – | **** | – |
| Loans to Bank clients | ||||||||
| Performing | **** | 2,503 | **** | 129 | **** | – | **** | 2,632 |
| Non-performing | **** | – | **** | – | **** | 11 | **** | 11 |
| Total | **** | 2,503 | **** | 129 | **** | 11 | **** | 2,643 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | 4 | **** | 3 | **** | 4 | **** | 11 |
| Net of allowance | **** | 2,499 | **** | 126 | **** | 7 | **** | 2,632 |
| Allowance for credit losses on assets measured at FVOCI | **** | – | **** | – | **** | – | **** | – |
| Other invested assets | ||||||||
| Investment grade | **** | – | **** | – | **** | – | **** | – |
| Below investment grade | **** | 300 | **** | – | **** | – | **** | 300 |
| Default | **** | – | **** | – | **** | – | **** | – |
| Total | **** | 300 | **** | – | **** | – | **** | 300 |
| Allowance for credit losses on assets measured at amortized<br>cost | **** | – | **** | – | **** | – | **** | – |
| Net of allowance | **** | 300 | **** | – | **** | – | **** | 300 |
| Allowance for credit losses on assets measured at FVOCI | **** | 12 | **** | – | **** | – | **** | 12 |
| Loan commitments | ||||||||
| Allowance for credit losses | **** | 5 | **** | – | **** | – | **** | 5 |
| Net of allowance, total | $ | 287,718 | $ | 7,442 | $ | 261 | $ | 295,421 |
| Manulife Financial Corporation – Second Quarter 2023 | 141 | |||||||
| --- | --- |
Table of Contents
| (II) | Allowance for credit losses |
|---|
The following table provides details on the allowance for credit losses by stage as at and for the six months ended June 30, 2023 and under IFRS 9.
| Stage 1 | Stage 2 | Stage 3 | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Balance, January 1, 2023 | $ | 511 | $ | 141 | $ | 72 | $ | 724 |
| Net remeasurement due to transfers | **** | 3 | **** | (9) | **** | 6 | **** | – |
| Transfer to stage 1 | **** | 8 | **** | (8) | **** | – | **** | – |
| Transfer to stage 2 | **** | (4) | **** | 4 | **** | – | **** | – |
| Transfer to stage 3 | **** | (1) | **** | (5) | **** | 6 | **** | – |
| Net originations, purchases and disposals | **** | 17 | **** | (2) | **** | – | **** | 15 |
| Repayments | **** | – | **** | – | **** | – | **** | – |
| Changes to risk, parameters, and models | **** | (55) | **** | 23 | **** | 160 | **** | 128 |
| Foreign exchange and other adjustments | **** | (5) | **** | 4 | **** | (25) | **** | (26) |
| Balance, June 30, 2023 | $ | 471 | $ | 157 | $ | 213 | $ | 841 |
The following table presents past due but not impaired and impaired financial assets as at December 31, 2022 under IAS 39.
| Past due but not impaired | ||||||||
|---|---|---|---|---|---|---|---|---|
| As at December 31, 2022 | Less than 90<br>days | 90 days and<br>greater | Total | Total impaired | ||||
| Debt securities^(1),(2)^ | ||||||||
| FVTPL | $ | 2,059 | $ | 71 | $ | 2,130 | $ | 9 |
| AFS | 922 | – | 922 | – | ||||
| Private placements^(1)^ | 317 | 152 | 469 | 229 | ||||
| Mortgages and loans to Bank clients | 103 | – | 103 | 74 | ||||
| Other financial assets | 36 | 34 | 70 | 1 | ||||
| Total | $ | 3,437 | $ | 257 | $ | 3,694 | $ | 313 |
| ^(1)^ | Payments of $12 on $3,297 of financial assets past due less than 90 days were delayed. | |||||||
| --- | --- | |||||||
| ^(2)^ | Payments of $4 on $224 of financial assets past due greater than 90 days were delayed. | |||||||
| --- | --- | |||||||
| (III) | Significant judgements and estimates | |||||||
| --- | --- |
The following table shows certain key macroeconomic variables used to estimate the allowance for credit losses by market. For the base case, upside and downside scenarios, the projections are provided for the next 12 months and then for the remaining forecast period, which represents a medium-term view.
| Base case scenario | Upside scenario | Downside scenario 1 | Downside scenario 2 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As atJune 30, 2023 | Current<br>quarter | Next<br><br><br>12 months | Ensuing<br><br><br>4 years | Next<br>12 months | Ensuing<br><br><br>4 years | Next<br><br><br>12 months | Ensuing<br>4 years | Next<br><br><br>12 months | Ensuing<br>4 years | |||||||||
| Canada | ||||||||||||||||||
| Gross Domestic Product (GDP) | **** | 1,759 | **** | 1.4% | **** | 2.0% | **** | 3.4% | **** | 2.3% | **** | (2.4%) | **** | 2.2% | **** | (4.3%) | **** | 2.2% |
| Unemployment rate | **** | 5.2% | **** | 5.7% | **** | 5.7% | **** | 5.0% | **** | 4.8% | **** | 7.7% | **** | 7.6% | **** | 8.9% | **** | 9.2% |
| Oil prices | **** | 78.9 | **** | 82.3 | **** | 68.7 | **** | 84.7 | **** | 69.0 | **** | 68.7 | **** | 62.4 | **** | 58.4 | **** | 56.3 |
| U.S. | ||||||||||||||||||
| Gross Domestic Product (GDP) | **** | 20,322 | **** | 1.4% | **** | 2.5% | **** | 3.6% | **** | 2.5% | **** | (2.2%) | **** | 2.7% | **** | (3.9%) | **** | 2.7% |
| Unemployment rate | **** | 3.4% | **** | 3.8% | **** | 4.1% | **** | 3.1% | **** | 3.5% | **** | 6.4% | **** | 6.0% | **** | 6.7% | **** | 7.8% |
| 7-10 Year BBB U.S. Corporate Index | **** | 5.6% | **** | 6.0% | **** | 5.9% | **** | 5.8% | **** | 6.0% | **** | 5.6% | **** | 5.4% | **** | 6.2% | **** | 5.2% |
| Japan | ||||||||||||||||||
| Gross Domestic Product (GDP) | **** | 551,644 | **** | 1.1% | **** | 0.9% | **** | 3.3% | **** | 1.1% | **** | (4.0%) | **** | 1.2% | **** | (8.1%) | **** | 1.8% |
| Unemployment rate | **** | 2.6% | **** | 2.5% | **** | 2.3% | **** | 2.3% | **** | 2.0% | **** | 3.1% | **** | 3.1% | **** | 3.2% | **** | 3.5% |
| Hong Kong | ||||||||||||||||||
| Unemployment rate | **** | 3.0% | **** | 3.1% | **** | 3.3% | **** | 2.7% | **** | 3.0% | **** | 4.2% | **** | 4.1% | **** | 4.6% | **** | 4.9% |
| Share Index | **** | 21,200 | **** | 24.2% | **** | 4.4% | **** | 37.8% | **** | 3.2% | **** | (12.2%) | **** | 4.0% | **** | (34.2%) | **** | 5.2% |
| China | ||||||||||||||||||
| Gross Domestic Product (GDP) | **** | 106,073 | **** | 5.5% | **** | 5.0% | **** | 9.0% | **** | 5.0% | **** | (1.6%) | **** | 5.2% | **** | (5.1%) | **** | 4.5% |
| Share Index | **** | 10,672 | **** | 1.8% | **** | 7.8% | **** | 20.1% | **** | 5.8% | **** | (34.9%) | **** | 15.0% | **** | (44.9%) | **** | 16.5% |
| Manulife Financial Corporation – Second Quarter 2023 | 142 | |||||||||||||||||
| --- | --- |
Table of Contents
| (IV) | Sensitivity to changes in economic assumptions |
|---|
The following table compares the allowances resulting from the ECL baseline scenario and resulting from ECL scenarios weighted by probability of occurrence.
| As at | June 30, 2023 | |
|---|---|---|
| Probability-weighted ECLs | $ | 840 |
| Base ECLs | $ | 598 |
| Difference - in amount | $ | 241 |
| Difference - in percentage | **** | 28.75% |
| (c) | Securities lending, repurchase and reverse repurchase transactions | |
| --- | --- |
As at June 30, 2023, the Company had loaned securities (which are included in invested assets) with a market value of $1,045 (December 31, 2022 – $723). The Company holds collateral with a current market value that exceeds the value of securities lent in all cases.
As at June 30, 2023, the Company had engaged in reverse repurchase transactions of $1,379 (December 31, 2022 – $895) which are recorded as short-term receivables. In addition, the Company had engaged in repurchase transactions of $466 as at June 30, 2023 (December 31, 2022 – $895) which are recorded as payables.
(d) Credit default swaps
The Company replicates exposure to specific issuers by selling credit protection via credit default swaps (“CDS”) to complement its cash debt securities investing. The Company does not write CDS protection more than its government bond holdings.
The following table presents details of the credit default swap protection sold by type of contract and external agency rating for the underlying reference security.
| As at June 30, 2023 | Notional<br>amount^(1)^ | Fair value | Weighted<br>average<br>maturity<br><br><br>(in years)^(2)^ | |||
|---|---|---|---|---|---|---|
| Single name CDS^(3),(4)^– Corporatedebt | ||||||
| AA | $ | 23 | $ | 1 | **** | 4 |
| A | **** | 91 | **** | 3 | **** | 4 |
| BBB | **** | 14 | **** | – | **** | 1 |
| Total single name CDS | $ | 128 | $ | 4 | **** | 4 |
| Total CDS protection sold | $ | 128 | $ | 4 | **** | 4 |
| As at December 31, 2022 | Notional<br>amount^(1)^ | Fair value | Weighted<br>average<br>maturity<br><br><br>(in years)^(2)^ | |||
| Single name CDS^(3),(4)^– Corporatedebt | ||||||
| AA | $ | – | $ | – | – | |
| A | 133 | 4 | 4 | |||
| BBB | 26 | – | 1 | |||
| Total single name CDS | $ | 159 | $ | 4 | 4 | |
| Total CDS protection sold | $ | 159 | $ | 4 | 4 | |
| ^(1)^ | Notional amounts represent the maximum future payments the Company would have to pay its counterparties assuming a default<br>of the underlying credit and zero recovery on the underlying issuer obligations. | |||||
| --- | --- | |||||
| ^(2)^ | The weighted average maturity of the CDS is weighted based on notional amounts. | |||||
| --- | --- | |||||
| ^(3)^ | Ratings are based on S&P where available followed by Moody’s, DBRS, and Fitch. If no rating is available from a<br>rating agency, an internally developed rating is used. | |||||
| --- | --- | |||||
| ^(4)^ | The Company held no purchased credit protection as at June 30, 2023 and December 31, 2022.<br> | |||||
| --- | --- | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 143 | |||||
| --- | --- |
Table of Contents
(e) Derivatives
The Company’s point-in-time exposure to losses related to credit risk of a derivative counterparty is limited to the amount of any net gains that may have accrued with the particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in a loss position and the impact of collateral on hand. The Company limits the risk of credit losses from derivative counterparties by: using investment grade counterparties, entering into master netting arrangements which permit the offsetting of contracts in a loss position in the case of a counterparty default, and entering into Credit Support Annex agreements whereby collateral must be provided when the exposure exceeds a certain threshold.
All contracts are held with or guaranteed by investment grade counterparties, the majority of whom are rated A- or higher. As at June 30, 2023, the percentage of the Company’s derivative exposure with counterparties rated AA- or higher was 35 per cent (December 31, 2022 – 36 per cent). As at June 30, 2023, the largest single counterparty exposure, without taking into consideration the impact of master netting agreements or the benefit of collateral held, was $1,531 (December 31, 2022 – $1,582). The net exposure to this counterparty, after taking into consideration master netting agreements and the fair value of collateral held, was $nil (December 31, 2022 – $nil).
(f) Offsetting financial assets andfinancial liabilities
Certain derivatives, securities lent and repurchase agreements have conditional offset rights. The Company does not offset these financial instruments in the Consolidated Statements of Financial Position, as the rights of offset are conditional.
In the case of derivatives, collateral is collected from and pledged to counterparties and clearing houses to manage credit risk exposure in accordance with Credit Support Annexes to swap agreements and clearing agreements. Under master netting agreements, the Company has a right of offset in the event of default, insolvency, bankruptcy or other early termination.
In the case of reverse repurchase and repurchase transactions, additional collateral may be collected from or pledged to counterparties to manage credit exposure according to bilateral reverse repurchase or repurchase agreements. In the event of default by a reverse purchase transaction counterparty, the Company is entitled to liquidate the collateral held to offset against the same counterparty’s obligation.
| Manulife Financial Corporation – Second Quarter 2023 | 144 |
|---|
Table of Contents
The following table presents the effect of conditional master netting and similar arrangements. Similar arrangements may include global master repurchase agreements, global master securities lending agreements, and any related rights to financial collateral pledged or received.
| Related amounts not set off in the<br><br><br>Consolidated Statements of Financial<br><br><br>Position | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at June 30, 2023 | Gross amounts of<br><br><br>financial<br> <br>instruments^(1)^ | Amounts subject to<br><br><br>an enforceable<br> <br>master netting<br><br><br>arrangement or<br> <br>similar agreements | Financial and<br><br><br>cash collateral<br> <br>pledged<br><br><br>(received)^(2)^ | Net amounts<br><br><br>including<br> <br>financing<br><br><br>entity^(3)^ | Net amounts<br><br><br>excluding<br> <br>financing<br><br><br>entity | |||||
| Financial assets | ||||||||||
| Derivative assets | $ | 8,930 | $ | (6,866) | $ | (1,965) | $ | 99 | $ | 99 |
| Securities lending | **** | 1,045 | **** | – | **** | (1,045) | **** | – | **** | – |
| Reverse repurchase agreements | **** | 1,379 | **** | (265) | **** | (1,114) | **** | – | **** | – |
| Total financial assets | $ | 11,354 | $ | (7,131) | $ | (4,124) | $ | 99 | $ | 99 |
| Financial liabilities | ||||||||||
| Derivative liabilities | $ | (13,158) | $ | 6,866 | $ | 6,209 | $ | (83) | $ | (37) |
| Repurchase agreements | **** | (466) | **** | 265 | **** | 201 | **** | – | **** | – |
| Total financial liabilities | $ | (13,624) | $ | 7,131 | $ | 6,410 | $ | (83) | $ | (37) |
| Related amounts not set off in the<br><br><br>Consolidated Statements of Financial<br><br><br>Position | ||||||||||
| As at December 31, 2022 | Gross amounts of<br><br><br>financial<br> <br>instruments^(1)^ | Amounts subject to<br><br><br>an enforceable<br>master netting<br> <br>arrangement or<br><br><br>similar agreements | Financial and<br><br><br>cash collateral<br> <br>pledged<br><br><br>(received)^(2)^ | Net amounts<br><br><br>including<br> <br>financing<br><br><br>entity^(3)^ | Net amounts<br><br><br>excluding<br> <br>financing<br><br><br>entity | |||||
| Financial assets | ||||||||||
| Derivative assets | $ | 9,072 | $ | (7,170) | $ | (1,687) | $ | 215 | $ | 215 |
| Securities lending | 723 | – | (723) | – | – | |||||
| Reverse repurchase agreements | 895 | (779) | (116) | – | – | |||||
| Total financial assets | $ | 10,690 | $ | (7,949) | $ | (2,526) | $ | 215 | $ | 215 |
| Financial liabilities | ||||||||||
| Derivative liabilities | $ | (15,151) | $ | 7,170 | $ | 7,834 | $ | (147) | $ | (103) |
| Repurchase agreements | (895) | 779 | 116 | – | – | |||||
| Total financial liabilities | $ | (16,046) | $ | 7,949 | $ | 7,950 | $ | (147) | $ | (103) |
| ^(1)^ | Financial assets and liabilities include accrued interest of $578 and $924, respectively (December 31, 2022 – $488<br>and $862, respectively). | |||||||||
| --- | --- | |||||||||
| ^(2)^ | Financial and cash collateral exclude over-collateralization. As at June 30, 2023, the Company was<br>over-collateralized on OTC derivative assets, OTC derivative liabilities, securities lending and reverse repurchase agreements and repurchase agreements in the amounts of $494, $1,809, $75 and $3, respectively (December 31, 2022 – $507, $1,528,<br>$63 and $nil, respectively). As at June 30, 2023, collateral pledged (received) does not include collateral-in-transit on OTC instruments or initial margin on<br>exchange traded contracts or cleared contracts. | |||||||||
| --- | --- | |||||||||
| ^(3)^ | Includes derivative contracts entered between the Company and its unconsolidated financing entity. The Company does not<br>exchange collateral on derivative contracts entered with this entity. | |||||||||
| --- | --- |
The Company also has certain credit linked note assets and variable surplus note liabilities which have unconditional offsetting rights. Under the netting agreements, the Company has rights of offset including in the event of the Company’s default, insolvency, or bankruptcy. These financial instruments are offset in the Consolidated Statements of Financial Position.
| Manulife Financial Corporation – Second Quarter 2023 | 145 |
|---|
Table of Contents
A credit linked note is a debt instrument the term of which, in this case, is linked to a variable surplus note. A surplus note is a subordinated debt obligation that often qualifies as surplus (the U.S. statutory equivalent of equity) by some U.S. state insurance regulators. Interest payments on surplus notes are made after all other contractual payments are made. The following table presents the effect of unconditional netting.
| As at June 30, 2023 | Gross amounts of<br><br><br>financial<br> <br>instruments | Amounts subject to<br><br><br>an enforceable<br> <br>netting<br><br><br>arrangement | Net amounts of<br><br><br>financial<br> <br>instruments | |||
|---|---|---|---|---|---|---|
| Credit linked note | $ | 1,308 | $ | (1,308) | $ | – |
| Variable surplus note | **** | (1,308) | **** | 1,308 | **** | – |
| As at December 31, 2022 | Gross amounts of<br>financial<br>instruments | Amounts subject to<br>an enforceable<br>netting<br>arrangement | Net amounts of<br>financial<br>instruments | |||
| Credit linked note | $ | 1,242 | $ | (1,242) | $ | – |
| Variable surplus note | (1,242) | 1,242 | – | |||
| Note 8 Long-Term Debt | ||||||
| --- |
(a) Carrying value of long-term debt instruments
| As at | Issue date | Maturity date | Par value | December 31,<br>2022 | ||
|---|---|---|---|---|---|---|
| 3.050% Senior notes^(1)^ | August 27, 2020 | August 27, 2060 | US1,155 | 1,523 | $ | 1,559 |
| 5.375% Senior notes^(1)^ | March 4, 2016 | March 4, 2046 | US750 | 980 | 1,004 | |
| 3.703% Senior notes^(1)^ | March 16, 2022 | March 16, 2032 | US750 | 987 | 1,011 | |
| 2.396% Senior notes^(1)^ | June 1, 2020 | June 1, 2027 | US200 | 264 | 270 | |
| 2.484% Senior notes^(1)^ | May 19, 2020 | May 19, 2027 | US500 | 659 | 674 | |
| 3.527% Senior notes^(1)^ | December 2, 2016 | December 2, 2026 | US270 | 357 | 365 | |
| 4.150% Senior<br>notes^(1)^ | March 4, 2016 | March 4, 2026 | US1,000 | 1,320 | 1,351 | |
| Total | 6,090 | $ | 6,234 |
All values are in US Dollars.
| ^(1)^ | These U.S. dollar senior notes have been designated as hedges of the Company’s net investment in its U.S. operations<br>which reduces the earnings volatility that would otherwise arise from the re-measurement of these senior notes into Canadian dollars. |
|---|
(b) Fair value measurement
Fair value of long-term debt instruments is determined using the following hierarchy:
Level 1 – Fair value is determined using quoted market prices where available.
Level 2 – When quoted market prices are not available, fair value is determined with reference to quoted prices of similar debt instruments or estimated using discounted cash flows based on observable market rates.
The Company measures long-term debt at amortized cost in the Consolidated Statements of Financial Position. As at June 30, 2023, the fair value of long-term debt was $5,503 (December 31, 2022 – $5,587). Fair value of long-term debt was determined using Level 2 valuation techniques (December 31, 2022 – Level 2).
| Manulife Financial Corporation – Second Quarter 2023 | 146 |
|---|
Table of Contents
| Note 9 Capital Instruments |
|---|
(a) Carrying value of capital instruments
| As at | Issue date | Earliest par<br>redemption date | Maturity date | Par value | December 31,<br>2022 | ||
|---|---|---|---|---|---|---|---|
| JHFC Subordinated notes^(1)^ | December 14, 2006 | n/a | December 15, 2036 | 650 | 647 | $ | 647 |
| 2.818% MFC Subordinated debentures^(1)^ | May 12, 2020 | May 13, 2030 | May 13, 2035 | 1,000 | 996 | 996 | |
| 5.409% MFC Subordinated debentures^(1),(2)^ | March 10, 2023 | March 10, 2028 | March 10, 2033 | 1,200 | 1,194 | – | |
| 4.061% MFC Subordinated notes^(1),(3)^ | February 24, 2017 | February 24, 2027 | February 24, 2032 | US750 | 991 | 1,013 | |
| 2.237% MFC Subordinated debentures^(1)^ | May 12, 2020 | May 12, 2025 | May 12, 2030 | 1,000 | 998 | 998 | |
| 3.00% MFC Subordinated notes^(1)^ | November 21, 2017 | November 21, 2024 | November 21, 2029 | S500 | 489 | 504 | |
| 3.049% MFC Subordinated debentures^(1)^ | August 18, 2017 | August 20, 2024 | August 20, 2029 | 750 | 749 | 749 | |
| 7.375% JHUSA Surplus notes | February 25, 1994 | n/a | February 15, 2024 | US450 | 598 | 615 | |
| 3.317% MFC Subordinated debentures^(1),(4)^ | May 9, 2018 | May 9, 2023 | May 9, 2028 | 600 | – | 600 | |
| Total | 6,662 | $ | 6,122 |
All values are in US Dollars.
| ^(1)^ | The Company is monitoring regulatory and market developments globally with respect to the interest rate benchmark reform.<br>As these rates could potentially be discontinued in the future, the Company will take appropriate actions in due course to accomplish the necessary transitions or replacements. As at June 30, 2023, capital instruments of $647 (December 31, 2022<br>– $647) have interest rate referencing CDOR. In addition, capital instruments of $2,743, $1,194, $991 and $489 (December 31, 2022 – $3,343, $nil, $1,013, and $504, respectively) have interest rate reset in the future referencing CDOR,<br>CORRA, the USD Mid-Swap rate, and the SGD swap rate, respectively. |
|---|---|
| ^(2)^ | Issued by MFC during the first quarter, interest is payable semi-annually. After March 10, 2028, the interest rate<br>will reset to equal the Daily Compounded CORRA plus 1.85%. With regulatory approval, MFC may redeem the debentures, in whole, or in part, on or after March 10, 2028, at a redemption price together with accrued and unpaid interest.<br> |
| --- | --- |
| ^(3)^ | Designated as a hedge of the Company’s net investment in its U.S. operations which reduces the earnings volatility<br>that would otherwise arise from the re-measurement of the subordinated notes into Canadian dollars. |
| --- | --- |
| ^(4)^ | MFC redeemed in full the 3.317% MFC Subordinated debentures at par, on May 9, 2023, the earliest par redemption date.<br> |
| --- | --- |
(b) Fair value measurement
Fair value of capital instruments is determined using the following hierarchy:
Level 1 – Fair value is determined using quoted market prices where available.
Level 2 – When quoted market prices are not available, fair value is determined with reference to quoted prices of similar debt instruments or estimated using discounted cash flows based on observable market rates.
The Company measures capital instruments at amortized cost in the Consolidated Statements of Financial Position. As at June 30, 2023, the fair value of capital instruments was $6,301 (December 31, 2022 – $5,737). Fair value of capital instruments was determined using Level 2 valuation techniques (December 31, 2022 – Level 2).
| Manulife Financial Corporation – Second Quarter 2023 | 147 |
|---|
Table of Contents
| Note 10 Equity Capital and Earnings Per Share |
|---|
(a) Preferred shares and other equity instruments
The following table presents information about the outstanding preferred shares and other equity instruments as at June 30, 2023 and December 31, 2022.
| Annual | Earliest | Number of | Net amount^(4)^ | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| As at | Issue date | dividend rate /<br>interest rate^(1)^ | redemption<br><br><br>date^(2),(3)^ | shares<br>(in millions) | Face<br>amount | June 30,2023 | December 31,<br>2022 | |||||||
| Preferred shares | ||||||||||||||
| Class A preferred shares | ||||||||||||||
| Series 2 | February 18, 2005 | 4.65% | n/a | 14 | $ | 350 | $ | 344 | $ | 344 | ||||
| Series 3 | January 3, 2006 | 4.50% | n/a | 12 | 300 | **** | 294 | 294 | ||||||
| Class 1 preferred shares | ||||||||||||||
| Series 3^(5),(6)^ | March 11, 2011 | 2.348% | June 19, 2026 | 7 | 163 | **** | 160 | 160 | ||||||
| Series 4^(7)^ | June 20, 2016 | floating | June 19, 2026 | 1 | 37 | **** | 36 | 36 | ||||||
| Series 9^(5),(6)^ | May 24, 2012 | 5.978% | September 19, 2027 | 10 | 250 | **** | 244 | 244 | ||||||
| Series 11^(5),(6),(8)^ | December 4, 2012 | 6.159% | March 19, 2028 | 8 | 200 | **** | 196 | 196 | ||||||
| Series 13^(5),(6)^ | June 21, 2013 | 4.414% | September 19, 2023 | 8 | 200 | **** | 196 | 196 | ||||||
| Series 15^(5),(6)^ | February 25, 2014 | 3.786% | June 19, 2024 | 8 | 200 | **** | 195 | 195 | ||||||
| Series 17^(5),(6)^ | August 15, 2014 | 3.800% | December 19, 2024 | 14 | 350 | **** | 343 | 343 | ||||||
| Series 19^(5),(6)^ | December 3, 2014 | 3.675% | March 19, 2025 | 10 | 250 | **** | 246 | 246 | ||||||
| Series 25^(5),(6),(9)^ | February 20, 2018 | 5.942% | June 19, 2028 | 10 | 250 | **** | 245 | 245 | ||||||
| Other equity instruments | ||||||||||||||
| Limited recourse capital<br>notes^(10)^ | ||||||||||||||
| Series 1^(11)^ | February 19, 2021 | 3.375% | May 19, 2026 | n/a | 2,000 | **** | 1,982 | 1,982 | ||||||
| Series 2^(11)^ | November 12, 2021 | 4.100% | February 19, 2027 | n/a | 1,200 | **** | 1,189 | 1,189 | ||||||
| Series<br>3^(11)^ | June 16, 2022 | 7.117% | June 19, 2027 | n/a | 1,000 | **** | 990 | 990 | ||||||
| Total | 102 | $ | 6,750 | $ | 6,660 | $ | 6,660 | |||||||
| ^(1)^ | Holders of Class A and Class 1 preferred shares are entitled to receive<br>non-cumulative preferential cash dividends on a quarterly basis, as and when declared by the Board of Directors. Non-deferrable distributions are payable to all LRCN<br>holders semi-annually at the Company’s discretion. | |||||||||||||
| --- | --- | |||||||||||||
| ^(2)^ | Redemption of all preferred shares is subject to regulatory approval. MFC may redeem each series, in whole or in part, at<br>par, on the earliest redemption date or every five years thereafter, except for Class A Series 2, Class A Series 3 and Class 1 Series 4 preferred shares. Class A Series 2 and Series 3 preferred shares are past their respective<br>earliest redemption date and MFC may redeem these preferred shares, in whole or in part, at par at any time, subject to regulatory approval, as noted. MFC may redeem the Class 1 Series 4 preferred shares, in whole or in part, at any time, at<br>$25.00 per share if redeemed on June 19, 2026 (the earliest redemption date) and on June 19 every five years thereafter, or at $25.50 per share if redeemed on any other date after June 19, 2021, subject to regulatory approval, as<br>noted. | |||||||||||||
| --- | --- | |||||||||||||
| ^(3)^ | Redemption of all LRCN series is subject to regulatory approval. MFC may at its option redeem each series in whole or in<br>part, at a redemption price equal to par, together with accrued and unpaid interest. The redemption period for Series 1 is every five years during the period from May 19 and including June 19, commencing in 2026. The redemption period for<br>Series 2 is every five years during the period from February 19 and including March 19, commencing in 2027. After the first redemption date, the redemption period for Series 3 is every five years during the period from May 19 to and<br>including June 19, commencing in 2032. | |||||||||||||
| --- | --- | |||||||||||||
| ^(4)^ | Net of after-tax issuance costs. | |||||||||||||
| --- | --- | |||||||||||||
| ^(5)^ | On the earliest redemption date and every five years thereafter, the annual dividend rate will be reset to the five-year<br>Government of Canada bond yield plus a yield specified for each series. The specified yield for Class 1 preferred shares is: Series 3 – 1.41%, Series 9 – 2.86%, Series 11 – 2.61%, Series 13 – 2.22%, Series 15 – 2.16%,<br>Series 17 – 2.36%, Series 19 – 2.30%, and Series 25 – 2.55%. | |||||||||||||
| --- | --- | |||||||||||||
| ^(6)^ | On the earliest redemption date and every five years thereafter, Class 1 preferred shares are convertible at the<br>option of the holder into a new series that is one number higher than their existing series, and the holders are entitled to non-cumulative preferential cash dividends, payable quarterly if and when declared<br>by the Board of Directors, at a rate equal to the three-month Government of Canada Treasury bill yield plus the rate specified in footnote 5 above. | |||||||||||||
| --- | --- | |||||||||||||
| ^(7)^ | The floating dividend rate for the Class 1 Series 4 shares equals the three-month Government of Canada Treasury bill<br>yield plus 1.41%. | |||||||||||||
| --- | --- | |||||||||||||
| ^(8)^ | MFC did not exercise its right to redeem the outstanding Class 1 Shares Series 11 on March 19, 2023, which is<br>the earliest redemption date. The dividend rate was reset as specified in footnote 5 above to an annual fixed rate of 6.159%, for a five-year period commencing on March 20, 2023. | |||||||||||||
| --- | --- | |||||||||||||
| ^(9)^ | MFC did not exercise its right to redeem the outstanding Class 1 Shares Series 25 on June 19, 2023, which is the<br>earliest redemption date. The dividend rate was reset as specified in footnote 5 above to an annual fixed rate of 5.942%, for a five-year period commencing on June 20, 2023. | |||||||||||||
| --- | --- | |||||||||||||
| ^(10)^ | Non-payment of distributions or principal on any LRCN series notes when due will<br>result in a recourse event. The recourse of each noteholder will be limited to their proportionate amount of the Limited Recourse Trust’s assets which comprise of Class 1 Series 27 preferred shares for LRCN Series 1 notes, Class 1<br>Series 28 preferred shares for LRCN Series 2 notes, and Class 1 Series 29 preferred shares for LRCN Series 3 notes. All claims of the holders of LRCN series notes against MFC will be extinguished upon receipt of the corresponding trust assets.<br>The Class 1 Series 27, Class 1 Series 28, and Class 1 Series 29 preferred shares are eliminated on consolidation while being held in the Limited Recourse Trust. | |||||||||||||
| --- | --- | |||||||||||||
| ^(11)^ | The LRCN Series 1 distribute at a fixed rate of 3.375% payable semi-annually, until June 18, 2026; on June 19,<br>2026 and every five years thereafter until June 19, 2076, the rate will be reset at a rate equal to the five-year Government of Canada yield as defined in the prospectus, plus 2.839%. The LRCN Series 2 distribute at a fixed rate of 4.10%<br>payable semi-annually, until March 18, 2027; on March 19, 2027 and every five years thereafter until March 19, 2077, the rate will be reset at a rate equal to the five-year Government of Canada yield as defined in the prospectus, plus<br>2.704%. The LRCN Series 3 distribute at a fixed rate of 7.117% payable semi-annually, until June 18, 2027; on June 19, 2027 and every five years thereafter until June 19, 2077, the rate will be reset at a rate equal to the five-year<br>Government of Canada yield as defined in the prospectus, plus 3.95%. | |||||||||||||
| --- | --- | |||||||||||||
| Manulife Financial Corporation – Second Quarter 2023 | 148 | |||||||||||||
| --- | --- |
Table of Contents
(b) Common shares
As at June 30, 2023, there were 20 million outstanding stock options and deferred share units that entitle the holders to receive common shares or payment in cash or common shares, at the option of the holders (December 31, 2022 – 21 million).
| Number of common shares (in millions) | For the six months<br>ended June 30, 2023 | For the year ended<br>December 31, 2022 | ||
|---|---|---|---|---|
| Balance, beginning of period | **** | 1,865 | 1,943 | |
| Purchased for cancellation | **** | (33) | (79) | |
| Issued on exercise of stock options and deferred share<br>units | **** | 1 | 1 | |
| Balance, end of period | **** | 1,833 | 1,865 |
Normal course issuer bid
On February 21, 2023, the Company announced that the Toronto Stock Exchange (“TSX”) approved a normal course issuer bid (“NCIB”) permitting the purchase for cancellation of up to 55.7 million common shares, representing approximately 3% of its issued and outstanding common shares. Purchases under the NCIB commenced on February 23, 2023 and will continue until February 22, 2024, when the NCIB expires, or such earlier date as the Company completes its purchases.
During the six months ended June 30, 2023, the Company had purchased 26.0 million shares under the current NCIB commenced on February 23, 2023, and 6.9 million shares under the previous NCIB that expired on February 2, 2023, totaling 32.9 million shares for $841. Of this, $392 was recorded in common shares and $449 was recorded in retained earnings in the Consolidated Statements of Changes in Equity.
(c) Earnings per share
The following is a reconciliation of the denominator (number of shares) in the calculation of basic and diluted earnings per common share.
| For the | three months ended June 30, | six months ended June 30, | ||||||
|---|---|---|---|---|---|---|---|---|
| (in millions) | 2023 | 2022 | 2023 | 2022 | ||||
| Weighted average number of common shares | **** | 1,842 | 1,921 | **** | 1,850 | 1,930 | ||
| Dilutive stock-based awards^(1)^ | **** | 4 | 3 | **** | 4 | 3 | ||
| Weighted average number of diluted common shares^^ | **** | 1,846 | 1,924 | **** | 1,854 | 1,933 | ||
| ^(1)^ | The dilutive effect of stock-based awards was calculated using the treasury stock method. This method calculates the<br>number of incremental shares by assuming the outstanding stock-based awards are (i) exercised and (ii) then reduced by the number of shares assumed to be repurchased from the issuance proceeds, using the average market price of MFC common<br>shares for the period. | |||||||
| --- | --- | |||||||
| Note 11 Revenue from Service Contracts | ||||||||
| --- |
The Company provides investment management services, transaction processing and administrative services and distribution and related services to proprietary and third-party investment funds, retirement plans, group benefit plans, institutional investors and other arrangements. The Company also provides real estate management services to tenants of the Company’s investment properties.
The Company’s service contracts generally impose single performance obligations, each consisting of a series of similar related services for each customer.
The Company’s performance obligations within service arrangements are generally satisfied over time as the customer simultaneously receives and consumes the benefits of the services rendered, measured using an output method. Fees typically include variable consideration and the related revenue is recognized to the extent that it is highly probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty is subsequently resolved.
| Manulife Financial Corporation – Second Quarter 2023 | 149 |
|---|
Table of Contents
Asset based fees vary with asset values of accounts under management, subject to market conditions and investor behaviors beyond the Company’s control. Transaction processing and administrative fees vary with activity volume, also beyond the Company’s control. Some fees, including distribution fees, are based on account balances and transaction volumes. Fees related to account balances and transaction volumes are measured daily. Real estate management service fees include fixed portions plus recovery of variable costs of services rendered to tenants. Fees related to services provided are generally recognized as services are rendered, which is when it becomes highly probable that no significant reversal of cumulative revenue recognized will occur. The Company has determined that its service contracts have no significant financing components because fees are collected monthly. The Company has no significant contract assets or contract liabilities.
The following tables present revenue from service contracts by service lines and reporting segments as disclosed in note 14. Asia, Canada, and U.S. reporting segments are combined with Corporate and Other as a result of the implementation of IFRS 17.
| For the three months ended June 30, 2023 | Global WAM | Asia,<br>Canada,<br>U.S., and<br>Corporate<br>and Other | Total | |||
|---|---|---|---|---|---|---|
| Investment management and other related fees | $ | 797 | $ | (95) | $ | 702 |
| Transaction processing, administration, and service fees | **** | 636 | **** | 69 | **** | 705 |
| Distribution fees and other | **** | 213 | **** | 13 | **** | 226 |
| Total included in other revenue | **** | 1,646 | **** | (13) | **** | 1,633 |
| Revenue fromnon-service lines | **** | 1 | **** | 57 | **** | 58 |
| Total other revenue | $ | 1,647 | $ | 44 | $ | 1,691 |
| Real estate management services included in net investmentincome | $ | – | $ | 74 | $ | 74 |
| For the three months ended June 30, 2022 | Global WAM | Asia,<br>Canada,<br>U.S., and<br>Corporate<br>and Other | Total | |||
| --- | --- | --- | --- | --- | --- | --- |
| Investment management and other related fees | $ | 761 | $ | (77) | $ | 684 |
| Transaction processing, administration, and service fees | 595 | 68 | 663 | |||
| Distribution fees and other | 202 | 13 | 215 | |||
| Total included in other revenue | 1,558 | 4 | 1,562 | |||
| Revenue from non-servicelines | (6) | (110) | (116) | |||
| Total other revenue | $ | 1,552 | $ | (106) | $ | 1,446 |
| Real estate management services included in net investmentincome | $ | – | $ | 75 | $ | 75 |
| For the six months ended June 30, 2023 | Global WAM | Asia,<br>Canada,<br>U.S., and<br>Corporate<br>and Other | Total | |||
| --- | --- | --- | --- | --- | --- | --- |
| Investment management and other related fees | $ | 1,628 | $ | (189) | $ | 1,439 |
| Transaction processing, administration, and service fees | **** | 1,261 | **** | 138 | **** | 1,399 |
| Distribution fees and other | **** | 421 | **** | 26 | **** | 447 |
| Total included in other revenue | **** | 3,310 | **** | (25) | **** | 3,285 |
| Revenue from non-servicelines | **** | 2 | **** | 95 | **** | 97 |
| Total other revenue | $ | 3,312 | $ | 70 | $ | 3,382 |
| Real estate management services included in net investmentincome | $ | – | $ | 157 | $ | 157 |
| For the six months ended June 30, 2022 | Global WAM | Asia,<br>Canada,<br>U.S., and<br>Corporate<br>and Other | Total | |||
| --- | --- | --- | --- | --- | --- | --- |
| Investment management and other related fees | $ | 1,561 | $ | (155) | $ | 1,406 |
| Transaction processing, administration, and service fees | 1,217 | 137 | 1,354 | |||
| Distribution fees and other | 419 | 32 | 451 | |||
| Total included in other revenue | 3,197 | 14 | 3,211 | |||
| Revenue from non-servicelines | (7) | (236) | (243) | |||
| Total other revenue | $ | 3,190 | $ | (222) | $ | 2,968 |
| Real estate management services included in net investmentincome | $ | – | $ | 157 | $ | 157 |
| Manulife Financial Corporation – Second Quarter 2023 | 150 | |||||
| --- | --- |
Table of Contents
| Note 12 Employee Future Benefits |
|---|
The Company maintains a number of pension plans, both defined benefit and defined contribution, and retiree welfare plans for eligible employees and agents. Information about the financial impacts of the Company’s material pension and retiree welfare plans in the U.S. and Canada is as follows.
| Pension plans | Retiree welfare plans^(1)^**** | |||||||
|---|---|---|---|---|---|---|---|---|
| For the three months ended June 30, | 2023 | 2022 | 2023 | 2022 | ||||
| Defined benefit current service cost | $ | 10 | $ | 11 | $ | – | $ | – |
| Defined benefit administrative expenses | **** | 2 | 2 | **** | – | 1 | ||
| Service cost | **** | 12 | 13 | **** | – | 1 | ||
| Interest on net defined benefit (asset) liability | **** | 1 | 1 | **** | – | – | ||
| Defined benefit cost | **** | 13 | 14 | **** | – | 1 | ||
| Defined contribution cost | **** | 22 | 21 | **** | – | – | ||
| Net benefit cost reported in earnings | $ | 35 | $ | 35 | $ | – | $ | 1 |
| Actuarial (gain) loss on economic assumption changes | $ | (35) | $ | (315) | $ | (5) | $ | (45) |
| Investment (gain) loss (excluding interest income) | **** | 22 | 280 | **** | 9 | 29 | ||
| Change in effect of asset limit | **** | (1) | 3 | **** | – | – | ||
| Remeasurement (gain) loss recorded in AOCI, net oftax | $ | (14) | $ | (32) | $ | 4 | $ | (16) |
| Pension plans**** | Retiree welfare plans^(1)^**** | |||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| For the six months ended June 30, | 2023 | 2022 | 2023 | 2022 | ||||
| Defined benefit current service cost | $ | 20 | $ | 22 | $ | – | $ | – |
| Defined benefit administrative expenses | **** | 5 | 5 | **** | – | 1 | ||
| Service cost | **** | 25 | 27 | **** | – | 1 | ||
| Interest on net defined benefit (asset) liability | **** | 2 | 1 | **** | (1) | – | ||
| Defined benefit cost | **** | 27 | 28 | **** | (1) | 1 | ||
| Defined contribution cost | **** | 50 | 46 | **** | – | – | ||
| Net benefit cost reported in earnings | $ | 77 | $ | 74 | $ | (1) | $ | 1 |
| Actuarial (gain) loss on economic assumption changes | $ | 30 | $ | (621) | $ | 4 | $ | (85) |
| Investment (gain) loss (excluding interest income) | **** | (65) | 573 | **** | (2) | 58 | ||
| Change in effect of asset limit | **** | 3 | 12 | **** | – | – | ||
| Remeasurement (gain) loss recorded in AOCI, net oftax | $ | (32) | $ | (36) | $ | 2 | $ | (27) |
| ^(1)^ | There are no significant current service costs for the retiree welfare plans as they are closed and mostly frozen. The<br>remeasurement gain or loss on these plans is due to the volatility of discount rates and investment returns. | |||||||
| --- | --- | |||||||
| Note 13 Commitments and Contingencies | ||||||||
| --- | ||||||||
| (a) | Legal proceedings | |||||||
| --- | --- |
The Company is regularly involved in legal actions, both as a defendant and as a plaintiff. The legal actions where the Company is a party ordinarily relate to its activities as a provider of insurance protection or wealth management products, reinsurance, or in its capacity as an investment adviser, employer, or taxpayer. Other life insurers and asset managers, operating in the jurisdictions in which the Company does business, have been subject to a wide variety of other types of actions, some of which resulted in substantial judgments or settlements against the defendants; it is possible that the Company may become involved in similar actions in the future. In addition, government and regulatory bodies in Canada, the United States, Asia, and other jurisdictions where the Company conducts business regularly make inquiries and sometimes require the production of information or conduct examinations concerning the Company’s compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers.
In June 2018, a class action was initiated against the Company in the U.S. District Court for the Southern District of New York on behalf of owners of Performance Universal Life (“Perf UL”) policies issued between 2003 and 2010 whose policies were subject to a Cost of Insurance (“COI”) increase announced in 2018. The class policies in the COI-increase block made up approximately two-thirds of the total face amount of the policies in the COI-increase block. The class case was settled effective May 17, 2022, and the settlement has been implemented.
| Manulife Financial Corporation – Second Quarter 2023 | 151 |
|---|
Table of Contents
In addition to the class action, twelve individual lawsuits opposing the Perf UL COI increases were also filed; nine in federal court and three in state court. Each of the lawsuits, except two, have been brought by plaintiffs who own multiple policies. All of the pending federal cases, which made up approximately 21% of the total face amount of policies in the COI-increase block, have now been settled. The three state court cases are still pending.
There are also policies that have been “opted out” of the class settlement, and although no litigation is pending with respect to those policies, future litigation is possible. The remaining “opted out” policies constitute about 18% (by face value) of the COI-increase block. The Company continues to defend the three remaining state court individual lawsuits.
(b) Guarantees
(I) Guarantees regarding Manulife Finance (Delaware), L.P. (“MFLP”)
MFC has guaranteed the payment of amounts on the $650 subordinated debentures due on December 15, 2041 issued by MFLP, a wholly owned unconsolidated financing entity.
The following table presents certain condensed consolidated financial information for MFC and MFLP.
Condensed Consolidated Statements of Income Information
| For the three months ended June 30, 2023 | MFC<br>(Guarantor) | Other<br>subsidiaries<br>on a<br>combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | $ | – | $ | 887 | $ | – | $ | 887 | $ | – |
| Investment result | **** | 127 | **** | 769 | **** | (299) | **** | 597 | **** | 14 |
| Other revenue | **** | 25 | **** | 1,668 | **** | (2) | **** | 1,691 | **** | (5) |
| Net income (loss) attributed to shareholders and other equity<br>holders | **** | 1,025 | **** | 953 | **** | (953) | **** | 1,025 | **** | (2) |
| For the three months ended June 30, 2022 | MFC<br>(Guarantor) | Other<br>subsidiaries<br>on a<br>combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
| Insurance service result | $ | – | $ | 1,035 | $ | – | $ | 1,035 | $ | – |
| Investment result | 154 | (3,538) | (313) | (3,697) | 12 | |||||
| Other revenue | (3) | 1,450 | (1) | 1,446 | 7 | |||||
| Net income (loss) attributed to shareholders and other equity<br>holders | (2,119) | (2,202) | 2,202 | (2,119) | 8 | |||||
| For the six months ended June 30, 2023 | MFC<br>(Guarantor) | Other<br>subsidiaries<br>on a<br>combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Insurance service results | $ | – | $ | 1,736 | $ | – | $ | 1,736 | $ | – |
| Investment results | **** | 132 | **** | 1,746 | **** | (311) | **** | 1,567 | **** | 26 |
| Other revenue | **** | 21 | **** | 3,363 | **** | (2) | **** | 3,382 | **** | (5) |
| Net income (loss) attributed to shareholders and other equity<br>holders | **** | 2,431 | **** | 2,443 | **** | (2,443) | **** | 2,431 | **** | (1) |
| For the six months ended June 30, 2022 | MFC<br>(Guarantor) | Other<br>subsidiaries<br>on a<br>combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
| Insurance service results | $ | – | $ | 1,750 | $ | – | $ | 1,750 | $ | – |
| Investment results | 142 | (5,963) | (315) | (6,136) | 25 | |||||
| Other revenue | 7 | 2,962 | (1) | 2,968 | 4 | |||||
| Net income (loss) attributed to shareholders and other equity<br>holders | (3,339) | (3,353) | 3,353 | (3,339) | 9 | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 152 | |||||||||
| --- | --- |
Table of Contents
Condensed Consolidated Statements of Financial Position Information
| As at June 30, 2023 | MFC<br>(Guarantor) | Other subsidiaries<br>on a combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Invested assets | $ | 82 | $ | 403,346 | $ | – | $ | 403,428 | $ | 13 |
| Insurance contract assets | **** | – | **** | 404 | **** | – | **** | 404 | **** | – |
| Reinsurance contract held assets | **** | – | **** | 43,386 | **** | – | **** | 43,386 | **** | – |
| Total other assets | **** | 87,414 | **** | 98,906 | **** | (148,208) | **** | 38,112 | **** | 948 |
| Segregated funds net assets | **** | – | **** | 365,981 | **** | – | **** | 365,981 | **** | – |
| Insurance contract liabilities, excluding those for account of segregated fund holders | **** | – | **** | 358,413 | **** | – | **** | 358,413 | **** | – |
| Reinsurance contract held liabilities | **** | – | **** | 2,480 | **** | – | **** | 2,480 | **** | – |
| Investment contract liabilities | **** | – | **** | 10,557 | **** | – | **** | 10,557 | **** | – |
| Total other liabilities | **** | 41,789 | **** | 108,680 | **** | (83,745) | **** | 66,724 | **** | 702 |
| Insurance contract liabilities for account of segregated fund holders | **** | – | **** | 112,529 | **** | – | **** | 112,529 | **** | – |
| Investment contract liabilities for account of segregated fund<br>holders | **** | – | **** | 253,452 | **** | – | **** | 253,452 | **** | – |
| As at December 31, 2022 | MFC<br>(Guarantor) | Other subsidiaries<br>on a combined<br>basis | Consolidation<br>adjustments | Total<br>consolidated<br>amounts | MFLP | |||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Invested assets | $ | 63 | $ | 400,079 | $ | – | $ | 400,142 | $ | 21 |
| Insurance contract assets | – | 673 | – | 673 | – | |||||
| Reinsurance contract held assets | – | 45,871 | – | 45,871 | – | |||||
| Total other assets | 58,357 | 42,751 | (62,667) | 38,441 | 950 | |||||
| Segregated funds net assets | – | 348,562 | – | 348,562 | – | |||||
| Insurance contract liabilities, excluding those for account of segregated fund holders | – | 354,857 | – | 354,857 | – | |||||
| Reinsurance contract held liabilities | – | 2,391 | – | 2,391 | – | |||||
| Investment contract liabilities | – | 10,079 | – | 10,079 | – | |||||
| Total other liabilities | 11,544 | 58,474 | (444) | 69,574 | 712 | |||||
| Insurance contract liabilities for account of segregated fund holders | – | 110,216 | – | 110,216 | – | |||||
| Investment contract liabilities for account of segregated fund<br>holders | – | 238,346 | – | 238,346 | – |
(II) Guarantees regarding John Hancock Life Insurance Company (U.S.A.) (“JHUSA”)
Details of guarantees regarding certain securities issued or to be issued by JHUSA are outlined in note 16.
| Note 14 Segment and Geographic Reporting |
|---|
The Company’s reporting segments are Asia, Canada, U.S., Global WAM and Corporate and Other. Each reporting segment is responsible for managing its operating results, developing products, defining strategies for services and distribution based on the profile and needs of its business and market. The Company’s significant product and service offerings by the reporting segments are mentioned below.
Wealth and asset management businesses (Global WAM) – branded as Manulife Investment Management, provides investment advice and innovative solutions to retirement, retail, and institutional clients. Products and services are distributed through multiple distribution channels, including agents and brokers affiliated with the Company, independent securities brokerage firms and financial advisors pension plan consultants and banks.
Insurance and annuity products (Asia, Canada and U.S.) – include a variety of individual life insurance, individual and group long-term care insurance and guaranteed and partially guaranteed annuity products. Products are distributed through multiple distribution channels, including insurance agents, brokers, banks, financial planners and direct marketing. Manulife Bank of Canada offers a variety of deposit and credit products to Canadian customers.
| Manulife Financial Corporation – Second Quarter 2023 | 153 |
|---|
Table of Contents
Corporate and Other Segment – comprised of investment performance of assets backing capital, net of amounts allocated to operating segments; costs incurred by the corporate office related to shareholder activities (not allocated to the operating segments); financing costs; Property and Casualty Reinsurance Business; and run-off reinsurance operations including variable annuities and accident and health. In addition, consolidations and eliminations of transactions between operating segments are also included.
Effective January 1, 2023, the Company has made a number of changes to the composition of reporting segments to better align its financial reporting with its business strategy and operations. The Company’s international high net worth business was reclassified from the U.S. segment to the Asia segment to reflect the contributions of the Company’s Bermuda operations alongside the high net worth business that is reported in the Company’s Singapore and Hong Kong operations. The Company’s investment in the startup capital of segregated and mutual funds and investment-related revenue and expense were reclassified from the Corporate and Other segment to the Global WAM segment to more closely align with Global WAM’s management practices. Refinements were made to the allocations of corporate overhead and interest on surplus among segments. Prior period comparative information has been restated to reflect the changes in segment reporting.
The following tables present results by reporting segments and by geographical location.
(a) By Segment
| For the three months ended<br><br><br>June 30, 2023 | Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||||
| Life and health insurance | $ | 483 | $ | 217 | $ | 114 | $ | – | $ | 34 | $ | 848 |
| Annuities and pensions | **** | (23) | **** | 45 | **** | 17 | **** | – | **** | – | **** | 39 |
| Total insurance service result | **** | 460 | **** | 262 | **** | 131 | **** | – | **** | 34 | **** | 887 |
| Net investment income (loss) | **** | 2,336 | **** | 997 | **** | 1,237 | **** | (205) | **** | 454 | **** | 4,819 |
| Insurance finance income (expense) | ||||||||||||
| Life and health insurance | **** | (1,049) | **** | (794) | **** | (1,041) | **** | – | **** | 44 | **** | (2,840) |
| Annuities and pensions | **** | (1,497) | **** | 150 | **** | 453 | **** | – | **** | – | **** | (894) |
| Total insurance finance income (expense) | **** | (2,546) | **** | (644) | **** | (588) | **** | – | **** | 44 | **** | (3,734) |
| Reinsurance finance income (expense) | ||||||||||||
| Life and health insurance | **** | 137 | **** | 15 | **** | (17) | **** | – | **** | (24) | **** | 111 |
| Annuities and pensions | **** | 3 | **** | (1) | **** | (444) | **** | – | **** | – | **** | (442) |
| Total reinsurance finance income (expense) | **** | 140 | **** | 14 | **** | (461) | **** | – | **** | (24) | **** | (331) |
| Decrease (increase) in investment contract liabilities | **** | (26) | **** | (13) | **** | (83) | **** | (39) | **** | 4 | **** | (157) |
| Net segregated fund investment result | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Total investment result | **** | (96) | **** | 354 | **** | 105 | **** | (244) | **** | 478 | **** | 597 |
| Other revenue | **** | 47 | **** | 72 | **** | 16 | **** | 1,647 | **** | (91) | **** | 1,691 |
| Other expenses | **** | (63) | **** | (140) | **** | (28) | **** | (1,037) | **** | (90) | **** | (1,358) |
| Interest expense | **** | (3) | **** | (236) | **** | (4) | **** | (4) | **** | (134) | **** | (381) |
| Net income (loss) before income taxes | **** | 345 | **** | 312 | **** | 220 | **** | 362 | **** | 197 | **** | 1,436 |
| Income tax recovery (expense) | **** | (91) | **** | (64) | **** | (37) | **** | (44) | **** | (29) | **** | (265) |
| Net income (loss) | **** | 254 | **** | 248 | **** | 183 | **** | 318 | **** | 168 | **** | 1,171 |
| Less net income (loss) attributed to: | ||||||||||||
| Non-controlling interests | **** | 25 | **** | – | **** | – | **** | 1 | **** | – | **** | 26 |
| Participating policyholders | **** | 99 | **** | 21 | **** | – | **** | – | **** | – | **** | 120 |
| Net income (loss) attributed to shareholders and otherequity holders | $ | 130 | $ | 227 | $ | 183 | $ | 317 | $ | 168 | $ | 1,025 |
| Manulife Financial Corporation – Second Quarter 2023 | 154 | |||||||||||
| --- | --- |
Table of Contents
| For the three months ended<br>June 30, 2022 | Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||||
| Life and health insurance | $ | 365 | $ | 229 | $ | 337 | $ | – | $ | 12 | $ | 943 |
| Annuities and pensions | (5) | 64 | 33 | – | – | 92 | ||||||
| Total insurance service result | 360 | 293 | 370 | – | 12 | 1,035 | ||||||
| Net investment income (loss) | 546 | (1,616) | (895) | (424) | (65) | (2,454) | ||||||
| Insurance finance income (expense) | ||||||||||||
| Life and health insurance | 532 | 585 | (1,118) | – | 61 | 60 | ||||||
| Annuities and pensions | (1,496) | 15 | (371) | – | – | (1,852) | ||||||
| Total insurance finance income (expense) | (964) | 600 | (1,489) | – | 61 | (1,792) | ||||||
| Reinsurance finance income (expense) | ||||||||||||
| Life and health insurance | 196 | 4 | 189 | – | (64) | 325 | ||||||
| Annuities and pensions | (1) | (1) | 262 | – | – | 260 | ||||||
| Total reinsurance finance income (expense) | 195 | 3 | 451 | – | (64) | 585 | ||||||
| Decrease (increase) in investment contract liabilities | (25) | (13) | 15 | (16) | 3 | (36) | ||||||
| Net segregated fund investment result | – | – | – | – | – | – | ||||||
| Total investment result | (248) | (1,026) | (1,918) | (440) | (65) | (3,697) | ||||||
| Other revenue | 30 | 67 | 16 | 1,552 | (219) | 1,446 | ||||||
| Other expenses | (90) | (145) | (26) | (942) | (4) | (1,207) | ||||||
| Interest expense | (2) | (112) | (4) | – | (115) | (233) | ||||||
| Net income (loss) before income taxes | 50 | (923) | (1,562) | 170 | (391) | (2,656) | ||||||
| Income tax recovery (expense) | (100) | 327 | 336 | (20) | 10 | 553 | ||||||
| Net income (loss) | (50) | (596) | (1,226) | 150 | (381) | (2,103) | ||||||
| Less net income (loss) attributed to: | ||||||||||||
| Non-controlling interests | 52 | – | – | – | – | 52 | ||||||
| Participating policyholders | (51) | 15 | – | – | – | (36) | ||||||
| Net income (loss) attributed to shareholders and other equityholders | $ | (51) | $ | (611) | $ | (1,226) | $ | 150 | $ | (381) | $ | (2,119) |
| For the six months endedJune 30, 2023 | Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
| Insurance service result | ||||||||||||
| Life and health insurance | $ | 905 | $ | 428 | $ | 261 | $ | – | $ | 81 | $ | 1,675 |
| Annuities and pensions | **** | (75) | **** | 93 | **** | 43 | **** | – | **** | – | **** | 61 |
| Total insurance service result | **** | 830 | **** | 521 | **** | 304 | **** | – | **** | 81 | **** | 1,736 |
| Net investment income (loss) | **** | 4,420 | **** | 2,497 | **** | 2,626 | **** | (409) | **** | 838 | **** | 9,972 |
| Insurance finance income (expense) | ||||||||||||
| Life and health insurance | **** | (2,685) | **** | (1,735) | **** | (2,349) | **** | – | **** | 717 | **** | (6,052) |
| Annuities and pensions | **** | (1,607) | **** | 67 | **** | 80 | **** | – | **** | – | **** | (1,460) |
| Total insurance finance income (expense) | **** | (4,292) | **** | (1,668) | **** | (2,269) | **** | – | **** | 717 | **** | (7,512) |
| Reinsurance finance income (expense) | ||||||||||||
| Life and health insurance | **** | 89 | **** | 22 | **** | 180 | **** | – | **** | (694) | **** | (403) |
| Annuities and pensions | **** | 3 | **** | (1) | **** | (252) | **** | – | **** | – | **** | (250) |
| Total reinsurance finance income (expense) | **** | 92 | **** | 21 | **** | (72) | **** | – | **** | (694) | **** | (653) |
| Decrease (increase) in investment contract liabilities | **** | (31) | **** | (33) | **** | (79) | **** | (95) | **** | (2) | **** | (240) |
| Net segregated fund investment result | **** | – | **** | – | **** | – | **** | – | **** | – | **** | – |
| Total investment result | **** | 189 | **** | 817 | **** | 206 | **** | (504) | **** | 859 | **** | 1,567 |
| Other revenue | **** | 57 | **** | 144 | **** | 40 | **** | 3,312 | **** | (171) | **** | 3,382 |
| Other expenses | **** | (113) | **** | (279) | **** | (103) | **** | (2,092) | **** | (195) | **** | (2,782) |
| Interest expense | **** | (5) | **** | (468) | **** | (8) | **** | (9) | **** | (258) | **** | (748) |
| Net income (loss) before income taxes | **** | 958 | **** | 735 | **** | 439 | **** | 707 | **** | 316 | **** | 3,155 |
| Income tax recovery (expense) | **** | (196) | **** | (163) | **** | (70) | **** | (92) | **** | (53) | **** | (574) |
| Net income (loss) | **** | 762 | **** | 572 | **** | 369 | **** | 615 | **** | 263 | **** | 2,581 |
| Less net income (loss) attributed to: | ||||||||||||
| Non-controlling interests | **** | 79 | **** | – | **** | – | **** | 1 | **** | – | **** | 80 |
| Participating policyholders | **** | 34 | **** | 36 | **** | – | **** | – | **** | – | **** | 70 |
| Net income (loss) attributed to shareholders and otherequity holders | $ | 649 | $ | 536 | $ | 369 | $ | 614 | $ | 263 | $ | 2,431 |
| Total assets | $ | 167,352 | $ | 153,393 | $ | 242,963 | $ | 247,034 | $ | 40,569 | $ | 851,311 |
| Manulife Financial Corporation – Second Quarter 2023 | 155 | |||||||||||
| --- | --- |
Table of Contents
| For the six months ended<br>June 30, 2022 | Asia | Canada | U.S. | Global<br>WAM | Corporate<br>and Other | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||||
| Life and health insurance | $ | 845 | $ | 416 | $ | 263 | $ | – | $ | 40 | $ | 1,564 |
| Annuities and pensions | (72) | 154 | 104 | – | – | 186 | ||||||
| Total insurance service result | 773 | 570 | 367 | – | 40 | 1,750 | ||||||
| Net investment income (loss) | 956 | (3,009) | (636) | (702) | (151) | (3,542) | ||||||
| Insurance finance income (expense) | ||||||||||||
| Life and health insurance | 1,166 | 351 | (2,191) | – | 161 | (513) | ||||||
| Annuities and pensions | (2,616) | 475 | (42) | – | – | (2,183) | ||||||
| Total insurance finance income (expense) | (1,450) | 826 | (2,233) | – | 161 | (2,696) | ||||||
| Reinsurance finance income (expense) | ||||||||||||
| Life and health insurance | 228 | – | 175 | – | (163) | 240 | ||||||
| Annuities and pensions | (2) | (1) | 51 | – | – | 48 | ||||||
| Total reinsurance finance income (expense) | 226 | (1) | 226 | – | (163) | 288 | ||||||
| Decrease (increase) in investment contract liabilities | (74) | (24) | (40) | (57) | 9 | (186) | ||||||
| Net segregated fund investment result | – | – | – | – | – | – | ||||||
| Total investment result | (342) | (2,208) | (2,683) | (759) | (144) | (6,136) | ||||||
| Other revenue | (6) | 133 | 33 | 3,190 | (382) | 2,968 | ||||||
| Other expenses | (180) | (286) | (45) | (1,925) | (60) | (2,496) | ||||||
| Interest expense | (3) | (170) | (9) | – | (223) | (405) | ||||||
| Net income (loss) before income taxes | 242 | (1,961) | (2,337) | 506 | (769) | (4,319) | ||||||
| Income tax recovery (expense) | (173) | 710 | 512 | (73) | 17 | 993 | ||||||
| Net income (loss) | 69 | (1,251) | (1,825) | 433 | (752) | (3,326) | ||||||
| Less net income (loss) attributed to: | ||||||||||||
| Non-controlling interests | 54 | – | – | – | – | 54 | ||||||
| Participating policyholders | (73) | 32 | – | – | – | (41) | ||||||
| Net income (loss) attributed to shareholders and other equityholders | $ | 88 | $ | (1,283) | $ | (1,825) | $ | 433 | $ | (752) | $ | (3,339) |
| Total assets | $ | 154,239 | $ | 148,710 | $ | 241,787 | $ | 219,942 | $ | 45,713 | $ | 810,391 |
(b) By Geographic Location
| For the three months endedJune 30, 2023 | Asia | Canada | U.S. | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||
| Life and health insurance | $ | 488 | $ | 214 | $ | 108 | $ | 38 | $ | 848 |
| Annuities and pensions | **** | (23) | **** | 45 | **** | 17 | **** | – | **** | 39 |
| Total insurance service result | **** | 465 | **** | 259 | **** | 125 | **** | 38 | **** | 887 |
| Net investment income (loss) | **** | 2,350 | **** | 1,284 | **** | 1,190 | **** | (5) | **** | 4,819 |
| Insurance finance income (expense) | ||||||||||
| Life and health insurance | **** | (1,049) | **** | (781) | **** | (1,020) | **** | 10 | **** | (2,840) |
| Annuities and pensions | **** | (1,497) | **** | 150 | **** | 453 | **** | – | **** | (894) |
| Total insurance finance income (expense) | **** | (2,546) | **** | (631) | **** | (567) | **** | 10 | **** | (3,734) |
| Reinsurance finance income (expense) | ||||||||||
| Life and health insurance | **** | 133 | **** | (5) | **** | (17) | **** | – | **** | 111 |
| Annuities and pensions | **** | 3 | **** | (1) | **** | (444) | **** | – | **** | (442) |
| Total reinsurance finance income (expense) | **** | 136 | **** | (6) | **** | (461) | **** | – | **** | (331) |
| Decrease (increase) in investment contract liabilities | **** | (53) | **** | (30) | **** | (72) | **** | (2) | **** | (157) |
| Net segregated fund investment result | **** | – | **** | – | **** | – | **** | – | **** | – |
| Total investment result | $ | (113) | $ | 617 | $ | 90 | $ | 3 | $ | 597 |
| Other revenue | $ | 347 | $ | 563 | $ | 781 | $ | – | $ | 1,691 |
| Manulife Financial Corporation – Second Quarter 2023 | 156 | |||||||||
| --- | --- |
Table of Contents
| For the three months ended<br>June 30, 2022 | Asia | Canada | U.S. | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||
| Life and health insurance | $ | 376 | $ | 225 | $ | 325 | $ | 17 | $ | 943 |
| Annuities and pensions | (5) | 64 | 33 | – | 92 | |||||
| Total insurance service result | 371 | 289 | 358 | 17 | 1,035 | |||||
| Net investment income (loss) | 466 | (1,707) | (1,387) | 174 | (2,454) | |||||
| Insurance finance income (expense) | ||||||||||
| Life and health insurance | 531 | 585 | (1,057) | 1 | 60 | |||||
| Annuities and pensions | (1,496) | 15 | (371) | – | (1,852) | |||||
| Total insurance finance income (expense) | (965) | 600 | (1,428) | 1 | (1,792) | |||||
| Reinsurance finance income (expense) | ||||||||||
| Life and health insurance | 193 | (57) | 189 | – | 325 | |||||
| Annuities and pensions | (1) | (1) | 262 | – | 260 | |||||
| Total reinsurance finance income (expense) | 192 | (58) | 451 | – | 585 | |||||
| Decrease (increase) in investment contract liabilities | (34) | (19) | 17 | – | (36) | |||||
| Net segregated fund investment result | – | – | – | – | – | |||||
| Total investment result | $ | (341) | $ | (1,184) | $ | (2,347) | $ | 175 | $ | (3,697) |
| Other revenue | $ | 278 | $ | 516 | $ | 648 | $ | 4 | $ | 1,446 |
| For the six months endedJune 30, 2023 | Asia | Canada | U.S. | Other | Total | |||||
| Insurance service result | ||||||||||
| Life and health insurance | $ | 915 | $ | 418 | $ | 250 | $ | 92 | $ | 1,675 |
| Annuities and pensions | **** | (75) | **** | 93 | **** | 43 | **** | – | **** | 61 |
| Total insurance service result | **** | 840 | **** | 511 | **** | 293 | **** | 92 | **** | 1,736 |
| Net investment income (loss) | **** | 4,551 | **** | 2,920 | **** | 2,482 | **** | 19 | **** | 9,972 |
| Insurance finance income (expense) | ||||||||||
| Life and health insurance | **** | (2,685) | **** | (1,717) | **** | (1,662) | **** | 12 | **** | (6,052) |
| Annuities and pensions | **** | (1,607) | **** | 67 | **** | 80 | **** | – | **** | (1,460) |
| Total insurance finance income (expense) | **** | (4,292) | **** | (1,650) | **** | (1,582) | **** | 12 | **** | (7,512) |
| Reinsurance finance income (expense) | ||||||||||
| Life and health insurance | **** | 81 | **** | (664) | **** | 180 | **** | – | **** | (403) |
| Annuities and pensions | **** | 3 | **** | (1) | **** | (252) | **** | – | **** | (250) |
| Total reinsurance finance income (expense) | **** | 84 | **** | (665) | **** | (72) | **** | – | **** | (653) |
| Decrease (increase) in investment contract liabilities | **** | (112) | **** | (58) | **** | (66) | **** | (4) | **** | (240) |
| Net segregated fund investment result | **** | – | **** | – | **** | – | **** | – | **** | – |
| Total investment result | $ | 231 | $ | 547 | $ | 762 | $ | 27 | $ | 1,567 |
| Other revenue | $ | 682 | $ | 1,083 | $ | 1,624 | $ | (7) | $ | 3,382 |
| For the six months ended<br>June 30, 2022 | Asia | Canada | U.S. | Other | Total | |||||
| Insurance service result | ||||||||||
| Life and health insurance | $ | 861 | $ | 406 | $ | 241 | $ | 56 | $ | 1,564 |
| Annuities and pensions | (72) | 154 | 104 | – | 186 | |||||
| Total insurance service result | 789 | 560 | 345 | 56 | 1,750 | |||||
| Net investment income (loss) | 853 | (3,186) | (1,413) | 204 | (3,542) | |||||
| Insurance finance income (expense) | ||||||||||
| Life and health insurance | 1,165 | 354 | (2,034) | 2 | (513) | |||||
| Annuities and pensions | (2,616) | 475 | (42) | – | (2,183) | |||||
| Total insurance finance income (expense) | (1,451) | 829 | (2,076) | 2 | (2,696) | |||||
| Reinsurance finance income (expense) | ||||||||||
| Life and health insurance | 223 | (158) | 175 | – | 240 | |||||
| Annuities and pensions | (2) | (1) | 51 | – | 48 | |||||
| Total reinsurance finance income (expense) | 221 | (159) | 226 | – | 288 | |||||
| Decrease (increase) in investment contract liabilities | (87) | (37) | (62) | – | (186) | |||||
| Net segregated fund investment result | – | – | – | – | – | |||||
| Total investment result | $ | (464) | $ | (2,553) | $ | (3,325) | $ | 206 | $ | (6,136) |
| Other revenue | $ | 522 | $ | 1,064 | $ | 1,387 | $ | (5) | $ | 2,968 |
| Manulife Financial Corporation – Second Quarter 2023 | 157 | |||||||||
| --- | --- |
Table of Contents
| Note 15 Segregated Funds |
|---|
The Company manages a number of segregated funds on behalf of policyholders. Policyholders are provided with the opportunity to invest in different categories of segregated funds that hold a range of underlying investments. The underlying investments consist of both individual securities and mutual funds.
Segregated funds underlying investments may be exposed to a variety of financial and other risks. These risks are primarily mitigated by investment guidelines that are actively monitored by professional and experienced portfolio advisors. The Company is not exposed to these risks beyond the liabilities related to the guarantees associated with certain variable life and annuity products included in segregated funds. Accordingly, the Company’s exposure to loss from segregated fund products is limited to the value of these guarantees.
As at June 30, 2023, these guarantees are recorded within the Company’s insurance contract liabilities amounting to $2,860 (December 31, 2022 – $ 3,496), of which $986 are reinsured (December 31, 2022 – $1,249). Assets supporting these guarantees, net of reinsurance, are recognized in invested assets according to their investment type. “Insurance contract liabilities for account of segregated fund holders” on the Consolidated Statements of Financial Position exclude these guarantees and are considered to be a non-distinct investment component of insurance contract liabilities. The “Risk Management and Risk Factors Update” section of the Second Quarter 2023 MD&A provides information regarding market risk sensitivities associated with variable annuity and segregated fund guarantees.
| Note 16 Information Provided inConnection with Investments in Deferred Annuity Contracts and Signature Notes Issued or Assumed by John Hancock Life Insurance Company (U.S.A.) |
|---|
The following condensed consolidated financial information, presented in accordance with IFRS, and the related disclosure have been included in these Interim Consolidated Financial Statements with respect to JHUSA in compliance with Regulation S-X and Rule 12h-5 of the United States Securities and Exchange Commission (the “Commission”). These financial statements are (i) incorporated by reference in the registration statements of MFC and JHUSA that relate to MFC’s guarantee of certain securities to be issued by JHUSA and (ii) are provided in reliance on an exemption from continuous disclosure obligations of JHUSA. For information about JHUSA, the MFC guarantees and restrictions on the ability of MFC to obtain funds from its subsidiaries by dividend or loan, refer to note 24 to the Company’s 2022 Annual Consolidated Financial Statements.
| Manulife Financial Corporation – Second Quarter 2023 | 158 |
|---|
Table of Contents
Condensed Consolidated Statement of Financial Position
| As at June 30, 2023 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Invested assets | $ | 82 | $ | 107,114 | $ | 296,717 | $ | (485) | $ | 403,428 |
| Investments in unconsolidated subsidiaries | **** | 60,314 | **** | 8,575 | **** | 44,396 | **** | (113,285) | **** | – |
| Insurance contract assets | **** | – | **** | – | **** | 472 | **** | (68) | **** | 404 |
| Reinsurance contract held assets | **** | – | **** | 43,358 | **** | 10,243 | **** | (10,215) | **** | 43,386 |
| Other assets | **** | 27,100 | **** | 9,020 | **** | 62,354 | **** | (60,362) | **** | 38,112 |
| Segregated funds net assets | **** | – | **** | 182,485 | **** | 185,496 | **** | (2,000) | **** | 365,981 |
| Total assets | $ | 87,496 | $ | 350,552 | $ | 599,678 | $ | (186,415) | $ | 851,311 |
| Liabilities and equity | ||||||||||
| Insurance contract liabilities, excluding those for account of segregated fund holders | $ | – | $ | 145,378 | $ | 223,650 | $ | (10,615) | $ | 358,413 |
| Reinsurance contract held liabilities | **** | – | **** | – | **** | 2,482 | **** | (2) | **** | 2,480 |
| Investment contract liabilities | **** | – | **** | 2,645 | **** | 8,533 | **** | (621) | **** | 10,557 |
| Other liabilities | **** | 30,283 | **** | 5,850 | **** | 78,096 | **** | (60,257) | **** | 53,972 |
| Long-term debt | **** | 6,090 | **** | – | **** | – | **** | – | **** | 6,090 |
| Capital instruments | **** | 5,416 | **** | 598 | **** | 27,248 | **** | (26,600) | **** | 6,662 |
| Insurance contract liabilities for account of segregated fund holders | **** | – | **** | 51,013 | **** | 61,516 | **** | – | **** | 112,529 |
| Investment contract liabilities for account of segregated fund holders | **** | – | **** | 131,472 | **** | 123,980 | **** | (2,000) | **** | 253,452 |
| Shareholders’ and other equity | **** | 45,707 | **** | 13,649 | **** | 72,671 | **** | (86,320) | **** | 45,707 |
| Participating policyholders’ equity | **** | – | **** | (53) | **** | 36 | **** | – | **** | (17) |
| Non-controlling<br>interests | **** | – | **** | – | **** | 1,466 | **** | – | **** | 1,466 |
| Total liabilities and equity | $ | 87,496 | $ | 350,552 | $ | 599,678 | $ | (186,415) | $ | 851,311 |
Condensed Consolidated Statement of Financial Position
| Restated (note 2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| As at December 31, 2022 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
| Assets | ||||||||||
| Invested assets | $ | 63 | $ | 109,332 | $ | 291,266 | $ | (519) | $ | 400,142 |
| Investments in unconsolidated subsidiaries | 58,024 | 8,584 | 18,018 | (84,626) | – | |||||
| Insurance contract assets | – | – | 739 | (66) | 673 | |||||
| Reinsurance contract held assets | – | 44,849 | 11,215 | (10,193) | 45,871 | |||||
| Other assets | 333 | 8,899 | 33,082 | (3,873) | 38,441 | |||||
| Segregated funds net assets | – | 173,417 | 177,361 | (2,216) | 348,562 | |||||
| Total assets | $ | 58,420 | $ | 345,081 | $ | 531,681 | $ | (101,493) | $ | 833,689 |
| Liabilities and equity | ||||||||||
| Insurance contract liabilities, excluding those for account of segregated fund holders | $ | – | $ | 147,448 | $ | 217,942 | $ | (10,533) | $ | 354,857 |
| Reinsurance contract held liabilities | – | – | 2,391 | – | 2,391 | |||||
| Investment contract liabilities | – | 2,585 | 8,207 | (713) | 10,079 | |||||
| Other liabilities | 450 | 7,198 | 53,186 | (3,616) | 57,218 | |||||
| Long-term debt | 6,234 | – | – | – | 6,234 | |||||
| Capital instruments | 4,860 | 614 | 648 | – | 6,122 | |||||
| Insurance contract liabilities for account of segregated fund holders | – | 49,947 | 60,269 | – | 110,216 | |||||
| Investment contract liabilities for account of segregated fund holders | – | 123,470 | 117,092 | (2,216) | 238,346 | |||||
| Shareholders’ and other equity | 46,876 | 13,865 | 70,550 | (84,415) | 46,876 | |||||
| Participating policyholders’ equity | – | (46) | (31) | – | (77) | |||||
| Non-controlling<br>interests | – | – | 1,427 | – | 1,427 | |||||
| Total liabilities and equity | $ | 58,420 | $ | 345,081 | $ | 531,681 | $ | (101,493) | $ | 833,689 |
| Manulife Financial Corporation – Second Quarter 2023 | 159 | |||||||||
| --- | --- |
Table of Contents
Condensed Consolidated Statement of Income
| For the three months endedJune 30, 2023 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||
| Insurance revenue | $ | – | $ | 2,130 | $ | 3,823 | $ | (373) | $ | 5,580 |
| Insurance service expenses | **** | – | **** | (1,914) | **** | (3,043) | **** | 465 | **** | (4,492) |
| Net expenses from reinsurance contracts held | **** | – | **** | (77) | **** | (44) | **** | (80) | **** | (201) |
| Total insurance service result | **** | – | **** | 139 | **** | 736 | **** | 12 | **** | 887 |
| Investment result | ||||||||||
| Net investment income (loss) | **** | 127 | **** | 1,057 | **** | 3,834 | **** | (199) | **** | 4,819 |
| Insurance/reinsurance finance income (expenses) | **** | – | **** | (996) | **** | (3,165) | **** | 96 | **** | (4,065) |
| Other investment result | **** | – | **** | 66 | **** | (197) | **** | (26) | **** | (157) |
| Total investment result | **** | 127 | **** | 127 | **** | 472 | **** | (129) | **** | 597 |
| Other revenue | **** | 25 | **** | 194 | **** | 1,585 | **** | (113) | **** | 1,691 |
| Other expenses | **** | (18) | **** | (253) | **** | (1,154) | **** | 67 | **** | (1,358) |
| Interest expense | **** | (112) | **** | (2) | **** | (430) | **** | 163 | **** | (381) |
| Net income (loss) before income taxes | **** | 22 | **** | 205 | **** | 1,209 | **** | – | **** | 1,436 |
| Income tax (expense) recovery | **** | 13 | **** | (7) | **** | (271) | **** | – | **** | (265) |
| Net income (loss) after income taxes | **** | 35 | **** | 198 | **** | 938 | **** | – | **** | 1,171 |
| Equity in net income (loss) of unconsolidated<br>subsidiaries | **** | 990 | **** | 196 | **** | 394 | **** | (1,580) | **** | – |
| Net income (loss) | $ | 1,025 | $ | 394 | $ | 1,332 | $ | (1,580) | $ | 1,171 |
| Net income (loss) attributed to: | ||||||||||
| Non-controlling interests | $ | – | $ | – | $ | 26 | $ | – | $ | 26 |
| Participating policyholders | **** | – | **** | (90) | **** | 137 | **** | 73 | **** | 120 |
| Shareholders and other equity holders | **** | 1,025 | **** | 484 | **** | 1,169 | **** | (1,653) | **** | 1,025 |
| $ | 1,025 | $ | 394 | $ | 1,332 | $ | (1,580) | $ | 1,171 |
Condensed Consolidated Statement of Income
| Restated (note 2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| For the three months ended<br>June 30, 2022 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
| Insurance service result | ||||||||||
| Insurance revenue | $ | – | $ | 2,567 | $ | 3,546 | $ | (381) | $ | 5,732 |
| Insurance service expenses | – | (2,021) | (2,759) | 342 | (4,438) | |||||
| Net expenses from reinsurance contracts held | – | (237) | (55) | 33 | (259) | |||||
| Total insurance service result | – | 309 | 732 | (6) | 1,035 | |||||
| Investment result | ||||||||||
| Net investment income (loss) | 154 | (1,128) | (1,141) | (339) | (2,454) | |||||
| Insurance/reinsurance finance income (expenses) | – | (396) | (770) | (41) | (1,207) | |||||
| Other investment result | – | 191 | (201) | (26) | (36) | |||||
| Total investment result | 154 | (1,333) | (2,112) | (406) | (3,697) | |||||
| Other revenue | (3) | 55 | 1,513 | (119) | 1,446 | |||||
| Other expenses | (7) | (174) | (1,092) | 66 | (1,207) | |||||
| Interest expense | (104) | 3 | (597) | 465 | (233) | |||||
| Net income (loss) before income taxes | 40 | (1,140) | (1,556) | – | (2,656) | |||||
| Income tax (expense) recovery | (1) | 233 | 321 | – | 553 | |||||
| Net income (loss) after income taxes | 39 | (907) | (1,235) | – | (2,103) | |||||
| Equity in net income (loss) of unconsolidated subsidiaries | (2,158) | 201 | (705) | 2,662 | – | |||||
| Net income (loss) | $ | (2,119) | $ | (706) | $ | (1,940) | $ | 2,662 | $ | (2,103) |
| Net income (loss) attributed to: | ||||||||||
| Non-controlling interests | $ | – | $ | – | $ | 52 | $ | – | $ | 52 |
| Participating policyholders | – | (289) | 278 | (25) | (36) | |||||
| Shareholders and other equity holders | (2,119) | (417) | (2,270) | 2,687 | (2,119) | |||||
| $ | (2,119) | $ | (706) | $ | (1,940) | $ | 2,662 | $ | (2,103) | |
| Manulife Financial Corporation – Second Quarter 2023 | 160 | |||||||||
| --- | --- |
Table of Contents
Condensed Consolidated Statement of Income
| For the six months endedJune 30, 2023 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Insurance service result | ||||||||||
| Insurance revenue | $ | – | $ | 4,532 | $ | 7,616 | $ | (805) | $ | 11,343 |
| Insurance service expenses | **** | – | **** | (4,079) | **** | (6,030) | **** | 835 | **** | (9,274) |
| Net expenses from reinsurance contracts held | **** | – | **** | (229) | **** | (80) | **** | (24) | **** | (333) |
| Total insurance service result | **** | – | **** | 224 | **** | 1,506 | **** | 6 | **** | 1,736 |
| Investment result | ||||||||||
| Net investment income (loss) | **** | 132 | **** | 2,190 | **** | 7,791 | **** | (141) | **** | 9,972 |
| Insurance/reinsurance finance income (expenses) | **** | – | **** | (2,262) | **** | (6,005) | **** | 102 | **** | (8,165) |
| Other investment result | **** | – | **** | 48 | **** | (235) | **** | (53) | **** | (240) |
| Total investment result | **** | 132 | **** | (24) | **** | 1,551 | **** | (92) | **** | 1,567 |
| Other revenue | **** | 21 | **** | 402 | **** | 3,191 | **** | (232) | **** | 3,382 |
| Other expenses | **** | (29) | **** | (556) | **** | (2,337) | **** | 140 | **** | (2,782) |
| Interest expense | **** | (214) | **** | (33) | **** | (679) | **** | 178 | **** | (748) |
| Net income (loss) before income taxes | **** | (90) | **** | 13 | **** | 3,232 | **** | – | **** | 3,155 |
| Income tax (expense) recovery | **** | 51 | **** | 72 | **** | (697) | **** | – | **** | (574) |
| Net income (loss) after income taxes | **** | (39) | **** | 85 | **** | 2,535 | **** | – | **** | 2,581 |
| Equity in net income (loss) of unconsolidated<br>subsidiaries | **** | 2,470 | **** | 402 | **** | 487 | **** | (3,359) | **** | – |
| Net income (loss) | $ | 2,431 | $ | 487 | $ | 3,022 | $ | (3,359) | $ | 2,581 |
| Net income (loss) attributed to: | ||||||||||
| Non-controlling interests | $ | – | $ | – | $ | 80 | $ | – | $ | 80 |
| Participating policyholders | **** | – | **** | (75) | **** | 69 | **** | 76 | **** | 70 |
| Shareholders and other equity holders | **** | 2,431 | **** | 562 | **** | 2,873 | **** | (3,435) | **** | 2,431 |
| $ | 2,431 | $ | 487 | $ | 3,022 | $ | (3,359) | $ | 2,581 |
Condensed Consolidated Statement of Income
| Restated (note 2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| For the six months ended<br>June 30, 2022 | MFC<br>(Guarantor) | JHUSA<br>(Issuer) | Other<br>subsidiaries | Consolidation<br>adjustments | Consolidated<br>MFC | |||||
| Insurance service result | ||||||||||
| Insurance revenue | $ | – | $ | 4,960 | $ | 7,226 | $ | (756) | $ | 11,430 |
| Insurance service expenses | – | (6,041) | (6,229) | 2,740 | (9,530) | |||||
| Net expenses from reinsurance contracts held | – | (315) | 379 | (214) | (150) | |||||
| Total insurance service result | – | (1,396) | 1,376 | 1,770 | 1,750 | |||||
| Investment result | ||||||||||
| Net investment income (loss) | 142 | (1,122) | (2,292) | (270) | (3,542) | |||||
| Insurance/reinsurance finance income (expenses) | – | 1,367 | (2,064) | (1,711) | (2,408) | |||||
| Other investment result | – | 10 | (243) | 47 | (186) | |||||
| Total investment result | 142 | 255 | (4,599) | (1,934) | (6,136) | |||||
| Other revenue | 7 | 162 | 3,039 | (240) | 2,968 | |||||
| Other expenses | (15) | (390) | (2,233) | 142 | (2,496) | |||||
| Interest expense | (194) | 5 | (478) | 262 | (405) | |||||
| Net income (loss) before income taxes | (60) | (1,364) | (2,895) | – | (4,319) | |||||
| Income tax (expense) recovery | 30 | 296 | 667 | – | 993 | |||||
| Net income (loss) after income taxes | (30) | (1,068) | (2,228) | – | (3,326) | |||||
| Equity in net income (loss) of unconsolidated subsidiaries | (3,309) | 360 | (707) | 3,656 | – | |||||
| Net income (loss) | $ | (3,339) | $ | (708) | $ | (2,935) | $ | 3,656 | $ | (3,326) |
| Net income (loss) attributed to: | ||||||||||
| Non-controlling interests | $ | – | $ | – | $ | 54 | $ | – | $ | 54 |
| Participating policyholders | – | (360) | 371 | (52) | (41) | |||||
| Shareholders and other equity holders | (3,339) | (348) | (3,360) | 3,708 | (3,339) | |||||
| $ | (3,339) | $ | (708) | $ | (2,935) | $ | 3,656 | $ | (3,326) | |
| Manulife Financial Corporation – Second Quarter 2023 | 161 | |||||||||
| --- | --- |
Table of Contents
Consolidated Statement of Cash Flows
| For the six months ended June 30, 2023 | MFC<br><br><br>(Guarantor) | JHUSA<br><br><br>(Issuer) | Other<br><br><br>subsidiaries | Consolidation<br><br><br>adjustments | Consolidated<br><br><br>MFC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income (loss) | $ | 2,431 | $ | 487 | $ | 3,022 | $ | (3,359) | $ | 2,581 |
| Adjustments: | ||||||||||
| Equity in net income of unconsolidated subsidiaries | **** | (2,470) | **** | (402) | **** | (487) | **** | 3,359 | **** | – |
| Increase (decrease) in net insurance contract liabilities | **** | – | **** | 258 | **** | 5,662 | **** | – | **** | 5,920 |
| Increase (decrease) in investment contract liabilities | **** | – | **** | (67) | **** | 307 | **** | – | **** | 240 |
| (Increase) decrease in reinsurance contract assets excluding reinsurance transactions | **** | – | **** | 24 | **** | 863 | **** | – | **** | 887 |
| Amortization of (premium) discount on invested assets | **** | – | **** | 20 | **** | (42) | **** | – | **** | (22) |
| Contractual service margin (“CSM”) amortization | **** | – | **** | (258) | **** | (661) | **** | – | **** | (919) |
| Other amortization | **** | 5 | **** | 66 | **** | 208 | **** | – | **** | 279 |
| Net realized and unrealized (gains) losses on assets and impairment on assets | **** | 15 | **** | 182 | **** | (2,066) | **** | – | **** | (1,869) |
| Deferred income tax expense (recovery) | **** | (51) | **** | (75) | **** | 251 | **** | – | **** | 125 |
| Stock option expense | **** | – | **** | (2) | **** | 2 | **** | – | **** | – |
| Cash provided by (used in) operating activities before undernoted items | **** | (70) | **** | 233 | **** | 7,059 | **** | – | **** | 7,222 |
| Dividends from unconsolidated subsidiary | **** | – | **** | 172 | **** | (408) | **** | 236 | **** | – |
| Changes in policy related and operating receivables and payables | **** | (156) | **** | (1,304) | **** | 2,987 | **** | – | **** | 1,527 |
| Cash provided by (used in)operating activities | **** | (226) | **** | (899) | **** | 9,638 | **** | 236 | **** | 8,749 |
| Investing activities | ||||||||||
| Purchases and mortgage advances | **** | – | **** | (6,777) | **** | (32,824) | **** | – | **** | (39,601) |
| Disposals and repayments | **** | – | **** | 7,923 | **** | 27,439 | **** | – | **** | 35,362 |
| Changes in investment broker net receivables and payables | **** | – | **** | 64 | **** | 196 | **** | – | **** | 260 |
| Net cash flows from acquisition and disposal of subsidiaries and businesses | **** | – | **** | – | **** | (1) | **** | – | **** | (1) |
| Investment in common shares of subsidiaries | **** | (1,200) | **** | – | **** | – | **** | 1,200 | **** | – |
| Capital contribution to unconsolidated subsidiaries | **** | – | **** | (1) | **** | – | **** | 1 | **** | – |
| Notes receivable from parent | **** | – | **** | – | **** | (29,790) | **** | 29,790 | **** | – |
| Notes receivable from subsidiaries | **** | (26,633) | **** | – | **** | – | **** | 26,633 | **** | – |
| Cash provided by (used in)investing activities | **** | (27,833) | **** | 1,209 | **** | (34,980) | **** | 57,624 | **** | (3,980) |
| Financing activities | ||||||||||
| Change in repurchase agreements and securities sold but not yet purchased | **** | – | **** | – | **** | (430) | **** | – | **** | (430) |
| Issue of capital instruments, net | **** | 1,194 | **** | – | **** | – | **** | – | **** | 1,194 |
| Redemption of capital instruments | **** | (600) | **** | – | **** | – | **** | – | **** | (600) |
| Secured borrowing from securitization transactions | **** | – | **** | – | **** | 368 | **** | – | **** | 368 |
| Lease payments | **** | – | **** | (1) | **** | (39) | **** | – | **** | (40) |
| Changes in deposits from Bank clients, net | **** | – | **** | – | **** | (555) | **** | – | **** | (555) |
| Shareholders’ dividends and other equity distributions | **** | (1,493) | **** | – | **** | – | **** | – | **** | (1,493) |
| Dividends paid to parent | **** | – | **** | 408 | **** | (172) | **** | (236) | **** | – |
| Common shares repurchased | **** | (841) | **** | – | **** | – | **** | – | **** | (841) |
| Common shares issued, net | **** | 30 | **** | – | **** | 1,200 | **** | (1,200) | **** | 30 |
| Contributions from (distributions to) non-controlling interests,<br>net | **** | – | **** | – | **** | (4) | **** | – | **** | (4) |
| Capital contributions by parent | **** | – | **** | – | **** | 1 | **** | (1) | **** | – |
| Notes payable to parent | **** | – | **** | – | **** | 26,633 | **** | (26,633) | **** | – |
| Notes payable to subsidiaries | **** | 29,790 | **** | – | **** | – | **** | (29,790) | **** | – |
| Cash provided by (used in)financing activities | **** | 28,080 | **** | 407 | **** | 27,002 | **** | (57,860) | **** | (2,371) |
| Cash and short-term securities | ||||||||||
| Increase (decrease) during the period | **** | 21 | **** | 717 | **** | 1,660 | **** | – | **** | 2,398 |
| Effect of foreign exchange rate changes on cash and short-term securities | **** | (2) | **** | (45) | **** | (328) | **** | – | **** | (375) |
| Balance, beginning of period | **** | 63 | **** | 2,215 | **** | 16,357 | **** | – | **** | 18,635 |
| Balance, end ofperiod | **** | 82 | **** | 2,887 | **** | 17,689 | **** | – | **** | 20,658 |
| Cash and short-term securities | ||||||||||
| Beginning of period | ||||||||||
| Gross cash and short-term securities | **** | 63 | **** | 2,614 | **** | 16,476 | **** | – | **** | 19,153 |
| Net payments in transit, included in other liabilities | **** | – | **** | (399) | **** | (119) | **** | – | **** | (518) |
| Net cash and short-termsecurities, beginning of period | **** | 63 | **** | 2,215 | **** | 16,357 | **** | – | **** | 18,635 |
| End of period | ||||||||||
| Gross cash and short-term securities | **** | 82 | **** | 3,167 | **** | 17,769 | **** | – | **** | 21,018 |
| Net payments in transit, included in other liabilities | **** | – | **** | (280) | **** | (80) | **** | – | **** | (360) |
| Net cash and short-termsecurities, end of period | $ | 82 | $ | 2,887 | $ | 17,689 | $ | – | $ | 20,658 |
| Supplemental disclosures on cash flow information: | ||||||||||
| Interest received | $ | 152 | $ | 1,559 | $ | 4,835 | $ | (352) | $ | 6,194 |
| Interest paid | **** | 199 | **** | 64 | **** | 882 | **** | (352) | **** | 793 |
| Income taxes paid (refund) | **** | 1 | **** | 4 | **** | 199 | **** | – | **** | 204 |
| Manulife Financial Corporation – Second Quarter 2023 | 162 | |||||||||
| --- | --- |
Table of Contents
Consolidated Statement of Cash Flows
| Restated (note 2) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| For the six months ended June 30, 2022 | MFC<br><br><br>(Guarantor) | JHUSA<br><br><br>(Issuer) | Other<br><br><br>subsidiaries | Consolidation<br><br><br>adjustments | Consolidated<br><br><br>MFC | |||||
| Operating activities | ||||||||||
| Net income (loss) | $ | (3,339) | $ | (708) | $ | (2,935) | $ | 3,656 | $ | (3,326) |
| Adjustments: | ||||||||||
| Equity in net income of unconsolidated subsidiaries | 3,309 | (360) | 707 | (3,656) | – | |||||
| Increase (decrease) in net insurance contract liabilities | – | 1,730 | 1,020 | – | 2,750 | |||||
| Increase (decrease) in investment contract liabilities | – | (47) | 233 | – | 186 | |||||
| (Increase) decrease in reinsurance contract assets excluding reinsurance transactions | – | 5 | 762 | – | 767 | |||||
| Amortization of (premium) discount on invested assets | – | 25 | (33) | – | (8) | |||||
| Contractual service margin (“CSM”) amortization | – | (302) | (779) | – | (1,081) | |||||
| Other amortization | 4 | 72 | 176 | – | 252 | |||||
| Net realized and unrealized (gains) losses on assets and impairment on assets | 9 | 3,460 | 8,863 | – | 12,332 | |||||
| Gain on U.S. variable annuity reinsurance transaction<br>(pre-tax) | – | (1,065) | – | – | (1,065) | |||||
| Deferred income tax expense (recovery) | (30) | (261) | (1,404) | – | (1,695) | |||||
| Stock option expense | – | (2) | 5 | – | 3 | |||||
| Cash provided by (used in) operating activities before undernoted items | (47) | 2,547 | 6,615 | – | 9,115 | |||||
| Dividends from unconsolidated subsidiary | – | 193 | 734 | (927) | – | |||||
| Changes in policy related and operating receivables and payables | (145) | 688 | (1,172) | 12 | (617) | |||||
| Gain on U.S. variable annuity reinsurance transaction<br>(pre-tax) | – | (1,263) | – | – | (1,263) | |||||
| Cash provided by (used in) operatingactivities | (192) | 2,165 | 6,177 | (915) | 7,235 | |||||
| Investing activities | ||||||||||
| Purchases and mortgage advances | – | (16,909) | (44,768) | – | (61,677) | |||||
| Disposals and repayments | – | 13,456 | 39,409 | – | 52,865 | |||||
| Changes in investment broker net receivables and payables | – | (35) | (82) | – | (117) | |||||
| Investment in common shares of subsidiaries | (1,962) | – | – | 1,962 | – | |||||
| Return of capital from unconsolidated subsidiaries | – | 12 | – | (12) | – | |||||
| Notes receivable from parent | – | – | (21,701) | 21,701 | – | |||||
| Notes receivable from subsidiaries | (18,585) | (6) | – | 18,591 | – | |||||
| Cash provided by (used in) investingactivities | (20,547) | (3,482) | (27,142) | 42,242 | (8,929) | |||||
| Financing activities | ||||||||||
| Change in repurchase agreements and securities sold but not yet purchased | – | 266 | (202) | – | 64 | |||||
| Issue of long-term debt, net | 946 | – | – | – | 946 | |||||
| Secured borrowing from securitization transactions | – | – | 548 | – | 548 | |||||
| Changes in deposits from Bank clients, net | – | – | 850 | – | 850 | |||||
| Lease payments | – | (3) | (59) | – | (62) | |||||
| Shareholders’ dividends and other equity distributions | (1,391) | – | – | – | (1,391) | |||||
| Contributions from (distributions to) non-controlling interests,<br>net | – | – | 1 | – | 1 | |||||
| Common shares repurchased | (805) | – | – | – | (805) | |||||
| Common shares issued, net | 16 | – | 1,962 | (1,962) | 16 | |||||
| Preferred shares and other equity issued, net | 990 | – | – | – | 990 | |||||
| Preferred shares redeemed, net | (711) | – | – | – | (711) | |||||
| Dividends paid to parent | – | (734) | (193) | 927 | – | |||||
| Notes payable to parent | – | – | 18,591 | (18,591) | – | |||||
| Notes payable to subsidiaries | 21,701 | – | – | (21,701) | – | |||||
| Cash provided by (used in) financingactivities | 20,746 | (471) | 21,498 | (41,327) | 446 | |||||
| Cash and short-term securities | ||||||||||
| Increase (decrease) during the period | 7 | (1,788) | 533 | – | (1,248) | |||||
| Effect of foreign exchange rate changes on cash and short-term securities | – | 57 | (96) | – | (39) | |||||
| Balance, beginning of period | 78 | 3,565 | 18,287 | – | 21,930 | |||||
| Balance, end of period | 85 | 1,834 | 18,724 | – | 20,643 | |||||
| Cash and short-term securities | ||||||||||
| Beginning of period | ||||||||||
| Gross cash and short-term securities | 78 | 4,087 | 18,429 | – | 22,594 | |||||
| Net payments in transit, included in other liabilities | – | (522) | (142) | – | (664) | |||||
| Net cash and short-term securities,beginning of period | 78 | 3,565 | 18,287 | – | 21,930 | |||||
| End of period | ||||||||||
| Gross cash and short-term securities | 85 | 2,091 | 18,839 | – | 21,015 | |||||
| Net payments in transit, included in other liabilities | – | (257) | (115) | – | (372) | |||||
| Net cash and short-term securities,end of period | $ | 85 | $ | 1,834 | $ | 18,724 | $ | – | $ | 20,643 |
| Supplemental disclosures on cash flow information: | ||||||||||
| Interest received | $ | 149 | $ | 1,779 | $ | 3,961 | $ | (339) | $ | 5,550 |
| Interest paid | 183 | 33 | 517 | (339) | 394 | |||||
| Income taxes paid (refund) | – | 117 | 863 | – | 980 | |||||
| Manulife Financial Corporation – Second Quarter 2023 | 163 | |||||||||
| --- | --- |
Table of Contents
| Note 17 Comparatives |
|---|
Certain comparative amounts have been reclassified to conform to the current period’s presentation.
As disclosed in Note 2 “Accounting and Reporting Changes”, comparative amounts have been prepared and presented in accordance with IFRS 9 and IFRS 17. Refer to note 2 and also note 2 of the Company’s 2022 Annual Consolidated Financial Statements for adoption impacts of IFRS 9 and IFRS 17. Refer to note 25 of the Company’s 2022 Annual Consolidated Financial Statements for the Company’s accounting policies in accordance with IFRS 9 and IFRS 17.
| Manulife Financial Corporation – Second Quarter 2023 | 164 |
|---|
Table of Contents
SHAREHOLDER INFORMATION
MANULIFE FINANCIAL CORPORATION
HEAD OFFICE
200 Bloor Street East
Toronto, ON Canada M4W 1E5
Telephone: 416 926-3000
Website: www.manulife.com
INVESTOR RELATIONS
Financial analysts, portfolio managers and other investors requiring financial information may contact our Investor Relations Department or access our website at www.manulife.com Email: InvestRel@manulife.com
SHAREHOLDER SERVICES
For information or assistance regarding your share account, including dividends, changes of address or ownership, lost
certificates, to eliminate duplicate mailings or to receive shareholder material electronically, please contact our Transfer Agents in Canada, the United States, Hong Kong or the Philippines. If you live outside one of these countries, please contact our Canadian Transfer Agent.
TRANSFER AGENTS
Canada
TSX Trust Company
P.O. Box 700, Station B
Montreal, QC Canada H3B 3K3
Toll Free: 1 800 783-9495
Collect: 416 682-3864
Email: manulifeinquiries@tmx.com
Website: www.tsxtrust.com
TSX Trust Company offices are also located in Toronto, Vancouver and Calgary.
United States
Equiniti Trust Company, LLC
P.O. Box 199036
Brooklyn, NY
United States 11219
Toll Free: 1 800 249-7702
Collect: 416 682-3864
Email: manulifeinquiries@tmx.com
Website: https://equiniti.com/us/ast-access/
Hong Kong
Tricor Investor Services Limited
17/F, Far East Finance Centre
16 Harcourt Road
Hong Kong
Telephone: 852 2980-1333
Email: is-enquiries@hk.tricorglobal.com
Website: www.tricoris.com
Philippines
Rizal Commercial Banking Corporation Ground Floor, West Wing
GPL (Grepalife) Building
221 Senator Gil Puyat Avenue
Makati City, Metro Manila, Philippines
Telephone: 632 5318-8567
Email: rcbcstocktransfer@rcbc.com
Website: www.rcbc.com/stocktransfer
AUDITORS
Ernst & Young LLP
Chartered Professional Accountants
Licensed Public Accountants
Toronto, Canada
The following Manulife documents are available online at www.manulife.com
| • | Annual Report and Proxy Circular |
|---|---|
| • | Notice of Annual Meeting |
| --- | --- |
| • | Shareholders Reports |
| --- | --- |
| • | Public Accountability Statement |
| --- | --- |
| • | 2022 Environmental, Social and Governance Report |
| --- | --- |
Rating
Financial strength is a key factor in generating new business, maintaining and expanding distribution relations and providing a base for expansion, acquisitions and growth. As at June 30, 2023, Manulife had total capital of C$69.3 billion, including C$45.7 billion of total shareholders’ and other equity. The Manufacturers Life Insurance Company’s financial strength ratings are among the strongest in the insurance industry. Rating agencies include AM Best Company (“AM Best”), DBRS Limited and affiliated entities (“DBRS Morningstar”), Fitch Ratings Inc. (“Fitch”), Moody’s Investors Service Inc. (“Moody’s”), and S&P Global Ratings (“S&P”).
| Rating Agency | MLI Rating | Rank |
|---|---|---|
| S&P | AA- | (4^th^ of 21 ratings) |
| Moody’s | A1 | (5^th^ of 21 ratings) |
| Fitch | AA- | (4^th^ of 21 ratings) |
| DBRS Morningstar | AA | (3^rd^ of 22 ratings) |
| AM Best | A+ (Superior) | (2^nd^ of 13 ratings) |
Common Stock Trading Data
The following values are the high, low and close prices, including the average daily trading volume for Manulife Financial Corporation’s common stock on the Canadian exchanges, the U.S. exchanges, The Stock Exchange of Hong Kong and the Philippine Stock Exchange for the second quarter. The common stock symbol is MFC on all exchanges except Hong Kong where it is 945.
As at June 30, 2023, there were 1,833 million common shares outstanding.
| April 1 –<br><br><br>June 30,<br>2023 | Canada<br>Canadian | U.S.<br>United States | Hong Kong<br>Hong Kong | Philippines<br><br><br>Philippine<br> <br>Pesos | |
|---|---|---|---|---|---|
| High | P 1,045 | ||||
| Low | P 900 | ||||
| Close | P 980 | ||||
| Average Daily Volume (000) | 0.1 |
All values are in US Dollars.
| Manulife Financial Corporation – Second Quarter 2023 | 165 |
|---|
Table of Contents
Consent to receive documents electronically
Electronic documents available from Manulife.
Manulife is pleased to offer Electronic Documents. Access the information when you want, no more waiting for the mail.
The Manulife documents available electronically are:
| • | Annual Report and Proxy Circular |
|---|---|
| • | Notice of Annual Meeting |
| --- | --- |
| • | Shareholder Reports |
| --- | --- |
These documents will be available to you on our website www.manulife.com at the same time as they are mailed to other shareholders. Documents relating to the annual meeting, including annual reports, will be available on the website at least until the next version is available.
We will notify you when documents will be available on the website and confirm the instructions for accessing the documents at the same time. In the event that the documents are not available on our website, paper copies will be mailed to you.
This information is also available for viewing or downloading under quarterly reports from the Investor Relations section of our website at www.manulife.com
| Detach Here |
|---|
To receive documents electronically when they are available through Manulife’s electronic delivery service, complete this form and return it as indicated.
I have read and understand the statement on the reverse and consent to receive electronically the Manulife documents listed in the manner described. I acknowledge that I have the computer requirements to access the documents that are made available on Manulife’s website. I understand that I am not required to consent to electronic delivery and that I may revoke my consent at any time.
Please note: We will contact you by phone only if there is a problem with your email address.
The information provided is confidential and will not be used for any purpose other than that described.
Please Print:
| Shareholder Name | |
|---|---|
| Contact Phone Number | |
| Shareholder Email Address | |
| Shareholder Signature | |
| Date | |
| Manulife Financial Corporation – Second Quarter 2023 | 166 |
| --- | --- |
Table of Contents
manulife.com
Manulife, Manulife & Stylized M Design, and Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates, including Manulife Financial Corporation, under license.
EX-99.2
Form 52-109F2
Certification of Interim Filings
FullCertificate
I, Roy Gori, President and Chief Executive Officer of Manulife Financial Corporation, certify the following:
| 1. | Review: I have reviewed the interim financial report and interim MD&A (together, the “interim<br>filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended June 30, 2023. |
|---|---|
| 2. | No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not<br>contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered<br>by the interim filings. |
| --- | --- |
| 3. | Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report<br>together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the<br>interim filings. |
| --- | --- |
| 4. | Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and<br>maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure inIssuer’s Annual and Interim Filings, for the issuer. |
| --- | --- |
| 5. | Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other<br>certifying officer(s) and I have, as at the end of the period covered by the interim filings |
| --- | --- |
| (a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that<br> |
| --- | --- |
| (i) | material information relating to the issuer is made known to us by others, particularly during the period in which the<br>interim filings are being prepared; and |
| --- | --- |
| (ii) | information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or<br>submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
| --- | --- |
| (b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the<br>reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP. |
| --- | --- |
| 5.1 | Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the<br>issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. |
| --- | --- |
| 5.2 | N/A |
| --- | --- |
| 5.3 | N/A |
| --- | --- |
| 6. | Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR<br>that occurred during the period beginning on April 1, 2023 and ended on June 30, 2023 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR. |
| --- | --- |
Date: August 9, 2023
| /s/ Roy Gori |
|---|
| Roy Gori |
| President and Chief Executive Officer |
EX-99.3
Form 52-109F2
Certification of Interim Filings
FullCertificate
I, Colin Simpson, Chief Financial Officer of Manulife Financial Corporation, certify the following:
| 1. | Review: I have reviewed the interim financial report and interim MD&A (together, the “interim<br>filings”) of Manulife Financial Corporation (the “issuer”) for the interim period ended June 30, 2023. |
|---|---|
| 2. | No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not<br>contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered<br>by the interim filings. |
| --- | --- |
| 3. | Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report<br>together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the<br>interim filings. |
| --- | --- |
| 4. | Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and<br>maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure inIssuer’s Annual and Interim Filings, for the issuer. |
| --- | --- |
| 5. | Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other<br>certifying officer(s) and I have, as at the end of the period covered by the interim filings |
| --- | --- |
| (a) | designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that<br> |
| --- | --- |
| (i) | material information relating to the issuer is made known to us by others, particularly during the period in which the<br>interim filings are being prepared; and |
| --- | --- |
| (ii) | information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or<br>submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and |
| --- | --- |
| (b) | designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the<br>reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP. |
| --- | --- |
| 5.1 | Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the<br>issuer’s ICFR is Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. |
| --- | --- |
| 5.2 | N/A |
| --- | --- |
| 5.3 | N/A |
| --- | --- |
| 6. | Reporting changes in ICFR: The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR<br>that occurred during the period beginning on April 1, 2023 and ended on June 30, 2023 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR. |
| --- | --- |
Date: August 9, 2023
| /s/ Colin Simpson |
|---|
| Colin Simpson |
| Chief Financial Officer |